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PART I. INTRODUCTION 
A journey of a thousand miles starts with a single step. 
(Lao-Tzu) 
 
Fatty acids (FA) are an important component of lipids in animal, plant and micro-organisms. FA 
have important metabolic, structural and functional roles within the body as respectively, sources of 
energy, major components of all cell membranes and precursors to signalling molecules. These 
molecules enter the human body mainly as dietary constituents of the dietary fat, however, a number 
of FA can also be synthesized de novo by humans. In the introduction below the family of the FA 
will be discussed, considering the FA structure and properties, the nomenclature, classification, 
digestion and metabolism. Subsequently an overview of the role of FA in the human body will be 
given as well as the current recommendations and food intake patterns. Finally, the most important 
determinants of FA blood status will be discussed.  
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I.1 FATTY ACIDS 
I.1.1 STRUCTURE AND PROPERTIES 
All FA have a generic structure based on a hydrocarbon chain with a reactive carboxyl group at one 
end and a methyl group at the other (Calder, 2011). The carboxyl groups are able to form ester bonds 
with alcohol groups, for example those on glycerol, resulting in glycerolipids (see Figure 1) with 
one, two or three FA, named monoglycerides (MG), diglycerides (DG) and triglycerides (TG), 
respectively. The phospholipids (PL; Figure 2), being the major component of all cell membranes, 
have a very similar structure, namely a glycerol or sphingosine backbone with two FA attached at the 
sn-1 and the sn-2 position and a polar phosphate group linking the glycerol backbone with one of 
four base groups (choline, ethanolamine, serine and inositol).  Furthermore, the carboxyl groups of 
the FA can also be esterified with the alcohol group on cholesterol, forming cholesterol esters 
(Calder, 2011; FAO, 2010).  
 
  
 
 
Figure 1: Structure of triglyceride, composed of one glycerol 
backbone and three esterified fatty acids with variable 
properties and lengths. 
 
 
Figure 2: Structure of a phospholipid molecule, composed of a 
glycerol backbone with two fatty acids attached (typically at 
the sn-1 and the sn-2 position), resulting in a non-polar 
hydrophobic tail and a polar phosphate group to which a base 
groups is attached (choline, ethanolamine, serine or inositol). 
 
FA chains can consist of 2 to 30 or more carbon atoms. The most abundant FA have straight chains 
of an even number of carbon atoms and have unbranched structures (Calder, 2011). FA can have a 
different degree of unsaturation or double bonds. As illustrated in Figure 3, these double bonds can 
occur in cis configuration, meaning that the hydrogen atoms attached to the double bonds are on the 
same side, or in trans configuration, meaning that the  hydrogen atoms are on opposite sides (FAO, 
2010).  
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Figure 3: Oleic acid with a double bond in trans- and in cis-configuration. 
 
The melting point of fatty acids increases with the length of the hydrocarbon chain and decreases 
with the number of double bonds (Tvrzicka et al, 2011). In naturally occurring unsaturated fatty acids 
most often the cis orientation is found. The rigidity of the double bond freezes its conformation and, 
in the case of the cis isomer, causes the chain to bend and restricts the conformational freedom of the 
FA (Tvrzicka et al, 2011). The more double bonds the chain has in the cis configuration, the more it 
gets curved and the less flexibility it has. As a result, cis bonds limit the ability of fatty acids to be 
closely packed in restricted environments (e.g. FA in phospholipid in a lipid bilayer, TG in lipid 
droplets) and therefore decrease the melting temperature of the membrane or the fat. A trans 
configuration, by contrast, does not cause the chain to bend much, and their shape is similar to 
straight saturated fatty acids, as a results these fatty acids have higher melting points than their 
counterparts in cis-configuration (Tvrzicka et al, 2011).  
The length of the hydrocarbon chain also determines the hydrophobic properties of the FA chain 
(Tvrzicka et al, 2011). In contrast, the carboxyl group, being responsible for the acidic properties, has 
hydrophilic properties (making FA amphipathic molecules) (FAO, 2010). In diluted solutions, FA are 
present as monomers, however, in higher concentrations they aggregate to form cylindrical micelles. 
In these micelles the carboxyl sides are oriented into the water phase, while the hydrocarbon chains 
are packed within the centre.  
 
I.1.2 NOMENCLATURE 
The systematic name of FA as recommended by the International Union of Pure and Applied 
Chemistry (IUPAC) (IUPAC-IUB Commission on Biochemical Nomenclature, 1978) is determined 
by the number of carbon atoms and the number and position of double bonds in the acyl chain. The 
configuration of double bonds, location of branched chains and hetero (non-carbon) atoms and other 
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structural features are also identified. By convention, the carbon atom of the carboxyl group is named 
carbon 1 and the carbons in the FA chain are numbered consequently from the carboxylic carbon. 
Subsequently a double bond is identified by the lower number of the two carbons that it joins and is 
labelled as cis or trans according to its configuration. For example, the systematic name of linoleic 
acid (LA, Figure 4) is “cis-9, cis-12-octadecadienoic acid”.  
 
Figure 4 Linoleic acid, cis-9, cis-12-octadecadienoic acid 
 
Although the IUPAC nomenclature is unambiguous and technically clear, FA names are long and 
therefore, for convenience, “trivial” or historical names and shorthand notations are frequently used 
(FAO, 2010). These shorthand notations identify the number of carbon atoms in the chain, the 
number of double bonds and the position of the first double bond, which is in this case counted from 
the methyl terminus of the acyl chain. The first double bound is identified as ω-x or n-x (where x is 
the carbon number on which the double bond occurs). Therefore, stearic acid (octadecanoic acid) 
which is a saturated fatty acid with 18 carbon atoms is notated as C18:0 whilst linoleic acid is 
notated as C18:2n-6. This system easily represents the different metabolic series, such as n-9, n-6 
and n-3 (FAO, 2010). However, it is only applicable to unsaturated fatty acids in a cis configuration 
whose double bonds are arranged in a methylene interrupted manner.  
 
I.1.3 CLASSIFICATION AND FOOD SOURCES 
Fatty acids can be divided in several groups with respect to their structure, food sources, 
physiological roles or biological effects (Tvrzicka et al, 2011). The most commonly used is the 
classification according to their structure. In this classification the FA are subdivided into three main 
classes according to the degree of unsaturation. Saturated fatty acids (SFA) have no double bonds, 
mono-unsaturated fatty acids (MUFA) have one double bond and poly-unsaturated fatty acids 
(PUFA) have two or more double bonds. 
Table 1 lists the different dietary sources of the most common FA, classified according to their 
structure. 
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I.1.3.1 SATURATED FATTY ACIDS 
The SFA can be divided into different subgroups according to their chain length. However, there are 
various definitions used in the literature for the SFA-subclasses. In this thesis the following 
classification is used (Tvrzicka et al, 2011): 
 Short chain fatty acids (SCFA) are fatty acids with 2 – 5 carbon atoms. These include acetic 
(C2:0); propionic (C3:0) and butyric (C4:0) acid. These SCFA are an important residual of 
the fermentation of prebiotics and dietary fibers by gut microbiota.  
 Medium chain fatty acids (MCFA) are FA with 6 – 11 carbons atoms. 
 Long chain fatty acids (LCFA) have 12 – 19 carbon atoms. The most important are lauric 
(C12:0), myristic (C14:0), palmitic (C16:0) and stearic (C18:0) acid. 
 Very long chain fatty acids (VLCFA) are FA with 20 carbon atoms or more.  
The SFA can be synthesized in vivo or can be derived from the diet. SFA are mainly provided by 
animal and dairy fats but are also present in large amounts in palm oil and coconut oil (FAO, 2010; 
http://bls.nvs2.de; Tvrzicka et al, 2011) 
I.1.3.2 MONO-UNSATURATED FATTY ACIDS 
The MUFA can be synthesized de novo by the human organism; however, these FA can also be 
derived from the diet. The most common families in this group are the n-5, n-7 and n-9 families. 
Main representatives are oleic (OA; C18:1n-9), vaccenic (C18:1n-7) and palmitoleic (C16:1n-7) acid 
(Tvrzicka et al, 2011). OA is the most abundant MUFA and is present in considerable quantities in 
both animal and plant sources, mainly in olive oil, canola oil and high-oleic sunflower and safflower 
oil (FAO, 2010; http://bls.nvs2.de; Tvrzicka et al, 2011).  
I.1.3.3 POLY-UNSATURATED FATTY ACIDS 
Natural occurring PUFA with methylene interrupted double bonds of cis configuration can be 
divided into 12 families, ranging from the first double bonds located at the n-1 position to the n-12 
position. The most important families, in terms of occurrence, human health and nutrition are the n-6 
and n-3 families (FAO, 2010).  
a. n-6 PUFA 
In the n-6 PUFA family, the parent FA is linoleic acid (LA, C18:2n-6). This FA cannot be 
synthesized by mammals de novo, as mammals cannot introduce double bonds beyond the Δ10 
position (FAO, 2010). LA is therefore termed an essential fatty acid that has to be derived from the 
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diet. However, this precursor can be metabolized by humans to the long chain derivatives such as 
arachidonic acid (AA, C20:4n-6) by a sequence of alternating elongation and desaturation (insertion 
of additional double bonds) steps. The main food sources of LA (Table 1) are vegetable oils, such as 
corn, sunflower and soybean oils as well as products derived from these oils such as margarines 
(Chow, 2000). AA is found at low levels in meat, eggs, fish, algae and other aquatic plants (Chow, 
2000). 
b. n-3 PUFA 
Like the n-6 PUFA, the n-3 PUFA cannot be synthesized de novo in the human body. The essential 
precursor of this family is α-linolenic acid (ALA, C18:3n-3). ALA can be converted by humans to 
eicosapentaenoic acid (EPA, C20:5n-3) and subsequently to docosapentaenoic acid (DPA, C22:5n-3) 
and docosahexaenoic acid (DHA, C22:6n-3), by the same set of elongase and desaturase enzymes as 
for the n-6 PUFA series (FAO, 2010). Consequently, this results in a competition between the two 
series for the conversions. Given the relative abundance of LA compared to ALA in the human diet, 
the production of the n-3 LCPUFA, and in particular DHA, might be insufficient in certain 
circumstances (e.g. insufficient production in neonates to cover the physiologic need). As such, EPA 
and DHA are often termed conditionally essential fatty acids, because the biosynthetic pathway, 
generating these molecules from the precursor, does not appear to provide sufficient levels (AFSSA, 
2010; FAO, 2010).  
ALA is predominantly present in green leafy vegetables, soybean, rapeseed, linseed, nuts, and their 
derived oils. Synthesis of EPA and DHA occurs in a high rate in phytoplankton, which is a major 
food source of marine fish, such as mackerel, salmon, sardine, herring and smelt (Chow, 2000). 
Furthermore, high concentrations of the LCn3PUFA are found in poultry and eggs, since poultry also 
synthesizes considerable amounts of these FA. However, the FA content of the feed of both fish and 
poultry will influence their LCn3PUFA content. As such, it has been shown that farmed fishes may 
have different n-3 to n-6 FA ratios than wild type fishes (Weaver et al, 2008). Due to several health 
benefits that have been attributed to n-3 FA, commercial products with high levels of EPA and DHA 
have become available such as fish oils, algal oils, singlecell oils.  
I.1.3.4 CONJUGATED AND TRANS FATTY ACIDS 
Conjugated fatty acids are PUFA in which at least one pair of double bonds is interrupted by a single 
bond and thus not by a methylene (-CH2-) group. The most abundant FA with conjugated double 
bonds is conjugated linoleic acid (CLA). Twenty-eight possible isomers exist of CLA, which differ 
in the position and configuration of the conjugated double bonds (Tvrzicka et al, 2011). The main 
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dietary sources are red meat and dairy products. In recent years, researchers gained interest in these 
FA because of their potentially beneficial health effects (FAO, 2010).  
Trans fatty acids have a non-curved structure and thus have similar physicochemical properties as 
SFA. Main trans FA are trans-vaccenic (C18:1n-7t) and elaidic (C18:1n-9t) acid (Tvrzicka et al, 
2011). Trans FA are of exogenous origin and cannot be produced in the human body. They generally 
originate from food processing techniques resulting in partially hydrogenated oils (such as 
margarines), as well as from ruminant deposits and milk fats (FAO, 2010). There is convincing 
evidence that these FA have unfavourable health effects through their atherogenic properties and thus 
intake is recommended to be low (FAO, 2010).  
However, in the present thesis these fatty acids will not be further discussed. 
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Table 1 Overview of most important fatty acids in human health with their richest food sources according to the BLS (http://bls.nvs2.de) 
 
Systematic name Trivial name Rich food sources* 
SFA 
   C4:0 Butanoic acid Butyric acid dairy fat 
C6:0 Hexanoic acid Caproic acid dairy fat 
C8:0 Octanoic acid Caprylic acid coconut fat, palm pith fat, dairy fat 
C10:0 Decanoic acid Capric acid coconut fat, palm pith fat, dairy fat 
C12:0 Dodecanoic acid Lauric acid palm fat, coconut fat, nutmeg butter, dairy fat, shea butter 
C14:0 Tetradecanoic acid Myristic acid nutmeg butter, coconut fat, palm fat, dairy fat, lard, fresh-water eel, 
walnut oil 
C16:0 Hexadecanoic acid Palmitic acid palm fat, cocoa butter, lard, dairy fat, cottonseed oil, pumpkin seed 
oil, wheat germ oil, olive oil, maize germ oil, soy bean oil 
C18:0 Octadecanoic acid Stearic acid shea butter, cocoa butter, lard, dairy fat, brazil nut, pumpkin seed oil 
C20:0 Eicosanoic acid Arachidic acid macademia nut, shea butter, peanut oil 
MUFA    
C18:1n9 Cis-9-Octadecenoic acid Oleic acid (OA) hazelnut oil, olive oil, almond oil, rape oil, peanut fat, shea butter, 
pecan nuts, lard, macadamia nut, sesame seed oil, palm fat, 
pistachio, cocoa butter, dairy fat, cashew nuts, maize germ oil, soy 
bean oil, pumpkin seed oil, sunflower fat, brazil nut 
PUFA    
C18:2n-6 All-cis-9,12-Octadecadienoic acid Linoleic acid (LA) safflower oil, poppy seed oil, grape seed oil, sunflower fat, walnut 
oil, maize germ oil, wheat germ oil, pumpkin seed oil, cottonseed oil, 
soy bean fat, sesame seed fat, walnut, safflower seed, peanut fat, 
brazil nut, almond oil, pine nuts, rape oil, beechnut, pecan nuts, 
margarine, linseed oil 
C20:4n-6 All-cis-5,8,11,14-Eicosatetraenoic acid Arachidonic acid (AA) peanut oil, lard 
C18:3n-3 All-cis-9,12,15-Octadecatrienoic acid α-linolenic acid (ALA) linseed oil, walnuts, rape oil, soy bean fat, wheat germ oil, dairy fat 
C20:5n-3 All-cis-5,8,11,14,17-Eicosapentaenoic acid Eicosapentaenoic acid (EPA) fresh-water eel, sesame seed oil, roe, marine fish 
C22:6n-3 All-cis-4,7,10,13,16,19-Docosahexaenoic acid Docosahexaenoic acid (DHA) roe, marine fish, crustacean, eggs 
        
*Sources are categorized from most abundant to less abundant. 
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I.2 CHOLESTEROL 
Cholesterol is a steroid, consisting of four cycloalkane rings and an alcohol group. It is an essential 
structural component of the cell membrane and also has a functional role in the human body as 
precursor of steroid hormones, bile acids and vitamin D (Janson and Tischer, 2012). The most 
important dietary sources are cheese, egg yolk, meat, fish and shrimps, and human breast milk. 
However, most of the dietary cholesterol is available in ester form, which is only poorly absorbed. 
Cholesterol is not found in significant amounts in plant sources, since plants cannot synthesize 
cholesterol. In contrast, certain plants contain phytosterols, which are cholesterol-like components, 
and seem to compete with cholesterol absorption in the intestines. As such, the cholesterol content in 
the human body is largely synthesized de novo from acetate (Janson and Tischer, 2012). Cholesterol 
is synthesized in all nucleated cells but synthesis occurs predominantly in the liver followed by the 
intestines, adrenal glands and reproductive organs. The liver excretes cholesterol in a non-esterified 
form (via bile) into the digestive tract where it is mainly reabsorbed by the small bowel into the 
bloodstream and transported back to the liver (enterohepatic cycle) (Longo et al, 2012). 
INTRODUCTION 
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I.3 DIGESTION, ABSORPTION, TRANSPORT AND 
METABOLISM OF DIETARY LIPIDS 
Dietary fat includes all the lipids in plant and animal tissues that are eaten as food. The most 
common fats or oils are glycerolipids, mostly TG, but also MG and DG. Other fats are phospholipids 
(PL) and sterol esters. 
 
I.3.1 FAT DIGESTION 
The digestive process of dietary fats is very complex and requires coordinated lingual, gastric, 
intestinal, biliary and pancreatic functions (FAO, 2010).  
Because fats are hydrophobic, they need to be solubilized into an emulsion by the mechanical actions 
of mastification and gastric peristaltis. During these processes the dietary fat is mixed with lingual 
lipase and gastric lipase, initiating hydrolysis. These lipases are, however, of little quantitative 
significance for the lipid digestion (Barret et al, 2012). Most fat digestion occurs in the proximal 
intestine by pancreatic lipase, hydrolyzing principally the sn-1 and sn-3 bonds of the TG yielding 2-
monoacyl-sn-glycerols and non-esterified fatty acids (NEFA) as final products. Hydrolysis of PL 
yields sn-1-lysophospholipids and NEFA; and cholesterol esters are hydrolyzed to cholesterol and 
NEFA by cholesterol esterase (FAO, 2010).  
The FA available at the sn-2 position of TG and PL is of great importance because the absorption of 
these FA as 2-monoacyl-sn-glycerols is facilitated and these FA are retained in the glycerol lipids 
that are subsequently generated and transferred to the tissues (Lehner and Kuksis, 1996). In most 
dietary fats from seed oils, animal fats and marine lipids, the sn-2 position is occupied by PUFA, 
whilst SFA and varying amounts of MUFA are attached at the sn-1 and sn-3 position. Also in PL, 
being constituents of cell membranes, a SFA is usually esterified at the sn-1 position and a PUFA at 
the sn-2 position. Thus, although a minor component of foods, PL can be important sources of PUFA 
(FAO, 2010). In milk, however, SCFA (C4:0 and C6:0) are in the sn-3 position, whereas LC-SFA 
(C14:0, C16:0 and C18:0) are equally distributed at the sn-1 and sn-2 positions (FAO, 2010).  
Due to the hydrophobic parts, the digestive products of fats are relatively insoluble, which impedes 
their transportation across the lumen to the enterocyte brush border membrane where they are 
absorbed (Barret et al, 2012). Therefore, these lipids are finely emulsified by the detergent action of 
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bile salts and lecithin, forming mixed micelles (Figure 5). These micelles are cylindrical aggregates 
with cholesterol and fatty acids in the hydrophobic core and amphipathic phospholipids and 
monoglycerides lined up with their hydrophobic tails in the core and hydrophilic heads on the 
surface. This formation solubilizes the lipids and transports them down their concentration gradient 
to the brush border of the mucosal cells. Dissociation of lipids from the micelles occurs in a thin 
layer of water with an acidic environment immediately adjacent to the brush border, called the 
unstirred layer (Barret et al, 2012).  
 
Figure 5: Schematic representation of a mixed micelle 
 
I.3.2 FAT ABSORPTION 
The process of fat absorption in illustrated in Figure 6. After digestion the lipids are absorbed by the 
enterocytes and the bile salts remain in the bowel lumen. The bile salts are actively reabsorbed in the 
terminal ileum, transported to the portal circulation to be finally resecreted in the bile (enterohepatic 
circulation) (Longo et al, 2012). The lipids are mostly absorbed in the jejunum by passive diffusion, 
facilitated by fatty acid binding proteins, or by active transport mediated by a sodium-coupled 
transporter. The short- and medium-chain FA are sufficiently water-soluble to pass unmodified 
through the enterocyte into the vascular circulation (Barret et al, 2012). These FA circulate as NEFA 
and are transported to the liver where they are oxidized. In contrast, the LCFA are too insoluble and 
need to be reconverted to TG inside the enterocyte. As such, a favorable concentration gradient is 
maintained from the lumen into the cells. Inside the cells, cholesterol and lysophospholipds are also 
reconverted to their fatty acid ester (FAO, 2010). The newly synthesized TG, PL and cholesterol 
esters are combined with proteins to form chylomicrons. Chylomicrons are the largest and least 
dense type of lipoproteins (Longo et al, 2012). These macromolecules contain a core of hydrophobic 
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lipids (TG and cholesteryl esters) surrounded by amphiphatic lipids (PL, unesterified cholesterol) and 
proteins (apolipoproteins). These proteins interact with enzymes important in lipoprotein metabolism 
and act as ligands for cell surface receptors. Each lipoprotein class comprises a family of particles 
that vary slightly in density, size, lipid and apolipoprotein composition. In chylomicrons the major 
structural protein is Apo-B48, other apolipoproteins found on chylomicrons are ApoE and ApoC-II 
(Longo et al, 2012).  
The chylomicrons are, subsequently, extruded by exocytosis out of the enterocyte into the intestinal 
lymphatic vessels, as they are too large to pass through the junctions between the capillary 
endothelial cells. Ultimately, after 1-3 hours, they enter the vascular circulation via the thoracic duct 
(Barret et al, 2012).  
 
Figure 6: Overview of fat digestion and absorption in the human 
SOURCE: Reprinted with permission from Nemecz, G. 
http://web.campbell.edu/faculty/nemecz/323_lect/fatty_acid/fa_chapter.html 
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I.3.3 FAT TRANSPORT 
In the bloodstream the dietary lipids are transported to the periphery via the exogenous pathway 
(Figure 7) (Longo et al, 2012). Lipoprotein lipase (LPL) acts on the chylomicrons and hydrolyzes 
TG to NEFA and glycerol. In this reaction ApoC-II acts as a required cofactor for LPL. The NEFA 
can subsequently bind to albumin to remain in the circulation or pass through the capillary walls 
together with glycerol to be used by cells as energy or stored as fats in adipose tissue. The remnants 
of chylomicron material are subsequently cleared from the vascular circulation by the liver through a 
process that requires ApoE as a ligand for receptors in the liver (Longo et al, 2012). Remaining FA 
and FA that were de novo synthesized by the liver (Figure 7, endogenous pathway) are converted to 
TG and transported to the blood as very-low-density lipoprotein (VLDL), consisting primarily of TG, 
small amounts of cholesterol and PL and carrying Apo-B100, ApoE and apolipoproteins of the C 
series. Through hydrolysis by LPL, the TG in VLDL are again broken down into NEFA and MG, 
resulting in intermediate-density lipoproteins (IDL). Meanwhile cholesterol is absorbed from other 
circulating lipoproteins. As a result of the remodelling by hepatic lipase (HL) and the changing ratio 
of lipids versus proteins the density of the globules increases, becoming low-density lipoproteins 
(LDL). Similar to VLDL and IDL, LDL carries one molecule of Apo-B100 (Longo et al, 2012). The 
cholesterol in LDL accounts for more than one-half of the plasma cholesterol in most individuals. 
LDL is absorbed via the LDL receptors in the peripheral tissue and liver. It primarily transfers 
cholesterol esters in plasma to the peripheral tissues where they are hydrolyzed to free cholesterol. 
The liver controls the total concentration of cholesterol in the plasma by removing LDL from the 
circulation (Figure 7).  
As described above (p 9), cholesterol is synthesized in all nucleated cells, but only hepatocytes and 
enterocytes can effectively excrete cholesterol from the body, into either the bile or the gut lumen. 
Cholesterol in peripheral cells is transported from the plasma membranes of these cells to the liver 
and intestine by a process termed "reverse cholesterol transport" that is facilitated by high-density 
lipoproteins (HDL) (Longo et al, 2012). ApoA-I is found on virtually all HDL particles and ApoA-II 
is the second most abundant HDL apolipoprotein. Initially, HDL particles are discoidal formations 
which then recruit unesterified cholesterol from the periphery. Within the HDL particle, the 
cholesterol is esterified and the more hydrophobic cholesteryl ester moves to the core of the HDL 
particle. As HDL acquires more cholesteryl ester it becomes spherical, and additional 
apolipoproteins and lipids are transferred to the particles from the surfaces of chylomicrons and 
VLDL during lipolysis (Longo et al, 2012). This exchange of fatty acids within and between lipid 
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classes in the tissues and blood ensures widespread distribution of dietary fatty acids throughout the 
body (Hodson et al, 2008).  
HDL carries about 15–40% of total plasma cholesterol in the human body (FAO, 2010). HDL 
cholesterol can be removed from the circulation by transfer to apoB-containing lipoproteins in 
exchange for TG. These lipoproteins are then removed from the circulation by LDL receptor–
mediated endocytosis. HDL can also be removed from the blood stream by direct uptake by the 
hepatocytes. The catabolisation of HDL can be enhanced by the action of hepatic lipase which 
hydrolyzes the TG and PL and thus generates smaller HDL particles (Longo et al, 2012). 
 
Figure 7:  The exogenous and endogenous lipoprotein metabolic pathways. The exogenous pathway transports dietary lipids to the 
periphery and the liver. The endogenous pathway transports hepatic lipids to the periphery. LPL, lipoprotein lipase; FFA, free fatty 
acid; VLDL, very low density lipoprotein; IDL, intermediate-density lipoprotein; LDL, low-density lipoprotein; LDLR, low-density 
lipoprotein receptor; HL, hepatic lipase.  
SOURCE: Reprinted with permission: Longo, D.L. et al. Harrison‟s Principles of Internal Medicine, 18th Edition. Chapter 356: 
Disorders of Lipoprotein Metabolism. 
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I.3.4 LIPID POOLS  
The FA status of an individual can be assessed in several biological samples. The most commonly 
used in research are briefly discussed below.  
I.3.4.1 ADIPOSE TISSUE 
The adipose tissue is the main storage site for FA in the human body (Hodson et al, 2008). Due to its 
slow turnover time in weight stable individuals, the FA composition of adipose tissue is considered 
as the gold standard for the representation of long term dietary intake. The half-life of adipose tissue 
has been estimated to be 1-2 years (Hodson et al, 2008), however, evidence with stable isotopes 
methodology, indicated that the half-life might be as short as 6-9 months (Strawford et al, 2004). 
However, collection of this biological sample in large-scale studies is not convenient because of its 
invasive and painful sampling procedure.  
I.3.4.2 NON-ESTERIFIED FATTY ACIDS (NEFA) (ALSO KNOWN AS FREE 
FATTY ACIDS) 
In the fasting state FA are released from the adipose tissue by the action of lipases. To allow 
transportation in the plasma these fatty acids form a complex with albumin. In the fasting state, this 
lipid pool has been shown to be a good surrogate measure of the adipose tissue FA composition 
(Hodson et al, 2008). After a meal, however, the short- and medium-chain FA are absorbed directly 
into the vascular circulation and circulate as NEFA until they are captured and metabolized in the 
liver. As such, this „spill-over effect‟ weakens the association with the adipose tissue FA 
composition (Hodson et al, 2008).   
I.3.4.3 PLASMA TRIGLYCERIDES 
The majority of the plasma TG is localized in the VLDL particles. Dietary FA have been shown to 
appear in the VLDL-TG within hours after consumption, as such it is estimated that this lipid pool 
reflects the dietary intake from the preceding days. Similar to the previously discussed lipid pools, 
the concentration of very LCPUFA is very low in this biological sample (Hodson et al, 2008).  
I.3.4.4 PHOSPHOLIPIDS 
PL are the major class of lipids in animal membranes and small lipoproteins, predominantly the HDL 
particles. The FA composition of the membrane PL is controlled by a constant process of 
degradation and resynthesis or by direct exchange of intact phosphatidylcholine molecules (Hodson 
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et al, 2008). The PL FA composition has been assessed in several fractions, but mainly in the plasma 
or serum (exclusive cell membranes), in erythrocyte membranes and in platelet membranes. 
Compared to the other discussed lipid pools, the phospholipids have the largest abundance of n-3 
LCPUFA (Hodson et al, 2008).     
I.3.4.5 PLASMA CHOLESTERYL ESTERS 
In blood, approximately two thirds of cholesterol is esterified to a single fatty acid. The enzymes 
responsible for the esterification have a strong specificity for certain FA, which closely regulates the 
FA composition of the cholesteryl esters in the plasma. However, the plasma cholesteryl ester 
composition could also be influenced by recently ingested FA (Hodson et al, 2008). 
I.3.4.6 INTER-CORRELATION OF LIPID POOLS  
The FA composition of the different blood lipid fractions discussed above shows a reasonable inter-
correlation, which is probably the result of the exchange and transfer of FA between plasma and 
membranes (Hodson et al, 2008). In an extensive review, Hodson et al reports very strong 
correlations between the PL composition of plasma, platelet and erythrocytes for LA (r=0.74-0.95), 
and relatively strong correlations for EPA and DHA (r=0.52-0.85). In contrast, the correlations 
between ALA (r=0.07-0.63) and AA concentrations (r=0.27-0.66) in plasma and platelet PL seem to 
be lower and more variable (Hodson et al, 2008). Inter-correlations between SFA and MUFA 
compositions of PL in plasma, platelets and erythrocytes have been reported in only a small number 
of studies with correlation coefficients varying from r=0.20 for myristic acid to r=0.80 for stearic 
acid and between r=0.51-0.76 for oleic acid. Moreover, the inter-correlation between the FA 
composition of plasma PL, TG, cholesteryl esters and NEFA are investigated less frequently, 
evidence is mainly available for LA indicating a moderate correlation (r=0.44-0.77) (Hodson et al, 
2008).  
In general, it is assumed that although each adipose tissue and blood lipid fraction has its regulation 
and thus unique pattern of FA, they all partially reflect dietary intake. It is believed that the reflection 
of the recent (days-weeks) (Hodson et al, 2008) to medium-term (weeks to months) (Jenab et al, 
2009) dietary intake of fatty acids can be best assessed in blood lipid fractions (except the non-
fasting NEFA status, because, through the direct absorption of short and medium-chain FA in the 
vascular circulation, a higher proportion of these FA will be present in the NEFA lipid pool, see 
above). Plasma cholesteryl esters have been validated in dose-response studies as a biomarker of 
dietary intake, particularly LA; whilst PL tend to be better to reflect changes in the n-3 PUFA. 
Overall there seems no advantage in using plasma TG to reflect dietary intake of any class of fatty 
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acid (Hodson et al, 2008).  In the present thesis the serum PL FA composition has been used for the 
assessment of the FA status.  
 
I.3.5 DE NOVO SYNTHESIS, ELONGATION AND DESATURATION 
OF FATTY ACIDS 
Although most FA needed by humans are supplied in the diet, FA synthesis plays a role in certain 
tissues to convert excess of glucose into the more efficient storage form of lipids or to produce 
specialized lipid molecules (e.g. MCFA produced by the mammary gland, which are essential for 
development of the newborn; structural lipid molecules in the brain, essential for growth and 
maturation of the nervous system; lipid mediators) (Janson and Tischer, 2012). New synthesis of FA 
in the human body takes place in the liver, adipose tissue, kidney, brain and mammary glands. Acetyl 
coenzyme A (acetylCoA), the intermediate between the glycolysis and the citric acid circle, is the 
branch point between the glucose and lipid metabolism (Janson and Tischer, 2012). The first step of 
the FA synthesis is the addition of a carboxyl (CO2-) group, donated by bicarbonate, to acetyl-CoA 
to form malonylCoA, catalyzed by acetylCoA carboxylase. Subsequently, acetylCoA combines with 
a series of malonylCoA molecules to form SFA of different carbon lengths, of which the end product 
is palmitic acid (C16:0). The FA synthetic reactions up to this stage take place within the fatty acid 
synthetic complex, located in the cytoplasma. Other FA are derived from palmitate by specific 
enzymatic reactions. Production of FA with an odd number of carbon atoms relies on the substitution 
of the three carbon, propionylCoA, for acetylCoA to initiate the FA synthase reaction (Janson and 
Tischer, 2012). Once palmitic acid is released from the synthetic complex, it can be elongated to 
stearic acid and even higher SFA by further additions of acetyl groups, through the action of FA 
elongation systems. This reaction mainly occurs in the endoplasmatic reticulum or in the 
mitochondria. Finally, the insertion of double bonds in fatty acids is realized in the endoplasmatic 
reticulum, via a desaturase enzyme. Mammals cannot introduce double bonds beyond the Δ10 
position, as such the desaturation of de novo synthesized SFA stops with the formation of the n-9 
series MUFA by Δ9-desaturase (FAO, 2010).  
The main products of de novo synthesis are C16:0, C18:0 and C18:1n9 (Chow, 2000). In the absence 
of dietary essential fatty acids and other PUFA, 18:1n-9 is further desaturated and this step is 
followed immediately by elongation to form the n-9 family of PUFA.  
The quantitative importance of de novo lipogenesis is still controversial. Current evidence indicates 
that hepatic de novo lipogenesis is a minor pathway in humans under conditions of a normal Western 
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(high fat) diet (Hellerstein, 1999). The synthesis rate of palmitic acid in the VLDL-TG pool is 
estimated to be < 1-2g/d (compared to 50-150g/d fat in the diet) (Hellerstein, 1999) and eucaloric 
replacement of dietary fat by carbohydrates does not seem to induce a substantial increase of hepatic 
lipogenesis (Hellerstein, 1999). In contrast, it was estimated that in free-living healthy humans, 
approximately 20% of newly formed adipose-TG originate from adipose tissue lipogenesis 
(Strawford et al, 2004). Factors such as background diet, alcohol intake, sex, genetics, hormones etc. 
can influence de novo synthesis (Hellerstein, 1999; Siler et al, 1999). Furthermore, upregulation of 
de novo lipogenesis has been shown in non-alcoholic fatty liver disease and in hypertriglyceridemia 
(Donnelly et al, 2005; Vedala et al, 2006).  
As discussed above, mammals cannot introduce additional double bonds between Δ10 and the 
methyl terminal end. Thus, fatty acids from the n-6 and the n-3 series cannot be synthesized de novo. 
However, the precursors (LA and ALA) can be metabolized by humans to LCPUFA by a sequence 
of alternating elongation and desaturation steps, by Δ6- and Δ5-desaturase, an elongase of the 
microsomal system and a chain shortening step involving β-oxidation (Figure 8) (Moore et al, 1995; 
Sprecher, 2002). Based on studies with stable isotope tracers the conversion rate of ALA to EPA is 
estimated at 0.2%, to DPA at 0.13% and to DHA at 0.05% (Pawlosky et al, 2001). A possible reason 
for this poor conversion might be that ALA is the most rapidly oxidized and metabolized unsaturated 
fatty acid (Nettleton, 1991). Also, the concentration of ALA in plasma and tissue PL is low, usually 
less than 0.5% of total FA (Burdge and Calder, 2005), which is probably insufficient to compete for 
the Δ6 desaturase with LA (mean concentration of 22% of total fatty acids in plasma PL (Hodson et 
al, 2008)).  
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Figure 8: The biosynthesis of PUFA. The first step involves insertion of a double bond at the Δ6 position of LA and ALA by the action 
of Δ6 desaturase, followed by chain elongation of two carbon units by elongase and insertion of another double bond at the Δ5 
position by Δ5-desaturase to form arachidonic acid (AA, C20:4n-6) and eicosapentaenoic acid (EPA, C20:5n-3), respectively. In the 
next step, AA and EPA are elongated to C22:4n-6 and C22:5n-3, respectively; further elongation produces C24:4n-6 and C24:5n-3, 
respectively. These C24 PUFA are desaturated by Δ6 desaturase to yield C24:5n-6 and C24:6n-3. This is the same desaturase enzyme 
that desaturates LA and ALA. Docosahexaenoic acid (DHA, C22:6n-3) is formed from C24:6n-3 through chain shortening by two 
carbon units during one cycle of the β-peroxisomal pathway. By the same chain shortening mechanism C22:5n-6 is produced from 
C24:5n-6. 
SOURCE: Reprinted with permission from Calder, P. C., 2011, Fatty acids and inflammation: the cutting edge between food and 
pharma: Eur J Pharmacol., 668 Suppl 1:S50-8. Epub 2011 Jul 28. S50-S58. 
 
I.3.6 METABOLISM OF FATTY ACIDS 
In the body, lipids have several functions. TG are stored in adipose tissue, provide insulation, and 
can be mobilized to meet energy requirements. PL, glycolipids and cholesterol play a structural role 
in cell membranes, thereby influencing the physical properties of the cell membranes such as fluidity 
and the functional properties such as membrane protein composition. Furthermore, FA can be 
transformed to several biologically active molecules such as eicosanoids. The metabolism of FA, 
consisting of catabolic processes that generate energy and anabolic processes that create biologically 
important molecules, is outlined below.  
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I.3.6.1 METABOLIC ROLE  
Fat stored as TG is the body‟s most concentrated source of energy because TG are both reduced and 
anhydrous. The energy yield from a gram of fat catabolism is approximately 9 Kcal (37.7 kJ)/g for 
LCFA and VLCFA and 7Kcal (29.3kJ)/g for MCFA, compared with 4 Kcal (16.8 kJ)/g from protein 
or carbohydrates (Kremmyda et al, 2011). 
FA are broken down to acetyl-CoA, which enters the citric acid cycle. The main breakdown occurs 
by β-oxidation in the mitochondria (Figure 9). MCFA and SCFA can enter the mitochondria without 
assistance, but LCFA require transport into the mitochondria by the aid of carnitine (Janson and 
Tischer, 2012).  
In β-oxidation two carbons at a time are cleaved from acyl-CoA molecules, starting at the carboxyl 
end. The two-carbon units formed are acetyl-CoA and the remaining acyl chain is again linked with a 
CoA. The process is catalyzed by several enzymes, located in the mitochondrial matrix or inner 
membrane adjacent to the respiratory chain, and collectively called the fatty acid oxidase. The 
system is coupled with the phosphorylation of ADP to ATP, as such generating energy for the 
organism (Barret et al, 2012; Janson and Tischer, 2012).  
Degradation of unsaturated fatty acids depends on the configuration of the double bond. Because part 
of the β-oxidation involves the creation of a double bond (by acyl-CoA dehydrogenase, see Figure 9) 
some unsaturated FA can directly be further metabolized. However, if the double bond is not in the 
correct configuration or at the wrong carbon an extra step is needed in the degradation cycle (Janson 
and Tischer, 2012).  
Furthermore, VLCFA (more than 22 carbons) cannot be degraded in the mitochondria. Oxidation of 
these FA initially takes place in peroxisomes where the FA are metabolized to an eight-carbon, 
octanoyl-CoA which is then further degraded in the mitochondria (Janson and Tischer, 2012).  
As illustrated above, the FA structure affects the rate of oxidation. In general, LCFA are oxidized 
more slowly and unsaturated FA oxidized more rapidly than SFA (DeLany et al, 2000; Leyton et al, 
1987). For unsaturated FA, 24-h oxidation is in the order, ALA>OA>LA>AA (FAO, 2010). 
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Figure 9:Pathway of β-oxidation of fatty acid molecules in the mitochondria 
SOURCE: Reprinted with permission from Da Poian, A. T., El-Bacha, T. & Luz, M. R.M.P. (2010) Nutrient Utilization in 
Humans: Metabolism Pathways. Nature Education 3(9):11 
 
I.3.6.2 STRUCTURAL ROLE  
The lipid bilayer of cell membranes is comprised of five major PL (phosphatidylcholine, 
phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol and spingomyelin). Each class 
of PL has a characteristic FA composition, which is closely regulated (Hodson et al, 2008). The 
selectivity of FA incorporated in the PL may be in part determined by the fatty acyl specificity of the 
acyl-CoA transferases that are involved in the deacylation and reacylation of phospholipids. 
Furthermore, the PL composition can be altered by direct exchange of intact phosphatidylcholine 
molecules between plasma HDL particles and cell membranes. The latter is probably the major 
pathway for the renewal of PL in erythrocyte membranes as these cells, in contrast to other cells, are 
incapable of de novo PL synthesis and FA chain elongation and desaturation (Hodson et al, 2008).  
The degree of unsaturation of the FA within the cell membrane significantly influences the 
microviscosity and thickness of these membranes, and consequently the function of associated 
membrane proteins (enzymes, cell receptors, membrane transporters and ion channels) (Tvrzicka et 
al, 2011). Also, membrane stability is influenced by the presence of specific molecules, such as 
cholesterol and proteins (Kremmyda et al, 2011).  
Besides this, FA exert an isolating role. In adipose tissue, the TG serve as temperature and 
mechanical isolators (Kremmyda et al, 2011). In neural tissue, the myelin sheath covering the 
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neurones is mainly composed of lipids (Kremmyda et al, 2011). The thicker the myelin layer, the 
faster the signal conduction along the axon (Janson and Tischer, 2012). Furthermore, ceramides 
(being a sphingomyelin) are present in high concentrations in epithelial skin cells where they aid to 
decrease the water permeability and prevents its losses. 
I.3.6.3 FUNCTIONAL ROLE  
FA from the diet or released from membrane phospholipids, are important cell signalling molecules. 
They can act as second messenger, they are precursors of lipid mediators or they can act as 
modulator molecules.  
a. Second messenger 
FA in the form of phosphatidylinositol in the cell membrane may play a role in signal transduction 
cascades. In response to extracellular signals, which interact with receptors on the outer layer of the 
plasma membrane, phosphatidylinositol 4,5 bisphosphate is cleaved into DG and inositol-
triphosphate. These second messengers further propagate the signals to target molecules inside the 
cell, the cytoplasma or the nucleus (Kremmyda et al, 2011; Murray et al, 2013).  
b. Lipid mediators 
FA in the cell membrane can be released by phospholipase A2 and transformed to lipid mediators, 
such as eicosanoids, docosanoids and lysophospholipids (Murakami, 2011). These regulating 
molecules mainly act through binding with membrane-associated G-protein coupled receptors 
(Janson and Tischer, 2012; Murakami, 2011).  
Eicosanoids are derivatives from the n-6 and n-3 PUFA with 20 carbon atoms (mainly AA and EPA) 
and have autocrine and paracrine actions (Kremmyda et al, 2011). The four major groups of 
eicosanoids include the prostaglandins (PG), the prostacyclins (PGI), the thromboxanes (TX), and 
the leukotrienes (LT). Figure 10 (Calder, 2010) shows the two primary pathways of synthesis of 
these lipid mediators, namely the cyclooxygenase (COX) pathway which converts the FA to 
prostanoids (PG, PGI and TX) and the lipoxygenase (LOX) pathway which converts them to LT 
(FAO, 2010). As the precursor FA have different numbers of double bonds, they give rise to different 
series of eicosanoids; AA is the precursor of 2-series prostanoids and 4-series LT, while 3-series 
prostanoids and 5-series LT are produced from EPA (Kremmyda et al, 2011).  
In addition to the eicosanoids, a novel group of lipid mediators formed from EPA and DHA has been 
identified. These are termed E-series resolvins and D-series resolvins and protectins, respectively 
(Calder, 2010). 
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Figure 10: General overview of the synthesis of lipid mediators from AA, EPA and DHA. 
SOURCE: Reprinted with permission from Calder, P. C., 2010, The 2008 ESPEN Sir David Cuthbertson Lecture: Fatty acids and inflammation--from 
the membrane to the nucleus and from the laboratory bench to the clinic: Clin Nutr., 29 (1); 5-12. 
 
The major functions of the PG include regulation of inflammation, smooth muscle contraction (blood 
vessels, gastrointestinal, bronchial, and uterus), neurological pain, platelet function, hormone 
activity, and cell growth. PGI are derived directly from a prostaglandin precursor (PGH2) and are 
important in decreasing platelet function and, thus, blood clot formation; as well as dilation of blood 
vessels. TX are also derived from PGH2 and, in contrast to PGI, act as vasoconstrictors, promote 
platelet aggregation and blood clot formation. LT, which are formed through the LOX-pathway, are 
mainly seen in inflammatory processes of the lung, including asthmatic reactions and the 
inflammation associated with bronchitis (Janson and Tischer, 2012).  
The effect of the lipid mediators is very much dependent on their FA substrate. The eicosanoids 
derived from EPA are generally less potent than those derived from AA and exert thus a less 
inflammatory or even anti-inflammatory effect. For example, PGE2 and TXA2 derived from AA 
promote inflammation, serve as vasoconstrictors and stimulate platelet aggregation. PG and TX from 
EPA, in contrast, act as vasodilators and anti-aggregators (FAO, 2010). Moreover, the resolvins and 
protectins, derived from EPA and DHA, are involved in the clearance and regulation of 
inflammatory substances (Kremmyda et al, 2011). It has to be noted, however, that also AA-derived 
PG, such as PGE2, possesses both pro- and anti-inflammatory actions. PGE2 is a potent inhibitor of 
the production of two pro-inflammatory cytokines, tumour necrosis factor α (TNF-α) and interleukin 
1 (IL-1), furthermore it inhibits 5-lipoxygenase and so decreases production of 4-series LTs, and 
induces 15-lipoxygenase so promoting the formation of lipoxins that have been found to have anti-
inflammatory effects (Calder, 2009b).  
An imbalance in the synthesis of eicosanoids in tissues could lead to development of certain 
pathological conditions, including thrombosis, inflammation, asthma, inflammatory bowel disease 
and several other inflammatory conditions (Calder, 2006; Simopoulos, 1991).  
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Other known lipid mediators are the lysophospholipids such as platelet-activating factor, 
lysophosphatidic acid, sphingosine-1-phosphate and endocannabinoids which interact in various 
physiological processes (Kremmyda et al, 2011; Murakami, 2011).  
c. Modulator of gene transcription 
As ligands of nuclear receptors of some transcription factors the LC-PUFA can modulate the 
transcription of genes. Both n-3 and n-6 FA can suppress gene transcription of several enzymes 
involved in lipogenic and glycolytic reactions, while SFA, MUFA and trans FA fail to suppress 
these genes. Generally, DHA seems to be more potent in its effect than other PUFA (Simopoulos, 
2006).  
FA modulated transcription factors include peroxisome proliferator-activated receptor (PPAR), liver 
X receptors (LXR), hepatic nuclear factor (HNF),  sterol regulatory element binding protein 
(SREBP) and carbohydrate regulatory element binding protein/Maxlike factor X (ChREBP/MLX) 
(Kremmyda et al, 2011). These transcription factors have various roles: SREBP upregulates the 
activity of enzymes involved in FA synthesis (including PUFA), desaturation and elongation, 
furthermore, SREBP are engaged in the synthesis of cholesterol and TG. ChREBP/MLX upregulates 
de-novo lipogenesis and MUFA synthesis and induces glucose transporter-2 and L-pyruvate kinase 
involved in glucose metabolism. PPAR-α induces mainly FA oxidation, and LXR induces de-novo 
lipogenesis and MUFA synthesis (Jump, 2008; Kremmyda et al, 2011). Generally, the PUFA 
promote a shift in metabolism toward FA oxidation and away from FA synthesis and storage by 
promoting PPAR and inhibiting LXR, SREBP, ChREBP/MLX (Jump, 2008). 
Apart from antagonizing AA metabolism via competitive inhibition of desaturase, COX and LOX, n-
3 FA have a number of other anti-inflammatory effects. The exact mechanisms are not yet fully 
understood but could at least partially be moderated by influencing expression of genes  involved in 
inflammation, such as cytokines (Simopoulos, 2010). Cytokines are a family of proteins produced 
and released by cells involved in the inflammatory process and in the regulation of the immune 
system by, amongst others, promoting leukocyte recruitment, adhesion to the endothelial cells and 
local amplification of inflammation (Janson and Tischer, 2012). EPA and DHA suppress IL-1β and 
IL-6 (Simopoulos, 2010); DHA, but not EPA, is effective in reducing endothelial expression of E-
selectin, ICAM-1 (intercellular cell-adhesion molecule1) and VCAM- 1 (vascular cell adhesion 
molecule 1), and impairs the ability of ligand bearing monocytes to adhere (De Caterina and Libby, 
1996). 
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I.3.6.4 PEROXIDATION 
Lipid peroxidation is a process in which lipids are oxidized without release of energy. This process is 
the result of a reduction-oxidation reaction between a FA and a free radical (ROO , RO , OH ), 
which is a by-product of mitochondrial oxidative phosphorylation (Catala, 2010). Moreover, the 
process can be catalyzed by enzymes (such as lipoxygenase) (Catala, 2010; Murray et al, 2013). 
This initiation phase is followed by a chain reaction (propagation phase) providing a continuous 
supply of free radicals that initiate further peroxidation. In general, the more double bonds a FA 
contains, the more it is prone to peroxidation. The peroxidation process can be terminated or 
prevented by antioxidants, such as vitamin E and vitamin C, which remove the produced free radical 
intermediates by being oxidized themselves (Murray et al, 2013).  
Free radicals (or reactive oxygen species) can be beneficial as they aid to protect the organism 
against the invasion of pathogens. However, in case of an imbalance between the pro-oxidant and 
anti-oxidant systems, an excessive quantity of reactive oxygen species can result in oxidative stress 
(Catala, 2010). As such, peroxidation of lipids can result in damage to tissues in vivo, where it may 
be a cause of cancer, inflammatory diseases, atherosclerosis, and aging (Murray et al, 2013).  
 
I.3.7 FUNCTIONAL ROLE OF CHOLESTEROL 
Similar to the functions of FA described above, cholesterol has a structural and functional role in the 
organism. The presence of cholesterol in the cell membrane influences its fluidity and permeability. 
Through the interaction with the phospholipid FA chains, cholesterol increases membrane packing, 
which reduces membrane fluidity. The myelin sheath of neurons is also rich in cholesterol, providing 
insulation for more efficient conduction of impulses. Within cells, cholesterol is the precursor 
molecule in several biochemical pathways. In the liver, cholesterol is converted to bile salts which 
solubilise fats in the digestive tract and aid in the intestinal absorption of fat molecules as well as the 
fat-soluble vitamins, A, D, E, and K. Furthermore, cholesterol is an important precursor molecule for 
the synthesis of vitamin D and the steroid hormones, including the adrenal gland hormones cortisol 
and aldosterone, as well as the sex hormones progesterone, estrogens, and testosterone, and their 
derivatives.  
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I.4 HEALTH RELATED EFFECTS OF FATTY ACIDS IN THE 
HUMAN BODY 
I.4.1 ESSENTIAL FATTY ACIDS 
Until the work of Burr and Burr in 1929, dietary fat was viewed simply as a source of calories, 
interchangeable with carbohydrates (Smith and Mukhopadhyay, 2012). However, animal experiments 
showed that rigid exclusion of fat lead to a number of disorders and even death (Smith and 
Mukhopadhyay, 2012). Linoleic and α-linolenic acid were identified as essential fatty acids (EFA) 
and EFA deficiency has been linked to growth retardation and increased skin permeability leading to 
epidermal losses of water and skin lesions. In both males and females, EFA deficiency has been 
shown to cause infertility. Furthermore, an increased predisposition to bacterial infections, disturbed 
cholesterol transport leading to liver steatosis, and increased fragility of capillaries and haematuria 
leading to kidney failure has been shown. Other symptoms include abnormal adaptation to darkness 
(dysopsia) and lower visual acuity, as well as neurological disturbances such as sensor and motor 
neuropathies (Kremmyda et al, 2011). 
 
I.4.2 CHRONIC DISEASES 
As described in the previous section (p 22) FA composition of PL may modulate immune functions 
and inflammatory processes, thus possibly playing a role in chronic diseases such as coronary heart 
disease, cancer, asthma, rheumatoid arthritis and other auto-immune diseases. An overview of the 
level of evidence of the association between fat intake and health outcomes is given in Table 2. 
Furthermore, fat intake is also important to allow a sufficient intake of fat-soluble vitamins, which 
are necessary for vision (vitamin A), regulation of calcium metabolism (vitamin D), prevention of 
auto-oxidation of unsaturated lipids (vitamin E), and normal clotting of blood (vitamin K).  
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Table 2: Overview of level of evidence of fat intake and health outcome 
 Total fat SFA MUFA PUFA n-6 PUFA n-3 PUFA ALA EPA + DHA trans FA References 
Perinatal outcome           PS (benefit)       
(FAO, 2010; Makrides et al, 2006; 
Schulzke et al, 2011; Simmer et al, 2011) 
Fatal Coronary Heart 
Disease 
C (NR) P (NR) 
(SFA for CHO) 
  C (↓risk) 
(PUFA for SFA) 
  P (↓risk)     
P  
(↑ risk) 
(FAO, 2010) 
Coronary Heart 
Disease events 
C (NR) P (NR) 
(SFA for CHO) 
  C (↓risk) 
(PUFA for SFA) 
  C (↓risk)     C (↑ risk) (FAO, 2010) 
Diabetes Mellitus           I       (FAO, 2010) 
Obesity C (NR)                 (FAO, 2010) 
Colorectal cancer C (NR) C (NR) C (NR)   C (NR)   C (NR) P (↓risk) C (NR) (FAO, 2010) 
Prostate Cancer C (NR) I P (NR)   C (NR)   I I PS (↑risk) (FAO, 2010) 
Breast Cancer P (NR) PS (↑risk) P (NR)   C (NR)   I PS (↓risk) I (FAO, 2010) 
Endometrial Cancer PS (↑risk)                 (FAO, 2010) 
Ovarian Cancer I                 (FAO, 2010) 
Rheumatoid 
Arthritis 
          C (benefit)       (FAO, 2010) 
Asthma           
PS (benefit  
children) 
      (FAO, 2010) 
Eczema           I       (Bath-Hextall et al, 2012) 
Crohn's Disease           
P  
(no effect) 
      (Turner et al, 2009) 
UC           I       (FAO, 2010) 
Cystic Fibrosis           PS (benefit)       (Oliver and Jahnke, 2011) 
Depression           P (benefit)       (FAO, 2010) 
Bipolar disorder           PS (benefit)       
(FAO, 2010; Montgomery and 
Richardson, 2008) 
Aggression            PS (benefit)       (FAO, 2010) 
Alzheimer's disease           I       (FAO, 2010) 
Schizophrenia           I       (FAO, 2010; Joy et al, 2006) 
Huntington's disease           I       (FAO, 2010) 
Autisme Spectrum 
Disorder 
          I       (James et al, 2011) 
Learning Disorders       I           (Tan et al, 2012) 
ADHD       PS (benefit)           (Gillies et al, 2012) 
Cognitive decline           PS (↓ risk)       (FAO, 2010) 
Age-related macular 
degeneration 
          PS (↓ risk)       (FAO, 2010) 
C, Convincing; P, Probable; PS, Possible; I, Insufficient;NR, Not related;  ↓ risk, decreased risk; ↑ risk, increased risk; benefit, beneficial therapeutic effect; CHO, Carbohydrates 
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I.4.3 GROWTH & DEVELOPMENT 
Environmental exposure during critical time periods in early life (in utero and early postnatal life) 
may influence health outcome in short-term and long-term by metabolic programming effects 
(Gluckman et al, 2010). Diet and FA intake can act as such environmental factors. A Cochrane 
review concluded that fish/marine oil supplements taken in pregnancy increase the length of 
pregnancy by two to three days, slightly increase a baby's birth weight and slightly reduce the 
number of babies born before 34 weeks gestation (Makrides et al, 2006). However, according to 
Makrides et al. the small effects did not reduce the overall risk of a baby being born too soon or too 
small, nor the mother developing pre-eclampsia (Makrides et al, 2006). Furthermore, the current 
evidence does not consistently show beneficial effects of postnatal LCPUFA supplementation of 
breastfeeding mothers or infant milk formula on the neurodevelopmental outcomes and visual acuity 
of term or preterm infants (Delgado-Noguera et al, 2010; Schulzke et al, 2011; Simmer et al, 2011). 
Two recent Cochrane reviews concluded that (1) routine supplementation of term infant milk 
formula with LCPUFA cannot be recommended (Simmer et al, 2011) and that (2) there is insufficient 
evidence to support or refute the practice of giving LCPUFA supplementation to breastfeeding 
mothers in order to improve infant growth and development (Delgado-Noguera et al, 2010). 
However, weighing the absence of toxicity and the potential for benefit, expert panels recommend a 
higher intake of EPA+DHA for pregnant and lactating women of 300mg/day (compared to 
250mg/day for males and non-pregnant/non-lactating women) (FAO, 2010).  
 
I.4.4 CARDIOVASCULAR DISEASE & METABOLIC SYNDROME 
The current evidence shows that it is not necessarily the total amount of fat intake, but instead the 
type of fat consumed, that is of importance in the risk for cardiovascular disease (CVD) (Willett, 
2011). A FAO expert consultation concluded that there is no direct relationship between total fat and 
obesity, but that it is the energy imbalance, the nutrients contributing to it, and lifestyles that are 
responsible for obesity in genetically susceptible persons (FAO, 2010). High intakes of SFA have 
been related to higher levels of serum total cholesterol and risk of CVD (Hu et al, 2001). However, it 
has been shown that different FA may have different effects on lipid status and health outcome. 
Whilst SFA with 12-16 carbon atoms tend to increase plasma total and LDL cholesterol levels, 
stearic acid (C18:0) does not have a cholesterol raising effect (Kris-Etherton and Yu, 1997). 
Furthermore, there is convincing evidence that replacement of SFA with vegetable oils rich in 
unsaturated FA results in a reduction of the TC:HDL-C ratio and CVD risk, whilst replacement of 
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SFA by carbohydrates does not reduce CVD risk (Mozaffarian, 2011). Also, the effect of trans FA 
has been well documented to promote CVD development by raising the LDL-C levels (FAO, 2010).   
Animal studies indicate that diets rich in SFA impair insulin sensitivity, whilst n-3 LCPUFA 
improve insulin sensitivity. However, there is only limited evidence in humans that replacing SFA 
with MUFA improves insulin sensitivity and glycaemic control in type 2 diabetes mellitus. Further 
studies to assess the importance of FA intake on insulin sensitivity are required (FAO, 2010).  
As discussed above, apart from the direct influence on lipid metabolism, another possible pathway 
by which fat intake might influence CVD risk and insulin sensitivity is by the modulation of the 
inflammatory state by the ratio of n-6:n-3 FA intake. However, further studies examining the 
association between dietary FA intake and inflammatory markers are necessary (FAO, 2010).  
 
I.4.5 CANCER 
It is assumed that there is no convincing relationship between total fat intake and colorectal cancer or 
prostate cancer. In contrast, there is a probable protective effect of n-3LCPUFA intake on colorectal 
cancer, for prostate cancer results are contradicting. For breast cancer there is no increased risk, up to 
a total fat intake of 30-33%E. But there is a possible increased risk for breast cancer associated with 
a high saturated fat intake (FAO, 2010). High intake of n3-LCPUFA is possibly associated with a 
reduced breast cancer risk, however, increased risks were recorded for some northern European 
countries. This increase might be related to less favourable contextual food patterns and/or to 
possible endocrine disruptor pollutants known to be present in the seas around these countries (FAO, 
2010). For endometrial cancer there is possible evidence of an increased risk with higher total fat 
intake. No conclusions can be drawn, however, for the different types of fat as studies are lacking 
(FAO, 2010).  
However, there is also evidence that the source of FA and foods may have an influence on cancer 
risk instead of purely the FA types. For example, there is limited but suggestive evidence that foods 
containing animal fat, which are energy-dens, increase the risk of colorectal cancer. Also, meat is a 
probable risk factor for colorectal cancer, replacing meat by fish might confound the risk reduction 
associated with high intakes of fish, regardless of the effect of the n-3 LCPUFA or the other 
bioactive components present in fish (e.g. vitamin D, selenium) (FAO, 2010).  
Furthermore, the effect of MUFA intake on cancer risk is contradicting in several studies suggesting 
the influence of the contributing food and the global dietary pattern. As such, olive oil provides a 
source of micro-constituents that might offer specific nutritional benefit, in addition to being a source 
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of fat, without deleterious effects on the level of LDL-cholesterol, thereby decreasing the risk of 
heart disease (FAO, 2010).  
 
I.4.6 AUTO-IMMUNE & INFLAMMATORY DISORDERS 
Most of the impact of dietary fat in modulating immune functions and inflammatory processes is 
attributed to the LCPUFA that target inflammatory processes by a variety of mechanisms, as 
described above. Currently, several studies have examined the potential therapeutic effect of 
LCPUFA supplementation in inflammatory disorders but no studies have investigated the prevention 
of these disorders by FA (FAO, 2010).  
Evidence of a therapeutic benefit is strong in rheumatoid arthritis. Several studies, supplying between 
2.1g and 7g n-3 LCPUFA/day with a duration of 12-52 weeks, reported a beneficial effect on several 
endpoints (e.g. reduced number of swollen or tender joints, decreased duration of morning stiffness, 
reduced use of anti-inflammatory medication) (FAO, 2010).  
Some studies report a favourable effect on Crohn‟s disease, including improved gut histology and 
better maintenance in remission (FAO, 2010), however, two large studies showed no benefit to n-3 
treatment (Turner et al, 2009). As such, a recent Cochrane review concluded that n-3 FA are 
probably not effective for maintenance of remission in Crohn's disease (Turner et al, 2009). Studies 
in ulcerative colitis do not indicate any benefit but currently evidence is insufficient to draw any 
conclusions (FAO, 2010).  
Another pathway by which FA could modulate inflammatory bowel disease are the SCFA. SCFA are 
formed by the action of colonic bacteria on complex carbohydrates, resistant starches, and other 
components of the dietary fiber, and are an important local energy source for the epithelial cells of 
the colon. The importance of SCFA as energy source for the organism is augmented in people 
suffering from short bowel syndrome. Through their anti-inflammatory, anti-oxidant and anti-
carcinogenic effects (Leonel and Alvarez-Leite, 2012; Meijer et al, 2010) the SCFA have been 
associated with reduced risk of some diseases, including irritable bowel syndrome, inflammatory 
bowel disease, cardiovascular disease, and cancer (Hijova and Chmelarova, 2007).  
 
I.4.7 NEUROLOGIC DISORDERS 
DHA is a major structural and functional component of photoreceptors, neurons and their signalling 
synapses and thus has been suggested to be associated with brain and neurologic disorders (FAO, 
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2010). However, for most disorders current evidence is insufficient to draw conclusions as the 
intervention studies thus far are too short-term and epidemiological research gives only evidence for 
associations with fish and seafood intake but not with purely n-3 LCPUFA intake (FAO, 2010).  
 
I.4.8 INTERACTIONS WITH GENOTYPE 
Apart from the observed direct associations, several gene polymorphisms in relation with lipid and 
haemostatic risk factors and carcinogenesis have been identified and may have interactions with 
dietary fat intake. These interactions between genes and environmental factors require further 
elucidation (FAO, 2010).   
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I.5 RECOMMENDATIONS AND DIETARY PATTERNS 
I.5.1 NUTRIENT RECOMMENDATIONS 
Dietary reference values are the common framework for public health activities aimed at covering 
the nutrient requirements of populations. However, nutrient requirements differ between individuals 
and vary in function of several factors such as age, sex, genetic background, disease, physical 
activity, etc. Consequently, the individual requirement on population level shows a broad 
distribution. Translation of nutrient requirement distributions into actual reference values for 
practical guidance of health professionals and public health workers is a complex exercise based on 
scientific data with regard to the relationship between the nutrient intake on one hand and risk for 
deficiency and for chronic diseases on the other hand. In this process, the most commonly used and 
simplest model assumes a normal distribution of the nutrient requirement and the recommended 
dietary intake is then defined as the estimated average requirement plus two times the standard 
deviation (BHC, 2009; Institute of Medicine.Food and Nutrition Board, 2005) (Figure 11). As such, 
a recommended intake is obtained that should be sufficient to cover the need of 97.5% of the 
population. In contrast to what is often assumed, this recommended intake is not a minimum intake 
level but instead an intake level that is higher than the individual need for the large  majority of the 
population (BHC, 2009). On population level inadequate intake is defined as an intake below the 
average requirement. This value, however, is often not known or widely available. As such, it has 
been proposed to estimate the average requirement as being 80% (WHO, 2006) or even as little as 
2/3 (Farris et al, 1998) of the recommended intake.  
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Figure 11: Distribution of the individual requirements from a nutrient. 
SOURCE: Adapted with permission from Belgian Health Council, 2009, Voedingsaanbevelingen voor België. Herziene versie 2009 (Nutritional 
recommendations for Belgium. Revised version 2009).  Brussels :BHC. 
 
Due to the several health effects that have been attributed to the FA, recommendations for dietary 
intake have been formulated by different expert organizations. However, these recommendations can 
be quite diverse in quantity and mode of expression. This variation often results from differences in 
criteria of adequate intake. In the past, nutrient recommendations were set up to prevent deficiency 
syndromes, however, nowadays recommendations are often aimed at prevention of chronic diseases 
(Institute of Medicine, Food and Nutrition Board, 2005). In Table 3 an overview of the 
recommendations of some organizations is given. In the present PhD, the recommendations 
formulated by the Food and Agriculture Organization (FAO, 2010) and of the Belgian Health 
Council (BHC, 2009) are used.  
 
  
INTRODUCTION 
34 
Table 3  Overview of recommendations for dietary intake of FA of different organizations.  
Recommended 
dietary intake 
WHO  
(2003) 
FAO  
(2008) 
BHC 
(2009) 
IOM 
(2005) 
ISSFAL 
(2004) 
AFSSA  
(2010) 
SFA <10%E <8%E <10%E  <8%E 
C12:0–C16:0: 
<8%E 
Total SFA: <12%E 
MUFA 
Total fat – 
(SFA+PUFA+ 
transFA) 
Total fat – 
(SFA+PUFA+ 
transFA) 
>10%E   
Oleic acid:  
15-20%E 
PUFA 6-10%E 6-11%E 5.3-10%E    
N-6 FA 5-8%E  4-8%E    
LA  >2.5%E >2%E 
11 g/d ♀ 
16 g/d ♂ 
2%E 4%E 
N-3 FA 1-2%E 0.5-2%E 1.3-2%E    
ALA  >0.5%E >1%E 
1.1 g/d ♀ 
1.6 g/d ♂ 
0.7%E 1%E 
EPA+DHA  250-2000 mg >0.3%E  500 mg 
250mg EPA + 
250mg DHA 
WHO: World Health Organization (WHO, 2003),FAO: Food and Agricullture Organization of the United Nations (FAO, 2010), BHC: 
Belgian Health Council, Belgium (BHC, 2009), IOM: Institute of Medicine, USA (Institute of Medicine.Food and Nutrition Board, 
2005), ISSFAL: International Society for the Study of Fatty Acids and Lipids (International Society for the Study of Fatty Acids and 
Lipids (ISSFAL), 2004), AFSSA: Agence Française de Sécurité Sanitaire des Aliments, France (AFSSA, 2010) 
 
Due to the competition effect between the n-6 and n-3 FA for the desaturase and elongase enzymes, 
much attention has been paid in the past to the ratio of n-6/n-3 FA intake. It is estimated that, during 
evolution, this ratio has increased from around 0.8 in the late paleolithic period, to around 15.0 or 
even higher in the current western society (Simopoulos, 2008). Taken into consideration the different 
properties of the n-3 and n-6 FA derivatives (as discussed above, Chapter I.3.6.3, p 22), this dietary 
change could largely influence the risk for non-communicable diseases, such as coronary heart 
disease (Simopoulos, 2008). However, more recently the meaning and usefulness of ratios has been 
questioned as these can disguise extremely low or high intakes (Deckelbaum and Calder, 2010). 
Consequently, due to the unconvincing evidence and conceptual limitations, the FAO judged that 
there is no rationale for setting a recommendation for the n-6/n-3 ratio (FAO, 2010).  
 
I.5.2 FOOD BASED DIETARY GUIDELINES  
To translate the nutrient recommendations into messages that are easy to understand by the lay 
public, food based dietary guidelines are developed. These guidelines can be broad and unspecific 
such as „eat a variety of foods each day‟ or „eat plenty of fruits and vegetables‟, or more specific 
such as „eat five portions of fruits and vegetables a day‟. Messages may also indicate the type of 
food, such as „eat low fat dairy products and drink low fat milk‟, or be meal specific such as „eat 
breakfast every day‟ (WHO, 1998; Sandstrom, 2001). Often, these guidelines are country-specific 
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and adapted to local habits as well as specific local needs. Because, although the individual need and 
thus the recommendation for a specific nutrient (e.g. iodine, selenium) is more or less the same in 
different countries it might be that this micronutrient is less available in the local food and thus more 
attention should be paid on sufficient consumption. For example, in the US the soil is richer in 
selenium than in European countries (Johnson et al, 2010), as such, selenium deficiency is seldom a 
problem in the US while in Europe a lot of people, certainly critically ill, risk a deficit. Also, in 
certain countries the drinking water is fortified with iodine ensuring a sufficient intake of this 
micronutrient, in contrast, in countries where this is not the case, extra attention should be paid by 
more specifically directing the food based dietary guidelines to reach the nutrient recommendations 
(WHO, 2006). Concerning lipids, nowadays, foods are also more frequently fortified with factors 
influencing the lipid status, such as phytosterols and omega-3 fatty acids. Such fortified foods might 
help to reach some of the nutrient recommendations. 
 
I.5.3 DIETARY INTAKE PATTERNS OF FATTY ACIDS 
Above (see Table 1, p8), an overview of food sources rich in the different fatty acids has been given. 
However, several of these food sources are not frequently consumed or at least not in large amounts 
or they are processed in other food items. As such, these rich food sources often differ from the main 
food contributors from which the consumer derives the different fatty acids. In order to adapt or 
develop dietary guidelines and to identify the main public health concerns, several studies have been 
conducted to assess adherence to the nutrient recommendations and identify the most important food 
contributors.  
A recent review, conducted by Harika et al. (2011), assessed the FA intake in children and 
adolescents across thirty countries worldwide and compared them with the 2003 recommendations of 
the WHO (see Table 3, p 34). This study shows that the majority of adolescents has an excessive 
intake of SFA and that overall the PUFA intake is low (Harika et al, 2011). These findings have also 
been found in other independent studies, indicating that mainly the intake of LA and the LCn-
3PUFA are insufficient in this age group (Meyer and Kolanu, 2011; O'Sullivan et al, 2011).  
Considering the dietary intake patterns of FA, Matthys et al. (2003) observed that Flemish 
adolescents obtained the highest proportion of total fat, SFA, MUFA and PUFA intake from the 
lunch followed by the dinner and snacks; only small amounts of the daily intake (<15%) were 
consumed during the breakfast. In general, the most important contributors to total fat intake in 
adolescents are meat products, dairy products, and fats & oils (Joyce et al, 2009; Matthys et al, 2006; 
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Meyer et al, 2003; O'Sullivan et al, 2011). Also cereal-based products are important sources of total 
fat intake (Matthys et al, 2006; Meyer et al, 2003). The SFA are mainly derived from dairy products 
and meat products (Joyce et al, 2009; Matthys et al, 2006; Meyer et al, 2003; O'Sullivan et al, 2011) 
and together with fat & oils these foods are the most important sources of total MUFA intake (Joyce 
et al, 2009; Meyer et al, 2003; O'Sullivan et al, 2011). The main contributors of PUFA intake are 
meat products and fat & oils (Joyce et al, 2009; Meyer et al, 2003; O'Sullivan et al, 2011; Sioen et al, 
2013), however, in a study in Irish adolescents chipped and fried potatoes have been shown to be an 
important source as well (Joyce et al, 2009). The essential FA intake originates mainly from fat & 
oils followed by cereal products and for ALA also from meat & poultry consumption (Meyer et al, 
2003; O'Sullivan et al, 2011; Sioen et al, 2007). The LCn-6PUFA, AA, is mainly derived from meat 
& poultry (Meyer et al, 2003; Sioen et al, 2007) whilst the LCn-3PUFA, EPA and DHA are mainly 
derived from fish and marine foods (Meyer et al, 2003; Sioen et al, 2007). However, as meat & 
poultry are consumed more frequently and in larger amounts than fish & fish products, a 
considerable amount of the EPA and DHA is also delivered by these products (Howe et al, 2006; 
Meyer et al, 2003). Moreover, docosapentaenoic acid (DPA; C22:5n-3), another LCn-3PUFA, has 
been shown to be mainly delivered by meat & poultry with fish & fish products being only the 
second most important contributor (Howe et al, 2006; O'Sullivan et al, 2011).  
Finally, as stated above, fortified foods can be an important source of FA intake. O‟Sullivan et al. 
(2011) found in a study of Australian adolescents that n-3 fortification in bread accounted for 17.2% 
of the total n-3 from bread, and were the only sources of LCn-3PUFA in breads. N-3 enrichment of 
eggs contributed to 8.8% of the total n-3 from eggs but only 2.6% of the LCn-3PUFA from eggs. 
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I.6 DETERMINANTS OF FATTY ACID STATUS 
The FA serum status is partly determined by the diet, however, it is not merely a reflection of the 
dietary intake but it can be influenced by different environmental factors as well as endogenous 
factors, such as FA synthesis, metabolism and partitioning in lipid pools (Jenab et al, 2009). As this 
thesis focuses on the serum PL FA concentration, the main determinants of the serum PL FA 
composition in humans will be reviewed in the following section.   
 
I.6.1 ENDOGENOUS FACTORS 
I.6.1.1 GENETIC BACKGROUND 
The importance of the genetic influence on serum FA composition is largely unexplored (Jenab et al, 
2009). In the 1960s a study in prisoners from different ethnic groups, consuming the same diet 
reported no significant differences in FA composition of plasma PL (Antonis and Bersohn, 1962). 
However, more recent findings showed that monozygotic twins, living apart, had a remarkable 
concordance in their FA composition (Kunesova et al, 2002). Also, Guerra et al. showed that there 
was a tracking of plasma LC-PUFA levels in children in the absence of tracking of dietary intake 
patterns (Guerra et al, 2007). These findings suggest that there is an interindividual variation in the 
ability to control the FA composition, which could most likely be due to genetically determined 
differences in metabolic turnover, such as specificity for certain FA to be incorporated in the lipid 
pools or activity of desaturase and elongase enzymes catalyzing the conversion of the PUFA in 
humans.  
More evidence for the influence of genetic background on the FA status comes from genome wide 
association studies (GWAS) in which associations are examined between common genetic variants 
and several traits in large study populations. Indeed, a single nucleotide substitution in a DNA 
sequence can lead to a loss of function or formation of a variant protein with altered properties 
(Nussbaum et al, 2004). Some DNA changes, however, may have no phenotypic effect, either 
because the change does not alter the primary amino acid sequence or because the resulting change 
does not alter the functional properties of the protein. Moreover, most of the genetic variation is 
found in extragenic sequences or in noncoding regions of the chromosomes (Nussbaum et al, 2004). 
When alleles are so common that they are found in more than 1 percent of chromosomes of the 
general population, the alleles constitute what is known as a genetic polymorphism. Single 
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Nucleotide Polymorphisms (SNP‟s) are more frequent in non-coding than in coding regions, where 
natural selection is acting and fixating the allele of the SNP with the most favorable genetic 
adaptation (Nussbaum et al, 2004). Several GWAS with metabolic traits indentified new SNP‟s that 
might be associated with FA concentrations, an overview of the candidate genes and the suggested 
pathways are given in Table 4. 
Further investigation of these candidate genes, correcting for dietary intake and assessing possible 
interaction effects is very limited. The most studied is the FADS gene cluster. Genetic variability in 
the FADS1 and FADS2 genes (encoding Δ5- and Δ6-desaturase) has been associated with serum 
LCPUFA and lipid levels in adults (Baylin et al, 2007; Malerba et al, 2008; Martinelli et al, 2008; 
Rzehak et al, 2009; Schaeffer et al, 2006; Tanaka et al, 2009; Xie and Innis, 2008) and adolescents 
(Bokor et al, 2010). These studies have shown that the minor alleles of single nucleotide 
polymorphisms (SNPs) were associated with higher levels of LA and lower levels of AA in serum 
phospholipids (Bokor et al, 2010). Furthermore, Schaeffer et al. estimated that 28% of the variance 
of AA and up to 12% of the variance of its precursors could be explained by SNPs in the FADS gene 
cluster (Schaeffer et al, 2006).  
However, further exploration of other promising candidate genes of which associations have been 
replicated in independent populations such as ELOVL2, LIPC, GCKR, etc. is lacking. Results of such 
studies might be of importance because, depending on the genetic variants, the requirements of 
dietary FA intakes to achieve comparable biological effects may differ between individuals.  
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Table 4: Overview of genes associated with FA composition in genome wide association studies 
Gene Encoded enzyme Function Suggested pathway Reference 
FADS1 fatty acid Δ5 desaturase introduction of double bonds at the Δ5 
position of the fatty acyl chain 
altered desaturase activity (Demirkan et al, 2012; Gieger 
et al, 2008; Illig et al, 2010; 
Lemaitre et al, 2011; Tanaka 
et al, 2009) 
FADS2 fatty acid Δ6 desaturase introduction of double bonds at the Δ6 
position of the fatty acyl chain 
altered desaturase activity (Demirkan et al, 2012; Gieger 
et al, 2008; Illig et al, 2010; 
Lemaitre et al, 2011; Tanaka 
et al, 2009) 
LIPC hepatic lipase triglyceride hydrolase and ligand/bridging 
factor for receptor-mediated lipoprotein 
uptake 
altered activity of hydrolase (Demirkan et al, 2012; Gieger 
et al, 2008; Illig et al, 2010; 
Lemaitre et al, 2011; Tanaka 
et al, 2009) 
GCKR glucose kinase regulator protein regulatory protein inhibiting glucokinase 
in liver and pancreatic islet cells 
modulation of triglyceride levels (Demirkan et al, 2012; Gieger 
et al, 2008; Illig et al, 2010; 
Lemaitre et al, 2011) 
PLEKHH1 pleckstrin homology domain 
containing  family H  
(with MyTH4 domain) member 1 
undetermined unknown (Demirkan et al, 2012; Gieger 
et al, 2008; Illig et al, 2010) 
APOA1 Apolipoprotein A-I promotes cholesterol efflux from tissues 
to the liver for excretion and  cofactor for 
lecithin cholesterolacyltransferase (LCAT) 
alters cholesterol metabolism (Demirkan et al, 2012; Illig et 
al, 2010) 
APOA2 Apolipoprotein A-II stabilizes HDL (high density lipoprotein) 
structure 
alters HDL metabolism (Illig et al, 2010) 
APOC3 Apolipoprotein C-III inhibits lipoprotein lipase and hepatic 
lipase 
delay catabolism of triglyceride-rich 
particles 
(Demirkan et al, 2012; Illig et 
al, 2010) 
APOA4 Apolipoprotein A-IV undetermined unknown (Demirkan et al, 2012; Illig et 
al, 2010) 
APOA5 Apolipoprotein A-V role in regulating the plasma TG levels unknown (Demirkan et al, 2012; Illig et 
al, 2010) 
ELOVL2 fatty acid elongase 2 elongation of very long chain fatty acids altered elongase activity (Demirkan et al, 2012; Gieger 
et al, 2008; Illig et al, 2010) 
ACADS short-chain acyl-CoA 
dehydrogenase 
catalyzes the initial step of the 
mitochondrial beta-oxidation pathway of 
C2-C3 FA 
lower enzymatic turnover in minor 
alleles, which might result in impaired 
beta-oxidation 
(Demirkan et al, 2012; Illig et 
al, 2010) 
ACADM medium-chain acyl-CoA 
dehydrogenase 
catalyzes the initial step of mitochondrial 
beta-oxidation pathway of C4-C12 FA 
lower enzymatic turnover in minor 
alleles, which might result in impaired 
beta-oxidation 
(Demirkan et al, 2012; Illig et 
al, 2010) 
AGPAT3 1-acylglycerol-3-phosphate O-
acyltransferase 3 
transfers FA in the sn-2 position of 
lysophosphatic acid in the phospholipid 
biosynthesis pathway 
variation in specificity for DPA transfer  (Lemaitre et al, 2011) 
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Table 4 continued: Overview of genes associated with FA composition in genome wide association studies 
Gene Encoded enzyme Function Suggested pathway Reference 
PAQR9 progestin and adipoQ receptors receptor for adiponectin unknown (Demirkan et al, 2012) 
AGPAT1 1-acyl-sn-glycerol-3-phosphate 
acyltransferase alpha 
converts lysophosphatidic acid to 
phosphatidic acid 
converts lysophosphatidic acid to 
phosphatidic acid 
(Demirkan et al, 2012) 
PKD2L1 Polycystic kidney disease 2-like 1 
protein 
calcium-regulated nonselective cation 
channel 
via the SCD(FADS5) gene, located 25kb 
away, which encodes for stearoyl-CoA 
desaturase  
(delta9-desaturase)  
(Demirkan et al, 2012) 
PDXDC1 pyridoxal-dependent 
decarboxylase domain-
containing protein 1 
vitamin B6-dependent decarboxylase via the PLA2G10 gene (Phospholipase 
A2, groupX), which plays a role in 
releasing AA from cell membrane PL 
(Demirkan et al, 2012; 
Lemaitre et al, 2011) 
PNLIPRP2 pancreatic lipase-related  
protein 2  
hydrolyzing triglycerides dietary fat absorption by hydrolyzing 
triglycerides, diglycerides and 
monoglycerides 
(Demirkan et al, 2012) 
PCDH20  Protocadherin-20 undetermined, potential calcium-
dependent cell-adhesion protein 
unknown (Demirkan et al, 2012) 
ABDH3  Unknown undetermined  unknown (Demirkan et al, 2012) 
ZNF600 zinc finger protein 600 may be involved in transcriptional 
regulation 
unknown (Demirkan et al, 2012) 
ALG1 asparagine-linked glycosylation 
1, beta-1,4-mannosyltransferase 
homolog 
catalyzes the first mannosylation step in 
the biosynthesis of lipid-linked 
oligosaccharides 
catalysator in the biosynthesis of lipid-
linked oligosaccharides 
(Demirkan et al, 2012) 
KLF12 Kruppel-like factor 12 repress expression of the AP-2 alpha gene 
(activator protein-2 alpha), which is a 
developmentally-regulated transcription 
factor and important regulator of gene 
expression during vertebrate 
development and carcinogenesis 
unknown (Demirkan et al, 2012) 
DLG2 Discs, large homolog 2 interacts at postsynaptic sites to form 
multimeric scaffolds for the clustering of 
receptors, ion channels, and associated 
signaling proteins. 
unknown (Demirkan et al, 2012) 
ILKAP integrin-linked kinase-associated 
serine/threonine phosphatase 
protein serine/threonine phosphatase unknown (Demirkan et al, 2012) 
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Table 4 continued: Overview of genes associated with FA composition in genome wide association studies 
Gene Encoded enzyme Function Suggested pathway Reference 
ILKAP integrin-linked kinase-associated 
serine/threonine phosphatase 
protein serine/threonine phosphatase unknown (Demirkan et al, 2012) 
ITGA9 integrin alpha 9 mediate cell-cell and cell-matrix adhesion unknown (Demirkan et al, 2012) 
OR8I2 olfactory receptor, family 8, 
subfamily I, member 2 
recognition and G protein-mediated 
transduction of odorant signals. 
unknown (Demirkan et al, 2012) 
CDK17 cyclin-dependent kinase 17 undetermined, thought to play a role in 
terminally differentiated neurons 
unknown (Demirkan et al, 2012) 
SYT9 synaptotagmin IX undetermined, potential role in Ca2+-
dependent exocytosis of secretory 
vesicles 
unknown (Demirkan et al, 2012) 
CDH8 cadherin 8, type 2 mediate Ca-dependent cell-cell adhesion unknown (Demirkan et al, 2012) 
KCNH7 potassium voltage-gated 
channel, subfamily H  
(eag-related), member 7 
pore-forming (alpha) subunit unknown (Demirkan et al, 2012) 
ALG14 asparagine-linked glycosylation 
14 homolog 
regulates protein folding and stability in 
endoplasmic reticulum N-linked 
glycosylation 
unknown (Demirkan et al, 2012) 
SLC22A4 solute carrier family 22  
(organic cation/ergothioneine 
transporter), member 4 
elimination of  endogenous small organic 
cations and wide array of drugs and 
environmental toxins 
unknown (Illig et al, 2010) 
CPS1 carbamoyl-phosphate synthase 1 catalyzes synthesis of carbamoyl 
phosphate from ammonia and 
bicarbonate 
unknown (Illig et al, 2010) 
SLC16A9 solute carrier family 16,  
member 9 (monocarboxylic  
acid transporter 9) 
transport across the plasma membrane 
of monocarboxylates (e.g. pyruvate, 
lactate) 
mutations in the SLC16A9 gene have 
been associated with carnitine levels 
in blood 
(Illig et al, 2010) 
ETFDH electron-transferring-
flavoprotein dehydrogenase 
accepts electrons from electron-transfer 
flavoprotein (located in mitochondrial 
matrix) and reduces ubiquinone in the 
mitochondrial membrane 
unknown (Illig et al, 2010) 
MGAT1 mannosyl (alpha-1,3-)-
glycoprotein beta-1,2-N-
acetylglucosaminyltransferase 
catalyzes the first step in the conversion 
of oligomannose to N-glycans of 
glycoproteins 
altered glycosylation, which may 
affect proteins and lipids that are 
dependent on complete glycosylation 
(Jacobsson et al, 2012) 
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I.6.1.2 SEX 
Cross-sectional studies have reported higher proportions of DHA in serum PL in women than in men 
(Crowe et al, 2008; Spinneker, 2009). It is suggested that this sex difference is due to a difference in 
the conversion rate of ALA to EPA and DHA, which would substantially be greater in women than 
in men of similar age, possibly due to hormonal effects by estrogens (Burdge et al, 2002; Burdge and 
Wootton, 2002; Pawlosky et al, 2003; Smit et al, 2003). Further evidence for this hypothesis comes 
from studies with transsexual subjects where after 4 months of sex hormone therapy a significant 
increase in serum DHA was seen in male-to-female subjects and a decrease in the female-to-male 
subjects (Giltay et al, 2004b). Similar results were seen in postmenopausal women receiving 
hormone replacement therapy (Giltay et al, 2004a). 
I.6.1.3 AGE 
The effect of age on serum FA proportions has been investigated in several studies, indicating weak 
correlations (Asciutti-Moura et al, 1988; Crowe et al, 2008; de Groot et al, 2009; Holman et al, 
1979; Spinneker, 2009). Except from the study of de Groot et al., which reported an increase of EPA 
and DHA and a decrease of LA with older age (de Groot et al, 2009), none of these studies adjusted 
their analysis for dietary intakes, which could in part explain the observed differences.  
I.6.1.4 OTHER INTRINSIC FACTORS 
Several studies indicate a relation between body composition and plasma FA composition in both 
adults (Kunesova et al, 2002), adolescents (Decsi et al, 1996; Karlsson et al, 2006; Spinneker, 2009; 
Steffen et al, 2008) and children (Okada et al, 2005). In general, overweight or obese subjects had 
higher levels of MUFA and SFA (Karlsson et al, 2006; Kunesova et al, 2002; Okada et al, 2005) 
which could be attributed to an increase in de novo lipogenesis due to leptin resistance. However, 
results are contradicting and further studies are necessary. 
Furthermore, there is limited data on other diseases that could possibly influence serum FA 
concentrations. A study comparing diabetic subjects to healthy controls reported that diabetics had 
higher levels of SFA, EPA, DHA and AA (Pelikanova et al, 2001). In contrast, diabetic ketosis 
showed to be associated with a significant decrease in plasma phospholipid n-6 PUFA, especially 
AA (Bassi et al, 1996; Tilvis and Miettinen, 1985). In patients with liver disease, levels of LCPUFA 
are low (FAO, 2010; Van Biervliet et al, 2010; Watanabe et al, 1999), which could result from a 
decreased efficiency of conversion of LA and ALA which takes mainly place in the liver.  
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Apart from these disorders also metabolic diseases, resulting in an accumulation of VLCFA, should 
be mentioned. Examples of such storage diseases are Zellweger syndrome, adrenoleucodystrophy, 
infantile Refsum‟s disease, etc. 
 
I.6.2 ENVIRONMENTAL FACTORS 
I.6.2.1 DIETARY INTAKE 
Serum PL FA, are largely derived from the diet, and as such have been extensively used as 
biomarkers for dietary intake (Hodson et al, 2008; Jenab et al, 2009). Although in humans the 
absorption [(intake-excreted)/intake] of most common dietary FA is high (> 95%) (Baer et al, 2003), 
the concentration of the biomarkers cannot be translated directly into absolute levels of intake (Jenab 
et al, 2009), because, after absorption, the FA take part in several metabolic processes, as described 
above (p 22).  
The strength of association between the dietary intake and the biomarker depends on the type of FA 
analyzed, for example better correlations are found for FA that are not synthesized in vivo, such as 
trans FA, odd-chain FA, the essential FA (LA and ALA) and the LCn3PUFA (Hodson et al, 2008; 
Jenab et al, 2009). Still, reported association vary widely (e.g. the correlation between dietary intake 
and serum PL concentration of LA varies from r=0.01 to r=0.49 in cross-sectional studies) (Hodson 
et al, 2008) as competition between metabolic pathways might lead to changes in FA composition. 
For example, dietary cholesterol and high fat diets have been shown to decrease the activity of the 
desaturase enzymes and thus the conversion of LA and ALA to their long chain derivatives (Garg et 
al, 1986).  
Furthermore, analyses between diet and biomarker are limited by errors and limitations of dietary 
assessment. For example, the temporal relationship between the period of dietary assessment and the 
measurement of the FA composition must be considered (i.e. for associations between diet and FA 
composition in adipose tissue, assessment of dietary intake should cover a longer time frame 
compared to associations with FA composition in plasma TG). Also, a lot of dietary assessment tools 
are self-reported (e.g. food frequency questionnaire, 24h-recall, dietary history,...), being prone to 
under-reporting (Biro et al, 2002), moreover, the usual diet can be altered, consciously or sub-
consciously, during the recording period (Hill and Davies, 2001). Apart from the possible bias during 
the recording of the consumed food, several limitations can occur during the processing of the data. 
As such, there is a potential loss of dietary information if food ingredients need to be counted from 
mixed dishes. Also, the subsequent translation from foods to nutrients is prone to errors. Often an 
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exact match of food or preparation method is not available and a different origin of food might result 
in a very different nutrient composition (Weaver et al, 2008). Furthermore, food composition 
databases often use different analytic techniques, which might result in substantial variation in 
nutrient composition of certain foods. Finally, very few food composition databases include a 
complete set of values for individual fatty acids (Biro et al, 2002; Vuckovic et al, 2000).  
Furthermore, foods and nutrients are not eaten in isolation and can have complex interactions; also, 
nutrient bioavailability and absorption often depend on food structure, food preparation methods and 
eating patterns (Hu, 2002). For example, EPA and DHA consumed as fish are more effectively 
incorporated into plasma lipids than when consumed as capsules (Visioli et al, 2003). Another 
example can be found in the consumption of dairy products where there is evidence that consumption 
of dairy fat (high in SFA) consumed as cheese or milk does not raise total and LDL cholesterol in 
contrast to dairy fat consumed as butter (Givens, 2012; Nestel et al, 2005).  
As such, correlations between the biomarker and food intake (e.g. fish) might be more reliable than 
correlations with the individual FA (e.g. EPA and DHA) (Vandevijvere et al, 2012). To further 
account for the interactions between nutrients, food preparation methods and eating patterns and, as 
such, capture the complexity of human diets, dietary quality indices have been developed (Hu, 2002; 
Kant, 2004; Waijers et al, 2007). Over the last decades, a number of diet quality indices, measuring 
adherence to dietary guidelines, have been developed (Kant, 1996; Kennedy et al, 1995; Patterson et 
al, 1994; Waijers et al, 2007).  The majority of existing indices are, however, unsuitable for children 
and adolescents, because their development is based on dietary recommendations for adults (Manios 
et al, 2010a). Nevertheless, appropriate indices for children and adolescents have been developed, 
based on recommendations specific for these age groups (Feskanich et al, 2004; Huybrechts et al, 
2010; Kranz et al, 2008; Manios et al, 2010a; Manios et al, 2010b). However, most of these indices 
are calculated based on a combination of food and nutrient (e.g. cholesterol, natrium) intake. This 
again implies the need for detailed dietary information and use of food composition tables with its 
formerly mentioned limitations.  
I.6.2.2 PHYSICAL ACTIVITY 
The effect of exercises on FA composition of blood lipids has been extensively reviewed by 
Nikolaidis and Mougios (Nikolaidis and Mougios, 2004). They commented that reliable data in 
humans are difficult to obtain as diet cannot be completely controlled in free-living individuals. 
However, they concluded that in general, MUFA was stable or decreased and PUFA was stable or 
increased in the plasma lipid classes of trained animals and humans (Nikolaidis and Mougios, 2004).   
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I.6.2.3 OTHER ENVIRONMENTAL FACTORS 
Smoking and alcohol consumption may influence the absorption, synthesis, or metabolism of serum 
FA. In epidemiological studies, cigarette smoking and alcohol consumption was associated with 
higher levels of 16:1n-7 and OA and lower levels of DHA and AA in plasma PL (Santos et al, 1984; 
Simon et al, 1996). In contrast, a stable isotope study which was controlled for diet, reported higher 
plasma levels of n-3 fatty acids in cigarette smokers (Pawlosky et al, 2007). Thus, the observed 
decrease of LCPUFA in the observational studies could be due to differences in dietary intake.   
 
I.6.3 INTERACTION BETWEEN DIET AND GENETIC 
BACKGROUND 
Health and disease are determined by the interaction between genetics and environment (nature and 
nurture). Whilst genetic factors determine susceptibility to disease, the environmental factors 
determine which genetically susceptible individuals will be affected (Simopoulos, 2008).  
The interplay between environment and genetics acts in both ways. In nutrition, being an 
environmental factor of major importance, two research fields have been distinguished namely, 
nutrigenomics (studies on the role of nutrients on gene expression, see p 24) and nutrigenetics 
(studies of the mechanisms by which genes influence the individual differences to nutrient response 
such as nutrient absorption, metabolism, excretion, taste perception and degree of satiation, see p 37). 
Genes can be turned on and off according to metabolic signals that the nucleus receives from internal 
factors (e.g. hormones), and external factors (e.g. nutrients). Dietary-derived regulators of gene 
expression may be nutritive (e.g. FA, iron or selenium) and non-nutritive (e.g. phytochemicals) 
components of food, metabolites of food components (e.g. eicosanoids, retinoic acid), result from the 
cooking process (e.g. heterocyclic amines in cooked meat) or end products of intestinal bacterial 
metabolism (e.g. SCFA) (Harland, 2005).  
The interplay between genes and diet has been shown to influence FA status. As such, individuals 
with different polymorphisms might require different amounts of dietary FA to achieve comparable 
biological effects (Simopoulos, 2010).  
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I.7 OUTLINE AND AIMS  
This thesis is situated in the domain of nutrition and nutrigenetics as determinants of serum FA status. 
The FA status of an individual has been extensively associated with several non-communicable 
diseases such as CVD, cancer, inflammatory and auto-immune diseases (FAO, 2010). Although most 
of these diseases usually manifest in adulthood, cardiometabolic risk factors (such as hypertension, 
hyperlipidaemia, insulin resistance, obesity, etc.) may appear as early as childhood and adolescence 
(Berenson et al, 1998) and these risk factors may track into adulthood (Camhi and Katzmarzyk, 
2010). Because studies in younger age groups are generally scarce, this thesis focuses on the 
determinants of serum FA status in adolescents. The main determinants and their interactions are 
illustrated in Figure 12.  
 
 
Figure 12: Main determinants of fatty acid status and their interactions. Dark arrows indicate associations explored in the thesis, 
numbers indicate the respective chapters. 
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The present thesis was conducted in the framework of the HELENA study (Healthy Lifestyle by 
Nutrition in Adolescence). A brief discussion of this study, the measurements and indicators that 
were assessed and the analytical methods that were used, is given in Part II METHODS.  
Subsequently in Part III the results of the different studies are given. The first objective of the thesis 
was to describe the FA intake and its main food sources in a population of healthy European 
adolescents and to study the variation in intake as a function of non-dietary factors such as sex, age, 
body composition, sexual maturation, socio-economic status and physical activity. The results of this 
study are described in Chapter III.1. 
Secondly, in Chapter III.2 it was aimed to investigate the influence of specific nutrient and food 
intake on the serum PL FA concentration by exploring the correlations and the amount of variance 
that was explained by these nutritional factors.  
However, as foods and nutrients are not eaten in isolation and may have complex interactions, it is 
important to also evaluate the effect of the overall dietary habits. Therefore, an index for the overall 
dietary quality, assessing adherence to Food Based Dietary Guidelines (FBDG), was developed. In 
Chapter III.3, this DQI-A was validated by investigating whether adherence to FBDG (using the 
DQI-A as a proxy measure) was associated with better adherence to nutrient dietary 
recommendations and a better nutritional biomarker blood profile in European adolescents. 
Subsequently, in Chapter III.4, the relation between the overall diet quality (assessed using the 
DQI-A) and the FA intake and FA and lipid serum profile was evaluated. In addition, the association 
between the diet quality and inflammatory biomarkers was assessed.  
The final objective of the thesis was to investigate the combined influence of genetic predisposition 
and nutrition on the PL FA serum status. As discussed in the introduction (see p 37), several 
candidate genes have been identified in GWAS. In the current thesis the focus was put on a common 
variant in the FADS1-FADS2 gene cluster (Chapter III.5) and a promoter variant in the hepatic 
lipase gene (LIPC) (Chapter III.6). In these studies the association with the serum lipid and PL FA 
concentrations was assessed as well as the interaction with dietary intake (with FADS and LIPC) and 
physical activity (LIPC only).  
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PART II. METHODS 
Le mieux est l’ennemi du bien. 
 
The Healthy Lifestyle in Europe by Nutrition in Adolescence (HELENA) project was a European 
collaborative research project financed by the EU Sixth Framework Programme in the area of 
nutrition-related adolescent health (De Henauw et al, 2007). The project was a multi-centre study of 
the nutritional and lifestyle status of adolescents, carried out in 10 European cities (Vienna in 
Austria, Ghent in Belgium, Lille in France, Dortmund in Germany, Athens and Heraklion in Greece, 
Pécs in Hungary, Rome in Italy, Zaragoza in Spain and Stockholm in Sweden). Data were collected 
from October 2006 till December 2007. The purpose of the study was to obtain standardized, reliable 
and comparable data from a sample of European adolescents on a broad array of relevant nutrition 
and health-related parameters like dietary intake, food choices and preferences, serum indicators of 
lipid metabolism and glucose metabolism, vitamin and mineral status, anthropometry, physical 
activity, fitness and genetic markers (De Henauw et al, 2007).  
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The HELENA project has been split in four substudies: 
1. A cross-sectional study (CSS) which focuses on clinical assessment, diet, physical activity, 
body composition, blood analysis and genetics.  
2. A study on behaviour and development of new foods  
3. A lifestyle education intervention study 
4. A cross-over multi-centre study examining the effects of diets with varying degrees of 
glycaemic index.  
All work presented in this thesis is based upon data derived from the HELENA-CSS.  
 
A detailed description of the HELENA study design and sampling procedure has been published 
elsewhere (De Henauw et al, 2007; Moreno et al, 2008a; Moreno et al, 2008b).  
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II.1 STUDY POPULATION 
The study population was a city-based sample of adolescents aged 13 – 17 years in 10 European 
cities of more than 100 000 inhabitants, located in different geographical regions in Europe. The 
participating cities were selected based on geographical distribution in Europe 
(north/south/east/west), cultural reference and socio-economic situation and presence of an 
experienced research group. Figure 13 shows the random cluster sampling design (all pupils from a 
selection of classes from all schools in 10 cities) of 3000 adolescents, stratified for geographical 
location, age and socio-economic status (Moreno et al, 2008a). The sample size of 3000 adolescent 
has been estimated using BMI (confidence level 95% and + 0.3 error) as parameter with the largest 
expected dispersion with regard to the study aims (Moreno et al, 2008a).   
 
 
Figure 13: Sampling procedure scheme: (1) Geographic balance and presence of an experienced research group; (2) Strata by age, 
sex, and school in every city; (3) Strata by age, sex and school in every city  
SOURCE : Reprinted with permission from Moreno, L. A. et al., 2008, Design and implementation of the Healthy Lifestyle in 
Europe by Nutrition in Adolescence Cross-Sectional Study: Int.J.Obes.(Lond), 32 Suppl 5, p. S4-11. 
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Blood sampling was performed in one third of the recruited adolescents (selection of whole classes). 
In case a selected school could not participate, another school with comparable characteristics from a 
reserve list was taken (Moreno et al, 2008a). 
For practical reasons and considering both educational and psychological reasons, complete school 
classes were recruited, as such the age of the participating adolescents ranged between 11-19 years 
and a total number of 4372 adolescents (52.3% girls) participated in the study. Adolescents were 
excluded from the database a posteriori if they met one of the exclusion criteria, namely age <12.5 
or > 17.5 years, or lacking data on sex, weight and/or height or participating simultaneously in 
another clinical trial (Moreno et al, 2008b). The final study population comprised 3528 adolescents 
(52.3% girls) of whom 1089 adolescents (53.3% girls) provided blood samples. To maximize 
statistical power, the age restrictions were not applied for the genetic studies, this resulted in a 
sample of 1155 adolescents (47.8 % girls), aged 11.5 – 18.8 years, for these analyses.   
The study was performed following the ethical guidelines of the Declaration of Helsinki, the Good 
Clinical Practice rules, and the legislation about clinical research in humans in each of the 
participating countries. All study participants and their parents provided a signed informed consent 
form. The protocol was approved by the Human Research Review Committees of the institutions 
involved (Beghin et al, 2008). 
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II.2 MEASUREMENTS AND ASSESSMENTS 
Within HELENA-CSS a large array of measurements was performed in order to establish a complete 
overview of the nutritional and lifestyle status of European adolescents: a clinical examination 
including assessment of pubertal stage and body composition, blood sampling, dietary assessment, 
objective and self-reported assessment of physical activity and fitness, questionnaires on nutritional 
knowledge, dietary habits and preferences, sedentary behaviour and determinants of diet and 
physical activity. The methodological aspects of these measurement tools have been described 
previously (Gonzalez-Gross et al, 2008; Hagstromer et al, 2008; Moreno et al, 2008b; Nagy et al, 
2008; Vereecken et al, 2008); an overview of the measurements relevant for the present thesis is 
outlined below.  
 
II.2.1 DIETARY INTAKE ASSESSMENT 
II.2.1.1 24H DIETARY RECALL 
The dietary intake assessment was performed by a computer-based tool for self-reported 24h recalls, 
HELENA-DIAT (Dietary Assessment Tool). This tool was based on a previous version developed 
for Flemish adolescents, called Young Adolescents‟ Nutrition Assessment on Computer (YANA-C) 
and has been proven to give a valid measurement of food consumption compared to an interview by 
a dietitian (Vereecken et al, 2008). Food intake referred to the day before the 24h recall assessment 
and was divided into six meal occasions. For each occasion the user was invited to select all the 
consumed food items and beverages from a standardized food list. Foods and beverages not included 
in the list could be added at all times. Information on quantities was gathered by using household 
measurements or pictures of portion sizes. Control mechanisms were built in to remind the 
participant to report all consumed foods in case of frequently used combinations (e.g. if French fries 
were selected, consumption of sauces was inquired). Furthermore a warning was given when extreme 
amounts or zero values were entered. After completing each meal occasion, the program checked for 
beverages, for milk when cornflakes were consumed and for butter or margarine when bread was 
consumed. At the end of the 24-h recall, the program checked the entries for occurrence of fruit, 
vegetables and sweets. If one of these items had not been entered, the adolescent was asked to 
confirm. The interview ended with an overview of all food entries on the different meal occasions, 
asking the adolescents to review this list and adapt where appropriate. After entering a password, 
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which was done by a field worker, the energy intake was shown as a check for the field workers 
(Vereecken et al, 2008). The self-administration took place in a computer classroom where the pupils 
completed the program autonomously whilst field workers were present to give assistance if 
necessary (Vereecken et al, 2008). Two non-consecutive 24-h recalls were collected for each 
participant, comprising both weekdays as weekend-days, though not necessarily a weekday and 
weekend-day for each participant. Days of assessment were randomly selected in each school; 
however, as the 24h recalls were collected at school, no data was available on dietary intake on 
Fridays and Saturdays.  
II.2.1.2 FOOD FREQUENCY QUESTIONNAIRE 
In addition, food intake was assessed by means of a brief food frequency questionnaire (FFQ) that 
was used in the Health Behaviour in School-aged Children (HBSC) Study (Vereecken et al, 2005). 
The aim of the FFQ was not to provide quantitatively precise estimates of nutrient intakes, but to 
assess the intake of important sources of dietary fibre and calcium as well as the intake of a number 
of popular nutrient-low food items, in order to provide crude information on subgroup differences 
and trends in dietary intakes of these food items (Vereecken et al, 2005). The FFQ consisted of the 
following items: fruits, vegetables, sweets (candies or chocolates), coke or other soft drinks that 
contain sugar, diet coke or diet soft drinks, low-fat/semi-skimmed milk, whole-fat milk, cheese, other 
milk products (like yoghurt, chocolate milk, pudding and quark), cereals (like cornflakes, muesli and 
choco pops), white bread, brown bread, crisps, French fries. In the HELENA study a 15
th
 item 
namely fish intake was added. Participants were asked to indicate the frequency of eating these foods 
by ticking one of the following seven responses: (1) never; (2) rarely, less than once a week; (3) once 
a week; (4) 2–4 times a week; (5) 5–6 times a week; (6) once a day, every day; and (7) more than 
once a day, every day.  
II.2.1.3 DATA PROCESSING 
a. Food composition table 
Food intake data from the 24h recalls were converted to estimated nutrient intakes by use of the 
German Food Code and Nutrient Data Base (Bundeslebensmittelschlüssel, BLS Version II.3.1) 
(Dehne et al, 1999). It was decided to use the same food composition table for the different European 
countries in order to promote comparison of nutrient intake and to overcome  differences in 
definitions, analytical methods, units and modes of expression that exist between different tables. 
The BLS is based on German, American, English, Swedish, Danish and Dutch food composition 
tables, on analytical values of food producing firms, publications and research results of the Federal 
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Research Centers and Universities (http://bls.nvs2.de). The BLS includes about 11000 raw and 
cooked foods and recipes and is widely used in epidemiological studies. Furthermore the BLS is one 
of the tables giving the most complete coverage of the individual FA (Deharveng et al, 1999). 
Although most of the recipes had been decomposed into ingredients, some complex foods that were 
available in the food composition table have been linked to the complex food directly (e.g. coffee or 
tea with milk were linked to these complex foods directly, without disaggregation in coffee/tea and 
milk).  
b. Multiple Source Method 
The Multiple Source Method (MSM) is a statistical modelling technique estimating usual dietary 
intake of nutrients and foods from short-term measurements (https://nugo.dife.de/msm; Haubrock et 
al, 2011). The method combines dietary intake data, such as 24h dietary recalls or food records, with 
data on consumption frequency from for example FFQ (used to determine the proportion of habitual 
consumer and habitual non-consumer). If no information on consumption frequency is available it 
can be assumed that all subjects are habitual consumers or that a certain percentage is habitual non-
consumer (https://nugo.dife.de/msm). This assumption can be based upon population specific data or 
upon the short-term measurements. For nutrient intakes all participants can be considered as habitual 
consumers by default, given the fact that the same nutrients derive from different food sources. 
 
The usual dietary intake is estimated with MSM in a three step procedure:  
 First, the probability of eating a certain food on a random day is estimated for each individual 
(Haubrock et al, 2011) by a logistic regression model that may contain a set of covariates 
assumed to be predictive for consumption like sex and age as well as information on 
consumption frequency, if available (https://nugo.dife.de/msm).   
 Secondly, the usual amount of food intake on a consumption day is estimated by applying a 
linear regression model with the observed food intake as a function of covariates that are 
assumed to be predictive for dietary intake, such as sex and age as well as consumption 
frequency, if available (https://nugo.dife.de/msm).   
 Finally, the resulting numbers from step one and two are multiplied to estimate the usual 
daily food or nutrient intake for each individual. 
 
In the HELENA project, study centre, age, sex and an interaction term for age and sex were 
considered as covariates. As only a limited number of participants provided data on consumption 
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frequency in a FFQ (because this was an optional part in the study), and as this FFQ was very 
limited, these data have not been included and all participants have been considered as habitual 
consumers for both foods and nutrients.  
In the present thesis, these MSM derived estimates of usual dietary nutrient and food intake were 
used as indicators for dietary intake.   
c. Underreporters 
Identification of underreporters of dietary intake data was based on the criteria of Goldberg 
(Goldberg et al, 1991). Underreporting was considered when the ratio of energy intake (EI) on 
estimated basal metabolic rate (BMRest) was lower than 0.96 (Black, 2000).This cut-off is the lower 
confidence limit of the equation of Goldberg, taken into account an evaluation at the individual level 
(n=1), based on dietary intake data of 2 days (d=2) and a physical activity level for a normally active 
but sedentary population (PAL=1.55) (Black, 2000).  
𝐸𝐼𝑟𝑒𝑝 : 𝐵𝑀𝑅𝑒𝑠𝑡 > 𝑃𝐴𝐿 𝑥 𝑒𝑥𝑝  𝑠𝑑𝑚𝑖𝑛 𝑥
(𝑆 100) 
 𝑛
  
with  𝑆 =   
𝐶𝑉𝑤𝐸𝐼
2
𝑑
 + 𝐶𝑉𝑤𝐵
2 + 𝐶𝑉𝑡𝑃
2  
Where sdmin is -2 for the 95% confidence interval, CVwEI is the within-subject coefficient of variation 
in energy intake, CVwB is the coefficient of variation of the precision of the estimated BMR 
compared to the measured BMR, and CVtP is the total variation in PAL.  
BMRest was calculated with the equations of the FAO/WHO/United Nations University, based on the 
weight and sex of the adolescent (WHO, 1985).   
Boys: BMRest = 17.5 x weight(kg) + 651 
Girls: BMRest = 12.2 x weight(kg) + 746 
For obese adolescents the equations, including weight and height were used (Dietz et al, 1991). 
Boys: BMRest = 16.6 x weight(kg) + 77 x height(m) + 572 
Girls: BMRest = 7.4 x weight(kg) + 482 x height(m) + 217 
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II.2.2 PHYSICAL EXAMINATION 
For the anthropometric measurements participants were barefoot and in underwear. Weight was 
measured with an electronic scale (model 861, SECA, Hamburg, Germany) to the nearest 0.1 kg. 
Height was measured with the head in the Frankfort plane position using a telescopic stadiometer 
(model 225, SECA, Hamburg, Germany) to the nearest 0.1 cm. A set of skinfold thicknesses (biceps, 
triceps, subscapular, suprailiac, thigh and calf) and circumferences (waist and hip) were measured 
three times on the left side of the body, with a Holtain caliper (to the nearest 0.2 mm) and with a non-
elastic tape (Seca 200) to the nearest 0.1 cm, respectively, according to Lohman‟s anthropometric 
standardization reference manual (Nagy et al, 2008). Pubertal status (stages I-V) was assessed by a 
medical doctor according to Tanner and Whitehouse (Tanner and Whitehouse, 1976), based on breast 
development and pubic hair status in females and genital and pubic hair development in males.  
During data processing, indicators for body composition were derived from the actual measurements. 
BMI was calculated as body weight in kilograms divided by the square of height in meters. In 
addition, BMI was adjusted for age and sex to give a BMI standard deviation score (SDS) using 
British 1990 Growth Reference Data from the Child Growth Foundation (Cole et al, 1995). Body fat 
percentage was obtained from the triceps and subscapular skin folds using the Slaughter formulae 
(Slaughter et al, 1988), which seem to be the most suitable to be used in adolescents (Rodriguez et 
al, 2005).  
 
II.2.3 PHYSICAL ACTIVITY AND FITNESS 
A measure for physical activity was obtained by the International Physical Activity Questionnaire for 
Adolescents (IPAQ-A), assessing the physical activity over the past 7 days. The validity of this 
questionnaire has been published previously (Hagstromer et al, 2008). IPAQ-A covers four domains 
of physical activity: school-related physical activity (including activity during physical education 
classes and breaks), transportation, housework and activities during leisure time. To limit over-
reporting, the time spent in walking was requested before the time spent in moderate or vigorous 
physical activities (Ottevaere et al, 2011).  
Furthermore, in the HELENA study, physical activity was objectively measured by accelerometry 
(Actigraph model GT1M, Manufacturing Technology Inc., Pensacola, FL). This uni-axial 
accelerometer measures accelerations in the vertical axis. The adolescents wore the accelerometers 
on the lower back, underneath clothing and only during waking hours, during 7 consecutive days. 
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The adolescents were asked to keep a non-wear activity diary during the recording period. They were 
asked to record the times at which the accelerometer was put on and removed as well as the reason 
for removing the device during waking hours and a description of the activities done during those 
periods (Ottevaere et al, 2011). Although accelerometry is an objective measure of physical activity 
there are some drawbacks to this technique. First, activities such as cycling and carrying heavy loads 
may be recorded as little or no activity with uni-axial accelerometers as these activities do not induce 
large changes in the vertical axis. Secondly, since accelerometers should be removed during certain 
activities, they may underestimate physical activity levels when not taken into account the non 
wearing time and activities (Ottevaere et al, 2011). In the HELENA study, swimming and sports 
with a high probability of contact with other participants or objects (e.g. team sports, gymnastics, and 
fighting sports) were the activities most frequently mentioned as being undertaken when not wearing 
the accelerometer (Ottevaere et al, 2011). Since valid non-wearing diaries were unavailable for a 
large number of adolescents in the HELENA study, it was decided to not use the accelerometry data 
in the present thesis.  
Physical fitness was assessed by means of several tests such as the backsaver sit-and-reach test, the 
handgrip test, the standing broad jump test, bent arm test, etc (Moreno et al, 2008b). To assess 
cardiorespiratory fitness a 20-m shuttle run test was performed as described earlier by Léger et al. 
(1984). Participants were required to run between two lines 20 m apart, while keeping the pace with 
audio signals from a pre-recorded CD. The initial speed was 8.5 km/h, which was increased by 0.5 
km/h per minute. Participants were instructed to run in a straight line, to pivot on completing a 
shuttle, and to pace themselves in accordance with the audio signals. The test was finished when the 
participant failed to reach the end lines concurrent with the audio signals on two consecutive 
occasions. Otherwise, the test ended when the subject stopped because of fatigue.  
During data processing, activities from the IPAQ-A were classified into low, moderate and vigorous 
activity according to the guidelines for data processing and analyses of IPAQ 
(http://www.ipaq.ki.se/ipaq.htm). To avoid over-estimations, physical activity scores were truncated 
in the different domains (school: max 1800 min/week or 4 h/day; home: max 1680 min/week or 4 
h/day; transport: max 1290 min/week or 3 h/day; leisure time: max 1680 min/week or 4 h/day; total 
physical activity: max 2540 min/week or 6 h/day) as well as in the different intensity domains (max 
1260 min/week or 3 h/day for moderate and vigorous physical activity) (Haerens et al, 2007; 
Ottevaere et al, 2011). In the present thesis, the indicator used for physical activity was obtained by 
summing the total, truncated, time spent on moderate and vigorous activity.  
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As indicator for cardiorespiratory fitness, maximal oxygen consumption (VO2max) was selected. 
This was estimated from the 20-m shuttle run test via the Ruiz equations, based on the performance 
in the shuttle run test, age, sex, weight and height of the adolescent (Ruiz et al, 2008).   
 
II.2.4 SOCIO-ECONOMIC STATUS 
Questionnaires completed by the adolescents were used to collect data on socioeconomic status 
(SES). It has been shown that children of 11–12 years old were able to describe their parents‟ 
occupation in sufficient detail in a survey setting (Looker, 1989; West et al, 2001). Furthermore, 
Looker concluded in a review of 30 studies that proxy reports from children and adolescents can be 
seen as accurate indicators of parental status characteristics if the child responders are high school 
seniors, when most of the children in the sample can be expected to be living at home with the 
relevant parent and when the children are asked to report on current status characteristics that are 
likely to have some salience to them (Looker, 1989). The self-reported SES questionnaire used in the 
HELENA study collected information on (Iliescu et al, 2008): 
 living conditions  
 family structure  
 employment status of both parents  
 occupation of both parents  
 education level of both parents 
 subjective family affluence  
In the present thesis, maternal education level (lower education, secondary education and higher or 
university education) was chosen as an indicator for socioeconomic status of the adolescents. Also 
the Family Affluence Scale (FAS) was calculated based on the concept of material conditions in the 
household. Calculation of the score is based on ownership of a private bedroom by the adolescent 
and the number of cars, the number of computers and internet access at home (Currie et al, 2008). 
The scores were coded in low, medium and high FAS. 
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II.3 BLOOD SAMPLING AND ANALYSES 
After an overnight fasting period venous blood samples were drawn in the morning at school 
according to a standardized collection protocol (Gonzalez-Gross et al, 2008). Details about the 
sampling, processing and transportation can be found elsewhere (Gonzalez-Gross et al, 2008). In 
short, after blood collection, serum samples were clotted at room temperature for at least 30 minutes. 
Subsequently, the serum samples were centrifuged directly at the school at 3500 rpm for 15 min 
(room temperature). Aliquots for FA analyses were stored locally at -20°C/-80°C as soon as possible, 
no antioxidant or stabilizer was used to avoid FA oxidation. After all fieldwork of one center was 
finished these samples were transported once, all together, to the central laboratory (IEL, Bonn, 
Germany) on dry ice. The remaining serum blood samples for routine lipid parameters and the 
EDTA tubes for genotyping analyses were sent the day of blood collection, at room temperature, to 
the Analytical Laboratory from the University Hospital of Bonn. The EDTA aliquots were stored at 
Bonn until they were sent to the Genomic Analysis Laboratory at the Institut Pasteur de Lille (Lille, 
France) for further analysis. The serum aliquots for lipid parameters were analyzed at the central 
laboratory of Bonn within 24 hours after blood collection (Spinneker, 2009).  
 
II.3.1 FATTY ACIDS ANALYSIS 
Serum samples were defrosted at room temperature and an internal standard (1,2-dipentadecanoyl-
sn-glcerol-3-phosphocholine) was added (Spinneker, 2009). The FA extraction was based on a 
modified method (Spinneker, 2009) by Folch (Folch et al, 1957) and Sperry and Brand (Sperry and 
Brand, 1955). Subsequently, the PL fraction was separated using thin-layer chromatography 
(Gonzalez-Gross et al, 2008). The PL band was scraped off and the FA were converted into their 
methyl esters by trans-esterification with methanol/hydrochloric acid. The fatty acid methyl esters 
(FAME) were analyzed using Gas Chromatography (Model 3900, Varian GmbH, Darmstadt, 
Germany) on a 30m x 0.25mm x 0.25µm polyethylene glycol column (Zebron ZB-WAXplus, 
Phenomenex). Peaks of interest were identified by comparison of the retention time with authentic 
FAME standards (Sigma-Aldrich).   
FA were expressed as area% by dividing the area under the peak for each FA by the total area for all 
FA. The area under the peak was calculated by integration, expressed in µV/min, with standard 
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software (Galaxie CDS, version 1.8.14.1.) provided by Varian GmbH (Darmstadt, Germany) 
(Spinneker, 2009).  
The intra-assay precision of the gas chromatography was evaluated by measuring the different 
FAME reference standards in three different runs. The coefficient of variation was < 4.4% for all FA 
analyses. 
 
II.3.2 OTHER BIOCHEMICAL ANALYSES 
Serum triglycerides (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C) and 
low-density lipoprotein cholesterol (LDL-C) were measured enzymatically on the Dimension RxL 
clinical chemistry system (Dade Behring, Schwalbach, Germany) using the manufacturer‟s reagents 
and instructions. Apolipoprotein A-1 and B concentrations were measured in an immunochemical 
reaction with a BN II analyzer (Dade Behring, Schwalbach, Germany) according to the 
manufacturer‟s instructions. The proteins contained in the serum sample form immune complexes 
with specific antibodies, scattering a light beam that is passed through the sample. The intensity of 
the scattered light is proportional to the concentration of the relevant protein in the sample. The result 
is evaluated by comparison with a standard of known concentration.  
Plasma folate was measured by means of an immunoassay using the Immunolite 2000 analyzer (DPC 
Biermann GmbH, Bad Nauheim, Germany). Holo-transcobalamin (the biological active form of 
vitamin B12) was determined by an automated microparticle enzyme immunoassay with the AxSYM 
analyzer (Abbott Laboratories, Abbott Park, IL). Vitamin C, β-carotene and retinol were analyzed by 
high-performance liquid chromatography (Sykam Gilching, Germany) using ultraviolet detection 
(UV-Vis 205, Merck, Darmstadt, Germany). Plasma 25(OH)D was analysed by ELISA using a kit 
(OCTEIA 25-Hydroxy Vitamin D) from Immunodiagnostic System (Germany) and measured with a 
SunriseTM Photometer by TECAN (Germany).  
CRP was measured in serum by immunoturbidimetry (AU2700 biochemistry analyzer; Olympus, 
Watford, UK). Serum cytokines IL-1, IL-6, INF-γ and TNF-α were determined using the High 
Sensitivity Human Cytokine MILLIPLEXTM MAP kit (Millipore Corp., Billerica, MA, USA) and 
collected by flow cytometry (Luminex-100 v.2.3, Luminex Corporation, Austin, TX, USA) 
(Gonzalez-Gross et al, 2008).  
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II.3.3 SNP GENOTYPING 
Blood for DNA extraction was collected in EDTA K3 tubes, stored at the Analytical Laboratory 
from the University Hospital of Bonn and then sent to the Genomic Analysis Laboratory at the 
Institut Pasteur de Lille (Lille, France). DNA was extracted from white blood cells with the Puregene 
kit (QIAGEN, Courtaboeuf, France) and stored at -20°C. Adolescents were genotyped on an Illumina 
system using GoldenGate technology. 
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PART III. RESULTS 
Freedom is not worth having if it does not include the freedom to make mistakes. 
 (Mahatma Gandhi) 
In this part of the thesis the different studies that were conducted are described. The first chapter 
(Chapter III.1) handles on the FA intake and its main food sources in the adolescents that 
participated in the HELENA study. In order to get an insight in the factors which influence the 
habitual FA intake, the variation in intake as a function of non-dietary factors, such as sex, age, body 
composition, sexual maturation, socio-economic status and physical activity, was assessed.     
Subsequently it was explored to which extent the dietary intake influences the FA serum status. 
Firstly, in Chapter III.2 the correlation between the intake of specific nutrients or foods and the 
serum PL FA status was assessed. Secondly, as nutrients and foods are not eaten in isolation, the 
association between the overall dietary habits and the serum FA concentrations was evaluated 
(Chapter III.4). Hereto an overall index of the dietary quality, the Diet Quality Index for 
Adolescents (DQI-A) was developed and validated in the HELENA study population (Chapter 
III.3).  
Finally, the combined influence of nutrition and genetic predisposition on the FA serum status in 
adolescents was investigated. This was done for a common SNP in the FADS1-FADS2 gene cluster 
(Chapter III.5) and for a promoter variant in the LIPC gene (Chapter III.6). 
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ABSTRACT  
Dietary fatty acids (FA) play a role in several (patho)physiological processes at any age, and 
different FA have different effects on lipid status and health outcome. This study aims to describe the 
FA intake and its main food sources in a population of healthy European adolescents and to assess 
the variation in intake as a function of non-dietary factors. FA intake was assessed with 24h-recall 
interviews in 1804 adolescents aged 12.5-17.5. Usual intakes were calculated using the Multiple 
Source Method. Multilevel analyses, adjusting for study centre, were used to investigate the 
influence of non-dietary factors. The mean total fat intake was 33.3% of total energy intake (%E) 
(SD 1.2). The mean saturated fatty acid (SFA) intake was 13.8 %E (SD 1.2), with 99.8% of the 
population exceeding the recommendations. SFA was mainly delivered by meat and 
cake/pies/biscuits. In most adolescents, the poly-unsaturated fatty acid intake was too low, and the 
minimum recommended intake for alpha-linolenic acid (ALA) and the long chain n3PUFA was not 
achieved by 35.5% and 74.3% of the population, respectively. The main determinants of FA intake in 
our study population were age and sex, as well as physical activity in the male subgroup. No 
contributions of body composition, socioeconomic status or sexual maturation to the variance in FA 
intake were observed. In conclusion, the most important public health concerns regarding FA intake 
in this adolescent population were the low intake of n3FA and the high intake of SFA, mainly seen in 
the younger-aged boys. In this group the major contributor to SFA was meat. Changing meat 
consumption to vegetarian alternatives or fish and stimulating a more frequent use of linseed and 
rapeseed oil in meal preparation could substantially contribute to a higher intake of n3FA and lower 
intakes of SFA. 
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III.1.1 INTRODUCTION 
Diet and more specifically intake of fats and fatty acids has been extensively correlated with 
cardiovascular disease (CVD) risk (Hu and Willett, 2002). Although CVD usually manifests in 
adulthood, cardiometabolic risk factors (such as hypertension, hyperlipidemia, insulin resistance, 
obesity, etc.) can already settle during childhood and adolescence (Berenson et al, 1998). These risk 
factors may track into adulthood (Camhi and Katzmarzyk, 2010), demonstrating the importance of 
direct research and intervention for CVD towards younger age groups such as adolescence. Apart 
from this well documented association with CVD, dietary fats also play a role in modulation of 
immune functions and inflammatory processes (Calder, 2009a; FAO, 2010), growth and 
development (Innis, 2007), mental and neurodegenerative diseases and possibly in certain forms of 
cancer (FAO, 2010). 
Studies assessing the intake of fats generally show that too high amounts of saturated fatty acids 
(SFA) and too low amounts of poly-unsaturated fatty acids (PUFA) are consumed compared to 
current dietary guidelines (Elmadfa et al, 2009; Harika et al, 2011; Joyce et al, 2009; O'Sullivan et 
al, 2011). Although blood lipid and fatty acid status are not only determined by their individual 
intake, most studies only assess the intake of total fat, SFA, PUFA, mono-unsaturated fatty acids 
(MUFA) and cholesterol. However, it has been shown that different fatty acids (FA) may have 
different effects on lipid status and health outcome. Whilst SFA with 12-16 carbon atoms tend to 
increase plasma total and LDL cholesterol levels, stearic acid (C18:0) does not have a cholesterol 
raising effect (Kris-Etherton and Yu, 1997). Replacement of SFA in the diet by both n-6 or n-3 
PUFA reduces the risk of CVD (Mozaffarian, 2011) but the biological pathways behind these effects 
differ (Kuller, 2011). Regarding their influence on lipid status, n-6 FA have a LDL cholesterol 
lowering effect (Rassias et al, 1991) whilst n-3 FA reduce triglyceride levels (Harris, 1989). In 
contrast, replacement of SFA by carbohydrates can even increase the risk of CVD (Willett, 2011). 
Also sex differences have been reported regarding effects of dietary fat on CVD by lowering the 
HDL cholesterol and increasing the levels of triglycerides (Mozaffarian et al, 2004). As such, it is 
accepted that the food sources and type of fat consumed is most probably of greater importance than 
the total amount of fat, although the optimal intake of different FA remains unsettled (Hu et al, 2001; 
Willett, 2011). 
Numerous dietary surveys have been conducted across Europe at national and local level; however 
only little information exists on the usual dietary intake of healthy adolescents. Furthermore, 
comparison between these studies is often difficult because of differences in dietary intake 
assessment methods (Harika et al, 2011), failure to exclude under-reporters, lack of anthropometric 
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data and varying age categories (Lambert et al, 2004). Besides, in different countries, various food 
composition tables are used for the conversion of food intake data into the estimated nutrient intakes, 
making comparisons difficult and inaccurate (Harika et al, 2011; Lambert et al, 2004).   
To our knowledge, few studies have examined the influence of certain determinants on the intake of 
fat and individual FA. The objective of this study was to describe the FA intake and its main food 
sources in a population of healthy European adolescents and to study the variation in intake as a 
function of non-dietary factors such as sex, age, body composition, sexual maturation, 
socioeconomic status and physical activity.  
 
III.1.2 SUBJECTS AND METHODS 
 
III.1.2.1 STUDY DESIGN AND POPULATION 
Data were obtained from the HELENA-Cross Sectional Study (HELENA-CSS) that has been 
described in more detail in Part II  Methods.   
For the purpose of this study, only adolescents with two 24h dietary recall assessments were included 
in the analyses, resulting in 2330 cases. As such, all participants from Heraklion (Greece) and Pécs 
(Hungary) (n =678) were excluded for these analyses as no nutrient intake information could be 
calculated for these two cities. Furthermore, exclusion of under-reporters resulted in a valid sample 
of 1804 adolescents (53 % females). In this sample, information on physical activity was only 
available in 800 boys and 893 girls resulting in a total, final study population of 1693 adolescents for 
these analyses.  
III.1.2.2 DATA COLLECTION 
The methods of data collection have been described in more detail in Part II Methods. Briefly, the 
dietary intake assessment was performed by use of the HELENA-DIAT (Dietary Assessment Tool) 
and the Multiple Source Method (MSM) was used to estimate the habitual dietary intake of nutrients 
and foods (https://nugo.dife.de/msm; Haubrock J. et al, 2010).  
Height and weight were measured in fasting state and the BMI standard deviation score was 
calculated subsequently. Body fat percentage was calculated from the triceps and subscapular skin 
folds using the Slaughter formulae (Slaughter et al, 1988). Pubertal status (stages I-V) was assessed 
by a medical doctor according to Tanner and Whitehouse (Tanner and Whitehouse, 1976). Data on 
maternal education level and physical activity were collected by self-reported questionnaires.  
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III.1.2.3 STATISTICAL ANALYSES 
PASW 18.0 for Windows (SPSS Inc., Chicago, IL, USA) was used. Characteristics of the study 
sample are presented as mean (standard deviation), unless otherwise stated. Baseline characteristics 
between both sexes were compared using a Student‟s t-test or Mann-Whitney U-test for continuous 
variables and Pearson χ²-test for categorical variables.  
Associations between the usual fatty acid intake and its determinants (sex, age, body composition, 
sexual maturation, maternal education and physical activity) were tested with multilevel analysis to 
correct for the study design (clustering of cases within cities). Fatty acid intake was expressed as 
percentage of energy (%E) to correct for the varying total energy intake between different age groups 
and sex. Tests for normality were performed using the Kolmogorov-Smirnov test. Variables on usual 
intake were logarithmically transformed and geometrical means and 95% confidence intervals were 
reported. Because of physiological differences occurring during puberty, all values were presented 
stratified by sex. Differences between sexes within the same age group were assessed with a 
multilevel analyses stratified for age group. To correct for multiple testing a Bonferroni correction 
was applied, as such a p-value of 0.003 (0.05/18=0.003) was used as the threshold of significance 
and p-values between 0.003 and 0.01 were denoted as borderline significant. Two-sided significance 
levels were quoted. 
The usual daily intakes of total fat, SFA and PUFA were compared with recommended population 
goals in adolescents. According to the recommendation of the Food and Agriculture Organization 
(FAO) (FAO, 2010), the selected goals were as follows: total fat 25-35% of total energy intake (%E), 
SFA < 8%E, PUFA 6-11%E, linoleic acid (LA) > 2.5%E, alpha-linolenic acid (ALA) > 0.5%E and 
eicosapentaenoic acid (EPA) + docosahexaenoic acid (DHA) 250-2000mg/d. Differences between 
groups were assessed with a Pearson χ²-test.  
The population proportion formula was used to determine the percentage contribution of food groups 
to the intake of fats and fatty acids. This was done by summing the amount of the component 
provided by the food for all individuals divided by the total intake of that component from all foods 
for the entire study population (Krebs-Smith et al, 1989; O'Sullivan et al, 2011; Sioen et al, 2007).  
 
III.1.3 RESULT 
The mean age was 14.7 years (SD 1.2) with a median BMI of 20 kg/m², most participants (92%) 
were categorized in Tanner stage 3 or higher. Significant sex differences were found for Tanner stage 
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with more males having a prepubertal Tanner stage. Characteristics of the study population for both 
sexes separately can be found in Table 5.  
 
Table 5: Basic characteristics of the study population as mean (standard deviation) 
    Boys   Girls   p 
N (N%) 
 
855 (47.4) 
 
949 (52.6) 
  Age (years) * 
 
14.8 (1.3) 
 
14.7 (1.2) 
 
0.312 
BMI(kg/m²) † 
 
19.9 (14.2 ; 35.2) 
 
20.2 (14.1 ; 40.8) 
 
0.084 
SDS BMI* 
 
0.4 (1.1) 
 
0.2 (1.0) 
 
0.001 
BMI category‡ Underweight 58 (6.8) 
 
84 (8.9) 
 
0.060 
 
Normal weight 649 (75.9) 
 
734 (77.3) 
  
 
Overweight 114 (13.3) 
 
108 (11.4) 
  
 
Obese 34 (4.0) 
 
23 (2.4) 
  
Body fat percentage 1, † 16.0 (6.3 ; 64.6) 
 
24.2 (10.7 ; 54.8) 
 
<0.001 
Physical activity (min/week) 2, † 680.0 (0.0 ; 2520.0) 
 
455.0 (0.0 ; 2520.0) 
 
<0.001 
Tanner 3, ‡  Stage 1 & 2 94 (11.4) 
 
45 (4.9) 
 
<0.001 
 
Stage 3 200 (24.2) 
 
232 (25.1) 
  
 
Stage 4 329 (39.8)  403 (43.6)   
 
Stage 5 204 (24.7) 
 
245 (26.5) 
  
Education Mother 4, ‡ Lower 268 (32.7) 
 
283 (31.3) 
 
0.139 
 
Secondary 238 (29) 
 
302 (33.4) 
   Higher 314 (38.3) 319 (35.3) 
              
SDS, Standard Deviation Score. 
1
boys n=822; girls n=942; 
2
boys n=800; girls n=893; 
3
boys n=827; girls n=925; 
4
boys n=820, girls n= 904 
*Differences between sexes were assessed with a Student’s t-test; † median (min ; max), differences between sexes were 
assessed with a Mann-Whitney U-test; ‡ N(N%), differences between sexes were assessed with a chi-square test 
The usual daily total fat intake ranged from 17.8%E - 58.9%E (P5 25.7%E, P95 41.6%E) with the 
lowest intake observed in the male study population and the highest intake in the female study 
population. The mean (M) total fat intake was 33.3%E (SD 1.2), with a mean SFA intake of 13.8%E 
(SD 1.2; P5 10.1%E, P95 18.2%E), MUFA intake of 12.2%E (SD 1.2; P5 9.2%E, P95 16.3%E) and, 
PUFA intake of 4.6%E (SD 1.3; P5 3.2%E, P95 7.0%E). MUFA intake consisted mainly of oleic acid 
(OA) (M 10.7%E, SD 1.2; P5 8.0%E, P95 14.4%E). The geometric mean intake of lipids and FA in 
the male and female study population can be found in Table 6. 
In absolute amounts, the daily intake of fat and FA was, in general, significantly higher in the boys 
compared to the girls, except for EPA (boys = 56mg/d and girls = 51mg/d, p = 0.020) and DHA 
(boys = 133mg/d and girls = 129mg/d, p = 0.383). However, when considering the %E intake from 
fats and FA, the girls had significantly higher %E intakes for all PUFA (boys = 4.4%E and girls = 
4.8%E, p < 0.001) and borderline significant higher intakes for total fat (boys = 33.1%E and girls = 
RESULTS 
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33.7%E, p = 0.009). No sex differences in MUFA and SFA intake were found, except for a 
borderline higher intake of lauric acid (C12:0) (boys = 0.69%E and girls = 0.72%E, p = 0.005) in the 
female study sample. For the PUFA a higher intake of n-6 FA as well as n-3 FA was observed in the 
female study sample. The usual daily PUFA:SFA ratio was 0.33 in boys and 0.36 in girls (p < 0.001). 
The ratio of n-6 to n-3 fatty acid intake was 5.95 in the total study sample and did not differ 
significantly between boys and girls; the intake of LA compared to ALA was 6.9:1. 
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Table 6: Usual fatty acid intake of European adolescents (geometrical means and 95% CI).   
    Boys (n=800)   Girls (n=893) p* 
  
Mean 95% CI   Mean 95% CI 
 Total fat (g/d) 98.73 (93.75; 103.96) 
 
78.59 (74.65; 82.74) < 0.001 
SFA (g/d) 41.05 (38.91; 43.32) 
 
32.27 (30.59; 34.05) < 0.001 
 
Lauric Acid C12:0 (g/d) 2.05 (1.88; 2.25) 
 
1.67 (1.52; 1.82) < 0.001 
 
Myristic Acid C14:0 (g/d) 4.41 (4.16; 4.67) 
 
3.52 (3.32; 3.74) < 0.001 
 
Palmitic Acid C16:0 (g/d) 20.37 (19.35; 21.45) 
 
16.02 (15.22; 16.86) < 0.001 
 
Stearic Acid C18:0 (g/d) 9.12 (8.48; 9.81) 
 
7.07 (6.58; 7.60) < 0.001 
MUFA (g/d) 36.26 (33.83; 38.86) 
 
28.87 (26.94; 30.93) < 0.001 
 
OA C18:1n9 (g/d) 31.61 (29.40; 33.99) 
 
25.20 (23.44; 27.09) < 0.001 
PUFA (g/d) 13.09 (12.18; 14.06) 
 
11.09 (10.32; 11.91) < 0.001 
 
Total n-6 PUFA (g/d) 11.06 (10.29; 11.88) 
 
9.39 (8.74; 10.09) < 0.001 
 
LA C18:2n6 (g/d) 10.65 (9.88; 11.48) 
 
9.08 (8.43; 9.79) < 0.001 
 
AA C20:4n6 (g/d) 0.32 (0.27; 0.37) 
 
0.24 (0.21; 0.28) < 0.001 
 
Total n-3 PUFA (g/d) 1.89 (1.72; 2.07) 
 
1.60 (1.46; 1.75) < 0.001 
 
ALA C18:3n3 (g/d) 1.60 (1.44; 1.79) 
 
1.33 (1.19; 1.49) < 0.001 
 
EPA C20:5n3 (g/d) 0.06 (0.05; 0.07) 
 
0.05 (0.04; 0.06) NS 
 
DPA C22:5n3 (g/d) 0.02 (0.01; 0.02) 
 
0.01 (0.01; 0.01) < 0.001 
 
DHA C22:6n3 (g/d) 0.13 (0.11; 0.17) 
 
0.13 (0.10; 0.16) NS 
Cholesterol (mg/d) 402.10 (368.72; 438.51) 
 
317.23 (290.92; 345.91) < 0.001 
Total fat (%E) 33.12 (31.91; 34.37) 
 
33.73 (32.51; 35.01) NS 
SFA (%E) 13.77 (13.37; 14.18) 
 
13.85 (13.45; 14.26) NS 
 
Lauric Acid C12:0 (%E) 0.69 (0.64; 0.74) 
 
0.72 (0.67; 0.77) NS 
 
Myristic Acid C14:0 (%E) 1.48 (1.41; 1.55) 
 
1.51 (1.45; 1.58) NS 
 
Palmitic Acid C16:0 (%E) 6.83 (6.61; 7.07) 
 
6.87 (6.65; 7.11) NS 
 
Stearic Acid C18:0 (%E) 3.06 (2.92; 3.20) 
 
3.04 (2.90; 3.18) NS 
MUFA (%E) 12.17 (11.37; 13.02) 
 
12.39 (11.59; 13.26) NS 
 
OA C18:1n9 (%E) 10.61 (9.88; 11.39) 
 
10.82 (10.08; 11.61) NS 
PUFA (%E) 4.39 (4.16; 4.64) 
 
4.76 (4.51; 5.03) <0.001 
 
Total n-6 PUFA (%E) 3.71 (3.52; 3.91) 
 
4.03 (3.82; 4.25) <0.001 
 
LA C18:2n6 (%E) 3.57 (3.38; 3.77) 
 
3.90 (3.69; 4.12) <0.001 
 
AA C20:4n6 (%E) 0.11 (0.09; 0.13) 
 
0.11 (0.09; 0.12) NS 
 
Total n-3 PUFA (%E) 0.63 (0.58; 0.69) 
 
0.69 (0.63; 0.74) <0.001 
 
ALA C18:3n3 (%E) 0.54 (0.49; 0.59) 
 
0.57 (0.52; 0.63) <0.001 
 
EPA C20:5n3 (%E) 0.02 (0.02; 0.02) 
 
0.02 (0.02; 0.03) <0.001 
 
DPA C22:5n3 (%E) 0.01 (0.00; 0.01) 
 
0.00 (0.00; 0.01) <0.001 
 
DHA C22:6n3 (%E) 0.05 (0.04; 0.06) 
 
0.06 (0.04; 0.07) <0.001 
Cholesterol (mg/1000kcal) 149.99 (134.66; 167.07) 
 
151.33 (135.87; 168.55) NS 
SFA, saturated Fatty Acid; MUFA, mono-unsaturated fatty acid; OA, oleic acid; PUFA, poly-unsaturated fatty acid; LA, 
linoleic acid; AA, arachidonic acid; ALA, alpha-linolenic acid; EPA, eicopentaenoic acid; DPA, docosapentaenoic acid; 
DHA, docosahexaenoic acid 
*Comparison of geometrical means between boys and girls, assessed with a multilevel analyses corrected for study 
centre, including age and physical activity as independent variables. (NS > 0.003) 
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Figure 14 displays the distribution of the intake of FA %E in the population with an indication of the 
recommended intakes according to the FAO (FAO, 2010). Up to 57.4% of the study population 
(58.4% of the boys; 56.5% of the girls; p = 0.420) met the recommendations of the FAO for total fat 
intake. In 39% of the adolescents, total fat intake was higher than 35%E, and 3.6% had a usual intake 
lower than 25%E. SFA intake generally exceeded the dietary guidelines of < 8%E in almost all 
adolescents (99.8%) whilst PUFA intake was mostly too low, with only 12.7% of the adolescents 
adhering to the recommendations (6-11%E). More girls than boys were in compliance with the 
PUFA guideline (10.3% of the boys; 15% of the girls; p = 0.003). Whilst most adolescents (95.7%) 
had an adequate intake of > 2.5%E of LA to prevent deficiency symptoms, only 64.5% of the 
adolescents (58.5% of the boys; 70% of the girls; p < 0.001) achieved the minimum intake values for 
ALA (> 0.5%E), with the lowest intake in the study population being 0.24%E. If an inadequate 
intake is defined as 2/3 of the recommended dietary intake (being < 0.33%E) then only 0.7% of the 
adolescents did not reach this daily intake. However, a large proportion of the adolescents had an 
inadequate intake of the LCn3PUFA (53%) and only 25.7% had an intake above the recommended 
lower level.  
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Figure 14: Population distribution of intake of different FA with recommendations of FAO indicated 
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Table 7 presents the percentage contributions of the major food groups to the usual lipid and fatty 
acid intake in the total study population. The major source of total fat was meat (23.7%), followed by 
cakes, pies and biscuits (12.8%), and cheese (7.4%). This same order applied for SFA and MUFA 
intake. Furthermore, sauces were an important contributor for lauric acid, milk for myristic acid, and 
chocolate for stearic acid. For all these FA the most important food sources were identical and of 
similar magnitude for boys and girls. Generally, meat was a slightly higher contributor to these FA in 
boys whilst cakes, pies and biscuits as well as nuts and seeds seemed to be of a higher importance in 
girls. PUFA were mostly delivered by the group of meat, fish, egg and its substitutes as well as by 
low-nutrient, energy-dense foods (mainly cakes/pies/biscuits, savoury snacks and chocolate). A 
similar contribution pattern was seen for the essential FA, LA and ALA. However, where dairy 
products contributed for only 5.7% to the LA intake, they counted for 13.4% of the ALA intake. The 
intake of AA was mainly provided by meat (46.2%) followed by cakes, pies and biscuits. For EPA 
and DHA the major contributors were fish products followed by meat. In the female sample these 
foods contributed to EPA intake for 70.2% and 22.9% respectively, whilst in the male population 
they contributed for 56.7% and 33.6% respectively. In contrast, the major food source of 
docosapentaenoic acid (DPA), another long chain n-3 PUFA, was meat (65.6% in boys and 50.9% in 
girls) followed by fish products (28.9% in boys and 43.6% in girls). The major contributors to 
cholesterol were meat, eggs, and cakes/pies/biscuits.  
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Table 7: Percentage contributions of food groups to the intake of fats and fatty acids in European adolescents. 
Food Group Total Fat SFA Lauric A Myristic A Palmitic A Stearic A MUFA Oleic A Cholesterol 
 
% R % R % R % R % R % R % R % R % R 
Beverages 2.43 
 
2.34 
 
2.29 
 
2.24 
 
2.56 
 
2.13 
 
2.20 
 
2.16 
 
2.14 
 Water 0.00 
 
0.00 
 
0.00 
 
0.00 
 
0.00 
 
0.00 
 
0.00 
 
0.00 
 
0.00 
 Coffee and tea 0.25 
 
0.34 
 
0.32 
 
0.49 
 
0.31 
 
0.24 
 
0.21 
 
0.20 
 
0.17 
 Fruit and vegetable juices 0.40 
 
0.20 
 
0.09 
 
0.05 
 
0.34 
 
0.09 
 
0.18 
 
0.18 
 
0.00 
 Carbonated/soft/isotonic drinks 0.06 
 
0.03 
 
0.02 
 
0.01 
 
0.05 
 
0.02 
 
0.01 
 
0.01 
 
0.00 
 Alcoholic beverages 0.03 
 
0.04 
 
0.20 
 
0.06 
 
0.02 
 
0.02 
 
0.02 
 
0.02 
 
0.02 
 Soups / bouillon 1.69 
 
1.73 
 
1.66 
 
1.63 
 
1.84 
 
1.76 
 
1.78 
 
1.75 
 
1.95 
 Bread and Cereals 6.32 
 
5.25 
 
6.49 
 
5.23 
 
5.37 
 
4.52 
 
6.40 
 
6.39 
 
2.93 
 Bread and rolls 4.94 7 4.27 8 5.69 7 4.59 7 4.28 8 3.38 7 4.69 7 4.49 7 2.33 10 
Breakfast cereals 0.66 
 
0.40 
 
0.05 
 
0.08 
 
0.47 
 
0.68 
 
0.77 
 
0.88 
 
0.01 
 Flour 0.72 
 
0.58 
 
0.75 
 
0.56 
 
0.62 
 
0.46 
 
0.94 
 
1.02 
 
0.59 
 Potatoes & Grains 5.37 
 
3.91 
 
4.88 
 
3.62 
 
4.33 
 
3.13 
 
4.65 
 
4.69 
 
7.98 
 Rice and other grains 1.23 
 
0.90 
 
0.72 
 
0.82 
 
1.05 
 
0.74 
 
1.59 
 
1.72 
 
0.63 
 Starch roots, potatoes 2.25 
 
1.63 
 
3.14 9 1.40 
 
1.70 
 
1.39 
 
1.65 
 
1.60 
 
0.58 
 Pasta 1.89 
 
1.38 
 
1.02 
 
1.40 
 
1.58 
 
1.00 
 
1.41 
 
1.37 
 
6.77 4 
Vegetables & Fruits 3.37 
 
2.55 
 
2.53 
 
2.24 
 
2.94 
 
2.07 
 
3.58 
 
3.78 
 
1.54 
 Vegetables 2.58 9 2.14 10 2.38 10 2.12 10 2.28 9 1.87 10 2.90 9 3.04 9 1.51 
 Fruits 0.54 
 
0.30 
 
0.14 
 
0.09 
 
0.49 
 
0.14 
 
0.21 
 
0.22 
 
0.02 
 Olives & advocado 0.25 
 
0.11 
 
0.01 
 
0.03 
 
0.17 
 
0.06 
 
0.47 
 
0.52 
 
0.01 
 Dairy & Soy products 16.93 
 
23.07 
 
22.39 
 
32.86 
 
20.38 
 
17.70 
 
14.64 
 
14.15 
 
13.59 
 White milk and buttermilk 4.89 8 6.86 6 7.05 5 10.22 3 6.00 6 4.83 6 4.18 8 3.95 8 4.57 6 
Yogurt and fromage blanc 1.31 
 
1.85 
 
1.79 
 
2.76 9 1.62 
 
1.30 
 
1.11 
 
1.04 
 
1.09 
 Milk and yogurt beverages 1.71 
 
2.41 9 1.82 
 
2.81 8 2.11 10 2.67 9 1.49 
 
1.48 
 
1.14 
 Soya beverages 0.33 
 
0.12 
 
0.02 
 
0.03 
 
0.16 
 
0.12 
 
0.21 
 
0.23 
 
0.01 
 Cheese 7.44 3 10.21 3 9.85 3 14.94 2 9.02 3 7.41 4 6.56 3 6.38 4 4.50 7 
Desserts and puddings milk based 1.21 
 
1.57 
 
1.82 
 
2.03 
 
1.42 
 
1.33 
 
1.05 
 
1.03 
 
2.22 
 Desserts and puddings soya based 0.01 
 
0.01 
 
0.00 
 
0.01 
 
0.01 
 
0.01 
 
0.01 
 
0.01 
 
0.00 
 Other milk products 0.03 
 
0.04 
 
0.04 
 
0.06 
 
0.04 
 
0.03 
 
0.03 
 
0.03 
 
0.06 
 Fat & Oil 7.73 
 
8.36 
 
8.04 
 
10.99 
 
7.92 
 
6.66 
 
7.83 
 
7.03 
 
3.83 
 Margarine and lipids of mixed origins 2.33 10 1.49 
 
1.49 
 
1.34 
 
1.69 
 
1.52 
 
2.78 10 2.41 10 0.63 
 Butter and animal fats 5.40 5 6.87 5 6.55 6 9.65 5 6.23 5 5.14 5 5.05 6 4.62 6 3.20 9 
Meat/Fish/Egg/Meat alternative 28.74 
 
23.22 
 
12.93 
 
12.78 
 
28.12 
 
27.72 
 
33.43 
 
34.01 
 
48.87 
 Meat 23.69 1 19.84 1 7.81 4 10.11 4 24.36 1 24.91 1 28.14 1 28.56 1 31.98 1 
Fish products 1.49 
 
1.19 
 
4.11 8 1.54 
 
1.05 
 
0.69 
 
1.14 
 
0.95 
 
4.75 5 
Eggs 1.82 
 
1.54 
 
0.77 
 
0.91 
 
1.91 
 
1.51 
 
1.93 
 
2.01 
 
12.00 3 
Meat substitutes and vegetarian products 0.17 
 
0.10 
 
0.06 
 
0.07 
 
0.13 
 
0.08 
 
0.13 
 
0.14 
 
0.06 
 Nuts and seeds 1.43 
 
0.47 
 
0.14 
 
0.11 
 
0.56 
 
0.44 
 
1.97 
 
2.22 
 
0.00 
 Pulses 0.14 
 
0.08 
 
0.04 
 
0.04 
 
0.11 
 
0.09 
 
0.12 
 
0.13 
 
0.08 
 Low-nutrient, energy-dense foods 29.11 
 
31.33 
 
40.46 
 
30.05 
 
28.39 
 
36.06 
 
27.30 
 
27.77 
 
19.11 
 Cakes, pies, biscuits 12.76 2 14.47 2 20.01 1 18.29 1 12.86 2 12.03 3 12.16 2 11.28 2 12.20 2 
Savoury snacks 1.99 
 
1.11 
 
2.25 
 
0.41 
 
1.38 
 
0.89 
 
0.62 
 
0.63 
 
0.07 
 Sugar, honey, jam and syrup 0.22 
 
0.30 
 
0.29 
 
0.43 
 
0.27 
 
0.22 
 
0.18 
 
0.17 
 
0.13 
 Confectionery non chocolate 0.20 
 
0.10 
 
0.18 
 
0.07 
 
0.09 
 
0.11 
 
0.32 
 
0.36 
 
0.02 
 Chocolate 6.34 4 7.74 4 1.63 
 
1.86 
 
6.81 4 17.31 2 6.34 4 7.19 3 0.68 
 Sauces 5.06 6 5.05 7 13.39 2 6.02 6 4.47 7 3.32 8 5.08 5 5.48 5 3.35 8 
Creams 0.43 
 
0.59 
 
0.68 
 
0.87 
 
0.52 
 
0.42 
 
0.36 
 
0.34 
 
0.47 
 Miscellaneous 2.11 
 
1.97 
 
2.03 
 
2.10 
 
1.99 
 
1.76 
 
2.24 
 
2.32 
 
2.19 
 R, Rank; SFA, saturated Fatty Acid; MUFA, mono-unsaturated fatty acid  
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Table 7 – continued: Percentage contributions of food groups to the intake of fats and fatty acids in European adolescents. 
Food Group PUFA Total n-6 PUFA LA AA Total n-3 PUFA ALA EPA DPA DHA 
 
% R % R % R % R % R % R % R % R % R 
Beverages 2.81 
 
2.69 
 
2.69 
 
2.70 
 
3.48 
 
3.97 
 
1.40 
 
1.12 
 
1.21 
 Water 0.00 
 
0.00 
 
0.00 
 
0.00 
 
0.00 
 
0.00 
 
0.00 
 
0.00 
 
0.00 
 Coffee and tea 0.14 
 
0.12 
 
0.12 
 
0.00 
 
0.24 
 
0.29 
 
0.00 
 
0.00 
 
0.00 
 Fruit and vegetable juices 1.18 
 
1.08 
 
1.12 
 
0.00 
 
1.74 
 
2.12 
 
0.00 
 
0.00 
 
0.00 
 Carbonated/soft/isotonic drinks 0.18 
 
0.17 
 
0.18 
 
0.00 
 
0.25 
 
0.30 
 
0.00 
 
0.00 
 
0.00 
 Alcoholic beverages 0.01 
 
0.01 
 
0.01 
 
0.01 
 
0.01 
 
0.02 
 
0.00 
 
0.00 
 
0.01 
 Soups / bouillon 1.30 
 
1.31 
 
1.26 
 
2.69 6 1.24 
 
1.24 
 
1.40 4 1.12 3 1.20 7 
Bread and Cereals 7.54 
 
7.92 
 
7.78 
 
13.00 
 
5.40 
 
6.24 
 
1.38 
 
0.93 
 
1.84 
 Bread and rolls 5.88 5 6.11 5 5.91 5 12.73 3 4.60 7 5.33 6 1.18 6 0.85 6 1.49 6 
Breakfast cereals 1.09 
 
1.22 
 
1.27 
 
0.05 
 
0.34 
 
0.41 
 
0.00 
 
0.00 
 
0.00 
 Flour 0.57 
 
0.59 
 
0.60 
 
0.22 
 
0.46 
 
0.50 
 
0.20 9 0.08 
 
0.35 
 Potatoes & Grains 10.03 
 
10.42 
 
10.75 
 
1.68 
 
7.87 
 
9.34 
 
0.80 
 
0.86 
 
1.49 
 Rice and other grains 1.29 
 
1.36 
 
1.39 
 
0.58 
 
0.90 
 
0.88 
 
0.69 8 0.86 5 1.10 9 
Starch roots, potatoes 5.32 6 5.38 6 5.57 6 0.23 
 
5.01 5 6.11 4 0.08 
 
0.00 
 
0.08 
 Pasta 3.42 8 3.68 8 3.79 8 0.87 10 1.96 
 
2.35 
 
0.03 
 
0.00 
 
0.31 
 Vegetables & Fruits 4.76 
 
4.45 
 
4.58 
 
1.46 
 
6.47 
 
7.50 
 
1.80 
 
0.97 
 
1.99 
 Vegetables 3.00 
 
2.84 
 
2.90 
 
1.39 8 3.89 10 4.39 9 1.66 3 0.88 4 1.80 5 
Fruits 1.57 
 
1.41 
 
1.47 
 
0.00 
 
2.46 
 
3.00 
 
0.00 
 
0.00 
 
0.01 
 Olives & advocado 0.19 
 
0.20 
 
0.21 
 
0.07 
 
0.12 
 
0.11 
 
0.14 
 
0.09 
 
0.18 
 Dairy & Soy products 6.39 
 
5.54 
 
5.72 
 
0.97 
 
11.16 
 
13.44 
 
0.19 
 
0.23 
 
1.35 
 White milk and buttermilk 1.44 
 
1.14 
 
1.18 
 
0.15 
 
3.06 
 
3.70 10 0.01 
 
0.01 
 
0.26 
 Yogurt and fromage blanc 0.37 
 
0.29 
 
0.30 
 
0.00 
 
0.83 
 
1.01 
 
0.00 
 
0.00 
 
0.00 
 Milk and yogurt beverages 0.44 
 
0.38 
 
0.39 
 
0.01 
 
0.80 
 
0.97 
 
0.04 
 
0.01 
 
0.04 
 Soya beverages 1.31 
 
1.39 
 
1.44 
 
0.00 
 
0.89 
 
1.09 
 
0.00 
 
0.00 
 
0.00 
 Cheese 2.28 
 
1.85 
 
1.91 
 
0.38 
 
4.68 6 5.68 5 0.14 
 
0.21 9 0.23 
 Desserts and puddings milk based 0.51 
 
0.45 
 
0.46 
 
0.42 
 
0.86 
 
0.94 
 
0.00 
 
0.00 
 
0.80 10 
Desserts and puddings soya based 0.03 
 
0.03 
 
0.03 
 
0.00 
 
0.02 
 
0.02 
 
0.00 
 
0.00 
 
0.00 
 Other milk products 0.01 
 
0.01 
 
0.01 
 
0.01 
 
0.02 
 
0.03 
 
0.00 
 
0.00 
 
0.02 
 Fat & Oil 7.41 
 
7.57 
 
7.85 
 
0.16 
 
6.57 
 
7.99 
 
0.10 
 
0.06 
 
0.21 
 Margarine and lipids of mixed origins 4.29 7 4.61 7 4.78 7 0.06 
 
2.54 
 
3.09 
 
0.01 
 
0.00 
 
0.07 
 Butter and animal fats 3.12 10 2.96 10 3.07 10 0.10 
 
4.03 8 4.90 7 0.09 
 
0.06 
 
0.14 
 Meat/Fish/Egg/Meat alternative 32.81 
 
32.63 
 
31.68 
 
54.16 
 
33.78 
 
21.51 
 
92.34 
 
94.93 
 
85.82 
 Meat 24.34 1 25.30 1 24.38 1 46.17 1 19.02 1 16.11 1 27.80 2 58.42 1 30.81 2 
Fish products 2.77 
 
1.40 
 
1.26 
 
4.49 4 10.31 2 0.85 
 
64.33 1 36.36 2 48.58 1 
Eggs 1.65 
 
1.48 
 
1.43 
 
3.31 5 2.61 
 
2.32 
 
0.07 
 
0.13 10 6.38 3 
Meat substitutes and vegetarian products 0.52 
 
0.55 
 
0.57 
 
0.03 
 
0.35 
 
0.42 
 
0.01 
 
0.02 
 
0.03 
 Nuts and seeds 3.23 9 3.60 9 3.73 9 0.08 
 
1.17 
 
1.42 
 
0.08 
 
0.00 
 
0.00 
 Pulses 0.30 
 
0.30 
 
0.31 
 
0.08 
 
0.32 
 
0.39 
 
0.05 
 
0.00 
 
0.02 
 Low-nutrient, energy-dense foods 28.22 
 
28.76 
 
28.94 
 
25.85 
 
25.30 
 
29.98 
 
2.00 
 
0.90 
 
6.08 
 Cakes, pies, biscuits 9.91 2 9.93 2 9.56 2 22.13 2 9.82 3 11.47 2 0.03 
 
0.25 8 3.95 4 
Savoury snacks 6.75 3 6.43 4 6.65 4 0.51 
 
8.57 4 10.48 3 0.00 
 
0.00 
 
0.01 
 Sugar, honey, jam and syrup 0.12 
 
0.11 
 
0.11 
 
0.04 
 
0.19 
 
0.23 
 
0.00 
 
0.00 
 
0.00 
 Confectionery non chocolate 0.20 
 
0.22 
 
0.23 
 
0.00 
 
0.06 
 
0.08 
 
0.00 
 
0.00 
 
0.00 
 Chocolate 2.56 
 
2.88 
 
2.99 
 
0.07 
 
0.77 
 
0.93 
 
0.00 
 
0.00 
 
0.13 
 Sauces 6.45 4 6.89 3 7.10 3 1.20 9 4.02 9 4.81 8 0.71 7 0.08 
 
0.49 
 Creams 0.13 
 
0.10 
 
0.10 
 
0.06 
 
0.27 
 
0.32 
 
0.02 
 
0.02 
 
0.10 
 Miscellaneous 2.10 
 
2.20 
 
2.20 
 
1.84 7 1.60 
 
1.66 
 
1.24 5 0.55 7 1.40 8 
R, rank; PUFA, poly-unsaturated fatty acid; LA, linoleic acid; AA, arachidonic acid; ALA, alpha-linolenic acid; EPA, eicopentaenoic acid; DPA, docosapentaenoic acid; DHA, docosahexaenoic acid 
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The results of the multilevel analyses, investigating the contribution of potential sociodemographic 
determinants to the variance in fat intake, are presented in Table 8. In the male study sample, a 
significantly higher %E intake from total fat and PUFA was seen in the older age group compared to 
the younger age group, leading to an equal intake of total fat in boys and girls between 15 and 17.5 
years old (boys = 33.6%E and girls = 34.0%E, p = 0.997). In the older boys higher %E intakes of the 
essential fatty acids (LA and ALA) and lower intakes of DPA intake were observed. In girls a 
significant lower arachidonic acid (AA) and cholesterol intake was observed in the older age group. 
The %E intake of lauric acid was significantly higher in the oldest age group of both boys and girls 
(p < 0.001).  
 
Besides the differences between age groups, a higher physical activity was associated with a 
significant lower intake of total fat (β = -0.000015, p < 0.001), total SFA (β = -0.000016, p = 0.001), 
total MUFA (β = -0.000018, p < 0.001), OA (β = -0.000018, p < 0.001), plamitic acid (β = -
0.000016, p < 0.001) and stearic acid (β = -0.000017, p = 0.002) in the male population, whilst in 
girls no significant contribution of physical activity to the variance in FA intake was observed (data 
not shown).  
Furthermore, no significant associations were found between fatty acid intake and the other 
determinants (BMI, body fat percentage, socioeconomic status and sexual maturation) after 
correction for age, sex and physical activity and application of the Bonferroni correction (data not 
shown).  
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Table 8: Fatty acid intake of European adolescents (geometrical means (%E)) according to age category and sex. 
 Male 
 12.50 - <15.00 (n= 455)   15.00  - 17.50 (n= 345)   p* 
Total fat (%E) 32.53 (31.33; 33.78)  33.61 (32.35; 34.92)  0.002 
SFA (%E) 13.64 (13.19; 14.11)  13.86 (13.39; 14.36)  NS 
Lauric Acid C12:0 (%E) 0.66 (0.61; 0.71)  0.74 (0.68; 0.8)  <0.001 
Myristic Acid C14:0 (%E) 1.47 (1.39; 1.54)  1.49 (1.42; 1.57)  NS 
Palmitic Acid C16:0 (%E) 6.76 (6.53; 7.01)  6.87 (6.63; 7.12)  NS 
Stearic Acid C18:0 (%E) 3.06 (2.91; 3.22)  3.03 (2.87; 3.19)  NS 
MUFA (%E) 11.97 (11.23; 12.76)  12.27 (11.51; 13.09)  NS 
OA C18:1n9 (%E) 10.42 (9.76; 11.13)  10.72 (10.04; 11.45)  NS 
PUFA (%E) 4.23 (3.98; 4.5)  4.58 (4.3; 4.87)  <0.001 
Total n-6 PUFA (%E) 3.57 (3.36; 3.79)  3.87 (3.65; 4.12)  <0.001 
LA C18:2n6 (%E) 3.43 (3.23; 3.64)  3.74 (3.51; 3.98)  <0.001 
AA C20:4n6 (%E) 0.11 (0.09; 0.13)  0.1 (0.09; 0.12)  NS 
Total n-3 PUFA (%E) 0.62 (0.57; 0.67)  0.65 (0.6; 0.71)  0.001 
ALA C18:3n3 (%E) 0.52 (0.47; 0.57)  0.57 (0.52; 0.62)  <0.001 
EPA C20:5n3 (%E) 0.02 (0.02; 0.02)  0.02 (0.01; 0.02)  NS 
DPA C22:5n3 (%E) 0.01 (0.01; 0.01)  0 (0; 0.01)  0.001 
DHA C22:6n3 (%E) 0.05 (0.04; 0.06)  0.04 (0.03; 0.05)  NS 
Cholesterol 
(mg/1000kcal) 
150.86 (135.08; 168.48)  147.51 (132.03; 164.82)  NS 
 Female 
 12.50 - <15.00 (n= 518)   15.00  - 17.50 (n= 375)   p* 
Total fat (%E) 33.73 (32.39; 35.13)  33.99 (32.63; 35.42)  NS 
SFA (%E) 13.86 (13.47; 14.27)  13.91 (13.5; 14.34)  NS 
Lauric Acid C12:0 (%E) 0.69 (0.64; 0.73)  0.75 (0.71; 0.81)  <0.001 
Myristic Acid C14:0 (%E) 1.5 (1.43; 1.57)  1.54 (1.47; 1.61)  NS 
Palmitic Acid C16:0 (%E) 6.91 (6.67; 7.17)  6.87 (6.62; 7.13)  NS 
Stearic Acid C18:0 (%E) 3.07 (2.95; 3.21)  3.01 (2.89; 3.14)  NS 
MUFA (%E) 12.41 (11.52; 13.37)  12.49 (11.6; 13.46)  NS 
OA C18:1n9 (%E) 10.82 (10; 11.71)  10.93 (10.1; 11.83)  NS 
PUFA (%E) 4.73 (4.49; 4.99)  4.83 (4.58; 5.1)  NS 
Total n-6 PUFA (%E) 4.01 (3.81; 4.23)  4.09 (3.88; 4.31)  NS 
LA C18:2n6 (%E) 3.88 (3.68; 4.09)  3.96 (3.76; 4.18)  NS 
AA C20:4n6 (%E) 0.11 (0.09; 0.13)  0.1 (0.08; 0.12)  <0.001 
Total n-3 PUFA (%E) 0.68 (0.63; 0.74)  0.7 (0.64; 0.76)  NS 
ALA C18:3n3 (%E) 0.56 (0.51; 0.62)  0.58 (0.53; 0.64)  NS 
EPA C20:5n3 (%E) 0.02 (0.02; 0.03)  0.02 (0.02; 0.03)  NS 
DPA C22:5n3 (%E) 0 (0; 0.01)  0 (0; 0)  NS 
DHA C22:6n3 (%E) 0.06 (0.04; 0.07)  0.05 (0.04; 0.07)  NS 
Cholesterol 
(mg/1000kcal) 
155.54 (138.86; 174.22)  146.33 (130.6; 163.95)  <0.001 
SFA, saturated Fatty Acid; MUFA, mono-unsaturated fatty acid;  OA, oleic acid; PUFA, poly-unsaturated fatty acid; LA, 
linoleic acid; AA, arachidonic acid; ALA, alpha-linolenic acid; EPA, eicopentaenoic acid; DPA, docosapentaenoic acid; 
DHA, docosahexaenoic acid. *Comparison of geometrical means between age groups within sex, assessed with a 
multilevel analyses corrected for study centre, including physical activity as independent variable. (NS > 0.003) 
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III.1.4 DISCUSSION 
In accordance with previous studies, high mean intakes of total fat and SFA and low mean intakes of 
MUFA and PUFA were observed in our European adolescent study population (Elmadfa et al, 2009; 
Ervin et al, 2004; Harel et al, 2001; Harika et al, 2011; Joyce et al, 2009; Kersting et al, 1998; 
Lambert et al, 2004; Matthys et al, 2006; O'Sullivan et al, 2011; Samuelson et al, 2001). Across 
Europe, mean total fat intakes of 25.5%E – 44.2%E have been recorded, with generally higher 
intakes in the Southern countries and lower intakes in the Northern countries (Elmadfa et al, 2009; 
Lambert et al, 2004). In the present study, the usual daily PUFA:SFA ratio was 0.33 in boys and 0.36 
in girls. Only few studies report this ratio, making comparison difficult. If ratios were calculated 
from the provided means of PUFA and SFA, often higher ratios have been observed in the female 
population (Joyce et al, 2009; O'Sullivan et al, 2011) whilst Samuelson et al. reported higher ratios 
in the male population (Samuelson et al, 2001). Much higher PUFA:SFA ratios (exceeding 0.5) have 
been recorded in the USA and Mexico (Howe et al, 2006; Ramirez-Silva et al, 2011). The proportion 
of n-6 PUFA to n-3 PUFA intake in our study population was about 6:1 and the proportion of 
LA:ALA was about 7:1. These ratios were much lower than generally reported in Western countries 
(Howe et al, 2006; Simopoulos, 2008) and in Mexico (Ramirez-Silva et al, 2011), but still much 
higher than the ratio of n-6:n-3 of 0.8 which would seem optimal from an evolutionary point of view 
(Simopoulos, 2008). However, due to unconvincing evidence and conceptual limitation, the FAO 
judged that there is no rationale for setting a recommendation for the n-6:n-3 or LA:ALA ratio (FAO, 
2010). Also the meaning and usefulness of ratios has been questioned previously because ratios can 
disguise extremely low or high intakes (Deckelbaum and Calder, 2010). Instead it was recommended 
by the UK Food Standards Agency to focus on the effects of absolute amounts of individual n-6 and 
n-3 FA (Stanley et al, 2007).  
Compared to the recently published recommendations of the FAO for fats and FA intake, our results 
suggested that about half of the European adolescents met the recommended range of intake for total 
fat, but for about 39% of the adolescents total fat intake was too high. According to our data, 3.6% of 
the study population had a usual fat intake of less than 25%E, which could render this group prone to 
have an inadequate consumption of fat-soluble vitamins (FAO, 2010). A slightly higher intake of 
total fat (in %E) was observed in the female population due to a higher intake of MUFA and PUFA 
in comparison to boys. However, mean PUFA intake did not meet the recommendation for either 
sex. Differences in intake pattern between both sexes disappeared with older age except for PUFA 
intake, which continued to be higher in the female population. A high proportion (35.5%) of the 
adolescents did not meet the minimum intake value for ALA (> 0.5 %E). ALA is however 
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indispensable since humans cannot synthesize it and major deficiencies of this essential n-3 fatty acid 
can result in skin changes, abnormal visual function and peripheral neuropathy (Holman et al, 1982). 
Also the intake of the EPA and DHA was in general too low with more than half of the adolescents 
having an inadequate intake. Although these long chain derivatives can be converted in the human 
body from the precursor, ALA, this process is often not efficient. Given the low intake of ALA on 
one hand and the inefficient in vivo conversion on the other hand, EPA and DHA are generally 
considered as conditionally essential FA (AFSSA, 2010; FAO, 2010). This indicates the need to 
further stress the importance of a sufficient intake of these FA. This could be achieved by a more 
frequent intake of seafood and fish, mainly fatty fish, by for example, using fish preparations instead 
of meat as sandwich spreads. Furthermore, a higher use of ALA-rich oils, such as linseed oil and 
rapeseed oil, and nuts and seeds in general, could help to reach adequate intake levels of ALA.  
Similar to other studies (Harika et al, 2011; Joyce et al, 2009; O'Sullivan et al, 2011) almost all 
adolescents (99.8%) exceeded the FAO recommendation of 8%E for SFA intake. Even if the old 
recommendation of < 10%E is used, only 4.4% of the population was in compliance with the 
guideline. It is generally accepted that an excessive intake of SFA results in long-term health 
complications. However, as discussed in the “Great Fat Debate”, the proportion of calories from 
saturated fat has little effect on disease risk when the replacement nutrient is not specified (Kuller, 
2011; Lichtenstein, 2011; Mozaffarian, 2011; Willett, 2011; Willett et al, 2011). Replacing SFA by 
PUFA has been shown to reduce the risk on CVD, but replacement by carbohydrates is unlikely to 
have any major effect on CVD risk, whilst replacement with highly refined carbohydrates may 
increase CVD risk (Mozaffarian, 2011). Furthermore, evidence even suggests a potentially protective 
effect of saturated fat consumption for stroke risk (Micha and Mozaffarian, 2010). Also, different 
SFA have different effects on plasma lipid levels and risk of CVD (Hu et al, 2001). As such, myristic 
acid appears to raise total cholesterol in a more potent way than lauric acid and even more than 
palmitic acid, whilst stearic acid has no cholesterol raising effect (Kris-Etherton and Yu, 1997). In 
our study sample, as well as in others  (Howe et al, 2006; Samuelson et al, 2001), the intake of 
palmitic and stearic acid accounted for more than 70% of the total SFA intake, making it 
questionable whether these intakes might be tolerable. However, there is still insufficient data on the 
long-term health effects and usual intake of these individual FA to establish guidelines for these 
nutrients.  
Comparison of the main contributors of food groups to nutrient intake is difficult because food 
groupings often differ. However, the top three contributors to total fat, SFA, MUFA and PUFA 
intake were meat, dairy products and cakes/pies/biscuits, which is in agreement with other studies 
(Joyce et al, 2009; Matthys et al, 2006; O'Sullivan et al, 2011). In contrast to our results, Joyce et al. 
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(2009) reported a higher contribution of whole milk than of cheese. The higher contribution of meat 
in boys compared to girls has also been reported previously (Matthys et al, 2006). As described by 
others, (Howe et al, 2006; O'Sullivan et al, 2011; Sioen et al, 2007) the main source of EPA and 
DHA came from fish intake, followed by meat. In contrast to previous assumptions (Meyer et al, 
2003; Ollis et al, 1999; Sioen et al, 2007), our results showed that DPA intake was primarily 
provided by meat. This has also been reported by others (Howe et al, 2006; O'Sullivan et al, 2011) 
and is most likely due to the high consumption rate of meat compared to fish.  
Only few studies have investigated the influence of non-dietary factors on FA intake. The main 
determinants of FA intake in our study population were age and sex. Chronological age was a 
stronger determinant of fatty acid intake than sexual maturation. In the male population, fat and fatty 
acid intake was also inversely related to their level of physical activity. Measures of body 
composition were not related to the usual fat and fatty acid intake, and no differences in fat intake as 
a function of socioeconomic status, assessed by the educational level of the mother were observed. In 
contrast, Joyce et al. (2009) found that adolescents, whose parents had secondary education, had 
significantly higher %E from MUFA than those whose parents had tertiary education. Furthermore, 
some studies showed an influence of a rural compared to an urban lifestyle (Joyce et al, 2009; 
Monge-Rojas et al, 2005). This could not be evaluated in our study as our total population was 
sampled from urban schools. In our study, boys had a significantly lower intake of %E from total 
PUFA than girls, which has also been described by Joyce et al. (2009) for Irish children and 
adolescents. In contrast to our findings, Samuelson et al. found a significantly higher %E intake from 
PUFA and LA, and higher, although not significantly, intake of total fat, SFA and MUFA in 15-year-
old boys compared to age-matched girls (Samuelson et al, 2001). These results were, however, based 
on a small sample size (n=42 and n=51 respectively). A significantly higher intake of LA was also 
found for boys in a group of 1117 American adolescents (Harel et al, 2001). Furthermore, in our 
study, girls had a significantly higher intake of the n-3 precursor ALA and of LC-PUFA (EPA and 
DHA), when expressed in %E; this difference has not been found by others (Harel et al, 2001; 
Samuelson et al, 2001). In boys aged 15 - 17.5 years compared to 12.5 - 14.9 year-olds a higher 
intake in %E from total fat and PUFA was found. Other studies, on the contrary, have shown a 
tendency of decreasing intakes of these FA with increasing age in Irish and German adolescents 
(Joyce et al, 2009; Kersting et al, 1998). In addition, older boys had a higher intake of the essential 
fatty acids (LA and ALA) and lauric acid and a lower intake of the n-3 LC-PUFA. In summary, girls 
showed a more beneficial fatty acid intake pattern; however, differences between boys and girls 
became less apparent or disappeared with increasing age.   
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STRENGTHS AND LIMITATIONS 
Being part of a multicentre European study, data were collected in a standardized way, following 
strict procedures. The analyses were performed on a group of adolescents of different ethnicities, 
with data available on anthropometrics, lifestyle factors and socioeconomic status. The adolescents 
were randomly selected in 10 European cities. Based on the HELENA key variables, no signs of 
selection bias were identified between participants and non-participants within these cities (Beghin et 
al, 2012), thus, the study sample seems to be representative for an urban European adolescent 
population. However, the selection of the cities was done in a convenient way, based on geographical 
distribution and the presence of an active research group. This selection was representative of the 
average level of demography, cultural, social and economic markers. The towns were equivalent and 
comparable between countries and their size was sufficiently large to ensure cultural and 
socioeconomic diversity. These parameters as well as age and sex were taken into consideration in 
the selection of the participating schools. Still, as in all epidemiological studies, selection bias is 
difficult to identify and therefore cannot be ruled out.   
A number of validation studies have shown that misreporting is a major problem in dietary surveys 
of adolescents. Following recommendations of the “European Food Consumption Survey method 
(EFCOSUM)” 24h recalls were preferred because these are open-ended questionnaires in which 
detailed information can be obtained. A limitation of the used method is that only information of two 
days was obtained. As such, the dietary intake is prone to exceptional intakes. The 24h dietary recall 
method does not allow quantifying proportions of non-consumers for particular food items, a fortiori 
for infrequently consumed foods. To decrease this influence, days of assessment were randomly 
selected and nutrient intakes were corrected for within-person variability by applying the MSM 
method. As only nutrient intakes were studied and not food intake, the influence of non-consumption 
days of certain food items (e.g. fish) was attenuated. Still, as fish is a major contributor of EPA and 
DHA, an underestimation cannot be ruled out. However, the present study aimed to assess the mean 
FA intake in the total population and not the exact intake for each individual. Due to the high number 
of participants, variations by chance in individuals‟ LC-PUFA intake were attenuated. Furthermore, 
the obtained mean intake results are in line with literature (Ervin et al, 2004; Harika et al, 2011; 
Sioen et al, 2007). 
Another limitation of the 24h recalls is that data collection relies on the individual‟s ability to 
remember foods and beverages consumed in the past 24 hours, accuracy might therefore be biased 
towards underreporting. In this respect, the 24h dietary recalls were performed through computer-
assisted HELENA-DIAT software to standardize the recall procedures as much as possible. 
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Moreover there is a potential loss of dietary information from mixed dishes, as food ingredients were 
sometimes counted from mixed dishes. Also, some information on food intake is less detailed as 
adolescents are not acquainted with the applied food preparation methods and thereby used cooking 
fats. As such, average values and types of used cooking fats were estimated according to the 
countries habitual preparation methods.  
The same food composition table for conversion of food intake data to estimated nutrient intakes was 
used for all survey centres. In this way, differences in definitions, analytical methods, units and 
modes of expression were overcome. In this regard, the German food composition tables 
(Bundeslebensmittelschlüssel, BLS) was chosen. The BLS is based on German, American, English, 
Swedish, Danish and Dutch food composition tables, on analytical values of food producing firms, 
publications and research results of the Federal Research Centres and Universities 
(http://bls.nvs2.de). The BLS includes about 11000 raw and cooked foods and recipes and is widely 
used in epidemiological studies. Furthermore, the BLS is one of the tables giving the most complete 
coverage of the individual FA (Deharveng et al, 1999). The FA composition of foods is based on 
analysis or estimation. Therefore, the intake of the different FA is only an approximation for a single 
individual. However, as stated above, in this study, only the mean intake values of FA in the 
complete study sample were assessed. Therefore, the impact of potential errors is minimized due to 
the high number of study participants.  
It is noteworthy that the linking between the food consumption data and the BLS was done on the 
level of complex foods instead of its ingredients for some particular food items or drinks (e.g. coffee 
or tea with milk) what should be considered when interpreting the contribution of food items and 
drinks to the different fatty acids (e.g. part of the contribution of coffee/tea to the fatty acid intakes 
might come from the milk that was added to it).  
 
III.1.5 CONCLUSION 
In general, girls showed a more beneficial fatty acid intake pattern than boys. However, differences 
between boys and girls became less apparent or disappeared with increasing age. Furthermore in 
boys but not in girls, physical activity appeared to be a determinant of fat intake. The most important 
public health concerns regarding fat intake in this adolescent population were the low intake of n3FA 
and the high intake of SFA, mainly palmitic and stearic acid. This was primarily seen in the younger-
aged boys, where the major contributor to SFA was meat. A lower consumption of total fat and SFA 
could be achieved by changing meat consumption to vegetarian alternatives or fish and by 
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substituting snacks, such as cakes, pies and biscuits for alternatives such as fruits, vegetables or nuts 
and seeds. Apart from these interventions also a more frequent use of ALA-rich oils such as linseed 
and rapeseed oil in meal preparation would contribute to a higher intake of n3FA. However, at the 
same time meat was also an important dietary source of DPA. As such, more information on the 
individual health effects of the different FA is needed to elucidate their importance and to set goals 
for these individual FA.  
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ABSTRACT  
The present study aimed to assess the correlation between food and fatty acid (FA) intake and the FA 
serum profile in European adolescents and explored the percentage of variation in FA serum 
concentrations that could be attributed to dietary habits. Participants included 528 adolescents who 
were recruited in the HELENA Study. Dietary intake was assessed by two, non-consecutive 24h 
recalls and the phospholipid FA concentrations were measured in venous serum samples. Reduced 
rank regressions were applied to examine the combined effect of food intakes. Results indicated that 
the variance in serum phospholipid FA concentrations in adolescents, that could be explained by diet 
varied from 7.0% for the MUFA to 14.2% for the n-3FA. The variance in the longchain n-3FA was 
mainly explained by fish intake but also by coffee & tea consumption. In conclusion this study 
indicated that dietary intake influences the FA serum status in a limited amount but that also other 
factors interfere. Furthermore the results suggest that the overall dietary habits should be considered 
instead of only the consumption of single foods or nutrients, as the medium of the food or 
concomitant intake of foods and nutrients might interact and as such influence absorption or 
metabolisation. 
  
III.2 CORRELATION BETWEEN INTAKE AND FATTY ACID SERUM PROFILE 
87 
III.2.1 INTRODUCTION 
Fatty acids (FA) are important molecules in the human body because they can influence 
inflammatory processes and modulate cell membrane properties through a variety of mechanisms. As 
precursors of signalling molecules, derivatives of the n-6 arachidonic acid (AA) have pro-
inflammatory effects while derivatives of the n-3 FA, eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA), tend to have more anti-inflammatory effects (Calder, 2011).  
It has been shown that some effects of FA are associated with changes in the phospholipid FA 
composition of cell membranes (Calder, 2008b) and that this FA composition can be altered by 
dietary changes (Calder, 2008b; Hodson et al, 2008; Skeaff et al, 2006; Yaqoob et al, 2000). The 
change in FA concentration is generally dose-dependent and reaches a plateau after a variable time, 
in function of the lipid pool under investigation (Hodson et al, 2008). For example, after a dietary 
change the FA composition of plasma triglycerides (TG) reaches a maximum after little more than 1 
day whilst the incorporation of FA into the human cell membrane begins within days to weeks and 
reaches its peak after 2-4 weeks (Calder, 2008b; Skeaff et al, 2006). In contrast, it has been shown 
that in adipose tissue, the time needed to reach this incorporation is longer, exceeding several months 
(Katan et al, 1997). As such it is accepted that adipose tissue reflects the dietary intake of the past 
several months whilst the FA composition of cell membranes and serum cholesterylesters or 
phospholipids reflect the short-term intake of the past days-weeks (Hodson et al, 2008; Skeaff et al, 
2006).  
However, apart from the influence of the dietary intake, it is known that the FA concentrations in the 
human body are determined by several other factors as well, such as genetic background, sex, 
smoking habits, etc. (Hodson et al, 2008). For example, it has been estimated that 29% of the 
variance of AA and up to 9% of the variance of linoleic acid (LA) could be explained by genetic 
variants in the FADS gene cluster, encoding the Δ5- and Δ6-desaturase (Schaeffer et al, 2006).  
Several studies, mainly in adults, have examined the influence of dietary changes in FA intake on the 
FA concentrations in different lipid fractions (Andersen et al, 1999; Asciutti-Moura et al, 1988; 
Hodge et al, 2007; Hodson et al, 2008; Katan et al, 1997; Ma et al, 1995; Skeaff et al, 2006; Wolk et 
al, 2001; Yaqoob et al, 2000). However, studies in younger age groups, such as adolescents, are 
scarce and the investigated lipid fractions often differ. Moreover, the proportion of variation in the 
serum phospholipid FA concentration of adolescents that can be explained by dietary intake of 
specific food groups has not been assessed previously. As such, the current study aims to explore 
these shortcomings in literature by assessing the correlation between food and FA intake and the FA 
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serum profile in adolescents and by exploring the percentage of variance in FA serum concentrations 
that could be attributed to dietary habits.  
 
III.2.2 SUBJECTS AND METHODS 
III.2.2.1 STUDY DESIGN AND POPULATION 
Data were obtained from the HELENA-Cross Sectional Study (HELENA-CSS) that has been 
described in more detail in Part II  Methods.   
For the purpose of this study, only adolescents who provided data on two 24h non-consecutive 
dietary recalls were included in the analysis, however, underreporters were excluded. It is 
noteworthy that participants from Heraklion and Pècs were excluded for these analyses as no nutrient 
intake information was calculated for these two cities due to logistical reasons. Furthermore, blood 
samples were collected in one third of the total HELENA population by randomly selecting classes 
in each survey centre in which blood withdrawal was performed. As such, the final study sample 
counted 528 adolescents, of this sample additionally 57 adolescents were excluded in the RRR 
analyses due to missing data on covariates.  
III.2.2.2 DATA COLLECTION 
The methods of data collection have been described in more detail in Part II Methods. Briefly, the 
dietary intake assessment was performed by use of the HELENA-DIAT (Dietary Assessment Tool) 
and the Multiple Source Method (MSM) was used to estimate the habitual dietary intake of nutrients 
and foods (https://nugo.dife.de/msm; Haubrock J. et al, 2010).  
Height and weight were measured in fasting state and the BMI standard deviation score was 
calculated subsequently. Pubertal status (stages I-V) was assessed by a medical doctor according to 
Tanner and Whitehouse (Tanner and Whitehouse, 1976). Data on maternal education level and 
physical activity were collected by self-reported questionnaires. The serum FA composition from 
phospholipids was determined in fasting venous blood samples. For all analyses, FA were expressed 
as relative FA profile, based on the peak area (area%).  
III.2.2.3 STATISTICAL ANALYSES 
Statistical analyses were performed with SAS 9.3 for Windows (SAS Institute Inc., Cary, NC) and 
SPSS 20.0 for Windows (SPSS Inc., Chicago, IL, USA). As dietary intake data and blood values 
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were skewed Spearman rank correlations analyses were performed. A p-value of 0.05 was used as 
the threshold of significance. For clarity only the significant correlations were presented. Food 
intakes were expressed as g/day and FA intakes were expressed as percentage of total fat intake 
(%Fat) because previously it has been shown that the association between a FA expressed as an 
absolute amount in the diet and the concentration of FA in blood, is more variable and weaker than 
when fatty acids are expressed as relative amounts (Hodson et al, 2008). 
To identify food groups that explain the largest proportion of variation in FA serum concentrations, 
reduced rank regression (RRR) was applied using the partial least square procedure in SAS. RRR 
determines linear functions of predictors (i.e. food groups) and extracts so-called factors by 
maximizing the explained variation in responses (i.e. FA serum concentrations) (Hoffmann et al, 
2004). Factor loadings indicate the relationship between the food groups and the derived factor and 
thus indicate which food groups load highly onto the factor which explains variation in FA serum 
concentrations. Data on food intake and FA serum levels were firstly adjusted for several covariates 
(age, sex, BMI z-score, physical activity, maternal education and tanner stage) using multilevel 
regression analysis with a random intercept for center and then entered as residuals into the RRR 
analyses. As RRR implies that the number of extracted factors equals the number of selected 
responses, one factor was obtained for each FA. For clarity, only food groups with factor loadings 
≥|0.20| were reported.  
 
III.2.3 RESULTS 
Table 9 shows the Spearman rank correlation coefficients between the individual FA intakes and the 
FA serum concentrations. Significant correlations ranged from weak (rs=0.09) to strong (rs=0.31). 
Comparing the correlations between the FA intake and their same FA concentrations in the serum, 
significant associations were found for SFA, MUFA, LA, AA and DHA but not for total PUFA, 
ALA, EPA and DPA. Furthermore, intake of the LCn-3PUFAs, EPA and DPA, correlated positively 
with DHA serum status (rs=0.31 and rs=0.14 respectively). However, the results demonstrated a 
negative correlation between the parent molecule ALA and its derivatives EPA and DHA (rs= -0.09 
and rs= -0.14 respectively). Also LA was not correlated with its LC derivative AA (rs= -0.08, 
p=0.067). Furthermore, SFA intake showed a positive correlation with the n-3PUFA serum 
concentrations except with DHA. Also, LA and ALA showed a remarkable positive inter-correlation.  
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Table 9: Spearman correlations between FA intake (in percentage of total fat intake) and FA serum concentrations (in area%) 
(n=528) 
  
Serum  
SFA  
(%) 
MUFA 
(%) 
PUFA 
(%) 
LA  
(%) 
AA  
(%) 
ALA  
(%) 
EPA  
(%) 
DPA  
(%) 
DHA  
(%) 
Intake   
         
SFA (%F) rs 0.08*    -0.10* 0.12** 0.12** 0.21**  
MUFA (%F) rs -0.16** 0.17**  -0.14** 0.17** -0.22**  -0.20**  
PUFA (%F) rs  -0.09*   0.14**  0.09* -0.09*   
LA (%F) rs    0.13**  0.11* -0.10*   
AA (%F) rs -0.11*  0.09*  0.11* -0.17**  -0.11**  
ALA (%F) rs 0.12** -0.11*  0.15**    -0.09*  -0.14** 
EPA (%F) rs -0.10*   -0.11* 0.09* -0.11**    0.31** 
DPA (%F) rs          0.14** 
DHA (%F) rs -0.14**   0.10*     -0.15**     0.26** 
*p<0.05 
** p<0.01 
SFA Saturated Fatty Acid; MUFA Mono-unsaturated fatty acid; PUFA Poly-unsaturated fatty acid; LA Linoleic acid; ALA alfa-linolenic 
acid; EPA eicopentaenoic acid; DPA docosapentaenoic acid; DHA docosahexaenoic acid; %F % of total fat intake 
 
In Table 10 the crude Spearman rank correlation coefficients between food intake and FA serum 
status are presented. SFA serum status showed a negative correlation with items of the food group of 
meat/fish/eggs/meat alternatives and flour intake but was, in contrast, positively associated with 
sweet food items such as chocolate, confectionery and mainly cakes, pies and biscuits. The opposite 
was true for the concentration of total MUFA and the sum of n-3FA in the serum phospholipids. 
Results indicated a weak correlation between fish intake and EPA serum status (rs=0.09) and a 
moderate correlation with DHA (rs=0.23). Furthermore, consumption of yoghurt and butter was 
positively correlated with the concentration of the n-3PUFAs in serum phospholipids, whilst cheese 
intake showed a negative correlation with DHA serum status (rs==0.20). Also, margarines and oils, 
savoury snacks and miscellaneous food items were negatively correlated with DHA. LA, the 
precursor molecule of the n-6PUFA, was negatively associated with flour intake and yoghurt 
consumption but positively with sweet and savoury snacks. The serum concentration of the LC 
derivative, AA, in contrast was weakly but positively correlated with flour, margarine and oils and 
meat intake but negatively with chocolate consumption. Total energy intake was significantly 
correlated with DHA (rs= -0.17, p<0.001) but not with the other FA. The results indicated that 
several beverages were correlated to the serum FA profile which is rather unexpected as these items 
do not contain fats. It has to be noted that these analyses were only crude Spearman rank correlations 
and that no adjustment was made for covariates. The association between beverages and FA serum 
status could, as such, possibly be attributed to a concomitant dietary pattern.  
Finally, the proportion of variation in serum FA profile that could be explained by the overall dietary 
intake was assessed (Table 11), this varied between 6.71% and 14.23%. The smallest variation that 
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could be attributed to dietary intake was observed for ALA (6.71%), total MUFA (6.96%) and total 
SFA (7.61%), whilst the largest variation was observed for n-3 FA (14.23%) and more specifically 
EPA (11.12%), followed by AA (10.80%) and DHA (10.77%). Examination of food groups that 
contributed to these RRR factors revealed that the food groups of potatoes & grains, bread & rolls, 
vegetables, milk/yoghurt/soy beverages, cheese, pulses, sweet sandwich spreads and confectionery 
did not influence in large extent the serum FA profile. The factors explaining the SFA serum 
concentrations consisted mainly of meat, which loaded negatively on the factor and butter and animal 
fats, breakfast cereals and milk-based desserts and puddings, which all loaded positively on the 
factor. For MUFA serum status the factor loaded highly on chocolate and negatively on coffee and 
tea, milk-based desserts and puddings and margarine and oils, suggesting that these food items might 
be less frequently consumed by adolescents with a high MUFA serum status. The factor explaining 
the variation in PUFA serum status mainly loaded positively on coffee & tea, margarine & oils, and 
negatively on chocolate. For the LCPUFA, meat seemed an important positive contributor to the AA 
serum status whilst chocolate and creams loaded negatively on this factor. For the EPA and DHA, 
fish intake was an important positive contributor together with coffee & tea, whilst nuts & seeds and 
low-nutrient, energy-dense items were generally negative contributors. 
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Table 10: Spearman correlations between food intake (in g/day) and FA serum concentrations (in area%) (n=528) 
  
SFA  
(%) 
MUFA 
(%) 
PUFA 
(%) 
LA  
(%) 
AA  
(%) 
ALA  
(%) 
EPA  
(%) 
DPA 
(%) 
DHA 
(%) 
Beverages 
 
       
 
 
Water  -0.11* 0.10*  0.17** -0.26**  -0.17**  
Coffee and tea       0.13**    
Fruit and vegetable juices           
Carbonated/soft/isotonic drinks       0.09*   -0.16** 
Alcoholic beverages    -0.13**     -0.10* -0.17** 
Soups / bouillon          0.11* 
Bread and Cereals         
 
 
Bread and rolls          -0.13** 
Breakfast cereals     -0.10*   0.10* 0.13**  
Flour  -0.29** 0.21**  -0.21** 0.14** -0.14** 0.10*  0.22** 
Potatoes & Grains         
 
 
Rice and other grains       0.13** 0.09* 0.16**  
Starch roots, potatoes  0.09*    -0.12** 0.12**    
Pasta       -0.09*    
Vegetables & Fruits         
 
 
Vegetables      0.11* -0.16**  -0.12**  
Fruits       0.12** 0.09* 0.12** 0.10* 
Olives & advocado         -0.10* -0.11* 
Dairy & Soy products         
 
 
White milk and buttermilk        0.13** 0.14**  
Yogurt and fromage blanc      -0.14**  0.12** 0.17** 0.27** 0.22** 
Milk and yogurt beverages      -0.11* 0.13**   -0.09* 
Soya beverages           
Cheese       -0.12**  -0.09* -0.20** 
Desserts and puddings    -0.11*        
Fat & Oil         
 
 
Margarine and oils      0.16** -0.30** -0.16** -0.32** -0.17** 
Butter and animal fats     -0.09*  0.23** 0.21** 0.29**  
Meat/Fish/Egg/Meat alternative         
 
 
Meat  -0.15** 0.12**  -0.10* 0.10*  0.09*   
Fish products  -0.09*      0.09*  0.23** 
Eggs  -0.10*         
Meat substitutes and vegetarian 
products 
 -0.21** 0.09*    -0.09*   0.18** 
Nuts and seeds        -0.10* -0.13**  
Pulses (excluding fresh peas, 
sweet corn and broad bean) 
 -0.09*   -0.11*     0.12** 
Low-nutrient, energy-dense foods         
  Cakes, pies, biscuits  0.15** -0.15**  0.15**  -0.13** -0.09* -0.14** 
 Savoury snacks     0.15**   -0.15** -0.12** 
 Sugar, honey, jam and syrup     -0.10*     
 Confectionery non chocolate  0.010*   0.11* -0.11*    
 Chocolate  0.09*    -0.19**    
 Sauces       0.12**  0.11* 
 Creams  -0.23** 0.20**  -0.15**   0.09*  0.12** 
Miscellaneous  0.22** -0.14**   0.18**     -0.13** -0.22** -0.26** 
*p<0.05 ** p<0.01  
SFA Saturated Fatty Acid; MUFA Mono-unsaturated fatty acid; PUFA Poly-unsaturated fatty acid; LA Linoleic acid; ALA alfa-linolenic acid; EPA 
eicopentaenoic acid; DHA docosahexaenoic acid 
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Table 11: Percentage of variation in FA status explained by Reduced Rank Regression analyses and factor loadings of foods with value ≥ 0.2 
(n=471) 
percent variation accounted 
for by RRR factor 
SFA MUFA PUFA n3FA n6FA LA AA ALA EPA DHA 
7.61 6.96 9.06 14.23 8.79 10.65 10.80 6.71 11.12 10.77 
Usual food intake  
factor 
loading 
factor 
loading 
factor 
loading 
factor 
loading 
factor 
loading 
factor 
loading 
factor 
loading 
factor 
loading 
factor 
loading 
factor 
loading 
Beverages 
          Water 
          Coffee and tea 
 
-0.45 0.49 0.48
    
0.29 0.40
Fruit and vegetable juices 
        
-0.26 
 Carbonated/soft/isotonic drinks 
    
0.27
 
0.27
   Alcoholic beverages 
          Soups / bouillon 
    
0.20 0.26
    Bread and Cereals 
          Bread and rolls 
        
-0.24 
 Breakfast cereals 0.30
         Flour 
     
0.25 -0.25
   Potatoes & Grains 
          Rice and other grains 
          Starch roots, potatoes 
          Pasta 
          Vegetables & Fruits 
          Vegetables 
          Fruits -0.22
  
0.33
   
0.46
 
0.34
Olives & advocado 
 
-0.25 0.29
 
0.35
  
-0.24 
  Dairy & Soy products 
          White milk and buttermilk 
       
0.29 
  Yogurt and fromage blanc  -0.22
      
0.32 
  Milk and yogurt beverages 
     
-0.23
    Soya beverages 
          Cheese 
          Desserts & puddings  0.28 -0.44 0.22
 
0.22 0.21
 
0.35
  Fat & Oil 
          Margarine and oils 
 
-0.42 0.41 
 
0.40 0.24 
    Butter and animal fats 0.31 -0.23 
        Meat/Fish/Egg/Meat 
alternative 
          Meat -0.47 
     
0.38 
   Fish products 
  
0.21 0.38
    
0.28 0.48
Eggs 
     
0.25
    Meat substitutes and 
vegetarian products -0.21 
   
0.27 
     Nuts and seeds 
   
-0.31 0.26 0.25
  
-0.23 -0.26
Pulses (excl fresh peas, sweet 
corn and broad bean)   
        Low-nutrient, energy-dense 
foods 
          Cakes, pies, biscuits 
       
0.28 0.25 
 Savoury snacks 
    
0.22 0.24
  
-0.23 
 Sugar, honey, jam and syrup 
          Confectionery non chocolate 
          Chocolate 
 
0.24 -0.30
  
0.26 -0.46
 
-0.24
 Sauces -0.23
   
0.25
   
-0.25 
 Creams 
     
0.35 -0.43
  
-0.26
Miscellaneous    0.23  -0.27    0.32   
SFA Saturated Fatty Acid; MUFA Mono-unsaturated fatty acid; PUFA Poly-unsaturated fatty acid; LA Linoleic acid; ALA alfa-linolenic acid; EPA 
eicopentaenoic acid; DPA docosapentaenoic acid; DHA docosahexaenoic acid 
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III.2.4 DISCUSSION 
The present study aimed to assess the correlation between food and FA intake and the FA serum 
profile in an adolescent population and explored the percentage of variance in FA serum 
concentrations that could be attributed to dietary habits.  
After ingestion, dietary FA are metabolized in the human body. FA can be oxidized to be used as 
source of energy or they can be elongated and desaturated to form bioactive molecules such as 
signalling molecules (Calder, 2008b). Furthermore, FA can be incorporated in cell membranes or 
stored in adipose tissue and as such, be partitioned in several lipid pools (Hodson et al, 2008). Also 
some FA, such as the SFA with an even number of carbon atoms and MUFA of the n-9 family can be 
synthesized de novo in the human body (Tvrzicka et al, 2011). As such, it is not surprising that the 
correlation between intake and serum status of these FA groups is rather weak. This was also 
reflected in the low proportion of variation that could be explained by the RRR factor for these 
groups of FA (7.61% for SFA and 6.96% for MUFA). The rather weak correlation between SFA 
intake and its concentration in the serum PL fraction was also found by others (rs=0.10 – 0.17), but, 
the correlation between total MUFA intake and serum status varied widely across these different 
studies (rs=0.05 – 0.40) (Asciutti-Moura et al, 1988; Hodge et al, 2007; Ma et al, 1995). Correlations 
on the level of food intake instead of nutrient intake, demonstrated that it were not necessarily items 
that were rich in SFA (such as meat) that determined the SFA status but that mostly items that were 
rich in simple sugars (such as cakes/pies/biscuits, confectionery and chocolate) were positively 
correlated. Analysis of the dietary pattern by the RRR analyses revealed that the most important 
contributors to the SFA serum status were butter and animal fats, breakfast cereals and milk-based 
desserts and puddings, whilst meat intake loaded negatively on the RRR factor. In the present study 
no distinction was made between fat or lean meat and short or long chain SFA, which could attenuate 
the results. Furthermore, nutrients delivered by a different medium of food can have different health 
effects, for example there is convincing evidence that consumption of milk might have some long-
term benefits but evidence for other dairy products such as cheese and butter is limited and 
inconsistent (Elwood et al, 2010; Givens, 2012; Nestel, 2012). This is also illustrated by the results of 
the RRR analyses where butter and milk-based desserts load positively on the RRR factor for SFA 
whilst yoghurt and fromage blanc load negatively. Consequently it also could be that the SFA 
delivered via meat are subject to a different path of metabolisation due to competition effects with 
other nutrients or due to different predominant chain lengths of the FA.  
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In contrast to the SFA and MUFA, the PUFA of the n-3 and n-6 families cannot be synthesized in 
vivo, and are thus essentially derived from the diet. In the human body the parent molecules of these 
FA, namely ALA and LA can be further processed to their long chain derivatives, EPA/DHA and 
AA. However, as the conversion of the n-3PUFA is not always sufficient, EPA and DHA are 
assumed to be conditionally essential (FAO, 2010). This was reflected in the moderate correlation 
(rs=0.26) that was found between DHA intake and DHA serum status, although this was lower 
compared to others which found correlations of >0.40 (Hodge et al, 2007; Ma et al, 1995). No 
significant correlation was found for ALA, however, this could be due to the fact that ALA is the 
most rapidly oxidized and metabolized unsaturated FA (Nettleton, 1991). The correlation between 
intake and serum status for LA and AA were weak and respectively lower and higher than previously 
found in literature (Asciutti-Moura et al, 1988; Hodge et al, 2007; Ma et al, 1995). Furthermore, a 
positive correlation was found between EPA and DPA intake on one hand and DHA serum status on 
the other hand, but this was not found the other way round, indicating that it is not merely a 
reflection of concomitant intake but rather that these n-3FA are further converted to DHA in vivo. 
Moreover, a negative correlation was demonstrated between LA intake and EPA serum status, and 
also between ALA intake and EPA and DHA serum status. Possibly, this negative correlation that 
was found could be due to a competition effect between ALA and LA. A highly significant and 
strong correlation was found between ALA (%F) and LA (%F) intake (rs=0.36, p=8*10
-19
). 
Furthermore, a positive association was found between ALA intake and LA serum status (rs=0.15, 
p=0.001) and vice versa, between LA intake and ALA serum status (rs=0.11, p = 0.012). 
Subsequently, as the usual LA intake is almost seven times higher than ALA intake, a concomitant 
intake could result in a lower production of the LCn3PUFA due to the competition effect of LA, as 
been demonstrated several years ago (von Houwelingen et al, 1989). However, it must be noted that 
according to this hypothesis, one would also expect a positive correlation between LA intake and AA 
serum status which was not observed in our analysis. Other literature examining this is limited. Only 
Ma et al found a significant, but positive, correlation between ALA intake and the plasma cholesterol 
ester concentrations of EPA and DHA (both r=0.15) (Ma et al, 1995).    
The proportion of variation in serum FA concentrations that could be attributed to dietary intake was 
markedly higher for the group of n-3PUFA (14.23%) than for the other examined FA. Previously this 
was also demonstrated by von Houwelingen et al. who found that no more than 20 percent of the 
variance in the serum values of EPA and DHA could be explained on the basis of dietary intake (von 
Houwelingen et al, 1989). This confirms that nutrient intake is just one of the determinants affecting 
the nutrient status. Other determinants are, e.g., the homeostatic control mechanisms and a wide 
array of genetic, environmental and life-style factors (Hunter, 1990). For example, Schaeffer et al. 
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suggested that 29% of the variance of AA serum concentrations could be attributed to genetic 
variants in the FADS gene cluster, encoding Δ5- and Δ6-desaturase (Schaeffer et al, 2006). The 
estimated variance in the other FA that could be attributed to this genetic variation, varied from 9% 
for LA to 3% for DHA (Schaeffer et al, 2006). Compared to the current findings from the influence 
of dietary intake, the influence of variants in the FADS gene cluster was higher for AA but lower for 
LA and DHA. However, as shown in genome-wide association studies, also variants in other genes 
could influence the FA serum concentrations (Demirkan et al, 2012; Tanaka et al, 2009). 
The RRR analyses suggested that mainly fish intake and coffee & tea consumption explained the 
variance in EPA and DHA serum concentrations. The latter is, however, not a „rich source‟ of these 
LCn-3PUFA but the high factor loading might mean that adolescents with a high LCn-3PUFA status 
have a dietary pattern which is marked by a high consumption of coffee and tea, indicating that it is 
not only important to assess the intake of single foods or nutrients but also to consider the overall 
dietary pattern of an individual. On the other hand, this might also indicate that certain bioactive 
molecules, such as polyphenols, present in these beverages, influence the n-3FA metabolism. 
Recently, it has been shown that addition of polyphenols during active digestion can limit the 
development of n-3PUFA oxidation products in the small intestine lumen and thereby promote 
intestinal uptake of the beneficial, unoxidized, n-3PUFA (Maestre et al, 2013).  
 
STRENGTHS AND LIMITATIONS 
Being part of a multicenter European study, data were collected in a large sample of European 
adolescents, in a standardized way, following strict procedures; all blood analyses were performed in 
the same laboratory.  
Dietary information was collected by two self-administered, computer-assisted, non-consecutive 24h 
recalls. Following recommendations of the “European Food Consumption Survey method 
(EFCOSUM)” 24-hour recalls were preferred because they are open-ended questionnaires in which 
detailed information can be obtained (Biro et al, 2002). According to Biro et al. (2002)
 
the 24h recall 
method is appropriate to assess both acute and habitual intake on the individual level by repeated 
short term measurements and modeling.  
A limitation of the method used is however that only information of two days was obtained and that 
the time between dietary data collection and blood sampling varied. As such the dietary intake was 
prone to exceptional intakes. The 24-h dietary recall method does not allow quantifying proportions 
of non-consumers for particular food items, mainly for infrequently consumed foods. In order to 
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decrease this influence, nutrient intakes were corrected for within-person variability by applying the 
MSM method. Moreover, accuracy of collected data relies on the individual‟s ability to remember 
foods and beverages consumed in the past 24 hours, and might, therefore, be biased. In this respect, 
the 24-h dietary recalls were performed through computer-assisted HELENA-DIAT software to 
standardize the recall procedures as much as possible and to allow quality controls during the 24-h 
recall interview. Another limitation of the use of 24-h recall interviews is the potential loss of dietary 
information from mixed dishes, as food ingredients needed to be estimated from mixed dishes. 
Furthermore, the quantification of the “hidden fats” in the diet is difficult (Arab, 2003; Bingham, 
2002), certainly in an adolescent population as they are often not acquainted with the applied food 
preparation methods and thereby used fats. As such average values of used cooking fats were 
estimated according to the countries habitual preparation methods. Finally, the translation from foods 
to nutrients is always prone to mistakes and loss of accuracy. Comparison of nutrient intake between 
the different European countries was promoted by using the same food composition table for the 
conversion of food intake data to estimated nutrient intakes. In this way differences in definitions, 
analytical methods, units and modes of expression were overcome. In this regard the German food 
composition tables (Bundeslebensmittelschlüssel, BLS) were chosen. However, food items, for 
example fishes, obtained from different places might have a very distinct FA composition (Weaver et 
al, 2008).  
 
III.2.5 CONCLUSION 
This study indicated that dietary intake is an important determinant of the FA serum status, and 
mainly of the n-3 PUFA, but that also other factors such as homeostatic control mechanisms and a 
wide array of genetic, environmental and life-style factors interfere. Furthermore, also the overall 
dietary habits should be considered instead of only the consumption of single foods or nutrients, this 
has been addressed in a subsequent chapter (Chapter III.4. Moreover, as the results from this study 
were derived from a cross-sectional, uncontrolled study, conclusions are only indicative and should 
be confirmed in a more elaborated well-controlled study.  
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III.3 DIET QUALITY INDEX FOR ADOLESCENTS 
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ABSTRACT 
Inadequate or excessive intake of nutrients can have important health consequences. However, also 
the overall dietary pattern is of importance as nutrients interact with each other and preparation and 
storage methods can influence the nutritional content of a meal. Food Based Dietary Guidelines 
(FBDG) aim to address the complexity of nutritional requirements at population level in order to 
prevent diseases and promote a healthy lifestyle. Diet quality indices can be used to assess the 
compliance with these FBDG and thus provide a measure for the overall dietary habits. This study 
aimed to investigate whether the newly developed Diet Quality Index for Adolescents (DQI-A) is a 
good surrogate measure for adherence to FBDG, and whether adherence to these FBDG effectively 
leads to better nutrient intakes and nutritional biomarkers in adolescents. This was done by testing 
the hypothesis that foods and nutrients that are recommended to be consumed in large amounts are 
positively associated with the index, whilst foods and nutrients that should be consumed in limited 
amounts are negatively associated. Participants included 1804 European adolescents who were 
recruited in the HELENA Study. Dietary intake was assessed by two, non-consecutive 24h recalls. A 
DQI-A score, considering the components dietary quality, diversity and equilibrium, was calculated. 
Associations between the DQI-A and food and nutrient intakes and blood concentration biomarkers 
were investigated using multilevel regression analysis, corrected for centre, age and sex. DQI-A 
scores were associated with food intake in the expected direction: positive associations with nutrient-
dense food items, such as fruits and vegetables, and inverse associations with energy-dense and low-
nutritious foods. On the nutrient level, the DQI-A was positively related to the intake of water, fiber 
and most minerals and vitamins. No association was found between the DQI-A and total fat intake. 
Furthermore, a positive association was observed with 25(OH)D, holo-transcobalamin, and n-3 fatty 
acids serum levels. This study has shown good validity of the DQI-A by confirming the expected 
associations with food and nutrient intakes and some biomarkers in blood. 
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III.3.1 INTRODUCTION 
It is generally accepted that inadequate or excessive nutrients intake can have important health 
consequences, such as nutritional deficiencies, increased risk of type 2 diabetes, cardiovascular 
disease and obesity. Food Based Dietary Guidelines (FBDG) have been developed to prevent such 
dietary related health problems (Food and Agriculture Organization of the United Nations/World 
Health Organization, 1996; Sandstrom, 2001). These guidelines are targeted at the general 
population and contain messages that give an indication of what a person should be eating in terms of 
foods rather than nutrients. These FBDG can be broad and nonspecific, such as „eat a variety of 
foods each day‟, or more targeted such as „eat five portions of fruits and vegetables a day‟. Messages 
may also specify the type of food, such as „at least half of the grains consumed should be whole 
grains‟, or be meal specific such as „eat a breakfast every day‟ (Sandstrom, 2001; World Health 
Organization, 2000). 
Over the last decades, a number of diet quality indices, measuring adherence to such dietary 
guidelines, have been developed (Kant, 1996; Kennedy et al, 1995; Patterson et al, 1994; Waijers et 
al, 2007). The advantage of such indices is that they capture the complexity of human diets in a 
single value, taking into account the interactions between nutrients, the food preparation methods and 
the eating patterns (Hu, 2002; Kant, 2004; Waijers et al, 2007). In general, indices representing 
overall diet quality showed stronger correlations with health outcomes than individual nutrients or 
foods (Kant, 1996).  
The majority of existing indices are, however, unsuitable for children and adolescents, because their 
development is based on dietary recommendations for adults (Manios et al, 2010a). Nevertheless, 
appropriate indices for children and adolescents have been developed, based on recommendations 
specific for these age groups, e.g. the Youth Healthy Eating Index (YHEI) (Feskanich et al, 2004), 
the Revised Children‟s Diet Quality Index (RC-DQI) (Kranz et al, 2008), the Diet Quality Index for 
Preschoolers (Huybrechts et al, 2010), the Preschoolers Diet-Lifestyle Index (PDL-Index) (Manios et 
al, 2010a), the Healthy Lifestyle-Diet Index (HLD-Index) (Manios et al, 2010b). However, most of 
these indices are calculated based on a combination of food and nutrient (e.g. cholesterol, sodium) 
intake. This implies the need for detailed dietary information and use of food composition tables.  
The purpose of this study was to develop a Diet Quality Index for Adolescents (DQI-A), calculated 
on food intake data only, for assessing adherence to FBDG. Furthermore, the aim of the study was to 
investigate whether adherence to FBDG (using the DQI-A as a proxy measure) is associated with 
better adherence to nutrient dietary recommendations and a better nutritional biomarker blood profile 
in European adolescents.  
III.3 DIET QUALITY INDEX FOR ADOLESCENTS 
101 
III.3.2 SUBJECTS AND METHODS 
III.3.2.1 STUDY DESIGN AND POPULATION 
Data were obtained from the HELENA-Cross Sectional Study (HELENA-CSS) that has been 
described in more detail in Part II Methods.  
For the purpose of this study, adolescents who provided data on two non-consecutive 24h dietary 
recalls were included in the analysis, resulting in 2330 subjects. Participants from Heraklion and 
Pècs were excluded for these analyses as no nutrient intake information was calculated for these two 
cities due to logistical problems. Exclusion of underreporters resulted in a final sample of 1804 
adolescents (52.6% females) for statistical analysis. The group of underreporters consisted of a 
slightly higher percentage of females (57.8% compared to 52.6% in the plausible reports, p = 0.036) 
and had higher median (min; max) Body Mass Index (BMI) values (22.5 (14.99; 45.63) compared to 
20.1 (14.08; 40.77) in the plausible reports; p < 0.001). No differences in age and DQI-A score were 
observed. Blood samples were collected in a randomly selected subset  of the total HELENA study 
population (1089 adolescents) of whom 697 provided two 24h recalls. Exclusion of underreporters 
resulted in a final sample of 552 adolescents (52.3% females) with biomarkers in our study. 
Characteristics of adolescents for whom no biochemical parameters were obtained were compared to 
those included in the sub-analysis. No significant differences in age, sex and BMI were observed 
between these two groups, however, the adolescents in the sub-analysis had higher mean values for 
the DQI-A compared to the total study population (52.6% SD 15.6 and 51.3% SD 16.5, respectively, 
p = 0.018).  
III.3.2.2 DIET QUALITY INDEX FOR ADOLESCENTS (DQI-A) 
Dietary intake data was assessed with the HELENA-DIAT (Dietary Assessment Tool) and the 
Multiple Source Method (MSM) was used to estimate the habitual dietary intake of nutrients and 
foods (https://nugo.dife.de/msm; Haubrock J. et al, 2010). Further details on these methods can be 
found in Part II Methods. 
A previously validated Diet Quality Index (DQI), originally developed for preschool aged children 
(Huybrechts et al, 2010) was adapted for use in adolescents to measure their compliance to the 
Flemish FBDG (VIG, 2006). These FBDG put forward three basic principles for a healthy and 
balanced diet, namely dietary quality, dietary diversity and dietary equilibrium. Furthermore the 
daily diet was divided in nine recommended food groups, namely (1) water, (2) bread & cereals, (3) 
grains & potatoes, (4) vegetables, (5) fruit, (6) milk products (7), cheese, (8) meat, fish, eggs & 
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substitutes (9) fat & oils. Milk products and cheese were allocated to different food groups because 
of the important difference in fat content. Meat and fish are considered in the same food group; 
because of the differences in nutrient-content, the FBDG recommended additionally to consume fish 
preferably two times per week. However, as only two 24h recalls were assessed, the frequency of 
fish consumption could not be considered separately in the DQI-A calculation. For each of the food 
groups a range of recommended daily intake specifically for adolescents was provided by the FBDG. 
The ranges in these FBDG were based upon the nutrient recommendations of the Belgian Health 
Council (BHC, 2009) and WHO, combined with data on habitual dietary intake in the Belgian 
population. These FBDG were very similar to dietary guidelines in other countries and to the CINDI 
pyramid (Countrywide Integrated Non communicable Disease Intervention program) developed by 
the WHO (http://www.eufic.org/article/en/page/RARCHIVE/expid/food-based-dietary-guidelines-in-
europe/), making the index applicable for a European population.  
 
The technical aspects of the calculation of the DQI-A are given in Table 12. Parallel to the FBDG, 
the DQI-A consisted of three components, namely quality, diversity and equilibrium.  
Dietary quality expressed whether the adolescent made the optimal food quality choices within a 
food group and was represented by a “preference group” (e.g. cereal/brown bread, fresh fruit, fish), 
an “intermediate group” (e.g. white bread, minced meat) and a “low-nutrient, energy-dense group” 
(e.g. soft drinks, sweet snacks, chicken nuggets). A comprehensive description of the allocation of 
food items to the different quality groups is given in Table 13. 
Dietary diversity expressed the degree of variation in the diet. One point was given per 
recommended food group if at least one serving of a food belonging to this food group was 
consumed (score ranging from 0 to 9). 
Dietary equilibrium was calculated from the difference between the adequacy component (which 
was the percentage of the minimum recommended intake for each of the main food groups, truncated 
to 1) and the excess component (which was the percentage of intake exceeding the upper level of the 
recommendation, truncated to 1 if larger than 1 and truncated to 0 when below 0; see Table 12). In 
the food group of meat, fish, eggs & substitutes, the daily intake of the total group was considered. 
As such a too high consumption of meat and fish was penalized in the excess component. However, 
the fish consumption was granted points in the quality component as fish is always allocated to the 
preference group in contrast to semi-fat and fat meat products.  
III.3 DIET QUALITY INDEX FOR ADOLESCENTS 
103 
These three components of the DQI-A were presented in percentages. The Dietary quality 
component ranged from -100% to 100% while dietary diversity and dietary equilibrium ranged from 
0% to 100%. To compute the DQI-A the mean of these components was calculated, as such, the 
DQI-A ranged from -33% to 100%, with higher scores reflecting a higher diet quality. The score was 
calculated for each day and a mean of the daily scores was taken as global index score of the 
individual. 
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Table 12 Overview of the calculation of the Diet Quality Index for Adolescents (DQI-A) 
FBDG DQI-A Components 
Food Groups (FG) 
Recommended  
daily intake (VIG, 
2006) 
Dietary Quality 
(DQ) 
Dietary Diversity 
(DD) 
Dietary Adequacy 
(DA) 
Dietary Excess (DEx) 
Dietary Equilibrium  
(DE) 
Recommended foods 
      
Water 1500 - 2250 ml 
 
DQ = 
Amount consumed  
food item (m) * 
weighting factor 
 
 
 
Weighting factor: 
+1 "preference 
group" 
0 "intermediate 
group" 
-1 "low-nutrient, 
energy-dense 
group" 
DD = 
1 point 
for each FG if at 
least one serving is 
consumed  
DA =  
actual intake FG/ 
min. recomm FG 
 
Values > than 1 
were truncated to 1 
 
DEx =  
(actual intake FG -  
max. recomm FG)/ 
max. recomm FG 
 
Values > than 1 
were truncated to 1; 
values < 0 were 
truncated to 0. 
DE = DA – DEx 
Bread & Cereal 150 - 360 g 
Potatoes & Grains 210 - 350 g 
Vegetables 300 - 450 g 
Fruits 250 - 375 g 
Milk products 450 - 600 ml 
Cheese 20 - 40 g 
Meat, fish and 
75 - 100 g 
substitutes 
Fat & Oils 10 – 15g 
  
    
Non-recommended foods 
  
Snacks & candy < 50 g 
  
Sugared drinks & fruit 
juice 
< 300 ml 
  
       
Score of components Σ(DQ)/ Σm * 100% Σ(DD)/9 * 100% Σ(DA)/9 * 100% Σ(DEx)/11 * 100% Σ(DE)/11*100% 
DQI-A score (Dietary Quality + Dietary Diversity  + Dietary Equilibrium) / 3 
FBDG, Food Based Dietary Guidelines. Further details on “preference group”, “intermediate group” and “low-nutrient, energy-dense group” can be found in  
Table 13. 
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Table 13 Classification of food items to the different quality groups within each food group, as advised by the Flemish FBDG 
 
Preference Group Intermediate Group Low-nutrient, Energy-dense Group 
Water Plain water 
Non-salted, energy-poor drinks 
(<5kcal/100ml) 
High-energy drinks (>5kcal/100ml), 
bouillons and alcoholic beverages  
Bread & Cereal 
Items rich in fiber and with a low 
fat-content (e.g. cereal bread) 
Items with a low fiber-content 
and/or added fat (e.g. white bread, 
raisin bread) 
High-fat preparations (e.g. pies, 
cakes) 
Potatoes & Grains 
Items rich in fiber and with a low 
fat-content (e.g. boiled potatoes, 
bulgur, whole-wheat pasta) 
Items with a low fiber-content 
and/or added fat (e.g. white rice, 
mashed potatoes) 
High-fat preparations (e.g. French 
fries, chips) 
Vegetables 
Fresh or frozen vegetables without 
additives 
Vegetables prepared with 
cream/sauces or conserved with 
added salt 
None 
Fruits 
Fresh or frozen fruits without 
additives 
Conserved and dried fruits Jam 
Milk products 
Semi-skimmed or skimmed milk 
products without added sugar or 
sweeteners 
Sugared and whole-milk  products 
(e.g. milk or soy-based puddings 
and desserts, flavored milk) 
Creams and desserts (e.g. chocolate 
mousse)  
Cheese Low-fat cheese (< 20% fat) Semi-fat and fat cheese None 
Meat, fish and 
substitutes 
Fish products and low-fat meat  
Semi-fat and fat meat products 
(e.g. minced meat) and eggs 
Fried meat and snacks (e.g. chicken 
nuggets) 
Fats & Oils Vegetable oils 
Margarines and lipids of mixed 
origins 
Butter and animal fats  
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III.3.2.3 BLOOD ANALYSES 
After an overnight fasting period, venous blood samples were drawn in the morning at school 
according to a standardized blood collection protocol. Details about the sampling, processing and 
transportation can be found elsewhere (Gonzalez-Gross et al, 2008). The studied biomarkers were 
chosen in view of clinical relevance to evaluate nutritional status (vitamin D, vitamin B12, retinol, 
triglycerides) or as dietary biomarker reflecting true intake (vitamin C, plasma folate, carotenoids, n-
3 fatty acids, trans fatty acids). Although plasma vitamin D concentrations are influenced by several 
factors such as sunlight exposure and adiposity, evidence also showed weak correlations with dietary 
intakes (Jacques et al, 1993). Strong correlations of dietary intakes of vitamin C and serum ascorbic 
acid concentrations have been reported mainly when habitual dietary intakes of vitamin C are 
relatively modest (Bates et al, 1979; Jenab et al, 2009). Many factors influence serum folate 
concentrations and bioavailability of dietary folate, however, intakes correlate moderately with 
serum concentrations (Jacques et al, 1993). Weak but positive correlations were reported for males 
and females between dietary vitamin B12 intake and holo-transcobalamin status, being a marker of 
long-term vitamin B12 status (Bor et al, 2010; Hvas et al, 2005). Weak correlations may be linked to 
the large size of liver vitamin B12 stores. Blood concentrations of carotenoids appear to be 
moderately correlated with fruit and vegetable intake (Jenab et al, 2009; Rock et al, 1992; Willett et 
al, 1983). Plasma retinol concentrations are only responsive to vitamin A intake in individuals with 
inadequate vitamin A status (Willett et al, 1983). Plasma triglycerides have been shown to be 
positively correlated with total fat intake and negatively with fiber intake. Levels may to some extent 
be indicative of the level of dietary fiber intake, but the findings to date are conflicting (Jenab et al, 
2009; Sonnenberg et al, 1996). Omega-3 fatty acid intake is moderately correlated with plasma 
phospholipid levels, reflecting intake on short to medium term (Andersen et al, 1996; Hodge et al, 
2007). Correlations between the intake of specific types of trans fatty acids and their levels in blood 
are generally good, however, correlation between the total sum of trans fatty acid intake and the sum 
of serum trans fatty acid levels is only weak (Baylin et al, 2005; Hodson et al, 2008). Details on 
laboratory analysis can be found in Chapter II.3: Blood sampling and Analyses, p 60.  
III.3.2.4 STATISTICAL ANALYSIS 
Statistical analyses were performed using the statistical software PASW for Windows version 18 
(SPSS Inc, Chicago, IL, USA).  
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Descriptive characteristics were summarized by calculating means and standard deviations (SD) for 
continuous variables and percentages for categorical variables. Pearson χ2- and t-tests were used to 
test differences between sexes in categorical and continuous variables, respectively.  
Normality was evaluated visually and based on the skewness of the data distributions. Skewness of 
variables on intake ranged from 0.869 (meat intake) to 9.809 (alcohol intake – due to a high number 
of non-consumers). Since these variables were studied in a large sample size (n=1804) it was 
considered that parametrical tests were allowed without transformations. However, variables with a 
skewness > 3 were transformed (log-transformation and square root transformations were tested) and 
the multilevel analyses were repeated with the transformed data. For all the variables, except for 
sodium intake, the results before and after transformation were similar. To facilitate the interpretation 
of the results it was chosen to display the non-transformed data, except for sodium intake which was 
log-transformed. The skewness of the variables on blood values ranged from -0.210 to 2.017; the 
skewness of holo-transcobalamine was 3.110. As these variables were only studied in a sample of 
552 adolescents it was decided to perform a log-transformation of holo-transcobalmine in order to 
achieve a more normal distribution. Multilevel linear regression analysis with inclusion of a random 
intercept for study centre was used to examine the relationship between the DQI-A and foods, 
nutrient intakes or blood biomarkers. Confounders (age and sex) were entered as covariates. The 
random intercept for centre ranged from 0.19% to 24.42% with the highest influence of centre 
observed for oils, butter and animal fats, and milk and yoghurt. Significant differences in mean DQI-
A scores were observed between both sexes, however, results of validation were very similar. As 
such, results were not stratified. To adjust for multiple testing a Bonferroni correction was applied to 
lower the significance level (α) taking into account the number of tests (0.05/number of tests). P-
values of 0.0019, 0.0013 and 0.006 were used as threshold of significance for the association 
between DQI-A and foods, nutrients and biomarkers, respectively.   
 
III.3.3 RESULTS 
The total study population consisted of 1804 participants (52.6% females); mean age was 14.7 years 
(SD 1.2). The DQI-A score ranged from -11.1% to 84.1%, the mean DQI-A scores were 49.0% (SD 
17.0) and 53.3% (SD 15.9) for males and females respectively (p < 0.001). No differences were 
observed in mean DQI-A between adolescents in different BMI-classes or between adolescents 
complying with the recommendation of 60 minutes physical activity versus non-compliers.  
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Multilevel regression analysis of the DQI-A scores with the usual consumption of different foods is 
shown in Table 14. A strong positive association between the DQI-A score and water intake (g/d) 
was observed (β = 19.529, p < 0.0001). In contrast, soft drinks, fruit juices, and alcoholic beverages 
showed a significant negative association with the DQI-A. Furthermore, the DQI-A score and 
bread/cereals had a positive association, but there was no significant association with potatoes and 
grains. Milk and cheese (g/d) were positively associated with the DQI-A score and animal fat (g/d) 
and vegetable fat (g/d) showed a small, however significant, positive association with the DQI-A (β 
= 0.100, p <0.0001 and β = 0.118, p < 0.0001; respectively). No significant relation was present with 
meat, fish, egg and substitutes. All non-recommended (energy-dense and low-nutritious) foods 
showed a significant negative association with the DQI-A score.  
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Table 14 Association between Diet Quality Index for Adolescents (DQI-A) scores and food intake*  
(β coefficients and 95% confidence intervals) 
 
DQI-A (N=1804) 
 
β 95% CI p-value 
Beverages 
    
Water (g/d) 19.529 18.298 20.761 < 0.0001 
Coffee and tea (g/d) 0.084 -0.243 0.412 0.6137 
Soups / bouillon (g/d) -0.016 -0.213 0.182 0.8777 
Bread and Cereals 
    
Bread and rolls (g/d) 0.494 0.330 0.658 < 0.0001 
Breakfast cereals (g/d) 0.239 0.177 0.301 < 0.0001 
Potatoes & Grains 
    
Rice and other grains (g/d) 0.008 -0.110 0.126 0.8961 
Starch roots, potatoes (g/d) 0.063 -0.062 0.188 0.3247 
Pasta (g/d) 0.254 0.094 0.414 0.0019 
Vegetables (g/d) 0.911 0.740 1.083 < 0.0001 
Fruits (g/d) 2.181 1.883 2.479 < 0.0001 
Milk products 
    
Milk, yoghurt and milk beverages (g/d) 4.257 3.669 4.845 < 0.0001 
Desserts and puddings milk based (g/d) -0.069 -0.148 0.010 
0.0883 
 
Cheese (g/d) 0.224 0.159 0.289 < 0.0001 
Meat/Fish/Egg/Meat alternative 
    
Meat (g/d) -0.004 -0.202 0.194 0.9687 
Fish products (g/d) 0.074 0.001 0.146 0.0466 
Eggs (g/d) -0.005 -0.055 0.044 0.8380 
Meat substitutes, nuts and pulses (g/d) 0.124 0.023 0.224 0.0160 
Fat & Oil 
    
Margarine and vegetable oils (g/d) 0.118 0.083 0.153 < 0.0001 
Butter and animal fats (g/d) 0.100 0.065 0.136 < 0.0001 
Non-recommended foods 
    
Snacks & candy 
    
Cakes, pies, biscuits (g/d) -0.287 -0.409 -0.166 < 0.0001 
Savoury snacks (g/d) -0.245 -0.295 -0.195 < 0.0001 
Sugar, honey, jam, candies, chocolate (g/d) -0.281 -0.404 -0.158 < 0.0001 
Sauces & creams (g/d) -0.143 -0.225 -0.062 0.0006 
Drinks 
    
Carbonated/soft/isotonic drinks (g/d) -11.456 -12.188 -10.724 < 0.0001 
Fruit and vegetable juices (g/d) -3.133 -3.588 -2.677 < 0.0001 
Alcoholic beverages (g/d) -0.798 -1.065 -0.531 < 0.0001 
*Multilevel regression analyses with inclusion of a random intercept for centre and corrected for age and sex as 
independent variables. After Bonferroni correction the adjusted α=0.0019. 
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Table 15  Associations between Diet Quality Index for Adolescents (DQI-A) scores and usual intake of macro- and 
micronutrients* (β coefficients and 95% confidence intervals) 
 
DQI-A (N=1804) 
 
β 95% CI p-value 
Macronutrients 
    
Energy(kcal/d) -2.893 -4.514 -1.271 0.0005 
Protein(g/d) 0.119 0.043 0.195 0.0020 
Carbohydrates (g/d) -0.836 -1.072 -0.599 <0.0001 
Total fat (g/d) 0.044 -0.034 0.123 0.2643 
Water (g/d) 10.646 8.952 12.339 <0.0001 
Fiber (g/d) 0.107 0.088 0.125 <0.0001 
Carbohydrates  
    
Monosaccharides (g/d) -0.853 -939.141 -766.813 <0.0001 
Disaccharides (g/d) -0.289 -405.958 -171.109 <0.0001 
Polysaccharides (g/d) 0.230 103.602 357.275 0.0004 
Fats 
    
Saturated fatty acids (mg/d) 37.695 2.810 72.580 0.0342 
Mono-unsaturated fatty acids (mg/d) 32.993 3.639 62.348 0.0276 
Poly-unsaturated fatty acids (mg/d) -17.256 -31.941 -2.570 0.0213 
Cholesterol (mg/d) 0.333 -0.017 0.684 0.0624 
Minerals 
    
Sodium (mg/d) † 1.003 1.002 1.005 <0.0001 
Potassium(mg/d)  7.687 5.226 10.147 <0.0001 
Chlorine(mg/d) 8.583 5.531 11.635 <0.0001 
Calcium(mg/d) 6.623 5.549 7.697 <0.0001 
Magnesium(mg/d) 0.923 0.653 1.192 <0.0001 
Iron (µg/d) -6.848 -17.827 4.132 0.2213 
Copper(µg/d) 2.793 0.957 4.630 0.0029 
Zinc(µg/d) 38.728 30.434 47.023 <0.0001 
Fluorine(µg/d) 2.247 1.557 2.937 <0.0001 
Iodine(µg/d) 0.595 0.500 0.691 <0.0001 
Phosphor(mg/d) 5.363 4.233 6.494 <0.0001 
Manganese(µg/d) 11.073 6.669 15.477 <0.0001 
Vitamins 
    
Thiamine(µg/d) 1.947 0.848 3.045 0.0005 
Riboflavin(µg/d) 7.936 6.452 9.420 <0.0001 
Niacin(µg/d) 17.818 2.495 33.140 0.0227 
Pantothenic(µg/d) 18.807 14.547 23.066 <0.0001 
Pyridoxine(µg/d) 4.140 2.556 5.723 <0.0001 
Biotin(µg/d) 0.171 0.133 0.209 <0.0001 
Total folicacid(µg/d) 0.699 0.511 0.887 <0.0001 
Cobalamin(µg/d) 0.020 0.013 0.027 <0.0001 
Vitamin C(g/d) 0.169 -0.007 0.345 0.0601 
Retinol Equivalents (µg/d) 5.075 3.713 6.436 <0.0001 
Vitamin D(µg/d) 0.005 0.002 0.008 0.0006 
Vitamin E(µg/d) 2.813 -6.578 12.204 0.5569 
Vitamin K(µg/d) 1.064 0.812 1.317 <0.0001 
*Multilevel regression analysis with inclusion of a random intercept for center and corrected for age and sex as 
independent variables. After Bonferroni the adjusted α=0.0013.  
† variable was log-transformed to obtain a normal distribution. 
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At the level of macronutrients (Table 15) a positive association was observed between the DQI-A 
and water (g/d) and fiber (g/d) intake, and a negative relationship was found with total energy intake 
(kcal/d) (β = -2.893, p = 0.0005). The usual intake of polysaccharides (g/d) was positively related to 
the dietary quality (β = 0.230, p = 0.0004) whilst the intake of mono- and disaccharides (g/d) showed 
a negative relationship (β = -0.853 and β = -0.289, respectively; both p < 0.0001). No significant 
association was seen between DQI-A and protein intake (g/d) or fat intake (g/d). All investigated 
minerals (Table 15) except iron and copper were positively associated with the DQI-A score. 
Furthermore, intake of almost all vitamins, except niacin, vitamin C, and vitamin E showed a 
significant positive association with the calculated index.  
Table 16 describes the results of the multilevel regression analysis between the DQI-A scores and 
nutritional biomarkers in a subgroup of 552 adolescents. Only for plasma 25(OH)D and holo-
transcobalamin a significant positive association was observed with the index score. The positive 
association with the n-3 FA status was borderline significant if expressed as µmol/L (β = 0.376, p = 
0.007) and significant if expressed as area% (β = 0.012, p = 0.0003). 
 
Table 16 Associations between the Diet Quality Index for Adolescents (DQI-A) scores and nutritional biomarkers*  
(β coefficients and 95% confidence intervals) 
 
DQI-A (N=552) 
 
Β 95% CI p-value 
25(OH)D (nmol/L) 0.301 0.164 0.438 <0.0001 
Vitamin C (mg/dL) 0.013 -0.006 0.031 0.1807 
Plasma folate(nmol/L) 0.051 -0.007 0.109 0.0826 
Holo-Transcobalamin (TC-II/B12) 
(pmol/L)† 
1.005 1.002 1.007 0.0002 
Beta carotene (ng/ml) 0.608 -0.445 1.661 0.2570 
Retinol (ng/ml) 0.310 -0.285 0.905 0.3062 
Triglyceride (mg/dL) -0.056 -0.231 0.118 0.5259 
n-3 fatty acids (µmol/L) 0.376 0.105 0.646 0.0066 
n-3 fatty acids (area%) 0.012 0.006 0.019 0.0003 
transFA (µmol/L) -0.005 -0.010 -0.001 0.0250 
transFA (area%) <0.001 <-0.001 0.001 0.0688 
*Multilevel regression analyses with inclusion of a random intercept for center and 
corrected for age and sex as independent variables. After Bonferroni correction the adjusted 
α=0.006.  † Variable was log-transformed to obtain a normal distribution. 
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III.3.4 DISCUSSION 
Diet quality indices are valuable tools to obtain a global assessment of the dietary quality of a person 
or population. The present study aimed to investigate whether the developed DQI-A, calculated 
solely from food items, was an adequate proxy measure for adherence to the FBDG. This was done 
by comparing the DQI-A scores with the usual intake of different foods. The hypothesis was tested 
that foods (and nutrients) that are recommended to be consumed in large amounts, and thus often 
under-consumed, are positively associated with the index, whilst foods (and nutrients) that should be 
consumed in limited amounts, and are thus often over-consumed, are negatively correlated. The 
results showed that DQI-A scores were significantly associated with most food items in the expected 
direction. Nutrient-dense food items, such as fruits and vegetables, were positively associated, whilst 
non-recommended foods showed negative associations. No significant relation between the DQI-A 
score and the usual intake of meat, fish, egg or its substitutes was found. This was due to the fact that 
this food group (calculated as the sum of meat, fish and eggs) was often consumed in excess, 
resulting in a lower score of the Dietary Equilibrium component. However, it is noteworthy that the 
overconsumption of this food group is mainly due to an excessive intake of meat products rather than 
fish or meat substitutes. Fish is only over-consumed in a minority of the adolescents (26 of the 1804 
adolescents had a habitual fish consumption of > 100g/day; range 0 to 328 g/d). Consumption of 
meat substitutes ranged from 0 to 143 g/d with 8 adolescents consuming more than 100g/day. 
Furthermore, a positive relation was observed between the DQI-A score and the consumption of fat 
and oils. A moderate intake of fat and oil is recommended in the Flemish FBDG. Also, a high 
consumption of vegetable oils is in line with the Mediterranean diet and the FBDG of Greece and 
Spain (http://www.eufic.org/article/en/page/RARCHIVE/expid/food-based-dietary-guidelines-in-
europe/). Moreover, adherence to the Mediterranean diet has been shown to have beneficial effects 
on cardiovascular risk factors (Estruch et al, 2006). In the past, it was generally assumed that 
saturated fats induced a higher risk of cardiovascular disease; however, this has been questioned 
lately, as replacement of saturated fatty acids with refined carbohydrates was suspected to increase 
the risk of cardiovascular disease (Mozaffarian, 2011; Willett, 2011). Furthermore, children and 
adolescents have higher lipid intake needs, which is essential for growth. Besides energy delivery, 
lipids have an important function as structural components in all tissues, because they are 
indispensable for cell and plasma membrane synthesis (Uauy et al, 2000).  
Another interesting fact was the inverse relationship between the DQI-A score and energy intake. 
This suggested that adolescents with large, excessive, food intake, thus more likely to meet minimal 
intake recommendations, did not necessarily obtain higher diet quality scores. This was in contrast 
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with other diet quality index validation studies where participants consuming more food, and thus 
more total energy, had higher quality scores compared with adolescents who ate less (Feskanich et 
al, 2004; Lowik et al, 1999).  
In the development of the DQI-A three other variants have been studied, namely one with inclusion 
of a measure for meal frequency, one with inclusion of a measure of physical activity and both (data 
not shown). The DQI-A, as described in the present paper, however, showed the strongest 
associations with the different food items as well as the largest variance between individuals. 
Overall, based on these results, it can be concluded that the DQI-A is indeed a good surrogate marker 
for adherence to FBDG.  
The second aim of the study was to investigate whether adherence to these FBDG, using the DQI-A 
as proxy measure, resulted in a better nutritional intake and blood biomarker profile. Indeed, the 
DQI-A was strongly related to higher intakes of water, fiber and most minerals and vitamins. The 
high fiber intake was a clear representation of the FBDG to consume sufficient vegetables and fruits, 
and to choose wholegrain products (VIG, 2006). Also, the DQI-A was positively associated with 
complex carbohydrates whilst the usual intake of mono- and disaccharides decreased with better 
adherence to the guidelines, as would be expected (VIG, 2006; World Health Organization, 2000). 
Increased consumption of simple carbohydrates-rich foods has been associated with obesity, type 2 
diabetes and metabolic syndrome (World Health Organization, 2000). The absence of association 
with vitamin C intake might be attributed to the fact that vitamin C is prevalent in fruit juices which 
are considered as non-recommended foods because of their high energy density. As such, high 
intakes of these items, and thus vitamin C, resulted in a lower DQI-A, whilst high intake of fruits and 
vegetables, and thus also vitamin C, tended to increase the DQI-A. Furthermore, the lack of 
association of iron and niacin with the adherence to FBDG could be due to the high concentration of 
these nutrients in meat products, whilst this food group showed no association with the DQI-A. In 
the present study population, no association could be found between the DQI-A score and the 
absolute intake of fat and fatty acids. This might be due to the fact that meat was the largest 
contributor to fat intake, followed by non-recommended foods and dairy products (Vyncke et al, 
2012). As such, the „penalization‟ for the excessive intake of meat and non-recommended foods is 
counteracted by the recommended intake of dairy products. Also associations might be attenuated 
due to faults that may arise through linkage with food composition tables. Of course, this finding 
might also indicate that the current FBDG are well tuned to the micronutrient recommendations but 
that the guidelines are not efficient in transferring the recommendations for fats and fatty acids.  
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Previously it has been shown that biomarkers do not always perform better than food intake 
assessment methods to evaluate true nutrient intake (Kabagambe et al, 2001). Moreover, not all 
nutrients have well-defined biological markers and many are influenced by other factors than intake. 
In the present study population a positive association was found between the DQI-A and levels of 
25(OH)D, holo-transcobalamin, representing the bioactive fraction of vitamin B12, and n-3 fatty 
acids. Amongst others, plasma levels of 25(OH)D are related to a better bone mineralization (Holick, 
2007), while deficiency has been linked to the pathogenesis of several disorders, including cancer, 
hypertension, multiple sclerosis and diabetes (Zhang and Naughton, 2010). Posthoc contribution 
analyses showed that vitamin D intake was mainly derived from fish products (30.21%). Other 
important contributors were cakes/pies and biscuits (15.62%) and dairy products (14.76%). As the 
vitamin D metabolism is dependent of sun exposure, the influence of seasonality and geographic 
location was further examined. This indicated that the highest levels of vitamin D serum concentrations 
were found in the more Southern countries, however, these countries also had the highest intake of 
vitamin D on nutrient levels, followed by the most Northern countries. On food level, the adolescents in 
the Southern countries consumed significant higher amounts of fish products and cakes, whilst the 
adolescents in the Northern countries had markedly higher intakes of dairy products. Influence of 
seasonality indicated the highest levels of vitamin D serum levels in the autumn, without an associated 
difference in vitamin D intake or DQI-A scores. Furthermore, physical activity was investigated for the 
influence on vitamin D status, however, results showed no significant direct effect and no interaction 
effect with the DQI-A.  
Adequate folate and vitamin B12 levels are essential for a good growth and development of the 
central nervous system in foetal and infant life (Selhub and Paul, 2011). Both, folate and vitamin 
B12 are also essential for the synthesis of nucleotide precursors, so if both are deficient this can 
result in impaired cell division and anemia (Pepper and Black, 2011). In addition, deficiencies in 
folate and vitamin B12 result in high values of homocysteine in blood and tissues, which in turn is 
associated with organ dysfunction in children that may lead to disease later in life, such as 
cardiovascular diseases (Bjorke Monsen and Ueland, 2003; Moreno et al, 2008b). For Vitamin B12 
intake the main contributor was meat (46.48%) followed by dairy products (24.52%) and fish products 
(9.27%). As discussed above, intake of meat and fish products were not associated with the DQI-A, 
possibly due to the frequent overconsumption. In contrast, dairy products are strongly associated with 
the index. Dairy products are generally consumed in limited amounts in this age group, as such high 
consumers can achieve markedly higher scores of the DQI-A than low consumers. Probably the high 
consumption of dairy products is the main reason for the positive association of vitB12 serum levels 
with the DQI-A.  
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Also, trans fatty acid levels showed an inverse relation with the DQI-A, which supports the 
recommendation of discouraging trans fatty acid intake in the human diet, because of their 
association with an increased cardiovascular risk (Remig et al, 2010). This finding was, however, not 
significant at the corrected level of p < 0.006.  
The aim of the DQI-A was to obtain a measure for overall dietary quality of an individual. In the 
present study statistically significant associations were only found with biomarkers representing 
long-term dietary intake (25(OH)D and holo-transcobalamin) whilst no statistically significant 
relationship was seen with biomarkers representing short to medium term intake. This might indicate 
that the DQI-A is a valid measure for long-term dietary habits. Also, the associations with the other 
biomarkers might be attenuated as supplement use was not taken into account in the present study.  
Several diet quality indices have been associated with specific nutrient intakes and plasma 
biomarkers. Comparison is difficult as different statistical approaches have been applied. Similar to 
our results, Hann et al. found significant positive associations between the Healthy Eating Index 
(HEI) and vitamin C, folate and fiber intake in a sample of adult women (Hann et al, 2001). In 
contrast to our results, carbohydrates and total energy were also positively associated. Also Newby et 
al. found significant associations between the Diet Quality Index-Revised (DQI-R) and intakes of 
several vitamins and minerals (Newby et al, 2003). In contrast to our results however, total fat and 
saturated fat were negatively correlated with the index. However, in this index, low total fat intake 
and low saturated fat intake were incorporated as two of the ten separate components in the 
calculation.  
Both the Healthy Eating Index and the DQI-Revised showed significant correlations with β-carotene 
serum values (r=0.12-0.42)(Hann et al, 2001; Newby et al, 2003; Weinstein et al, 2004). 
Furthermore, Weinstein et al. found significant but generally weak correlations between the HEI and 
serum vitamin C (r=0.21), serum folate (r=0.15), serum vitamin B12 (r=0.01), serum retinol (r=0.05) 
and serum triglycerides (r=0.06) in a large study population (n > 16 000) (Weinstein et al, 2004). 
Moreover, Neuhouser et al. (2003) could not observe any correlation between the DQI and long-
chain omega-3 phospholipd fatty acids in a sample of 102 women whilst Gerber et al. (2000) found a 
significant association with the omega-3 erythrocytes fatty acids. Both studies could not observe a 
relationship with serum β-carotene. 
 
STRENGTHS AND LIMITATIONS 
This was the first study to investigate the use and validity of a diet quality index in a European 
adolescent population. In the HELENA-study, all data have been collected according to standardized 
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protocols and strict procedures. Furthermore, in contrast to many other diet quality indices, the DQI-
A in the present study was not based on nutrient intakes, avoiding the limitations that coincide with 
the use of food composition data (such as the use of various tables in different countries with 
different methods of analysis used, unavailability of food items, loss of dietary information from 
mixed dishes, etc).  
A possible limitation of the present study is the observed significant differences in sex distribution 
and BMI between underreporters and non-underreporters. This differential underreporting could 
most probably attenuate our results as generally it would be expected that adolescents with a higher 
BMI would have a less healthy dietary pattern. Underreporting by these adolescents might, however, 
result in better DQI-A scores than that in reality. This could attenuate our results, especially the 
associations with the biomarkers. Therefore it was chosen to exclude the underreporters. This 
decision was supported by a previous evaluation of food and nutrient intake assessment in the 
HELENA study population (Vandevijvere et al, 2012), showing better correlations with the “true 
intake” (calculated with the Triads method (Kaaks, 1997)) after exclusion of underreporters. 
However, underreporting cannot be fully precluded as exclusion was only applied for adolescents 
indicating a negative energy balance. As such, attenuation of results might still be present.  
The developed DQI-A score was based on the Flemish FBDG whilst large variation in dietary habits 
was observed in the studied population. These guidelines were selected as base of the index score 
because of the great similarities with the CINDI pyramid developed by the WHO. The Flemish 
guidelines however are more specific concerning quality of different food items and recommended 
quantities. Compared to dietary guidelines of the other European countries rather minor differences 
were found (http://www.eufic.org/article/en/page/RARCHIVE/expid/food-based-dietary-guidelines-
in-europe/). The French and Austrian guidelines put greater emphasis on vegetables versus cereal 
intake compared to the Flemish. Furthermore, daily olive oil consumption is a specific 
recommendation in the Greek and Spanish guidelines. Given the large similarities on the most 
important aspects of the dietary guidelines the authors considered it appropriate to apply the Flemish 
guidelines to a European population.  
The DQI-A was calculated based on two self-administered, computer-assisted, non-consecutive 24h 
recalls. Following recommendations of the “European Food Consumption Survey method 
(EFCOSUM)” 24-hour recalls were preferred as these are open-ended questionnaires from which 
detailed information can be obtained. Furthermore, they are applicable in large populations of 
different ethnicity and standardization is possible by self-administered computer-assisted recall 
methods with pictures for portion sizes (Biro et al, 2002; Vereecken et al, 2010). According to Biro 
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et al. (2002), the 24h recall method is appropriate to assess both acute and usual intake on the 
individual level by repeated short term measurements and modelling.  
A limitation of the used method is however that only information of two days was obtained. Although 
this allows inclusion of exceptional intakes at the individual level, this effect is neutralized by the 
large number of observations. The 24-h dietary recall method does not allow quantifying proportions 
of non-consumers for particular food items, especially for infrequently consumed foods. In order to 
decrease this influence, nutrient intakes were corrected for within- person variability by applying the 
MSM method. Moreover, accuracy of collected data relies on the individual‟s ability to remember 
foods and beverages consumed in the past 24 hours, and might, therefore, be biased towards 
underreporting. In this respect, the 24-h dietary recalls were performed through the computer-
assisted HELENA-DIAT programme (Vereecken et al, 2008) to standardize the recall procedures as 
much as possible. Another limitation of the use of 24h recall interviews is the potential loss of 
dietary information from mixed dishes, as food ingredients were sometimes counted from mixed 
dishes. 
The same food composition table for conversion of food intake data to estimated nutrient intakes was 
used for all survey centres. In this way, differences in definitions, analytical methods, units and 
modes of expression were overcome. In this regard, the German food composition tables 
(Bundeslebensmittelschlüssel, BLS) was chosen. The BLS is based on German, American, English, 
Swedish, Danish and Dutch food composition tables, on analytical values of food producing firms, 
publications and research results of the Federal Research Centres and Universities 
(http://bls.nvs2.de). The BLS includes about 11000 raw and cooked foods and recipes and has been 
widely used in epidemiological studies (Deharveng et al, 1999).  
 
III.3.5 CONCLUSION 
This study has shown good validity of the DQI-A by confirming the expected associations with food 
and nutrient intakes and some biomarkers in blood. However, further investigation is necessary to 
explore why the current guidelines do not reach their goal of obtaining a more favorable lipid intake 
with increasing DQI-A scores.  
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III.4 CORRELATION BETWEEN DIETARY QUALITY AND 
INTAKE AND SERUM PROFILE OF FATTY ACIDS  
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ABSTRACT  
The present study aims to assess whether compliance with Food Based Dietary Guidelines (FBDG) 
is related with habitual fatty acid (FA) intake and blood lipid parameters. Dietary information was 
collected by two non-consecutive 24h recalls in 1804 European adolescents. Compliance with FBDG 
was expressed by calculating the Diet Quality Index for Adolescents (DQI-A). Blood samples were 
collected in a randomly selected subset (n= 552). Relations between FA intake/serum concentrations 
and DQI-A were tested with multilevel regression analysis to correct for the study design (clustering 
within cities). Analyses were stratified for sex; age was entered as covariate. Better DQI-A scores 
were related with increased proportional intakes of energy from total fat, saturated FA, mono-
unsaturated FA and cholesterol (p < 0.001) whilst no significant association was observed with poly-
unsaturated FA intakes. In adolescents with higher compared to lower DQI-A scores, dairy products 
contributed more (21.0% vs 12.7%) and low-nutrient, energy-dense items contributed less (17.2% vs 
26.3%) to the intake of total fat. A positive association was observed between the DQI-A scores and 
serum concentrations of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (all p < 
0.005). The latter, however, was only significant in girls. In boys, higher DQI-A scores were 
inversely associated with serum cholesterol concentrations (p < 0.05). Although compliance with 
FBDG was not always associated with a favorable FA intake pattern, a significant favorable 
association with some serum biomarkers was observed. This outcome underlines the importance to 
also consider dietary habits instead of focusing solely on nutrient or food intakes. 
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III.4.1 INTRODUCTION 
A balanced lipid and fatty acid (FA) intake is important for physiological functions such as growth 
and development (Innis, 2007; Simopoulos, 1991), regulation of gene expression, modification of 
cell membrane characteristics and modulation of inflammatory and immunological processes 
(Calder, 2006; Calder, 2009a; FAO, 2010). An imbalance in this intake is linked to a pro-
inflammatory state and an increased risk of non-communicable diseases such as cardiovascular 
disease, metabolic syndrome and inflammatory and auto-immune disorders.  
In the past, epidemiological studies examining the relationship between diet and chronic diseases 
often focused on the intake of single nutrients, food items or food groups. However, foods and 
nutrients are not eaten in isolation and may have complex interactions; also, nutrient bioavailability 
and absorption often depend on food preparation methods and eating patterns (Hu, 2002). As such, it 
is important to also assess the overall diet of an individual as evidence has shown stronger 
correlations with long-term health outcomes than specific nutrients or foods (Kant, 1996). In recent 
years, several indices of overall diet quality have been developed to evaluate simultaneously several 
aspects of the individual‟s diet (Kant, 1996; Waijers et al, 2007). 
Currently, epidemiological studies investigating the association between the overall diet and specific 
fatty acid intakes are rather scarce and mostly involve adult populations (Gerber et al, 2000; Hann et 
al, 2001; Neuhouser et al, 2003; Newby et al, 2003; Weinstein et al, 2004) or lack biomarker data 
(Chiplonkar and Tupe, 2010; Feskanich et al, 2004; Kranz et al, 2008; Manios et al, 2010a). 
However, adolescence is a crucial period in life during which health-related behaviors, such as 
dietary habits, are adopted and cardiometabolic risk factors can emerge with subsequent tracking into 
adulthood (Camhi and Katzmarzyk, 2010; Viner and Macfarlane, 2005). 
 The present study aimed to meet the shortcomings in this research area by investigating the 
relationship between the overall diet quality and the habitual FA intake and FA serum profile in a 
large multinational sample of European adolescents. In addition, the association between the diet 
quality and inflammatory biomarkers was assessed.  In the present study the overall diet quality was 
assessed by using the Diet Quality Index for Adolescents (DQI-A), measuring the adherence to the 
Food Based Dietary Guidelines (FBDG).  
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III.4.2 SUBJECTS AND METHODS 
III.4.2.1 STUDY DESIGN AND POPULATION 
Data were obtained from the HELENA-Cross Sectional Study (HELENA-CSS) that has been 
described in more detail in Part II  Methods.   
For the purpose of this study, only adolescents who provided data on two 24h non-consecutive 
dietary recalls were included in the analysis. It is noteworthy that participants from Heraklion and 
Pècs were excluded for these analyses as no nutrient intake information was calculated for these two 
cities. Furthermore under-reporters were excluded, this resulted in a final sample of 1804 adolescents 
(53 % girls). Blood samples were collected in one third of the total HELENA population by 
randomly selecting classes in each survey centre in which blood withdrawal was performed. As such, 
biochemical parameters were available in a subsample of 552 participants (52% girls). 
Characteristics of adolescents for whom no biochemical parameters were obtained were compared to 
those included in the sub-analysis. No significant differences in age, sex, BMI and socio-economic 
factors were observed between these two groups, however, the adolescents in the sub-analysis had 
higher mean values for the DQI-A compared to the total study population (52.7% SD 16.7 and 54.0% 
SD 15.8, respectively, Student‟s t-test p = 0.023).  
III.4.2.2 DATA COLLECTION 
The methods of data collection have been described in more detail in Part II Methods. Briefly, the 
dietary intake assessment was performed by use of the HELENA-DIAT (Dietary Assessment Tool) 
and the Multiple Source Method (MSM) was used to estimate the habitual dietary intake of nutrients 
and foods (https://nugo.dife.de/msm; Haubrock J. et al, 2010). An overall index of diet quality, the 
DQI-A, was calculated as described previously (Chapter III.3). 
Height and weight were measured in fasting state and the BMI standard deviation score was 
calculated subsequently. Pubertal status (stages I-V) was assessed by a medical doctor according to 
Tanner and Whitehouse (Tanner and Whitehouse, 1976). Data on maternal education level and 
physical activity were collected by self-reported questionnaires. Also the Family Affluence Scale 
(FAS) was calculated based on the concept of material conditions in the household. The serum FA 
composition from phospholipids was determined in fasting venous blood samples. For all analyses, 
FA were expressed as relative FA profile, based on the peak area (area%).  
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III.4.2.3 STATISTICAL ANALYSES 
PASW 18.0 for Windows (SPSS Inc., Chicago, IL, USA) was used. A p-value of 0.05 was used as 
the threshold of significance. Two-sided significance levels were quoted. Baseline characteristics 
between the total population and the biomarker subsample were compared using a Student‟s t-test for 
continuous variables and Pearson χ²-test for categorical variables.  
Associations between the FA intakes/serum concentrations and the DQI-A were tested with a 
multilevel regression analysis to correct for the study design (clustering of cases within cities). Age 
was entered as covariate. Habitual intake variables and blood values were skewed and 
logarithmically transformed before statistical analysis. Results were presented as geometrical means 
of the quartiles of the DQI-A. Because of significant sex differences between mean DQI-A scores as 
well as physiological differences occurring during puberty, all analyses were performed stratified by 
sex. FA intakes were expressed as percentage of energy (%E) to improve comparability.  
The population proportion formula was used to determine the percentage contribution of food groups 
to the intake of fats and FA. This was done by summing the amount of the component provided by 
the food for all individuals divided by the total intake of that component from all foods (Krebs-Smith 
et al, 1989; O'Sullivan et al, 2011; Sioen et al, 2007).  
 
III.4.3 RESULTS 
Characteristics of the study populations can be found in Table 17. The mean age was 14.7 years (SD 
1.2) with a median (range) BMI of 20.1 kg/m² (14.1 kg/m² to 40.8 kg/m²). Ninety-two percent of the 
participants were categorized in Tanner stage 3 or higher. Median (range) DQI-A score of the overall 
group was 53.7 (-11.1 to 84.1) and girls scored significantly higher than boys (55.5 range -9.0 to 84.1 
versus 51.5 range -11.1 to 82.5 respectively; p < 0.001). BMI z-scores were very weakly correlated 
with the DQI-A (r=0.055, p = 0.019); no correlation was observed with physical activity. Sex 
differences were found for Tanner stage with more boys having a prepubertal Tanner stage. The 
subgroup with data on blood parameters (n=552) had a median DQI-A score of 55.0 (-11.1 to 82.5) 
which differed significantly (p = 0.020) from the total sample. Also, significant differences in Tanner 
stage were found (p = 0.009).  
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Table 17: Characteristics of the study participants (n = 1804) with valid data on two, non-consecutive 24h recalls. Serum values of 
fatty acids and lipids were available in a subsample of 552 adolescents.  
  
Total population  Biomarker subsample  p-value 
n 1804  552   
Age (years)*  14.7 (1.2)  14.8 (1.2)  0.648 
Sex 
† Boys 855 (47.4%)  265 (48%)  0.759 
Girls 949 (52.6%)  287 (52%)   
BMI (kg/m²)
‡ 20.1 (14.1; 40.8)  20.1 (14.2; 35.2)  0.892 
BMI z-score* 0.27 (1.06)  0.26 (1.07)  0.844 
DQI-A
‡ 
 
53.7 (-11.1; 84.1)  55.0 (-11.1; 82.5)  0.020 
Tanner
 † Stage 1 & 2 139 (7.7%)  54 (9.8%)  0.009 
Stage 3 432 (23.9%)  123 (22.3%)  
 Stage 4 732 (40.6%)  246 (44.6%)  
 Stage 5 449 (24.9%)  120 (21.7%)  
Maternal 
Education
† 
Lower 551 (30.5%)  160 (28.8%)  0.292 
Secondary 540 (29.9%)  178 (32.1%)  
 Higher 633 (35.1%)  189 (34.1%)  
 Family 
Affluent 
Scale
† 
Low  182 (10.1%)  49 (8.8%)  0.510 
Medium 1014 (56.2%)  315 (56.8%)  
 High  601 (33.3%)  190 (34.2%)  
 Comparison between the total population and the biomarker subsample was performed using a Student‟s t-test 
for continuous variables and Pearson χ²-test for categorical variables. DQI-A, Diet Quality Index for 
Adolsecents. *mean(SD);
 †
 n(n%);
‡
 median(min;max) 
 
III.4.3.1 NUTRIENT INTAKE 
Table 18 shows the associations between the %E intake from different FA and the DQI-A score. In 
both boys and girls, the %E from total fat intake increased significantly with increasing DQI-A 
scores. Also, a higher intake of saturated fatty acids (SFA) and mono-unsaturated fatty acids 
(MUFA) was observed in the higher quartiles of the DQI-A score. No significant change in %E from 
poly-unsaturated fatty acids (PUFA) was observed. In the male study population, a significant higher 
intake of total n-3 FA, eicosapentaenoic acid (EPA) and alpha-linolenic acid (ALA) (borderline 
significant) was found with increasing DQI-A scores. However, when assessed in mg/day no 
association was observed between DQI-A and EPA intake. Furthermore the DQI-A scores showed a 
positive association with cholesterol intake in both sexes and total energy intake decreased with 
increasing DQI-A scores in girls.  
RESULTS 
124 
Table 18: Geometric mean nutrient intake (precentage of Energy (%E) in European adolescents by DQI-A score and results of multilevel 
analysis examining the associations between nutrient intake and DQI-A. 
Habitual intake Boys (N=855) 
 
Q1 SE Q2 SE Q3 SE Q4 SE β P-value 
           
Total fat (%E) 30.95 1.02 32.95 1.02 33.65 1.02 33.99 1.02 0.00097 < 0.001 
SFA (%E) 12.78 1.02 13.69 1.02 13.99 1.02 14.26 1.02 0.00114 < 0.001 
Lauric Acid C12:0 (%E) 0.66 1.04 0.69 1.04 0.70 1.04 0.70 1.04 0.00052 0.039 
Myristic Acid C14:0 (%E) 1.31 1.03 1.47 1.03 1.51 1.03 1.59 1.03 0.00193 < 0.001 
Palmitic Acid C16:0 (%E) 6.33 1.02 6.78 1.02 6.94 1.02 7.08 1.02 0.00115 < 0.001 
Stearic Acid C18:0 (%E) 2.89 1.03 3.04 1.03 3.10 1.03 3.10 1.03 0.00082 < 0.001 
MUFA (%E) 11.20 1.03 12.01 1.03 12.47 1.03 12.53 1.03 0.00125 < 0.001 
Oleic Acid C18:1n9 (%E) 9.79 1.03 10.44 1.03 10.88 1.03 10.92 1.03 0.00122 < 0.001 
PUFA (%E) 4.22 1.03 4.41 1.03 4.47 1.03 4.40 1.03 0.00033 0.146 
Ʃn-6 (%E) 3.56 1.03 3.71 1.03 3.79 1.03 3.70 1.03 0.00031 0.190 
LA C18:2n6 (%E) 3.43 1.03 3.56 1.03 3.66 1.03 3.57 1.03 0.00034 0.161 
AA C20:4n6 (%E) 0.10 1.08 0.11 1.08 0.11 1.08 0.10 1.08 -0.00009 0.830 
Ʃn-3 (%E) 0.60 1.04 0.64 1.04 0.63 1.04 0.65 1.04 0.00060 0.014 
ALA C18:3n3 (%E) 0.52 1.04 0.54 1.04 0.53 1.04 0.55 1.04 0.00047 0.050 
EPA C20:5n3 (%E) 0.02 1.00 0.02 1.00 0.02 1.00 0.03 1.00 0.00007 0.049 
EPA C20:5n3 (mg/d) 53.23 1.09 57.74 1.09 57.17 1.09 57.92 1.09 0.00108 0.099 
DHA C22:6n3 (%E) 0.05 1.01 0.06 1.01 0.06 1.01 0.06 1.01 0.00012 0.132 
DHA C22:6n3 (mg/d) 118.65 1.11 149.36 1.10 144.15 1.10 127.37 1.10 0.00060 0.428 
Cholesterol (mg/1000kJ) 32.82 1.05 35.80 1.05 36.82 1.05 36.47 1.05 0.00102 <0.001 
Total Energy intake 
(1000kJ/d) 
11.58 1.02 11.50 1.02 11.17 1.02 11.09 1.02 -0.00033 0.095 
 
Girls (N=949) 
          
 
Total fat (%E) 33.17 1.02 33.87 1.02 34.01 1.02 33.99 1.02 0.00047 < 0.001 
SFA (%E) 13.45 1.02 13.96 1.02 14.13 1.02 13.92 1.02 0.00063 < 0.001 
Lauric Acid C12:0 (%E) 0.69 1.03 0.74 1.03 0.72 1.03 0.70 1.03 0.00042 0.114 
Myristic Acid C14:0 (%E) 1.40 1.02 1.54 1.02 1.58 1.02 1.53 1.02 0.00122 < 0.001 
Palmitic Acid C16:0 (%E) 6.73 1.02 6.88 1.02 6.99 1.02 6.92 1.02 0.00057 < 0.001 
Stearic Acid C18:0 (%E) 3.02 1.02 3.03 1.02 3.07 1.02 3.06 1.02 0.00039 0.051 
MUFA (%E) 12.24 1.03 12.33 1.03 12.46 1.03 12.64 1.03 0.00051 0.001 
Oleic Acid C18:1n9 (%E) 10.70 1.03 10.75 1.03 10.84 1.03 11.08 1.03 0.00052 0.001 
PUFA (%E) 4.79 1.03 4.81 1.03 4.72 1.03 4.66 1.03 -0.00003 0.895 
Ʃn-6 (%E) 4.08 1.03 4.08 1.03 3.97 1.03 3.97 1.03 -0.00005 0.828 
LA C18:2n6 (%E) 3.94 1.03 3.95 1.03 3.84 1.03 3.84 1.03 -0.00004 0.862 
AA C20:4n6 (%E) 0.11 1.07 0.10 1.07 0.11 1.07 0.11 1.07 -0.00023 0.535 
Ʃn-3 (%E) 0.68 1.04 0.69 1.04 0.70 1.04 0.67 1.04 0.00010 0.687 
ALA C18:3n3 (%E) 0.58 1.04 0.58 1.04 0.57 1.04 0.56 1.04 -0.00010 0.656 
EPA C20:5n3 (%E) 0.03 1.01 0.03 1.01 0.03 1.01 0.03 1.01 0.00008 0.108 
EPA C20:5n3 (mg/d) 48.01 1.10 52.03 1.10 55.65 1.10 51.82 1.10 0.00072 0.291 
DHA C22:6n3 (%E) 0.06 1.02 0.07 1.01 0.08 1.01 0.07 1.02 0.00011 0.263 
DHA C22:6n3 (mg/d) 124.11 1.11 131.03 1.11 138.77 1.11 120.35 1.11 -0.00009 0.894 
Cholesterol (mg/1000kJ) 34.64 1.05 36.37 1.05 36.90 1.05 36.74 1.05 0.00076 0.001 
Total Energy intake 
(1000kJ/d) 
9.02 1.02 8.84 1.02 8.78 1.02 8.51 1.02 -0.00057 0.001 
All analyses were corrected for age and country.  Nutrient intakes were log transformed. DQI-A Diet Quality Index for 
Adolescents; SFA Saturated Fatty Acid; MUFA Mono-unsaturated fatty acid; PUFA Poly-unsaturated fatty acid; Ʃn-6 = 
C18:2n6 + C20:2n6 + C20:3n6 + C20:4n6 + C22:2n6 + C22:4n6. Ʃn-3 =C18:3n3 + C18:4n3 + C20:5n3 + C22:5n3 + C22:6n3. LA 
Linoleic acid; ALA alfa-linolenic acid; EPA eicopentaenoic acid; DHA docosahexaenoic acid 
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The associations between FA intake and the DQI-A in the subgroup that provided blood samples can 
be found in Table 19. In the girls of this subgroup no association was found between the DQI-A and 
total fat, SFA and MUFA intake. While in boys the increasing intake of n-3 FA and ALA with higher 
DQI-A was no longer visible. Also the association between DQI-A and cholesterol intake was no 
longer significant in both sexes. 
In boys with DQI-A scores in the lower quartile total fat was mainly delivered by low-nutrient, 
energy-dense items (35.4%) (e.g. candy bars, potato chips, biscuits) (Figure 15). In contrast, the 
main contributor of fat intake in boys with DQI-A scores in the highest quartile was meat (25.2%), 
followed by items from the low-nutrient, energy-dense group (22.9%). Furthermore, milk (liquid 
milk, yoghurt, fromage blanc and milk-based desserts, including ice-cream) and cheese products 
were a markedly larger source of fat intake in boys in the upper DQI-A quartiles compared to boys in 
the lower DQI-A quartiles (11.4% and 9.5% versus 6.4% and 6.3% respectively). Moreover, dairy 
products (milk, cheese and butter)  provided 36.2% (15.6%, 12.9% and 7.7% respectively) of the 
consumed SFA in boys and 32.4% (14.1%, 13.6% and 4.7% respectively) in girls in the highest DQI-
A quartile, being the main contributor to SFA intake in these groups, compared to snacks and sauces 
in the lowest quartiles. For PUFA, the contribution of mainly salty snacks lowered with increasing 
DQI-A scores in both boys and girls. Furthermore the contribution of fish to the intake of cholesterol 
was higher in the good compliers compared to the bad compliers.  
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Table 19: Multilevel analysis examining the associations between nutrient intake (expressed as geometrical means of the percentage of 
Energy (%E)) and the Diet Quality Index for Adolescents (DQI-A) in the subgroup with valid biomarker data. 
Habitual intake Boys (N=265) 
  Q1 SE Q2 SE Q3 SE Q4 SE β P-value 
Total fat (%E) 31.16 1.02 32.98 1.02 34.76 1.02 32.96 1.02 0.00077 0.002 
SFA (%E) 12.84 1.03 13.69 1.03 14.43 1.03 14.05 1.03 0.00102 0.001 
Lauric Acid C12:0 (%E) 0.69 1.05 0.69 1.05 0.71 1.05 0.71 1.05 0.00047 0.316 
Myristic Acid C14:0 (%E) 1.32 1.04 1.47 1.04 1.56 1.04 1.58 1.04 0.00201 < 0.001 
Palmitic Acid C16:0 (%E) 6.36 1.03 6.76 1.02 7.15 1.02 6.90 1.02 0.00097 < 0.001 
Stearic Acid C18:0 (%E) 2.85 1.04 3.04 1.04 3.22 1.04 3.07 1.04 0.00080 0.036 
MUFA (%E) 11.19 1.03 12.15 1.03 12.94 1.03 12.05 1.03 0.00109 < 0.001 
Oleic Acid C18:1n9 (%E) 9.83 1.03 10.51 1.03 11.24 1.03 10.51 1.03 0.00103 0.001 
PUFA (%E) 4.35 1.04 4.37 1.04 4.50 1.04 4.16 1.04 -0.00017 0.699 
n-6 (%E) 3.69 1.04 3.68 1.04 3.77 1.04 3.48 1.04 -0.00029 0.522 
LA C18:2n6 (%E) 3.56 1.05 3.53 1.04 3.62 1.04 3.36 1.04 -0.00028 0.534 
AA C20:4n6 (%E) 0.10 1.09 0.11 1.08 0.11 1.08 0.10 1.08 -0.00023 0.770 
n-3 (%E) 0.65 1.05 0.64 1.05 0.69 1.05 0.63 1.05 0.00038 0.418 
ALA C18:3n3 (%E) 0.55 1.06 0.52 1.06 0.57 1.06 0.53 1.06 0.00023 0.631 
EPA C20:5n3 (%E) 0.52 1.01 0.53 1.01 0.53 1.01 0.52 1.01 0.00006 0.372 
EPA C20:5n3 (mg/d) 51.87 1.15 65.26 1.15 69.83 1.15 55.48 1.15 0.00184 0.156 
DHA C22:6n3 (%E) 0.55 1.02 0.56 1.02 0.57 1.02 0.55 1.02 0.00012 0.405 
DHA C22:6n3 (mg/d) 114.80 1.16 153.25 1.16 161.75 1.16 123.05 1.16 0.00148 0.278 
Cholesterol (mg/1000kJ) 32.08 1.06 35.29 1.06 36.72 1.05 34.10 1.06 0.00080 0.063 
Total Energy intake 
(1000kJ/d) 
11.58 1.03 11.54 1.03 11.43 1.03 11.08 1.03 -0.00020 0.613 
 
Girls (N=287) 
Total fat (%E) 32.91 1.02 34.42 1.02 34.40 1.02 32.97 1.02 0.00020 0.386 
SFA (%E) 13.58 1.02 14.36 1.02 14.36 1.02 13.36 1.02 0.00010 0.736 
Lauric Acid C12:0 (%E) 0.70 1.05 0.77 1.05 0.76 1.05 0.69 1.05 -0.00003 0.956 
Myristic Acid C14:0 (%E) 1.43 1.04 1.57 1.03 1.63 1.03 1.44 1.04 0.00062 0.161 
Palmitic Acid C16:0 (%E) 6.73 1.02 7.04 1.02 7.04 1.02 6.67 1.02 0.00015 0.577 
Stearic Acid C18:0 (%E) 3.08 1.03 3.13 1.03 3.10 1.03 2.96 1.03 -0.00027 0.437 
MUFA (%E) 12.12 1.04 12.47 1.04 12.55 1.04 12.22 1.04 0.00022 0.409 
Oleic Acid C18:1n9 (%E) 10.62 1.04 10.88 1.04 10.93 1.04 10.72 1.04 0.00021 0.445 
PUFA (%E) 4.64 1.04 4.84 1.04 4.77 1.04 4.63 1.04 0.00017 0.664 
n-6 (%E) 3.95 1.04 4.09 1.04 3.98 1.04 3.94 1.04 0.00011 0.783 
LA C18:2n6 (%E) 3.83 1.04 3.96 1.04 3.85 1.04 3.80 1.04 0.00009 0.828 
AA C20:4n6 (%E) 0.10 1.08 0.11 1.08 0.10 1.08 0.11 1.09 0.00056 0.420 
n-3 (%E) 0.67 1.05 0.72 1.05 0.74 1.05 0.67 1.05 0.00042 0.407 
ALA C18:3n3 (%E) 0.56 1.06 0.59 1.06 0.59 1.06 0.54 1.07 -0.00006 0.888 
EPA C20:5n3 (%E) 0.52 1.01 0.53 1.01 0.54 1.01 0.53 1.01 0.00016 0.111 
EPA C20:5n3 (mg/d) 48.88 1.12 55.26 1.11 61.22 1.11 50.04 1.12 0.00078 0.522 
DHA C22:6n3 (%E) 0.56 1.02 0.57 1.02 0.58 1.02 0.57 1.02 0.00027 0.169 
DHA C22:6n3 (mg/d) 116.30 1.12 136.90 1.12 150.23 1.12 127.56 1.12 0.00167 0.193 
Cholesterol (mg/1000kJ) 35.15 1.05 37.25 1.05 37.45 1.05 36.30 1.05 0.00064 0.133 
Total Energy intake 
(1000kJ/d) 
9.10 1.02 8.70 1.02 8.80 1.02 8.29 1.02 -0.00079 0.010 
All analyses were corrected for age and country.  Nutrient intakes were log transformed. SFA Saturated Fatty Acid; MUFA 
Mono-unsaturated fatty acid; PUFA Poly-unsaturated fatty acid; Ʃn-6 = C18:2n6 + C20:2n6 + C20:3n6 + C20:4n6 + C22:2n6 + 
C22:4n6. Ʃn-3 =C18:3n3 + C18:4n3 + C20:5n3 + C22:5n3 + C22:6n3. LA Linoleic acid; ALA alfa-linolenic acid; EPA 
eicopentaenoic acid; DHA docosahexaenoic acid 
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Figure 15: Contributions of different food groups to the total intake of specific fatty acids in European boys (left) and girls (right) with DQI-A 
score in the lower quartile (Q1) compared to boys with DQI-A scores in the upper quartile (Q4) (Expressed as % of the total daily intake). SFA, 
Saturated fatty Acids; MUFA, Mono-unsaturated Fatty Acids; PUFA, Poly-unsaturated Fatty Acids. 
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Table 20: Multilevel analysis examining the associations between blood biomarker (expressed as geometrical means) and the Diet 
Quality Index for Adolescents (DQI-A). 
Serum values Boys (N=265) 
 
Q1 SE Q2 SE Q3 SE Q4 SE β P 
SFA (%area) 45.48 1.01 45.17 1.01 45.09 1.01 45.15 1.01 -0.00005 0.369 
Lauric Acid C12:0 (%area) 0.02 1.12 0.02 1.12 0.02 1.12 0.02 1.12 -0.00230 0.022 
Myristic Acid C14:0 (%area) 0.33 1.07 0.35 1.07 0.33 1.07 0.34 1.07 0.00001 0.979 
Palmitic Acid C16:0 (%area) 27.30 1.01 27.38 1.01 27.26 1.01 27.35 1.01 -0.00001 0.903 
Stearic Acid C18:0 (%area) 13.30 1.01 12.96 1.01 13.03 1.01 13.05 1.01 -0.00011 0.444 
MUFA (%area) 15.01 1.02 15.02 1.02 15.16 1.02 15.38 1.02 0.00004 0.877 
Oleic Acid C18:1n9 (%E) 10.14 1.03 10.35 1.03 10.25 1.03 10.53 1.03 -0.00003 0.926 
PUFA (%area) 39.17 1.01 39.48 1.01 39.56 1.01 39.24 1.01 0.00008 0.418 
Ʃn-6 (%area) 34.77 1.01 35.02 1.01 35.05 1.01 34.42 1.01 -0.00004 0.730 
LA C18:2n6 (%area) 21.52 1.02 21.98 1.02 21.84 1.02 20.75 1.02 -0.00033 0.111 
AA C20:4n6 (%area) 9.34 1.03 9.18 1.03 9.50 1.03 9.52 1.03 0.00025 0.377 
Ʃn-3 (%area) 4.22 1.06 4.21 1.06 4.25 1.06 4.47 1.06 0.00079 0.076 
ALA C18:3n3 (%area) 0.13 1.14 0.13 1.14 0.13 1.14 0.13 1.14 -0.00018 0.806 
EPA C20:5n3 (%area) 0.45 1.10 0.50 1.09 0.49 1.09 0.58 1.10 0.00283 0.001 
DHA C22:6n3 (%area) 2.80 1.06 2.79 1.06 2.86 1.06 2.93 1.06 0.00055 0.269 
Cholesterol (mg/dl) 156.31 1.02 151.16 1.02 148.08 1.02 144.11 1.02 -0.00061 0.031 
HDL (mg/dl) 51.75 1.02 54.98 1.02 52.42 1.02 50.82 1.02 -0.00017 0.571 
LDL (mg/dl) 91.49 1.03 84.40 1.03 85.13 1.03 83.05 1.03 -0.00072 0.115 
Triglycerides (mg/dl) 63.43 1.06 55.54 1.06 56.06 1.06 58.16 1.06 -0.00056 0.470 
           
CRP (mg/l) 0.56 1.22 0.69 1.25 0.74 1.22 0.67 1.24 0.00338 0.299 
IL-1 (pg/ml) 0.40 1.23 0.36 1.24 0.29 1.24 0.30 1.24 -0.00293 0.235 
IL-6 (pg/ml) 14.51 1.30 8.82 1.30 13.40 1.30 9.24 1.31 -0.00121 0.672 
INF-γ (pg/ml) 1.14 1.33 1.50 1.35 0.77 1.36 0.99 1.37 -0.00475 0.233 
TNF-α (pg/ml) 6.00 1.09 6.08 1.09 5.78 1.10 6.15 1.10 0.00053 0.639 
 
Girls (N=287) 
SFA (%area) 45.49 1.01 45.28 1.01 45.35 1.01 45.19 1.01 -0.00005 0.374 
Lauric Acid C12:0 (%area) 0.02 1.10 0.02 1.10 0.02 1.10 0.02 1.10 -0.00106 0.272 
Myristic Acid C14:0 (%area) 0.34 1.07 0.33 1.07 0.36 1.07 0.35 1.07 0.00025 0.630 
Palmitic Acid C16:0 (%area) 27.33 1.01 27.26 1.01 27.45 1.01 27.33 1.01 -0.00001 0.907 
Stearic Acid C18:0 (%area) 13.28 1.01 13.11 1.01 12.90 1.01 13.02 1.01 -0.00016 0.255 
MUFA (%area) 14.73 1.02 14.49 1.02 14.68 1.02 15.14 1.02 0.00016 0.499 
Oleic Acid C18:1n9 (%E) 9.84 1.03 9.63 1.03 9.77 1.03 10.03 1.03 0.00003 0.937 
PUFA (%area) 39.60 1.01 39.99 1.01 39.73 1.01 39.53 1.01 0.00000 0.985 
Ʃn-6 (%area) 35.24 1.01 35.23 1.01 34.84 1.01 34.52 1.01 -0.00020 0.052 
LA C18:2n6 (%area) 22.34 1.02 22.29 1.02 22.13 1.02 21.36 1.02 -0.00044 0.024 
AA C20:4n6 (%area) 9.13 1.03 9.19 1.03 8.90 1.03 9.27 1.03 0.00012 0.681 
Ʃn-3 (%area) 4.15 1.06 4.46 1.06 4.58 1.06 4.72 1.06 0.00143 0.001 
ALA C18:3n3 (%area) 0.13 1.16 0.13 1.16 0.15 1.16 0.14 1.16 0.00098 0.144 
EPA C20:5n3 (%area) 0.41 1.11 0.46 1.11 0.49 1.11 0.52 1.11 0.00236 0.003 
DHA C22:6n3 (%area) 2.86 1.06 3.04 1.06 3.12 1.06 3.23 1.06 0.00137 0.004 
Cholesterol (mg/dl) 162.94 1.02 165.66 1.02 161.86 1.02 165.07 1.02 0.00008 0.773 
HDL (mg/dl) 56.11 1.03 58.00 1.03 58.17 1.03 55.38 1.03 0.00010 0.827 
LDL (mg/dl) 91.61 1.03 94.01 1.03 89.19 1.03 96.69 1.03 -0.00007 0.301 
Triglycerides (mg/dl) 65.71 1.05 64.02 1.05 64.41 1.05 65.59 1.05 0.00047 0.891 
           
CRP (mg/l) 0.57 1.25 0.60 1.25 0.91 1.26 0.52 1.27 0.00109 0.753 
IL-1 (pg/ml) 0.43 1.23 0.25 1.23 0.44 1.23 0.33 1.26 -0.00082 0.739 
IL-6 (pg/ml) 9.61 1.32 5.26 1.31 6.46 1.31 8.22 1.34 -0.00020 0.945 
INF-γ (pg/ml) 1.99 1.41 0.75 1.40 1.24 1.41 1.10 1.47 -0.00362 0.413 
TNF-α (pg/ml) 5.09 1.13 4.88 1.13 4.72 1.13 4.46 1.14 -0.00112 0.336 
All analyses were corrected for age and country.  Blood values were log transformed. SFA Saturated Fatty Acid; MUFA Mono-unsaturated 
fatty acid; PUFA Poly-unsaturated fatty acid; Ʃn-6 = C18:2n6c + C18:2n6t + C18:3n6c + C20:2n6c + C20:3n6c + C20:4n6c + C22:2n6c. Ʃn-3 
=C18:3n3c + C18:4n3c + C20:5n3c + C22:5n3c + C22:6n3c. LA Linoleic acid; ALA alfa-linolenic acid; EPA eicopentaenoic acid; DHA 
docosahexaenoic acid 
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III.4.3.2 BIOMARKERS 
The relation between DQI-A scores and serum concentrations of the lipid and FA profile is shown in 
Table 20. Positive associations were observed between the DQI-A scores and the long-chain n-3 
PUFA, EPA and docosahexaenoic acid (DHA). The latter, however, was only significant in the 
female study population. In girls, furthermore, an increased value of total n-3 FA serum values as 
well as a decreased value of linoleic acid (LA) serum concentration was found in the higher DQI-A 
quartiles. In boys, higher DQI-A scores were inversely associated with the lauric acid serum 
concentrations. Furthermore, boys with the highest DQI-A scores showed to have significantly lower 
serum cholesterol concentrations.  
No significant associations were found between the DQI-A and the inflammatory biomarkers.  
 
III.4.4 DISCUSSION 
This study aimed to assess whether overall diet quality, measured as compliance with the current 
FBDG, was related with habitual FA intake and blood lipid parameters in European adolescents.  
Better global dietary quality, assessed with the DQI-A, was associated with a higher total fat intake 
(expressed as %E) in both sexes. The fat intake in the upper DQI-A quartile however resulted from 
more recommended food sources with especially a higher consumption of dairy products and a 
decrease in the consumption of snacks and sauces. This rise in dairy products consumption also 
explained the increase in %E from SFA and MUFA intake. In contrast, there was no significant 
association observed between DQI-A and the SFA serum values. This was, however, not expected as 
SFA have an important endogenous production and metabolism, independent of the habitual daily 
intake. Generally, it is accepted that an excessive intake of SFA results in long-term adverse health 
complications. However, as discussed in the “Great Fat Debate”, the proportion of calories from 
saturated fat has little effect on disease risk when the replacement nutrient is not specified (Kuller, 
2011; Lichtenstein, 2011; Mozaffarian, 2011; Willett, 2011; Willett et al, 2011). Replacing SFA by 
PUFA isocalorically has been shown to reduce the risk on CVD, but replacement by carbohydrates is 
unlikely to have any major effect on CVD risk, whilst replacement with highly refined carbohydrates 
may increase CVD risk (Mozaffarian, 2011). Furthermore, there is now convincing evidence that 
increased consumption of milk may provide some long-term benefits in reducing CVD risk (Elwood 
et al, 2010; Givens, 2012), diabetes, stroke, colon and bladder cancer and all-cause mortality 
(Elwood et al, 2010). However, for other dairy products, such as butter and cheese, evidence is 
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limited and inconsistent (Elwood et al, 2010). Intervention studies on CVD biomarkers have shown 
that a diet higher in SFA from whole fat milk increases LDL-C when substituting carbohydrates or 
unsaturated fatty acids. However, they may also increase HDL-C and therefore might not affect or 
even lower the TC:HDL-C ratio (Huth and Park, 2012). Similarly, in the present study a better diet 
quality was associated with lower total serum cholesterol levels in adolescent boys but no significant 
effect on HDL or LDL was observed. Sex differences in plasma lipid response to dietary fat have 
previously been described (Cobb et al, 1993; Keys and Parlin, 1966; Walden et al, 2000). Following 
a diet with a high PUFA:SFA ratio, normocholesterolemic males and females had similar reductions 
in LDL-C, however, reductions in HDL-C appeared to be sex specific with significantly larger 
declines in females (Cobb et al, 1993). Also in hypercholesterolemic subjects, a diet low in total fat 
and in saturated fat resulted in a significantly larger decrease in HDL-C in females than in males (p < 
0.001 for sex differences) and a decrease in TC:HDL-C in males versus an increase in females (p < 
0.01 for sex differences) (Walden et al, 2000).  
In contrast to the negative association between DQI-A scores and serum cholesterol, a positive 
relation was seen with cholesterol intake. This inverse relation with the DQI-A confirms that 
cholesterol intake is not the only factor of importance in this metabolism. Nutrients such as fibers 
and lifestyle factors such as physical activity also play a major role in this complex metabolic 
pathway (James et al, 2003). The strong positive relation between fiber intake and DQI-A scores in 
the study population supports this hypothesis (Vyncke et al, 2013). Also, in the present study, a 
significant negative association between physical activity and cholesterol intake was observed in the 
male population (data not shown). In contrast to daily practice, a cholesterol-lowering-diet should be 
focusing in a greater extent to a general healthy eating pattern instead of diminishing solely the 
cholesterol intake in order to improve the lipoprotein profile (Nicolosi et al, 2001). 
Furthermore, boys with higher DQI-A scores tend to have a higher relative intake (%E) of total n-3 
FA, EPA and ALA. However, the absolute intake of EPA and fish was not significantly higher with 
increasing DQI-A scores (Vyncke et al, 2013). Nevertheless, in both boys and girls higher serum 
levels of the long chain n-3 FA were shown in adolescents with better DQI-A scores. The equal 
absolute intake of n-3 FA in contrast to the higher serum levels observed in adolescents with better 
DQI-A might indicate that other food components are of importance. In adolescents with DQI-A 
scores in the lower quartiles, n-3 FA were delivered in large amounts by sweet and salty snacks, 
however, these food items also delivered large amounts of n-6 FA (Vyncke et al, 2012). Possibly, the 
equal absolute intake resulting in higher serum levels in adolescents with better diet quality could be 
attributed to a competition effect between n-6 and n-3 FA. 
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No association between diet quality and inflammatory markers was observed. Previous studies have 
shown that, when consumed in sufficient amounts, dietary fish oil results in decreased production of 
pro-inflammatory cytokines. However, most of these results are based on intervention studies with n-
3 FA supplementation. A review of these studies showed, however that inconsistent results are 
observed in view of the association with inflammatory biomarkers (Myhrstad et al, 2011). 
Furthermore, correlations between overall dietary patterns and inflammatory biomarkers have 
previously not often been assessed. Fung et al. investigated the correlation between several dietary 
indexes and inflammatory biomarkers in a sample of 690 middle aged women and concluded that 
dietary indexes, reflecting adherence to current dietary guidelines were not predictive of biomarkers 
of inflammation (Fung et al, 2005). As such, lack of association in our smaller sample of adolescents 
might not be surprising.  
Similar to our results the Revised Children-Diet Quality Index from the US was positively related 
with total fat intake, SFA intake, ALA intake (Kranz et al, 2006). In contrast, the Youth Healthy 
Eating Index showed to be negatively correlated with total fat intake (%E) (r=0.33) and SFA intake 
(%E) (r=0.30) (Feskanich et al, 2004). This was also found by others in adult populations (Gerber et 
al, 2000; Hann et al, 2001; Newby et al, 2003) and in adolescent girls on lacto-vegetarian diet 
(Chiplonkar and Tupe, 2010). Similar to our results Feskanich et al. found a weak positive 
correlation with cholesterol intake (mg/d) (r=0.09) in a large sample of children aged 9-14 years 
(Feskanich et al, 2004). In contrast, in adult populations associations between diet quality and 
cholesterol intakes were negative (Gerber et al, 2000; Hann et al, 2001; Newby et al, 2003; 
Weinstein et al, 2004). To our knowledge no similar studies assessing the relationship between diet 
quality and serum FA values in adolescents have been published. In a sample of 102 postmenopausal 
women Neuhouser et al. found a significant association between the DQI and palmitic and stearic 
acid (p =0.01), results that could not be confirmed in our study (Neuhouser et al, 2003). In contrast to 
our results and the findings of Gerber et al. (2000), they did not find an association with EPA and 
DHA serum status (Neuhouser et al, 2003). Furthermore, several other studies found a negative 
association between diet quality and cholesterol serum values (Hann et al, 2001; Newby et al, 2003; 
Weinstein et al, 2004).  In contrast to the present findings these groups also observed negative 
associations with dietary cholesterol intake. This negative association however is inherent to the fact 
that cholesterol intake is one of the components on which their quality score calculation (DQI-R and 
HEI) is based (Newby et al, 2003; Weinstein et al, 2004).  
Although no pronounced favorable intake pattern was observed, a beneficial FA serum profile was 
observed with higher levels of long chain (LC) n-3PUFA and lower cholesterol serum values in the 
adolescents with a better DQI-A. These observations might be due to a loss of information as a result 
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of the necessary linking with the food composition tables and the fact that supplement use was not 
considered, resulting in underestimations of the intake of LCn-3PUFA. Previously, it has been 
shown, by use of the Triads method, that EPA and DHA serum values might be better measures for 
LCn-3PUFA intake than the estimated nutrient intake calculated from dietary assessments 
(Vandevijvere et al, 2012). Also, this might indicate that serum levels are not only determined by the 
ingestion of a single nutrient but that it is subject to the interplay of different genetic and 
environmental factors (Jenab et al, 2009).  
 
STRENGTHS AND LIMITATIONS 
Being part of a multicenter European study, data were collected in a large sample of European 
adolescents, in a standardized way, following strict procedures; all blood analyses were performed in 
the same laboratory. The analyses were performed on a heterogeneous group of adolescents. As such 
interference of age-related diseases and medications use, generally occurring in an adult age group 
were excluded.    
The DQI-A has recently been validated in the HELENA study population (Vyncke et al, 2013). The 
DQI-A scores were calculated based on two self-administered, computer-assisted, non-consecutive 
24h recalls. Following recommendations of the “European Food Consumption Survey method 
(EFCOSUM)” 24-hour recalls were preferred because they are open-ended questionnaires in which 
detailed information can be obtained (Biro et al, 2002). According to Biro et al. (2002)
 
the 24h recall 
method is appropriate to assess both acute and habitual intake on the individual level by repeated 
short term measurements and modeling.  
A limitation of the method used is however that only information of two days was obtained.  As such 
the dietary intake is prone to exceptional intakes. The 24-h dietary recall method does not allow 
quantifying proportions of non-consumers for particular food items, a fortiori for infrequently 
consumed foods. In order to decrease this influence, nutrient intakes were corrected for within-
person variability by applying the MSM method. Moreover, accuracy of collected data relies on the 
individual‟s ability to remember foods and beverages consumed in the past 24 hours, and might, 
therefore, be biased. In this respect, the 24-h dietary recalls were performed through computer-
assisted HELENA-DIAT software to standardize the recall procedures as much as possible and to 
allow quality controls during the 24-h recall interview. Another limitation of the use of 24-h recall 
interviews is the potential loss of dietary information from mixed dishes, as food ingredients needed 
to be counted from mixed dishes. Also less detailed data could be collected as adolescents are not 
acquainted with the applied food preparation methods and thereby used fats. As such average values 
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of used cooking fats were estimated according to the countries habitual preparation methods, this 
could however explain the low relations found with the intake values. Furthermore research on lipid 
status should take alcohol use into account; however, values of reported alcohol intake seemed not to 
be reliable in the 24-h recalls. Consequently there was no correction for this factor in the analyses. 
Another limitation of the present study is the differential underreporting that was previously 
observed in the study population (Vyncke et al, 2013). As this differential underreporting could bias 
the results, it was decided to exclude those adolescents with a ratio of energy intake to BMRest lower 
than 0.96, according to the criteria of Goldberg and Black (Black, 2000). 
Comparison of nutrient intake between the different European countries was promoted by using the 
same food composition table for the conversion of food intake data to estimated nutrient intakes. In 
this way differences in definitions, analytical methods, units and modes of expression were 
overcome. In this regard the German food composition tables (Bundeslebensmittelschlüssel, BLS) 
were chosen. The BLS is based on German, American, English, Swedish, Danish and Dutch food 
composition tables, on analytical values of food producing firms, publications and research results of 
the Federal Research Centers and Universities (http://bls.nvs2.de). The BLS includes about 11000 
raw and cooked foods and recipes and is widely used in epidemiological studies. Furthermore the 
BLS is one of the tables giving the most complete coverage of the individual FA (Deharveng et al, 
1999). 
 
III.4.5 CONCLUSION 
Although compliance with FBDG was not always associated with a favorable FA intake pattern, a 
significant favorable association with some serum biomarkers, such as the n-3FA in both sexes and 
cholesterol in boys, was observed. This could possibly be due to the fact that in the upper DQI-A 
quartile, total fat intake, although larger in amount, resulted from more recommended food sources. 
As such, as suggested in Chapter III.2, this confirms the importance to also consider dietary habits 
instead of only single nutrient or food intakes. 
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ABSTRACT  
5- and 6-desaturases, two rate-limiting enzymes in PUFA biosynthesis, are respectively encoded 
by the FADS1 and FADS2 genes. Genetic variants in the FADS1-FADS2 gene cluster are associated 
with changes in plasma concentrations of PUFA, HDL- and LDL-cholesterol and triglycerides. 
However, little is known about whether dietary PUFA intake modulates these associations - 
especially in adolescents. We assessed whether dietary linoleic acid (LA) or -linolenic acid (ALA) 
modulate the association between the FADS1 rs174546 polymorphism and concentrations of PUFA, 
other lipids and lipoproteins in adolescents. Dietary intakes of LA and ALA, FADS1 rs174546 
genotypes, PUFA levels in serum phospholipids, and serum concentrations of triglycerides, 
cholesterol, and lipoproteins were determined in 573 European adolescents from the HELENA study. 
The sample was stratified according to the median dietary LA (≤ 9.4 and >9.4g/d) and ALA (≤ 1.4 
and >1.4g/d) intakes. The associations between FADS1 rs174546 and concentrations of PUFA, 
triglycerides, cholesterol, and lipoproteins were not affected by dietary LA intake (all P-
interaction>0.05). Similarly, the association between the FADS1 rs174546 polymorphism and serum 
phospholipid concentrations of ALA or eicosapentaenoic acid was not modified by dietary ALA 
intake (all P-interaction>0.05). In contrast, the rs174546 minor allele was associated with lower total 
cholesterol concentrations (P=0.01 under the dominant model) and non-HDL cholesterol 
concentrations (P=0.02 under the dominant model) in the high-ALA-intake group, but not in the low-
ALA-intake group (P-interaction=0.01). These results suggest that dietary ALA intake modulates the 
association between FADS1 rs174546 and serum total and non-HDL cholesterol concentrations at a 
young age. 
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III.5.1 INTRODUCTION 
Poly-unsaturated fatty acid (PUFA) concentrations are determined by (i) dietary intake and (ii) 
endogenous synthesis via the successive elongation and desaturation of the dietary precursors 
linoleic-acid (18:2(n-6), LA) and α-linolenic acid (18:3(n-3), ALA). 5-desaturase (D5D) and 6-
desaturase are required for the synthesis of long-chain PUFA (LC-PUFA) in mammals (Nakamura 
and Nara, 2004) and are encoded by the FADS1 and FADS2 genes, respectively (located in a cluster 
on chromosome 11q12-13.1). Several studies have reported strong associations between single 
nucleotide polymorphisms (SNP) in the FADS1-FADS2 gene cluster and PUFA concentrations in 
adipose tissue, plasma or erythrocytes in both adults (Baylin et al, 2007; Malerba et al, 2008; 
Martinelli et al, 2008; Rzehak et al, 2009; Schaeffer et al, 2006; Tanaka et al, 2009; Xie and Innis, 
2008) and adolescents (HELENA study) (Bokor et al, 2010). 
Other studies have reported relationships between several FADS1-FADS2 variants and plasma lipid 
concentrations (Aulchenko et al, 2009; Baylin et al, 2007; Kathiresan et al, 2009; Plaisier et al, 
2009; Sabatti et al, 2009; Tanaka et al, 2009). In a recent meta-analysis, the minor allele of the 
FADS1 rs174546 polymorphism was associated with lower concentrations of HDL- and LDL-
cholesterol and higher triglyceride concentrations in men and women of European ancestry 
(Teslovich et al, 2010). In contrast, in the HELENA study, the rs174546 polymorphism was not 
associated with serum lipid and lipoprotein concentrations in European adolescents (Bokor et al, 
2010). There are several explanations for the divergent results in adults and adolescents. Firstly, the 
discrepancy might be due to a lack of statistical power in the HELENA study. Indeed, based on the 
effect sizes reported by Teslovich et al. and with a minor allele frequency of 0.32 (such as for 
rs174546, for example), the statistical power values to detect a significant association (P<0.05) with 
total cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides were respectively 30%, 9%, 
34% and 72%. Secondly, the changes in plasma lipid/lipoprotein profile that occur during the 
transition from childhood to adolescence (Moran et al, 2008) may mask the association between 
FADS1 polymorphism and lipid concentrations in the young. Alternatively, dietary habits, which 
may differ between adults and adolescents, could confound the association between FADS1-FADS2 
genetic variants and lipid concentrations. In agreement with this hypothesis, Lu et al. recently 
reported that the association between rs174546 and cholesterol concentrations is modulated by the 
dietary intake of n-3 and n-6 PUFA in adults (Lu et al, 2010). Therefore, the goal of the present study 
was to determine whether the dietary intakes of LA and/or ALA influenced the association between 
FADS1 rs174546 and serum lipid and lipoprotein concentrations in European adolescents. 
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III.5.2 SUBJECTS AND METHODS 
III.5.2.1 STUDY DESIGN AND POPULATION 
Data were obtained from the HELENA-Cross Sectional Study (HELENA-CSS) that has been 
described in more detail in Part II  Methods. One third of the classes were randomly selected for 
blood collection; this resulted in a total of 1155 blood samples. From this sample two participating 
centres with missing data on dietary intake (Crete (n=110) and Hungary (n=137)), 175 adolescents 
with incomplete dietary recalls, and 149 under-reporters were excluded. This resulted in a sample of 
573 adolescents with fully available genetic, biochemical and dietary data (two valid 24-hour dietary 
recalls) (Vereecken et al, 2008). Main characteristics of included and excluded participants are 
presented in Table 21.   
    Excluded participants Included participants p 
    n=571 n=573   
Sex N (%) Boys 271 (47.5%) 281 (49.0%) 0.40 
 
Girls 300 (52.5%) 292 (51.0%) 
 Age (years) 14.8 + 0.2 14.7 + 0.2 0.06 
BMI (kg/m²) 22.2 + 0.2 20.5 + 0.2 < 0.0001 
C18:2n6 (% area) 22.0 + 0.2 22.0 + 0.2 0.91 
C18:3n3 (%area) 0.13 + 0.01 0.14 + 0.01 0.17 
Total cholesterol (mmol/L) 4.19 + 0.04 4.12 + 0.03 0.14 
HDL-cholesterol (mmol/L) 1.42 + 0.01 1.43 + 0.01 0.88 
non-HDL-cholesterol (mmol/L) 2.76 + 0.03 2.69 + 0.03 0.10 
LDL-cholesterol (mmol/L) 2.47 + 0.03 2.41 + 0.03 0.17 
Triglycerides (mmol/L) 0.76 + 0.02 0.77 + 0.02 0.66 
FADS1 rs174546 genotypes, % 
   
 
CC  49.9 47.3 0.09 
 
CT  42.5 41.4 
 
 
TT  7.6 11.3 
          
 
III.5.2.2 DATA COLLECTION 
The methods of data collection have been described in more detail in Part II Methods. Briefly, the 
dietary intake assessment was performed by use of the HELENA-DIAT (Dietary Assessment Tool) 
and the Multiple Source Method (MSM) was used to estimate the habitual dietary intake of nutrients 
and foods (https://nugo.dife.de/msm; Haubrock J. et al, 2010).  
Table 21: Characteristics of included and excluded participants (values are means  SEM adjusted for age, sex, and BMI or 
% when indicated). 
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Height and weight were measured in fasting state and the BMI standard deviation score was 
calculated subsequently. Serum FA, triglyceride, HDL-C and LDL-C concentrations were measured 
in fasting venous blood samples. Blood for DNA extraction was collected in EDTA K3 tubes.  
To test the interaction between PUFA intake and FADS gene cluster polymorphisms and serum lipid 
concentrations, the FADS1 rs174546 polymorphism was selected on the basis of the following 
criteria: (i) the strongest associations with serum phospholipid LC-PUFA have been observed for this 
polymorphism in the HELENA study (Bokor et al, 2010), (ii) it is a tag-SNP for the cluster of 
polymorphisms found to be associated with plasma lipid concentrations in a recent meta-analysis of 
genome-wide association studies (Teslovich et al, 2010) and (iii) the rs174546 polymorphism is the 
only one known to interact with dietary PUFA intake to affect plasma cholesterol concentrations in 
adults (Lu et al, 2010). Adolescents were genotyped for FADS1 rs174546 on an Illumina system 
using GoldenGate technology. The genotyping success rate was 99.8%. 
III.5.2.3 STATISTICAL METHODS 
Statistical analyses were performed with SAS software (SAS Institute Inc., Cary, NC, USA). 
Departure from Hardy-Weinberg equilibrium within the study groups was evaluated using a χ2 test. 
Dietary LA and ALA intakes were classified a priori into two groups, according to the study 
population median intake: ≤ 9.4 and >9.4 g/d for LA and ≤ 1.4 and >1.4 g/d for ALA. Prior to 
analysis, intake values were normalized by log-transformation. The strength of association between 
dietary LA and ALA intakes and their corresponding serum phospholipids concentrations was 
evaluated by estimating the Pearson‟s correlation coefficient (r). Due to the limited sample size, 
especially after stratification for dietary LA and ALA intakes, the number of subjects homozygous 
for the minor allele in each subgroup is low (29  n  36), resulting in: (i) a high variability of the 
relevant traits and (ii) an inequality of variance between genotypes. For this reason, analyses were 
performed using a dominant model. Sensitivity analyses were carried out using an additive model. 
To analyze the association between FADS1 genotypes and PUFA, lipid or lipoprotein concentrations, 
we relied on a multilevel random regression analysis using a mixed linear model. This multilevel 
analysis allows to take the variability associated with the school within center sampling strategy into 
account. The interactions between dichotomized LA and ALA intakes and genotypes on quantitative 
variables were explored by including additional interaction terms in the mixed linear model. All tests 
were adjusted for age, sex, BMI, and total energy intake. A P-value <0.05 was considered to be 
statistically significant. Power calculations were performed using Quanto v1.2. 
(http://hydra.usc.edu/gxe). The statistical power to detect a significant association (P<0.05) was 
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estimated on the basis of the effect sizes reported in a recent meta-analysis of genome-wide 
association studies (Teslovich et al, 2010) and with a minor allele frequency of 32%. 
 
III.5.3 RESULTS 
The FADS1 rs174546 genotype distribution fulfilled Hardy-Weinberg equilibrium (χ²=1.34, p=0.24). 
In the present sample, allele frequency for the minor allele of the rs174546 SNP was 0.32. Consistent 
with our previous work in a larger sample from the HELENA study (Bokor et al, 2010) and whatever 
the genetic model tested (i.e. additive or dominant), the minor allele of rs174546 was significantly 
associated with higher serum phospholipid concentrations of LA (P<0.0001) and ALA (P0.0002) 
and lower serum phospholipid levels of arachidonic acid (AA, P<0.0001) and EPA (P0.003) (Table 
22). The dietary intakes of LA and ALA did not differ significantly between FADS1 genotype 
groups. There were no statistically significant associations between the FADS1 rs174546 
polymorphism and HDL-, non-HDL-, LDL-cholesterol or triglyceride concentrations (Table 22).  
 
 
    FADS1 rs174546 genotypes     
  
CC CT TT CT+TT P 
2
 P 
3
 
  n=271 n=237 n=65 n=302     
Boys/Girls (n) 134/137 121/116 26/39 147/155 
  Age (years) 14.8 + 0.2 14.8 + 0.2 14.7 + 0.2 14.7 + 0.2 0.52 0.77 
BMI (Kg/m²) 20.7 + 0.3 20.3 + 0.3 20.4 + 0.4 20.3 + 0.3 0.17 0.12 
Serum phospholipids n-6 fatty acids 
      
 
C18:2n6 (% area) 21.4 + 0.2 22.3 + 0.2 23.3 + 0.3 22.5 + 0.2 <0.0001 <0.0001 
 
C20:4n6 (% area) 9.9 + 0.1 8.9 + 0.1 7.8 + 0.2 8.7 + 0.1 <0.0001 <0.0001 
Serum phospholipid n-3 fatty acids 
      
 
C18:3n3 (% area) 0.14 + 0.01 0.16 + 0.01 0.20 + 0.01 0.17 + 0.01 <0.0001 0.0002 
 
C20:5n3 (% area) 0.58 + 0.03 0.54 + 0.03 0.47 + 0.04 0.52 + 0.03 0.0002 0.003 
 
C22:6n3 (% area) 3.10 + 0.09 3.00 + 0.09 2.97 + 0.13 2.99 + 0.09 0.14 0.15 
Serum lipids and lipoproteins 
      
 
Total cholesterol (mmol/L) 4.15 + 0.05 4.11 + 0.05 4.04 + 0.09 4.09 + 0.05 0.23 0.35 
 
HDL-cholesterol (mmol/L) 1.45 + 0.02 1.46 + 0.02 1.42 + 0.03 1.45 + 0.02 0.54 0.87 
 
non-HDL cholesterol (mmol/L) 2.70 + 0.04 2.66 + 0.04 2.61 + 0.08 2.65 + 0.04 0.3 0.36 
 
LDL-cholesterol (mmol/L) 2.40 + 0.04 2.39 + 0.04 2.38 + 0.08 2.39 + 0.04 0.77 0.76 
 
Triglycerides (mmol/L) 0.76 + 0.02 0.75 + 0.02 0.79 + 0.04 0.76 + 0.02 0.80 0.90 
Usual dietary intake 
      
 
Linoleic Acid (g/d) 10.2 + 0.3 10.3 + 0.3 10.3 + 0.5 10.3 + 0.3 0.69 0.69 
 
Alpha-Linolenic acid (g/d) 1.59 + 0.06 1.54 + 0.07 1.49 + 0.09 1.53 + 0.06 0.18 0.24 
               
2
 P value under the additive model. 
3
 P value under the dominant model.  
Table 22: Characteristics of the HELENA sample, as a function of the FADS1 rs174546 genotypes (means  SEM adjusted for age, sex, and 
BMI). 
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Participants were classified into two groups (low and high) according to the median dietary LA and 
ALA intakes for the study population as a whole (with cut-offs at 9.4 g/d and 1.4 g/d, respectively). 
The median LA and ALA intakes were respectively 7.5 and 1.1 g/d in the low intake group and 12.0 
g/d and 1.8 g/d in the high intake group. Serum phospholipid levels of LA were higher in the high-
intake group (22.3 ± 0.2 %) than in the low-intake group (21.6 ± 0.2 %) (P=0.01). In contrast, ALA 
intake was not related to serum phospholipid levels of ALA. No statistically significant associations 
between dietary LA or ALA intake and any of the lipid or lipoprotein variables were observed (data 
not shown). 
Whatever the genetic model tested, there was no statistically significant interaction between dietary 
LA intake and the FADS1 rs174546 polymorphism on serum phospholipid levels of LA or AA 
(Table 23 and Table 24). In both the low- and high-LA-intake groups, the rs174546 T allele was 
associated with higher LA concentrations and lower AA concentrations. Similarly, there was no 
interaction between LA intake and FADS1 rs174546 on the concentrations of lipids and lipoproteins. 
After stratification by LA intake, there was still no association between the rs174546 genotype and 
lipid or lipoprotein variables in either group. 
Likewise, there was no statistically significant interaction between dietary ALA intake and rs174546 
SNP on serum phospholipid levels of ALA, EPA, and DHA (Table 25 and Table 26). In both the 
low- and high-ALA-intake groups, the rs174546 T allele was associated with higher concentrations 
of ALA. The rs174546 T allele was significantly associated with lower serum phospholipid EPA 
levels in the high-ALA-intake group and a similar trend was observed in the low-ALA-intake group. 
In contrast, no association between the FADS1 rs174546 polymorphism and DHA concentrations 
was observed in either group. There was a significant interaction between ALA intake and the 
rs174546 polymorphism on total (P=0.006) and non-HDL cholesterol concentrations (P=0.01) under 
the dominant model (Table 25). The rs174546 T allele was associated with lower serum total 
cholesterol (P=0.01) and non-HDL-cholesterol (P=0.02) concentrations in the high-ALA-intake 
group only. This association was only partially explained by lower LDL-cholesterol concentrations 
(P=0.11). Under the additive model, similar results were obtained although P values for interaction 
were at borderline significance (P-interaction = 0.06 and 0.08, for total and HDL-cholesterol, 
respectively) (Table 26). In contrast and whatever the genetic model tested, there was no association 
between FADS1 rs174546 and lipid or lipoprotein concentrations in the low-ALA-intake group.  
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   LA intake < 9.4 g/d  LA intake > 9.4 g/d   
 
CC CT + TT P CC CT + TT p p-interaction 
 
n=140 n=150 
 
n=131 n=152 
  LA intake (g/d) 7.4 (6.6; 8.3) 7.7 (6.5; 8.6) - 12.1 (10.4; 13.9) 11.9 (10.5; 15.1) - - 
C18:2n6 (% area) 21.1 ± 0.3 22.1 ± 0.3 0.0004 21.7 ± 0.2 22.9 ± 0.2 0.0002 0.72 
C20:4n6 (% area) 10.0 ± 0.2 8.7 ± 0.2 <0.0001 9.8 ± 0.1 8.6 ± 0.1 <0.0001 0.48 
Total cholesterol (mmol/L) 4.17 ± 0.06 4.17 ± 0.06 0.96 4.12 ± 0.07 4.00 ± 0.06 0.12 0.29 
HDL-cholesterol (mmol/L) 1.45 ± 0.02 1.44 ± 0.02 0.80 1.45 ± 0.02 1.45 ± 0.02 0.95 0.91 
non-HDL cholesterol (mmol/L) 2.72 ± 0.06 2.73 ± 0.06 0.86 2.68 ± 0.06 2.56 ± 0.06 0.13 0.26 
LDL-cholesterol (mmol/L) 2.43 ± 0.06 2.47 ± 0.06 0.53 2.35 ± 0.06 2.30 ± 0.06 0.27 0.28 
Triglycerides (mmol/L) 0.76 ± 0.03 0.75 ± 0.03 0.83 0.76 ± 0.03 0.76 ± 0.03 0.94 0.97 
LA Linoleic Acid; 
1
LA intake is given as the median and the inter-quartile range (Q1; Q3). Other values are means ± SEM adjusted for age, sex, BMI, and 
total energy intake. 
 
 
   LA intake < 9.4 g/day  LA intake > 9.4 g/day   
 
CC CT TT p-trend CC CT TT p-trend p-interaction 
  n=140 n=120 n=30   n=131 n=117 n=35     
LA intake (g/d) 
7.4 (6.6; 
8.3) 
7.6 (6.5; 
8.6) 
7.7 (6.4; 
8.2) - 
12.1 (10.4; 
13.9) 
11.9 (10.7; 
15.3) 
11.9 (10.3; 
14.9) - - 
C18:2n6 (% area) 21.1 ± 0.3 21.8 ± 0.3 23.4 ± 0.5 <0.0001 21.7 ± 0.2 22.7 ± 0.3 23.3 ± 0.4 <0.0001 0.54 
C20:4n6 (% area) 10.0 ± 0.2 8.9 ± 0.2 7.7 ± 0.3 <0.0001 9.8 ± 0.1 8.8 ± 0.1 7.9 ± 0.2 <0.0001 0.16 
Total cholesterol (mmol/L) 4.17 ± 0.06 4.22 ± 0.07 3.98 ± 0.12 0.48 4.12 ± 0.07 3.98 ± 0.07 4.05 ± 0.12 0.24 0.82 
HDL-cholesterol (mmol/L) 1.45 ± 0.02 1.45 ± 0.02 1.40 ± 0.05 0.53 1.45 ± 0.02 1.46 ± 0.02 1.42 ± 0.04 0.81 0.84 
non-HDL cholesterol 
(mmol/L) 2.72 ± 0.06 2.77 ± 0.06 2.59 ± 0.11 0.63 2.68 ± 0.06 2.53 ± 0.07 2.63 ± 0.11 0.29 0.76 
LDL-cholesterol (mmol/L) 2.43 ± 0.06 2.49 ± 0.06 2.39 ± 0.11 0.82 2.38 ± 0.06 2.27 ± 0.06 2.36 ± 0.11 0.50 0.63 
Triglycerides (mmol/L) 0.76 ± 0.03 0.75 ± 0.03 0.76 ± 0.06 0.89 0.76 ± 0.03 0.74 ± 0.04 0.81 ± 0.06 0.68 0.76 
LA Linoleic Acid; 
1
LA intake is given as the median and the inter-quartile range (Q1; Q3). Other values are means  SEM adjusted for age, sex, BMI and total energy intake. 
Table 23: Serum concentrations of n-6 PUFA, lipids, and lipoproteins according to dietary linoleic acid intake and FADS1 rs174546 genotypes under the 
dominant model1 
Table 24: Serum concentrations of n-6 PUFA, lipids, and lipoproteins according to dietary linoleic acid intake and FADS1 rs174546 genotypes under the additive model1 
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  ALA intake < 1.4 g/d ALA intake > 1.4 g/d   
 
CC CT + TT p CC CT + TT p 
p-
interaction 
 n=135 n=159   n=136 n=143     
ALA intake (g/d) 1.1 (1.0; 1.3) 1.1 (1.0; 1.3) - 1.8 (1.6; 2.2) 1.8 (1.6; 2.3) - - 
C18:3n3 (% area) 0.14 ± 0.01 0.17 ± 0.01 0.0008 0.15 ± 0.01 0.17 ± 0.01 0.05 0.29 
C20:5n3 (% area) 0.57 ± 0.04 0.53 ± 0.04 0.14 0.59 ± 0.03 0.51 ± 0.03 0.007 0.15 
C22:6n3 (% area) 3.09 ± 0.12 3.01 ± 0.11 0.58 3.02 ± 0.10 2.89 ± 0.10 0.17 0.38 
Total cholesterol (mmol/L) 4.10 ± 0.07 4.20 ± 0.06 0.23 4.18 ± 0.06 3.98 ± 0.06 0.01 0.006 
HDL-cholesterol (mmol/L) 1.43 ± 0.02 1.45 ± 0.02 0.52 1.46 ± 0.02 1.44 ± 0.02 0.51 0.34 
non-HDL cholesterol (mmol/L) 2.67 ± 0.06 2.75 ± 0.06 0.31 2.71 ± 0.05 2.54 ± 0.05 0.02 0.01 
LDL-cholesterol (mmol/L) 2.39 ± 0.06 2.48 ± 0.06 0.26 2.41 ± 0.06 2.29 ± 0.06 0.11 0.06 
Triglycerides (mmol/L) 0.74 ± 0.03 0.78 ± 0.03 0.45 0.79 ± 0.03 0.74 ± 0.03 0.25 0.12 
ALA alpha-linolenic acid; 
1
ALA intake is given as the median and the inter-quartile range (Q1; Q3). Other values are means ± SEM adjusted for 
age, sex, BMI, and total energy 
 
 
  ALA intake < 1.4 g/day ALA intake > 1.4 g/day   
 
CC CT TT p-trend CC CT TT 
p-
trend p-interaction 
 n=135 n=123 n=36   n=136 n=114 n=29     
ALA intake (g/d) 1.1 (1.0; 1.3) 1.1 (1.0; 1.3) 1.1 (1.0; 1.2) - 1.8 (1.6; 2.2) 1.8 (1.6; 2.4) 1.7 (1.5; 2.3) - - 
C18:3n3 (% area) 0.14 ± 0.01 0.16 ± 0.01 0.20 ± 0.02 <0.0001 0.15 ± 0.01 0.16 ± 0.01 0.20 ± 0.01 0.003 0.35 
C20:5n3 (% area) 0.57 ± 0.04 0.54 ± 0.04 0.49 ± 0.06 0.04 0.59 ± 0.03 0.53 ± 0.04 0.43 ± 0.06 0.0008 0.18 
C22:6n3 (% area) 3.09 ± 0.12 3.04 ± 0.12 2.92 ± 0.19 0.35 3.02 ± 0.10 2.87 ± 0.11 2.96 ± 0.16 0.32 0.77 
Total cholesterol (mmol/L) 4.10 ± 0.07 4.25 ± 0.07 4.03 ± 0.12 0.69 4.18 ± 0.06 3.96 ± 0.07 4.02 ± 0.12 0.02 0.06 
HDL-cholesterol (mmol/L) 1.43 ± 0.02 1.47 ± 0.02 1.39 ± 0.04 0.95 1.46 ± 0.02 1.44 ± 0.02 1.44 ± 0.05 0.54 0.63 
non-HDL cholesterol 
(mmol/L) 2.67 ± 0.06 2.79 ± 0.06 2.64 ± 0.11 0.69 2.71 ± 0.05 2.53 ± 0.06 2.59 ± 0.11 0.05 0.08 
LDL-cholesterol (mmol/L) 2.39 ± 0.06 2.50 ± 0.06 2.43 ± 0.11 0.44 2.41 ± 0.06 2.28 ± 0.06 2.33 ± 0.11 0.20 0.15 
Triglycerides (mmol/L) 0.74 ± 0.03 0.78 ± 0.03 0.76 ± 0.06 0.60 0.79 ± 0.03 0.72 ± 0.03 0.82 ± 0.06 0.67 0.37 
ALA alpha-linolenic acid; 
1
ALA intake is given as the median and the inter-quartile range (Q1; Q3). Other values are means ± SEM adjusted for age, sex, BMI and total energy 
intake. 
Table 25: Serum concentrations of n-3 PUFA, lipids, and lipoproteins according to dietary -linolenic acid intake and FADS1 rs174546 genotypes 
under the dominant model1 
Table 26: Serum concentrations of n-3 PUFA, lipids, and lipoproteins according to dietary -linolenic acid intake and FADS1 rs174546 genotypes under the additive model1 
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The LA and ALA intakes were correlated (r = 0.81, P<0.0001). Adjustment for LA intake did not 
alter the statistical significance of the associations between FADS1 polymorphism and total or non-
HDL cholesterol concentrations in the high-ALA-intake group. Further adjustment for physical 
activity level did not substantially change the results (data not shown). Lastly, we examined the 
interaction with ALA intake as a continuous variable, in order to avoid the arbitrary selection of cut-
off points (i.e. the medians). In agreement with the previous data, the interaction between ALA 
intake as a continuous variable and the FADS1 rs174546 polymorphism (under the dominant model) 
remained significant for total cholesterol (P=0.03) and was borderline-significant for non-HDL 
cholesterol (P=0.07). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16: Association of the FADS1 rs174546 polymorphism with total and non-HDL cholesterol according to 
dietary -linolenic acid intake. Data are means  SEM adjusted for age, sex, BMI, and total energy intake. White 
bars represent rs174546CC adolescents and black bars rs174546CT+rs174546TT adolescents. 
 
RESULTS 
144 
III.5.4 DISCUSSION 
The present study reports a significant interaction between dietary ALA intake and the FADS1 
rs174546 polymorphism on serum total and non-HDL cholesterol concentrations in European 
adolescents. High ALA intakes were associated with lower concentrations of total and non-HDL 
cholesterol in carriers of rs174546 minor allele only (Figure 16). Hence, our results (i) replicate, in 
an independent sample, the recently reported interaction between n-3 PUFA intake and rs174546 on 
serum total and non-HDL cholesterol concentrations in 3575 Dutch adults (Lu et al, 2010) and (ii) 
extend these observations to adolescents. Taken as a whole, our data suggest that ALA intake 
modulates the impact of FADS1 genetic variants on serum lipid concentrations and that this occurs at 
a young age. 
Tissue or serum levels of LA and ALA and of their biologically active LC-PUFA derivatives are 
influenced not only by diet, but to a larger extent also by genetic variants in the FADS1-FADS2 gene 
cluster. Numerous studies (including genome-wide association studies) consistently showed an 
association between polymorphisms in the FADS1-FADS2 gene cluster and the fatty acid 
composition of both adipose tissue (Baylin et al, 2007), erythrocyte membranes (Malerba et al, 2008; 
Martinelli et al, 2008; Rzehak et al, 2009; Tanaka et al, 2009; Xie and Innis, 2008) and plasma or 
serum phospholipids (Baylin et al, 2007; Bokor et al, 2010; Malerba et al, 2008; Martinelli et al, 
2008; Rzehak et al, 2009; Schaeffer et al, 2006; Tanaka et al, 2009; Xie and Innis, 2008). Carriers of 
minor alleles of these SNPs (including rs174546) had higher levels of desaturation substrates (such 
as LA, eicosadienoic acid, and ALA) and lower levels of desaturation products (such as AA, EPA 
and docosapentaenoic acid). It appears from these studies that minor alleles of these SNPs lead to a 
reduced efficiency of the endogenous synthesis of LC-PUFA from their precursors (LA and ALA). 
This hypothesis is further supported by Gieger et al. who showed significant associations between 
the FADS1 rs174548 polymorphism (which is in high linkage disequilibrium with rs174546) and a 
number of plasma glycerophospholipid concentrations (expressed in absolute values, µM), 
suggesting a reduced efficiency of the D5D reaction (Gieger et al, 2008). In addition, the rs174546 
polymorphism tags (r² ≥ 0.8) several other FADS cluster SNPs that have been associated with plasma 
lipid and lipoprotein concentrations in adults (Teslovich et al, 2010). Its minor allele is located within 
a microRNA target site and is associated with lower FADS1 mRNA levels in human liver (Teslovich 
et al, 2010), suggesting that the rs174546 SNP is either functional or in linkage disequilibrium with a 
functional SNP affecting D5D activity. 
We showed that the FADS1 rs174546 T allele was associated with both higher serum phospholipid 
ALA concentrations and lower total and non-HDL cholesterol concentrations in adolescents 
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reporting a high dietary ALA intake (median 1.8 g/d), but not in those with a low intake (median 1.1 
g/d). The mechanisms underlying this association remain to be elucidated. However, this observation 
might explain the results of earlier trials assessing the effects of moderate ALA supplementation on 
blood lipid concentrations (for a review, see (Geleijnse et al, 2010)). In these trials, moderate ALA 
supplementation (1.2–3.6 g/d) had no effect or inconsistent effects on plasma lipid and lipoprotein 
concentrations. In contrast, supplementation with high doses of ALA (8.8 g/d) lowers total and LDL-
cholesterol concentrations (by 0.20 and 0.13 mmol/L, respectively) (Dodin et al, 2005). In the 
present study, the combination of a modest ALA intake (median 1.8 g/d) and the raising effect of 
rs174546 T allele on ALA concentrations was sufficient to lower non-HDL cholesterol 
concentrations. 
The present study extends to adolescents the observation of an interaction between n-3 PUFA intake 
and the FADS1 rs174546 polymorphism on serum total and non-HDL cholesterol that was recently 
reported in adults by Lu et al. (2010). In contrast, the interaction between n-6 PUFA intake and 
rs174546 on HDL cholesterol concentrations (Lu et al, 2010) was not replicated here. The reasons 
for this apparent discrepancy are not clear. However, the significant changes in the plasma 
lipid/lipoprotein profile that occur during the transition from late childhood to adolescence (Moran et 
al, 2008) may have masked the interaction in our sample. We checked whether Tanner status 
modified this interaction and did not find a significant association (data not shown) suggesting that 
this is not a likely explanation. Alternatively, it cannot be excluded that dietary n-3 and n-6 PUFA 
intake differ between adults and adolescents. However, such differences are difficult to evaluate, due 
to the lack of international standardization in both the dietary recall methods and the food 
composition tables used to determine the food content in PUFA. In addition, studies that compare the 
mean dietary intake of n-3 and n-6 PUFA between adults and adolescents are still scarce. 
Nevertheless, a comparison of the mean Australian intake of n-3 and n-6 PUFA between adults and 
children or adolescents aged 18 years and younger has shown that adults consume nearly twice as 
much long-chain n-3 PUFA than children and adolescents, probably due to a higher consumption of 
fish and seafood products (Meyer et al, 2003). In contrast, the mean intake of LA and ALA was 
relatively similar between adults (10.8 g/d and 1.17 g/d, respectively) and adolescents aged from 12 
to 15 years (10.7 g/d and 1.22 g/d, respectively). Lastly, the discrepancy might be due to a lack of 
statistical power in the present study. With a minor allele frequency of 0.32, the statistical power to 
detect a significant association (P<0.05) with HDL-cholesterol (β=-0.019 mmol/l) (Teslovich et al, 
2010) in the high-LA-intake group was only 13%. Therefore, very large genetic association studies 
or meta-analyses are required to fully explore the interaction between dietary PUFA intake and 
FADS1 polymorphism on lipid/lipoprotein metabolism in the young. 
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STRENGTHS AND LIMITATIONS  
This study had several strengths and, conversely, a number of limitations. Firstly, our analyses were 
restricted to the FADS1 rs174546 polymorphism. However, as indicated above, this SNP shows the 
strongest associations with serum phospholipid levels of LC-PUFA in the HELENA study (Bokor et 
al, 2010) and tags a cluster of SNPs associated with plasma lipid concentrations (Teslovich et al, 
2010). Hence, this SNP was a logical choice for examining gene-diet interactions. Secondly, given 
that serum phospholipid LC-PUFA concentrations were measured in the HELENA study, we were 
able to assess the relationship between dietary LA and ALA intakes and their corresponding serum 
phospholipid levels. The dietary intake of LA was weakly but significantly correlated with the serum 
phospholipid LA level as a percentage of total fatty acids (r = 0.15, P=0.0004), whereas no such 
correlation was found for ALA (r = 0.03, P=0.51). This may possibly be explained by: (i) the lag (<1 
week) between the two 24-hour recalls and the blood sample collection and (ii) by the fact that 
PUFA were measured in serum phospholipid fraction rather than in adipose tissue. However, 
although adipose tissue is a preferred medium for the measurement of fatty acids as a reflection of 
long-term dietary intakes, it was shown that at least for several PUFA including LA, PUFA 
concentrations in serum phospholipids may reflect intake of fatty acids over the past few days or 
more (Arab, 2003; Hodge et al, 2007; Ma et al, 1995). In addition, our results are consistent with 
those of other studies having compared PUFA intake with biomarker concentrations in adults (Astorg 
et al, 2008; Hodge et al, 2007). Thirdly, the 24-hour dietary recall method used in the present study 
has some limitations. The accuracy of collected data relies on the individual‟s ability to remember 
the composition of previous meals, including mixed dishes. Accordingly, there is a risk of 
misreporting. In addition, adolescents do not usually know which food preparation methods have 
been applied (e.g. the choice of cooking fat). However, use of the computer-assisted HELENA-DIAT 
tool standardized the 24-hour dietary recalls as much as possible. Nutrient intakes were corrected for 
within-person variability by applying the MSM method and average values for cooking fat use were 
estimated according to each country's usual preparation methods. Nevertheless, our results would 
benefit from replication with an independent sample of adolescents. 
 
III.5.5 CONCLUSION 
The present study confirmed the gene-nutrient interaction between ALA intake and the FADS1 
rs174546 polymorphism on non-HDL cholesterol concentrations recently shown in adults and has 
extended the findings to European adolescents. This interaction may help to explain the 
interindividual differences in plasma cholesterol concentrations observed in response to n-3 PUFA 
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dietary content. However, this point requires further investigation with appropriate interventional 
studies.
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III.6 INTERACTION BETWEEN LIPC AND DIET AND PHYSICAL 
ACTIVITY  
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ABSTRACT 
Hepatic lipase plays an important role in reverse cholesterol transport and the remodeling of 
lipoproteins by hydrolyzing triglycerides and phospholipids of plasma lipoproteins. Polymorphisms 
in the hepatic lipase gene (LIPC) have been associated with higher plasma HDL-C concentrations. 
Moreover, interactions between polymorphisms in the promoter region and dietary habits and 
physical activity (PA) have been observed. Consequently, this study assessed whether the 514C/T 
polymorphism interacts with diet, PA and cardiorespiratory fitness to influence serum FA, 
cholesterol and triglyceride concentrations.  The rs1800588 (514C/T) genotype, FA concentrations, 
triglycerides, cholesterol and lipoproteins were measured in 1155 European adolescents (11-19 
years) from the HELENA study. Dietary intake was assessed with two 24h recalls (n=577), PA with 
self-reported questionnaires (n=957) and VO2max (n=874) with a shuttle run test. Associations 
between rs1800588 and outcome variables were assessed with linear regressions, corrected for age, 
sex, BMI, total energy intake (only analyses with diet) and center. The minor allele of rs1800588 was 
significantly associated with higher levels of total cholesterol, HDL-C, Apo-A1 and stearic acid. An 
interaction between rs1800588 and linoleic acid (LA) intake was observed for arachidonic acid (AA) 
concentrations (p=0.03). In high LA consumers only, TT subjects had higher AA (p=0.001) and 
HDL-C concentrations (p=0.007) than C allele bearers. TT subjects with a higher VO2max or PA had 
higher levels of HDL-C and ApoA1. Also, an interaction between VO2max and rs1800588 was 
found for AA levels (p=0.03). TT carriers with a VO2max above median had higher levels of AA 
(p=0.025), whilst TT subjects with a lower VO2max tended to have lower levels of AA than C allele 
carriers. In conclusion, this study confirmed gene-environment interactions between dietary 
intake/physical activity and the LIPC rs1800588 polymorphism on HDL-C and ApoA1 levels. 
Furthermore, a possible interaction on the levels of stearic acid and AA was observed, which might 
help to explain the observed increased risk for cardiovascular diseases in subjects with decreased 
hepatic lipase activity.  
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III.6.1 INTRODUCTION 
Hepatic lipase (HL) is an enzyme synthesized and secreted by the hepatocytes and found 
extracellular primarily in the liver as well as in the adrenal glands and ovaries. HL catalyzes the 
hydrolysis of acyl-ester bonds in triglycerides and phospholipids in most lipoprotein subtypes, 
thereby altering lipoprotein size and density (Connelly, 1999; Ehnholm and Kuusi, 1986; Thuren, 
2000). Furthermore, it has been suggested that HL enhances HDL-cholesterol ester uptake by the 
hepatocytes and it has been proven that it enhances uptake of remnant lipoproteins as an 
enzymatically inactive protein cofactor (Thuren, 2000).  
Numerous single nucleotide polymorphisms (SNPs) in the HL gene (LIPC), located on chromosome 
15q21, spanning nine exons, are under investigation. In previous studies, the minor alleles of two 
common LIPC promoter variants (rs1800588 (-514C>T) and rs2070895 (-250G>A)), which are in 
almost complete linkage disequilibrium, have been associated with lower plasma HL activity and 
higher HDL-cholesterol concentrations (Chen et al, 2003; Grarup et al, 2008; Guerra et al, 1997; 
Isaacs et al, 2004; Nettleton et al, 2007; Ordovas et al, 2002; Tahvanainen et al, 1998; Tai et al, 
2003; Talmud et al, 2001).   
Furthermore, strong gene-environment interactions between these SNPs and dietary intake (Lindi et 
al, 2008; Nettleton et al, 2007; Ordovas et al, 2002; Riestra et al, 2009; Tai et al, 2003) or physical 
activity (Ahmad et al, 2011; Grarup et al, 2008) on plasma lipid profiles have been reported in both 
adults and children. These findings, however, are difficult to compare as most studies found 
interactions with different types of dietary fat or different lipid outcomes and many studies were 
conducted in different ethnicities. For instance, the research group of Ordovas and colleagues found 
a significant interaction between the rs1800588 SNP and total fat intake, saturated fatty acid (SFA) 
intake and mono-unsaturated fatty acid (MUFA) intake on HDL-cholesterol levels in 2130 White 
adults (Ordovas et al, 2002). However, they could not reproduce this finding in a multiethnic Asian 
population (Tai et al, 2003). In contrast, in the latter study they observed an interaction between the 
SNP and total fat intake on triglyceride concentrations (Tai et al, 2003), which again was not 
reproduced by others (Nettleton et al, 2007; Riestra et al, 2009) as they found only an interaction 
between the SNP and SFA intake on triglyceride concentrations.  
The aim of the present study was to examine the association between the LIPC rs1800588 promoter 
variant and the phospholipid FA concentrations in a European, adolescent population. Furthermore, 
interactions with dietary intake (total fat intake, SFA intake, MUFA intake, poly-unsaturated fatty 
acid (PUFA) intake, linoleic acid (LA) intake, α-linolenic acid (ALA) intake and the overall dietary 
quality), physical activity and fitness levels were explored. Also the association of the SNP and 
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interactions with the same environmental factors were investigated for serum lipid concentrations in 
an attempt to add to the current body of literature on the basis of a population of European 
adolescents.  
 
III.6.2 SUBJECTS AND METHODS 
III.6.2.1 STUDY DESIGN AND POPULATION 
Data were obtained from the HELENA-Cross Sectional Study (HELENA-CSS) that has been 
described in more detail in Part II Methods. One third of the adolescents were randomly selected for 
blood collection, this resulted in a total of 1155 participants with blood values. From this sample 
82.9% (n=957) had valid data on physical activity, 75.7% (n=874) had valid data on 
cardiorespiratory fitness and 50.0% (n=577) had valid data on dietary intake (2 valid 24h recalls). 
Concerning dietary intake data, adolescents were excluded from the statistical analyses if they had 
missing data on dietary intake (all adolescents from Crete, n=110 and Hungary n=137), incomplete 
dietary recalls (n=182) or were classified as under-reporter (n=149). To maximize statistical power, 
the interaction with the different environmental factors was assessed in the largest possible 
subgroups with valid data. Because inclusion into the analysis required available data for genotype 
and lipid levels, the number of subjects with available data on FA varied from trait to trait. The exact 
sample size for each analysis is presented in the tables.   
III.6.2.2 DATA COLLECTION 
The methods of data collection have been described in more detail in Part II Methods. Briefly, the 
dietary intake assessment was performed by use of the HELENA-DIAT (Dietary Assessment Tool) 
and the Multiple Source Method (MSM) was used to estimate the habitual dietary intake of nutrients 
and foods (https://nugo.dife.de/msm; Haubrock J. et al, 2010). A Diet Quality Index for Adolescents 
(DQI-A) score was calculated for all subjects, as described in Chapter III.3. Height and weight were 
measured in fasting state and the BMI standard deviation score was calculated subsequently. 
Physical activity was assessed with a self-reported questionnaire (IPAQ-A) and as indicator for 
cardiorespiratory fitness the estimated VO2max, based on the Ruiz‟ equations, was used.  
Serum FA, triglyceride, HDL-C and LDL-C, serum apolipoprotein A-1 and B concentrations were 
measured in fasting venous blood samples. Based on the observation that plasma phospholipids 
mainly consisted of palmitic acid (C16:0), linoleic acid (LA; C18:2n6), stearic acid (C18:0), oleic 
acid (OA; C18:1n9) and arachidonic acid (AA; C20:4n6) (in decreasing order, ranging from 27.4 to 
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9.7 %area), only these fatty acids were included in the current statistical analyses. Blood for DNA 
extraction was collected in EDTA K3 tubes.  
According to the 1000 genomes project data (Interim Phase v3, october 2012), 729 tag-SNPs should 
be genotyped to cover the entire common genetic variability of the LIPC gene. In the present study, 
the LIPC rs1800588 polymorphism was the only SNP studied on the basis of the following criteria: 
(i) the most consistent effects on plasma lipids were observed for the rs1800588 polymorphism 
(Isaacs et al, 2004), (ii) this SNP is in high linkage disequilibrium with rs2070895 and these two 
SNPs are the only ones known to interact with diet (Lindi et al, 2008; Nettleton et al, 2007; Ordovas 
et al, 2002; Riestra et al, 2009; Tai et al, 2003) or physical activity (Ahmad et al, 2011; Grarup et al, 
2008) to affect plasma lipid profiles and (iii) the rs1800588 polymorphism, located in the promoter 
region, has been demonstrated to influence both transcriptional activity in transient transfection 
assays (Deeb and Peng, 2000) and HL activity levels (Tahvanainen et al, 1998; Zambon et al, 1998). 
The genotyping success rate was 100%. 
III.6.2.3 STATISTICAL ANALYSES 
Statistical analyses were performed with SAS 9.3 for Windows (SAS Institute Inc., Cary, NC) and 
SPSS 20.0 for Windows (SPSS Inc., Chicago, IL, USA). Departure from Hardy-Weinberg 
equilibrium within the study groups was evaluated using a χ² test. Due to deviance from normality, 
triglyceride serum values were analyzed on a logarithmic scale and back-transformed to the 
geometric mean for presentation. The association between genotypes and quantitative variables was 
estimated with a general linear model assuming both additive and recessive models. As significant 
associations were  restricted to the recessive model, only this model was presented. The interactions 
between diet/physical activity and genotypes on lipid and fatty acid serum concentrations were 
explored by including additional interaction terms in the linear regression analysis. In all analyses, 
physical activity was represented as minutes per week, dietary intake as g/day and DQI-A as % 
(continuous variables) or dichotomized according to the median value (for physical activity, dietary 
intake and DQI-A) or to the recommended norm (average of 60 minutes per day for physical 
activity). All tests were adjusted for age, sex, BMI z-scores and study center. The analyses 
investigating the interactions with dietary intake were additionally corrected for total energy intake. 
Power calculations were performed using Quanto v1.2.4 (http://hydra.usc.edu/gxe).  
 
 
 
III.6 INTERACTION BETWEEN LIPC AND DIET AND PHYSICAL ACTIVITY 
153 
III.6.3 RESULTS 
A descriptive table of the study population is presented in  Table 27. The genotype distribution of 
the LIPC rs1800588 SNP fulfilled the Hardy-Weinberg equilibrium (p=0.34), the minor allele 
frequency was 0.22. The minor allele of rs1800588 was significantly associated with higher levels of 
total cholesterol (p=0.002), HDL-C (p=0.0001), Apo-A1 (p=0.0002) and stearic acid (C18:0) 
(p=0.004) (Table 28). Usual dietary intake and physical activity did not differ significantly between 
the three genotype groups (data not shown).  
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 Table 27: Descriptives of the total study population (n=1155) 
    N Mean SD 
Age (years) 
 
1155 14.67 1.42 
Sex N (%) Boys 552 (47.8) 
 
 
Girls 603 (52.2) 
 BMI SDS 
 
1144 0.49 1.12 
BMI (kg/m²) 
 
1144 21.32 3.75 
Total Cholesterol (mg/dl) 
 
1151 161.08 27.51 
HDL-C (mg/dl) 
 
1151 55.36 10.65 
LDL-C (mg/dl) 
 
1149 94.52 24.41 
Triglycerides (mg/dl) 
 
1149 68.46 32.78 
ApoA1 (g/L) 
 
1120 1.50 0.22 
ApoB (g/L) 
 
1120 0.65 0.16 
     
Total fat intake (g/d) 
 
577 91.05 28.26 
LA intake (g/d) 
 
573 10.23 3.84 
ALA intake  (g/d) 
 
575 1.58 0.69 
PUFA intake  (g/d) 
 
572 12.48 4.45 
SFA intake  (g/d) 
 
577 38.05 12.28 
MUFA intake  (g/d) 
 
577 33.28 10.46 
DQI-A (%) 
 
577 52.72 15.52 
     
Physical activity (min/week) 968 728.48 595.52 
VO2max (ml/kg/min)   881 42.58 10.95 
SDS standard Deviation Score, HDL-C High Density Lipoprotein Cholesterol, LDL-C 
Low Density Lipoprotein Cholesterol, LA Linoleic Acid, ALA alfa-linolenic acid, 
PUFA Poly-unsaturated fatty acids, SFA Saturated fatty acids, MUFA Mono-
unsaturated fatty acids, DQI-A Diet Quality Index for Adolescents 
 
 
Table 28: Association between the rs1800588 polymorphism and serum fatty acid and lipid concentrations1 
  CC (n = 706) CT (n = 374) TT (n = 60) p 
C18:2n-6 (%area) * 22.08 (2.57) 22.00 (2.52) 22.12 (2.59) 0.942 
C20:4n-6 (%area) Ϯ 9.65 (1.57) 9.64 (1.68) 10.05 (1.75) 0.130 
C16:0 (% area) * 27.47 (1.42) 27.36 (1.56) 27.11 (1.55) 0.156 
C18:0 (% area) * 13.09 (1.06) 13.09 (1.02) 13.56 (0.96) 0.004 
C18:1n-9 (% area) * 9.94 (1.89) 10.12 (1.85) 9.57 (1.34) 0.151 
Total Cholesterol (mg/dL) 160.45 (27.67) 161.11 (27.61) 171.20 (24.01) 0.002 
HDL-C (mg/dL) 55.02 (10.80) 55.36 (10.10) 60.30 (11.53) 0.0001 
LDL-C (mg/dL) 94.50 (24.72) 94.22 (24.00) 98.63 (24.19) 0.113 
Triglycerides (mg/dL)2 61.00 (1.57) 63.25 (1.53) 65.74 (1.47) 0.287 
Apo A1 (g/L) # 1.50 (0.22) 1.51 (0.22) 1.61 (0.21) 0.0002 
Apo B (g/L) # 0.65 (0.16) 0.65 (0.16) 0.67 (0.16) 0.270 
        1 values are mean (SD); 2 geometrical mean (SD); P values adjusted for sex, age, BMI SDS and center  
*CC: n=636, CT: n=345, TT: n=53; † CC: n=630, CT: n=344, TT: n=51; 
# 
CC: n=685, CT: n=364, TT: n=60 
HDL-C High Density Lipoprotein Cholesterol, LDL-C Low Density Lipoprotein Cholesterol 
 
The possible interaction effect between the rs1800588 polymorphism and dietary intake on plasma 
lipid and fatty acid concentrations was examined by (i) a linear regression with the interaction term 
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as a dichotomous or a continuous variable and subsequently (ii) by a linear regression after 
stratification for the interaction term, classifying the participants in 2 groups, namely the high and the 
low consumers. No consistent, significant interaction between daily total fat intake, SFA intake, 
PUFA intake and -linolenic acid (ALA; C18:3n3) and the rs1800588 polymorphism was detected 
(results not shown). Furthermore, no significant interaction could be detected between the rs1800588 
SNP and MUFA intake when considering serum FA and other lipids levels (Table 29). However, 
after stratification on MUFA intake, significant higher HDL-C concentrations were seen in TT 
subjects compared to CC and CT subjects (p=0.009) in the group of low MUFA consumers only. 
Furthermore, stratification also revealed higher concentrations of plasma total cholesterol and 
ApoA1 in the homozygotes for the minor allele in the group of low MUFA consumers (p=0.027 and 
p=0.031, respectively). It is worth noting that in the group of high MUFA consumers, TT subjects 
also tended to have higher HDL-C (p=0.08) and ApoA1 (p=0.07) levels than C allele bearers, but to 
a less extent than for low MUFA consumers. In contrast, in the group of high MUFA consumers, 
higher plasma levels of AA (p=0.004) and stearic acid (p=0.006) were observed in TT subjects 
compared to CT and CC subjects. No significant association with plasma triglyceride levels in low or 
high MUFA consumers could be detected. 
Analysis of the possible interaction between the polymorphism and the intake of LA showed a 
significant interaction for AA concentrations (p=0.03) (Table 29). In the group of high LA 
consumers only, TT subjects had significant higher AA concentrations (p=0.001) and HDL-C 
concentrations (p=0.007) than CT or CC subjects, however, HDL-C concentrations also tended to be 
higher in the TT subjects in the group of low LA consumers (p=0.057). In both low and high LA 
consumers, TT subjects had higher stearic acid (p=0.034 and p=0.025, respectively) and ApoA1 
(p=0.041 and p=0.032, respectively) levels than C allele bearers.   
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Table 29: Serum concentrations of fatty acids and lipids according to dietary intake and LIPC rs1800588 genotype under the recessive model (mean (SD)1 
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Similarly to the effect of MUFA intake, stratification for DQI-A (Table 29) showed higher total 
cholesterol, HDL-C and ApoA1 concentrations in TT subjects compared to CC and CT subjects 
(p=0.044, p=2.10
-5
, p=6.10
-5
, respectively) in the group with a low DQI-A. Furthermore, the 
interaction between the DQI-A score and rs1800588 was significant for ApoA1 (p=0.022 if 
continuous and p=0.017 if dichotomous) and HDL-C (p=0.030 if dichotomous) concentrations. Last, 
significant higher levels of AA and stearic acid were seen in TT subjects compared to bearers of the 
C allele in both groups of DQI-A scores.  
Table 30 shows the findings of the interaction with physical activity, stratified for those reaching the 
daily recommended values (60 min/day) versus those not reaching them. In the linear regression 
analysis, a significant interaction was detected between the polymorphism and physical activity 
(dichotomous) for HDL-C (p=0.03). Stratification suggested that this was due to a more distinct rise 
in HDL-C concentrations in homozygotes for the minor allele in the group that was most physically 
active (p=0.0003). A similar association was found for Apo-A1 levels (p=0.001). In both the group 
with high and low physical activity a significant higher level of total cholesterol was seen in TT 
subjects (p=0.005 and p=0.048 respectively). Furthermore, carriers of the minor allele who do not 
reach the recommendation for physical activity level had higher concentrations of LDL-C (p=0.029) 
and higher concentrations of stearic acid (p=0.035), although for the latter the serum levels of stearic 
acid in homozygotes for the minor allele were similar in both groups of physical activity. Results 
stratified according to the median of physical activity in the study population were similar (data not 
shown).  
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Table 30: Serum concentrations of fatty acids and lipids according to physical activity/fitness and LIPC rs1800588 genotype under the recessive model1. 
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In line with the interaction effect of the level of physical activity, adolescents with a higher value of 
VO2max and carrying the TT genotype for the rs1800588 SNP had higher levels of HDL-C 
(p=0.005) and ApoA1 (p=0.004) (Table 30). In both groups (low and high VO2max), TT subjects 
had significant higher total cholesterol levels (p=0.046 and p=0.001) than CT or CC subjects. LDL-C 
and Apo-B concentrations were only significantly higher in TT subjects with a high VO2max (both 
p=0.029), however, these concentration also tended to be higher, and even to a larger extent, in 
homozygotes for the minor allele in the low VO2max group but this was not significant (p=0.127 and 
p=0.268 respectively). Concerning the fatty acids, an interaction between VO2max and the 
polymorphism was found for AA levels (p=0.03). Individuals homozygous for the minor allele and 
with a VO2max above the median had significant higher levels of AA (p=0.025). Whilst in the group 
with a VO2 max below median, the adolescents, homozygote for the minor allele, tended to have 
lower levels of AA than CC or CT subjects (Figure 17). Furthermore, TT subjects had significantly 
higher levels of stearic acid than their CC or CT counterparts in both groups (p=0.010 for low 
VO2max and p=0.040 for high VO2max). 
 
 
 
Figure 17: Association of the LIPC rs1800588 polymorphism with AA according to the VO2max. 
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III.6.4 DISCUSSION 
HL plays an important role in reverse cholesterol transport and the remodeling of lipoproteins by 
hydrolyzing triglycerides and phospholipids of plasma lipoproteins. It has been shown that HL 
activity is quite variable and is influenced by several  factors such as smoking, BMI, sex and genetic 
background (Tan et al, 2001).  
In the present study, we investigated whether the rs1800588 variant in the promoter region of the 
LIPC gene, encoding HL, was associated with the serum FA phospholipid and lipid concentrations in 
a population of European adolescents. Furthermore interactions with diet, physical activity and 
cardiorespiratory fitness were explored.  
As reviewed by Isaacs and colleagues (Isaacs et al, 2004), several studies showed a decrease in HL 
activity for both the CT and TT genotypes of the rs1800588 SNP. Moreover, this meta-analysis 
confirmed an increase in HDL-C with a weighted mean difference of 1.55 mg/dL (CT compared to 
CC) and 3.48 mg/dL (TT compared to CC) (Isaacs et al, 2004). This increase was also found in the 
present study in adolescents with a mean increase of 5.28 mg/dL (when comparing TT with CC 
subjects). Likewise, in adolescents carrying the TT alleles compared to CT and CC alleles, an 
increase in ApoA1 and total cholesterol was observed, which has also been described by others in 
both adults (Grarup et al, 2008; Isaacs et al, 2004; Nettleton et al, 2007) and children (Riestra et al, 
2009). However, we could not reproduce the finding of an increase in triglyceride concentrations as 
described by Tai et al. and Riestra et al. (Riestra et al, 2009; Tai et al, 2003).  
Low HDL-C is a well-established risk factor for cardiovascular diseases (Castelli et al, 1986). The 
observed increase in HDL-C may be of clinical relevance because a meta-analysis has shown that a 
1mg/dL increase in HDL-C was associated with a significant coronary heart disease risk decrement 
of 2% in men and 3% in women (Gordon et al, 1989). However, paradoxically, LIPC promoter 
variants, resulting in lower HL activity and thus higher HDL-C levels, have been shown to be 
associated with an increased risk for cardiovascular disease (Andersen et al, 2003; Dugi et al, 2001). 
This apparent contradiction might be due to a HL induced modulation of the two-sided anti-
inflammatory or pro-inflammatory state of the HDL particle (Ansell et al, 2007; Grarup et al, 2008) 
or other anti-atherogenic effects of HL activity (Ordovas et al, 2002).   
The influence of dietary intake on the effect of the LIPC polymorphism on plasma lipid levels has 
also been investigated in several studies; however data are often controversial (Lindi et al, 2008; 
Nettleton et al, 2007; Ordovas et al, 2002; Riestra et al, 2009; Tahvanainen et al, 1998; Tai et al, 
2003). In contrast to others we did not find important interaction effects between the rs1800588 and 
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dietary intake of total fat, SFA and PUFA (Ordovas et al, 2002; Riestra et al, 2009; Tai et al, 2003). 
However, we did observe significant higher total cholesterol levels (+15.4 mg/dL) in TT subjects that 
consumed lower amounts of MUFA. Also, similar to Ordovas et al. (2002) we observed higher 
HDL-C and ApoA1 concentrations in TT subjects that consumed lower amounts of MUFA in a 
recessive model. Though, this finding is in contrast to others (Riestra et al, 2009; Zhang et al, 2005) 
who found that a higher MUFA intake enhanced the rising effect of LIPC polymorphism on HDL-C 
levels. However, differences could be attributed to diversity in the study populations. Zhang and 
colleagues (Zhang et al, 2005) studied white men (aged 40-75 years) with type II diabetes and 
Riestra (Riestra et al, 2009) conducted a study in prepubescent children who had high intakes of 
MUFA (boys mean 18.3%E + 2.5 and girls mean 18.2%E +2.5) compared to our adolescent 
population (12.3%E +1.0). However, it has to be noted that in our study population, a trend was 
observed with higher levels of HDL-C and ApoA1 in TT subjects in the group of high MUFA 
consumers, which might not be significant due to a lack of statistical power in this group (n=289). 
With a minor allele frequency of 0.22, the statistical power to detect a significant association 
(p<0.05) with HDL-C (β = + 4 mg/dL) in the high-MUFA–intake group was only 28%. As such, no 
conclusion can be made in this adolescent population on an interaction between the rs1800588 SNP 
and MUFA intake on the HDL-C and ApoA1 concentrations. The same applies for the interaction 
between rs1800588 and LA intake on HDL-C levels. Although the association between the SNP and 
HDL-C was only significant in the high LA consumers, a similar but weaker trend was observed in 
adolescents consuming low amounts of LA. The influence of dietary LA intake on the effect of the 
LIPC polymorphism has not been assessed by others previously. However, Riestra et al. (2009) 
found higher HDL-C levels in male T allele carriers that consumed high levels of total PUFA. In 
adults, only an interaction between the LIPC polymorphism and total PUFA intake was observed for 
triglyceride levels in a Singaporean population (Tai et al, 2003).  
The present study is the first investigating the influence of the overall dietary intake (DQI-A) on the 
association of the LIPC polymorphism with serum lipid and FA levels. This DQI-A has been shown 
to be a good surrogate marker for adherence to food based dietary guidelines (Vyncke et al, 2013) 
and the consideration of dietary habits instead of single nutrient intakes is important as evidence has 
shown that the overall diet correlates better with long-term health outcome (Kant, 1996; Vyncke et al, 
2013). The results indicated an interaction on HDL-C and ApoA1 levels with higher levels in the TT 
subjects having a less “healthy” dietary intake, whilst in adolescents with a better DQI-A score, 
genotype did not seem to influence HDL-C and ApoA1 concentrations.  
Apart from the influence of dietary intake, results suggested that the effect of the rs1800588 
polymorphism was modulated by the self-reported physical activity level. As previously described by 
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others, higher levels of HDL-C (Ahmad et al, 2011; Grarup et al, 2008) and ApoA1 (Ahmad et al, 
2011) were observed in homozygous T-allele carriers that had higher amounts of moderate and 
vigorous physical activity, compared to CT and CC subjects. This effect was not observed in subjects 
that had a low physical activity or fitness. In agreement with the influence of physical activity, 
cardiorespiratory fitness showed to interact with the LIPC polymorphism. In addition to the effect on 
HDL-C and ApoA1 levels, a significant increase in LDL-C and, consequently, ApoB levels was 
detected in TT compared to CT and CC adolescents in the group with the highest VO2max. However, 
a similar and even more elevated increase was observed in adolescents with a lower VO2max. Given 
the low number of TT homozygote subjects in the latter group (n=16), the absence of significance in 
the association between the SNP and LDL-C might be attributed to a lack of statistical power. The 
mechanism behind the interaction with physical activity/fitness is not yet understood. However, it 
has been shown previously that regular physical exercise reduces HL activity (Krauss et al, 1979; 
Peltonen et al, 1981). Consequently, it is plausible that a regulatory effect of physical activity on 
LIPC expression is influenced by a promoter polymorphism.  
Furthermore, in the present study the association between the LIPC polymorphism and the serum FA 
concentrations in the phospholipid fraction was investigated. We observed an association between 
the rs1800588 polymorphism and stearic acid concentrations which varied according to MUFA 
intake and physical activity. Furthermore, an interaction was detected between the SNP and dietary 
intake of LA and MUFA as well as with cardiorespiratory fitness on serum AA levels. Given the 
present study is the first study to investigate interaction effects of environmental factors with LIPC 
variants on FA composition, comparison with other studies is difficult. However, evidence for a 
possible influence of LIPC variants on FA composition comes from GWAS, which found a nominal 
association between the rs4775041 (Gieger et al, 2008) and the rs10468017 (Demirkan et al, 2012) 
with several phosphatidylethanolamines carrying very long-chain fatty acids.  This is not surprising 
as it has been shown previously that HL preferentially hydrolyzes phosphatidylethanolamine (Landin 
et al, 1984), containing high amounts of AA (Connelly, 1999; Prisco et al, 1996). Landin and 
colleagues demonstrated that administration of hepatic lipase antiserum inhibited the clearance of 
chylomicron and HDL phosphatidylethanolamine and caused an elevation of more than 100% of the 
total serum level of phosphatidylethanolamine (Landin et al, 1984). As such, it can be assumed that a 
decreased activity of HL in subjects with the TT genotype of rs1800588 can result in a similar effect.  
Another hypothesis could be that HL has a specificity for phosphatidylinositol (PI), in which stearic 
acid and AA are predominant (Hodson et al, 2008). PI is only present in the plasma in the 
lipoproteins and not in the plasma lipoproteins free fraction (Dashti et al, 2011). Furthermore, it has 
been demonstrated that PI administration results in an increase in HDL-C and Apo-A1 and 
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reductions in serum triglycerides (Burgess et al, 2003; Burgess et al, 2005). As such it could be 
hypothesized that a decrease in HL results in a decrease of PI hydrolysis in the lipoproteins and that, 
consequently, the higher abundance of PI results in higher HDL-C levels.   
Overall, this observed interaction of LIPC polymorphism with environmental factors on FA 
phospholipid concentration could be another pathway explaining the increased incidence of 
cardiovascular diseases in subjects with decreased HL activity.  
 
STRENGTHS AND LIMITATIONS 
The present study was the first study exploring the association between the LIPC polymorphism and 
FA serum status. Moreover, this study in adolescents completed the existing literature in children and 
adults on the interaction between environmental factors and the rs1800588 promoter variant and 
included a more objective indicator of physical fitness, estimated by VO2max.  
A limitation of the study is, however, that the analyses were restricted to the LIPC rs1800588 
polymorphism. As indicated above, this SNP  showed the most consistent effects on plasma lipid 
levels  (Isaacs et al, 2004) and is in high linkage disequilibrium with the rs2070895 SNP. These 
SNPs in the promoter region of LIPC are the only ones known to interact with diet (Lindi et al, 2008; 
Nettleton et al, 2007; Ordovas et al, 2002; Riestra et al, 2009; Tai et al, 2003) and physical activity 
(Ahmad et al, 2011; Grarup et al, 2008). Hence, this SNP was a logical choice for examining gene-
environment interactions. However, extending this research to SNPs, recently identified in GWAS 
studies to be associated with FA status, namely rs4775041 (Gieger et al, 2008) and rs10468017 
(Demirkan et al, 2012), would be interesting.  
Given the recommendation of the European Food Consumption Survey method (EFCOSUM) (Biro 
et al, 2002), 24h recalls were used for dietary assessment as these are open-ended questionnaires in 
which detailed information can be obtained. A limitation of the method used is that only information 
of 2 days was obtained. As such, the food intake is prone to exceptional intakes. However, as a 
nutrient is derived from different food items, the effect of exceptional intake was attenuated as only 
nutrient intakes were used in the present study. Furthermore, nutrient intakes were corrected for 
within-person variability to further diminish this effect. Also, a measure of overall diet quality was 
calculated to evaluate the holistic effect of the diet. Another limitation of the 24h recalls is that the 
accuracy of data collection relies on the individual‟s ability to remember all foods and beverages 
consumed in the past 24h, including the composition of mixed dishes and the applied food 
preparation methods. As such, there is a risk for misreporting. To limit these restrictions, the 24h 
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recalls were performed through the computer-assisted HELENA-DIAT to standardize the recall 
procedures and underreporters were excluded a posteriori. A similar risk of misreporting exists for 
the questionnaires assessing physical activity. Barnett et al. observed that if respondents had to report 
physical activity in the order of vigorous, moderate and walking activities; higher levels were 
recorded for vigorous activity than if the questions were asked in the opposite order (Barnett et al, 
2007). As such, in the HELENA study, to limit over-reporting, the time spent in walking was 
requested before the time spent in moderate or vigorous physical activities (Ottevaere et al, 2011). 
Furthermore, in the present study the findings with physical activity are largely confirmed by the 
findings with the more objective measure of the estimated VO2max.  
 
III.6.5 CONCLUSION 
This study confirmed gene-environment interactions between dietary intake/physical activity and the 
LIPC rs1800588 polymorphism on HDL-C and ApoA1 levels. Furthermore, this study was the first 
to indicate a possible interaction between this SNP and dietary intake/physical activity and 
cardiovascular fitness on the levels of stearic acid and arachidonic acid, which might help to explain 
the observed increased risk for cardiovascular diseases in subjects with decreased HL activity.  
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PART IV. DISCUSSION 
Medicine, the only profession that labors incessantly to destroy the reason for its existence. 
(James Bryce) 
 
The serum FA, lipid and lipoprotein status of an individual has been extensively associated with 
several non-communicable diseases such as CVD, cancer, inflammatory and auto-immune diseases 
(see Chapter I.4) (FAO, 2010). Although most of these diseases usually manifest in adulthood, 
cardiometabolic risk factors (such as hypertension, hyperlipidaemia, insulin resistance, obesity, etc.) 
may appear as early as childhood and adolescence (Berenson et al, 1998) and these risk factors may 
track into adulthood (Camhi and Katzmarzyk, 2010). Because studies in younger age groups are 
generally scarce, this thesis focuses on adolescents. 
 
The general aim of the thesis was to further elaborate the current knowledge on the main 
determinants of the FA serum status in the healthy population. The focus was mainly put on the 
dietary FA intake and its interaction with polymorphisms in certain genes, namely the FADS1 and 
LIPC gene. This insight could help us to identify possible targets to modulate the FA serum status 
and as such help to prevent or treat certain diseases.  
DISCUSSION 
166 
IV.1 MAIN FINDINGS 
 
Numerous dietary surveys have been conducted across Europe, but only little information exists on 
the usual dietary fatty acid intake of adolescents. In the present thesis, high mean intakes of total fat 
and SFA and low mean intakes of MUFA and PUFA were observed, which is in accordance with 
previous studies (Elmadfa et al, 2009; Ervin et al, 2004; Harel et al, 2001; Harika et al, 2011; Joyce 
et al, 2009; Kersting et al, 1998; Lambert et al, 2004; Matthys et al, 2006; O'Sullivan et al, 2011; 
Samuelson et al, 2001). Most of these studies only assess the intake of total FA classes and do not 
distinguish between individual FA. However, various FA, even of the same class, differ in their 
structure, way of metabolism, cellular functions and effects on health outcome in case of excessive 
intake. Whilst the SFA, lauric, myristic and palmitic acid are atherogenic, stearic acid does not have 
a cholesterol raising effect (Kris-Etherton and Yu, 1997). Furthermore, the SCFA and MCFA, do not 
have deleterious effects and might even be beneficial (Hijova and Chmelarova, 2007). Therefore, the 
« Agence Française de Sécurité Sanitaire des Aliments (AFSSA) » distinguished in their 
recommendations of 2010 the group of lauric-myristic-palmitic acid (<8%E) from the group of total 
SFA (<12%E) (AFSSA, 2010). In contrast, other organizations and countries, such as the FAO (FAO, 
2010) and the Belgian Health Council (BHC) (BHC, 2009), still formulate recommendations for the 
total group of SFA, being <8%E and 10%E respectively.  
In the present thesis (Chapter III.1) the usual intakes of FA were compared to the recommendations 
of the FAO (FAO, 2010). This comparison indicated that almost all adolescents (99.8%) exceeded 
the FAO recommendation of 8%E for SFA intake. Even if the higher recommendation of the BHC 
(<10%E) was applied, this was exceeded by 93.4% of the adolescents. However, stearic acid intake 
accounted for more than 20% of the total SFA intake. If the recommendations of the AFSSA 
(AFSSA, 2010) are applied, 19.8% of the adolescents were in compliance with both the guideline of a 
habitual intake of lauric-myristic-palmitic acid of < 8%E and a total SFA intake of <12%E. 
Conversely this means that still the majority of the adolescents had an excessive intake of SFA.  
In contrast, the intake of n-3 FA was generally too low. A high proportion (35.5%) of the adolescents 
did not meet the recommended intake value for ALA of > 0.5 %E, according to the FAO (FAO, 
2010). If the recommendations of the AFSSA (AFSSA, 2010) and BHC (BHC, 2009) are adopted (> 
1%E) this proportion even increases to 96.5%. However, an inadequate intake, defined as an intake 
of less than 2/3 of the recommended daily intake (Farris et al, 1998; WHO, 2006) of the FAO, being 
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< 0.33%E, was only observed in 0.7% of the adolescents. The intake of LCn3PUFA seems to be of 
greater concern. Even if the mildest guidelines of the FAO were applied (EPA+DHA intake of 250-
2000mg/day), 74.3% of the adolescents did not meet the recommended intake and 53.0% had an 
inadequate intake (<170mg/day).  
Interestingly, this study also showed sex differences in intake patterns, with girls having a more 
beneficial FA intake pattern. These differences became less apparent or disappeared with older age 
(15 – 17.5 years) except for PUFA intake, which continued to be higher in the female population. 
Furthermore, chronological age was a stronger determinant of FA intake than sexual maturation and 
no differences in fat intake were observed as a function of socioeconomic status, assessed by the 
educational level of the mother. Furthermore, measures of body composition (BMI z-score and body 
fat percentage) were not related to the usual fat and fatty acid intake but in the male population, fat 
and fatty acid intake was inversely related to their level of physical activity. 
The top three contributors to total fat, SFA, MUFA and PUFA intake were meat, dairy products and 
cakes/pies/biscuits, which is in agreement with other studies (Joyce et al, 2009; Matthys et al, 2006; 
O'Sullivan et al, 2011). The most important food sources were identical and of similar magnitude for 
boys and girls but generally, meat was a slightly higher contributor in boys whilst cakes, pies and 
biscuits as well as nuts and seeds seemed to be of a higher importance in girls. For EPA and DHA 
the major contributors were fish products followed by meat. In the female sample these foods 
contributed to EPA intake for 70.2% and 22.9% respectively, whilst in the male population they 
contributed for 56.7% and 33.6% respectively.  
Furthermore, this thesis indicated that adolescents with a better overall dietary quality, assessed with 
the DQI-A, had higher intakes of total fat, SFA and MUFA than adolescents with a lower adherence 
to the FBDG. Nevertheless, it was observed that these adolescents derived their fat intake from more 
nutrient-dense food sources (Chapter III.4). Given that the DQI-A assesses the compliance to the 
FBDG, and thus the consumption of recommended, nutrient-dense foods, this could be partly 
expected. However, as mentioned before, the DQI-A (Chapter III.3) exists out of different 
components (food quality, dietary diversity, and adequacy/excess of intake) and goes broader than 
only the consumption of recommended or non-recommended foods. For example, a limited intake of 
energy-dense, nutrient-low foods is tolerated, while excessive intake of recommended food sources 
is penalized. As such, this DQI-A score gives an overview of the overall dietary pattern.  
Adolescents with a DQI-A score in the upper quartile had in particular a higher consumption of dairy 
products and lower consumption of snacks and sauces. The higher consumption of dairy products 
explained the higher %E intake of SFA and MUFA in this group of adolescents. However, dairy 
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products are also rich in other nutrients such as calcium and vitamin D but also in SCFA and some 
conjugated FA, which, as stated above, may have beneficial effects (Nestel, 2012). As nutrients are 
not eaten in isolation, these other food components may be of importance in the health effects of the 
food intake. As such, it has been shown that an increased consumption of milk may provide long-
term benefits in reducing CVD risk (Elwood et al, 2010; Givens, 2012), diabetes, stroke, colon and 
bladder cancer and all-cause mortality (Elwood et al, 2010). However, for other dairy products, such 
as butter and cheese, evidence is limited and inconsistent (Elwood et al, 2010; Hostmark and 
Tomten, 2011; Nestel, 2012). Also, in the present thesis it was demonstrated that the absolute intake 
of EPA and fish was not significantly higher in adolescents with a better dietary quality (Chapter 
III.3). Nevertheless, in both boys and girls, higher serum levels of the LCn-3PUFA were observed in 
adolescents with better DQI-A scores. The equal absolute intake of n-3 FA in contrast to the higher 
serum levels might indicate that other food components are of importance. In adolescents with DQI-
A scores in the lower quartiles, n-3 FA were delivered in large amounts by sweet and salty snacks, 
however, these food items also delivered large amounts of n-6 FA (Vyncke et al, 2012). Possibly, the 
competition effect between n-6 and n-3 FA could result in lower serum levels in adolescents with 
lower DQI-A scores. 
As described in the introduction, after ingestion and absorption, FA take part in several metabolic 
processes. As such, the serum concentration of FA is not merely a reflection of the dietary intake. In 
Chapter III.2it was demonstrated that the percentage of variation in PL FA serum levels that can be 
accounted for by dietary intake varied from 14.2% for n-3 FA to 7.0% for total MUFA. For AA and 
LA this was respectively 10.8% and 10.7%. This indicates that dietary intake is indeed a factor of 
considerable importance on the FA serum status but that also other determinants interfere such as the 
homeostatic control mechanisms and a wide array of genetic, environmental and life-style factors 
(Hunter, 1990). For example, it has been shown in the HELENA study population that serum FA 
status is influenced by sex, body composition (Spinneker, 2009) and even early life programming 
effects such as birth weight (Labayen et al, 2011). Furthermore, Schaeffer et al estimated that 29% of 
the variance of AA and up to 9% of the variance of its parent molecule, LA, could be explained by 
SNPs in the FADS gene cluster (Schaeffer et al, 2006) which encodes for the Δ5- and Δ6-
desaturases.  
However, the genetic influence on plasma FA composition is largely unexplored (Jenab et al, 2009). 
In the HELENA study population it was demonstrated that in the FADS1-FADS2 gene cluster, the 
minor allele of the rs174546 was associated with higher serum PL concentrations of LA and ALA 
and lower levels of AA and EPA but no association with DHA was observed (Chapter III.5). No 
significant interaction effects between dietary intake and the rs174546 polymorphism of the FADS 
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gene on the serum PL FA concentrations were observed. This could indicate that carriers of the 
minor allele would need a higher consumption of the LCPUFA instead of its precursors to achieve 
the same biological effects.  
In the LIPC gene, the minor T allele of the rs1800588, resulting in a lower activity of hepatic lipase 
(Isaacs et al, 2004), was associated with higher levels of stearic acid (Chapter III.6). After 
stratification, significantly higher levels of stearic acid were observed in the carriers of the minor 
alleles in the group that reported high consumption of MUFA or in those that reported low physical 
activity. A similar trend was also observed in the other groups, however, these were not significant. 
More interestingly, an interaction between the rs1800588 polymorphism and dietary LA intake or 
estimated VO2max on the serum PL AA levels was demonstrated. These interactions between 
lifestyle and the rs1800588 LIPC genetic variant might indicate that for adolescents with a TT 
genotype, the consumption of high amounts of MUFA or LA or practice of extreme sport could have 
detrimental effects and that, as such, the general accepted lifestyle advice might be less applicable to 
them than to their CC and CT counterparts. Of course, these findings need to be confirmed in other 
studies and the effect on hard end points related to the development of diseases has to be investigated 
before substantiated recommendations can be made.  
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IV.2 METHODOLOGICAL CONSIDERATIONS 
 
The HELENA cross-sectional study is a European multicentre study with a large sample size. Within 
HELENA great emphasis was laid on standardization of fieldwork procedures and blood analyses 
across the participating cities. This included adaptation of the measurement tools (e.g. translation and 
back translation of questionnaires, translation of manuals of operation), training of fieldworkers by 
international and local trainings, as well as quality control and performance monitoring (Beghin et al, 
2008; Moreno et al, 2008a). Furthermore, for the blood analyses and genotyping each measurement 
of a specific variable was performed in the same laboratory to ensure the use of a standard protocol, 
identical devices and reagents. This standardization precluded to a great extent the immeasurable 
confounding bias that often interferes when comparing results from isolated studies (Moreno et al, 
2008a). Moreover, in the study several body composition measurements were performed as well as 
the assessment of a large battery of lifestyle related variables, allowing correction for different 
possible confounding factors.   
A disadvantage of the multicentre design with sampling in schools within cities is the possible 
clustering of cases. However, in the statistical analyses this possible clustering effect was 
counteracted by applying multilevel models. Although the study was multinational, the selection of 
the European cities was a practical one in first instance (Beghin et al, 2012). Consequently, the 
sample of participating adolescents was not representative for the different countries (as only urban 
sites were sampled) but only for the selected cities. As such, it was not possible to compare the study 
findings between the different countries. Furthermore, the cross-sectional design does not allow 
saying anything about causality in the observed relationships. Further limitations or considerations 
related to the used methods in the present thesis are discussed below.  
 
IV.2.1 DIETARY INTAKE DATA & RECOMMENDATIONS 
IV.2.1.1 ASSESSMENT PROCEDURES 
The dietary intake assessment was based on two self-administered, computer-assisted, non-
consecutive 24h recalls. Following recommendations of the “European Food Consumption Survey 
method (EFCOSUM)” 24-hour recalls were preferred because they are open-ended questionnaires in 
which detailed information can be obtained (Biro et al, 2002). Furthermore, they are applicable in 
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large populations of different ethnicity, standardization is possible by self administration through 
computer assistance and use of pictures for portion sizes (Biro et al, 2002; Vereecken et al, 2010), 
and the procedure does not alter food intake pattern (Biro et al, 2002).  
Disadvantages are, however, that the accuracy of collected data relies on the individual‟s ability to 
remember foods and beverages consumed in the past 24 hours, and might, therefore, be biased (Biro 
et al, 2002). In this respect, the 24-h dietary recalls were performed through computer-assisted 
HELENA-DIAT software which structured the interview and allowed quality controls during the 24-
h recall interview.  
Another disadvantage is that an individual‟s diet varies day by day (Biro et al, 2002) and that in the 
present study only information of two days was obtained. Moreover, as the 24h recalls were collected 
at school, no data on dietary intake was available for Fridays and Saturdays. As such, the assessed 
dietary intake is subject to atypical or exceptional intakes and common dietary habits (such as fish on 
Friday) may result in under- or overestimation of intake of certain food items. Furthermore, the 24-h 
dietary recall method does not allow quantifying proportions of non-consumers for particular food 
items, mainly for infrequently consumed foods. In order to decrease this influence, days of 
assessment during the school week were randomly selected and nutrient intakes were corrected for 
within-person variability by applying the MSM method. Ideally, also a FFQ was collected to get 
further data on consumption frequency. However, as only a limited number of participants provided 
data on consumption frequency in a FFQ, and as this FFQ was very limited (only 15 items), this data 
was not included. Nevertheless, according to Biro et al. (2002)
 
the 24h recall method is appropriate 
to assess both acute and habitual intake on the individual level if repeated short term measurements 
and modeling techniques are used.  
Finally, as food ingredients needed to be estimated from mixed dishes, there is a potential loss of 
information. Also, less detailed data could be collected as adolescents are not acquainted with the 
applied food preparation methods and thereby used fats. As such, average values of used cooking fats 
were estimated according to the countries habitual preparation methods, this could however explain 
the weak relations found between fatty acid status and intake values. 
IV.2.1.2 UNDERREPORTING 
A difficulty in analyzing self-reported dietary data is the issue of misreporting (including both under- 
and over-reporting) that may arise. Identification of participants that over- or underreport is difficult 
and based on arbitrary cut-offs. As exclusion of over-reporters is difficult, certainly in adolescent age 
where high energy intake might be needed for physiological growth in combination with a possible 
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high physical activity; no measures were taken to exclude these adolescents. In the current thesis it 
was opted to only exclude the adolescents with a ratio of reported total energy intake on estimated 
basal metabolic rate lower than 0.96, according to the criteria of Goldberg and Black (Black, 2000). 
This may result on one hand in exclusion of correct reporters that are following an energy-restricted 
diet or on the other hand it can fail to exclude underreporters that do not report a negative energy 
balance but generally eat an excessive amount. Still, some measure to exclude underreporters seemed 
to be justified as generally it has been shown that underreporting is more frequent in an overweight 
or obese population (Pietilainen et al, 2010; Singh et al, 2009). Such differential underreporting can 
largely attenuate results. The decision to exclude underreporters was supported by a previous 
evaluation of food and nutrient intake assessment in the HELENA study population (Vandevijvere et 
al, 2012), showing better correlations with the “true intake” (calculated with the Triads method 
(Kaaks, 1997)) after exclusion of underreporters.  
IV.2.1.3 NON-NUTRITIVE FACTORS AND SUPPLEMENT USE 
As described in the introduction smoking and alcohol consumption may influence dietary habits or 
the absorption, synthesis, or metabolism of serum FA. Although this data was gathered in the 
HELENA study reliability of the variables was doubtful and as such was not taken into account in 
the present analyses. Furthermore, preliminary analyses in the HELENA study population 
(unpublished results) indicated that alcohol intake did not influence usual dietary intake of FA, if 
total energy intake was considered. Smoking did result in a significant lower intake of LCPUFA 
(%E), however, differences were small and could be attributed to other confounding factors such as 
age or sex, which were not taken into account. On the FA serum status significant differences were 
found for palmitic acid and stearic acid in function of alcohol consumption and for stearic acid only 
in function of smoking habits. In the literature, studies investigating specifically the influence of 
smoking or alcohol consumption on the FA intake and status are limited. Several studies on FA 
serum levels investigate the influence of smoking behavior, however, generally the dietary intake is 
not considered, thus making it difficult to distinguish if the altered serum levels are due to an altered 
dietary pattern or due to influences on the metabolism. Moreover, the lipid pools that are investigated 
often differ. A stable isotope study of Pawlosky is one of the few studies who investigated the 
influence of smoking on the n-3 FA status, controlling for diet (Pawlosky et al, 2007). They observed 
higher levels of n-3 FA in the plasma of smokers, which is in contrast to most other epidemiologic 
studies which observed lower levels of the n-3 FA (Santos et al, 1984; Simon et al, 1996). 
Furthermore, Simon et al. observed in a population of adult men, higher serum PL levels of oleic 
acid and lower levels of arachidonic acid with an increased number of cigarettes smoked (Simon et 
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al, 1996). Moreover, in this study, alcohol intake was associated with higher levels of palmitic and 
oleic acid and lower levels of linoleic acid and stearic acid. Another study in adult men and women 
observed a positive association between wine consumption and plasma levels of EPA and DHA (di 
Giuseppe et al, 2009).  
Another factor that could affect the associations between FA intake and serum status is the habitual 
intake of fish oil supplements, however, no detailed information on supplement intake was available 
from the HELENA study. The literature on the prevalence of fish oil supplement use in adolescents 
is only limited. In an American study based on the National Health Interview survey a prevalence of 
5.4% of all supplement use was observed in the age group of 13-17 years. Supplement use was 
significantly higher in adolescents from higher socioeconomic classes (Wu et al, 2013). Also, a study 
in Slovenian adolescents reported a use of fish oil supplements in less than 2.3% of the subjects 
(Sterlinko et al, 2012). A study in Flemish women of reproductive age found a prevalence of 5% of 
specifically n-3 supplement use. In this study a significant association was found between 
supplement users and women paying attention to what they eat. Furthermore, this study indicated 
that n-3 supplements contributed for 11.4% to the daily EPA and DHA intake and that the use of 
supplements leads to a much higher EPA and DHA intake (Sioen et al, 2010).  
Based on the low prevalence rate and the higher use in subject with a better health consciousness it 
can be assumed that this information would only have a limited influence on population level (in 
casu Chapter III.1). However, at individual level, due to the markedly higher intake that can be 
achieved by these supplements this could most probably influence the findings.  
IV.2.1.4 FOOD COMPOSITION TABLES 
In the present thesis the dietary intake data derived from the 24 recall assessments has been linked 
with the German Food Code and Nutrient Data base (Bundelebensmittelschlüssel, BLS) 
(http://bls.nvs2.de) for estimating nutrient intakes. However, it has to be noted that systematic and 
random errors in this food composition table could bias the estimated nutrient intakes in our study 
population (Cowin and Emmett, 1999; Weaver et al, 2008). Often the nutrient density of the less 
abundant nutrients (such as certain FA) is only an estimated value and not based on analysis. A 
further critical fact of food composition tables is that newly developed food products are not always 
included. Those food products may be enriched with n-3 FA to increase the nutritional value of the 
food products. Also, foods and food composition might differ between countries. For example, 
Weaver and colleagues observed in their study investigating the FA content of commonly consumed 
fishes in the USA that the amount of FA depends largely on the place where the fish is obtained, with 
Central American tilapia containing 10 times more AA than indicated in the USDA National 
DISCUSSION 
174 
Nutrition Database (Weaver et al, 2008). Nevertheless, in the HELENA study, preliminary analyses 
were executed to compare the macronutrient intake of adolescents estimated with the BLS compared 
to values estimated with the country-specific food composition tables. These analyses indicated a 
good correlation for both macronutrients (r > 0.9) and micronutrients (r > 0.8).  
Furthermore, comparison between studies is often impeded given the lack of standardized and valid 
food composition data. Deharveng et al. have compared the food composition tables of nine 
European countries, evaluating differences in terms of availability, definition, modes of expression 
and analytical methods (Deharveng et al, 1999). For the FA they observed that the usual mode of 
expression was g/100g or mg/100g but, some databases also stated them as a percentage of total FA. 
Analytical methods were generally comparable; however, they were not always mentioned. Often, 
the concentration of individual FA was only available for some foods, and generally these were 
indicated in appendices. According to Deharveng et al. the most complete coverage of FA was found 
in the German BLS (http://bls.nvs2.de) and Food composition and Nutrition tables (Souci et al, 
2008), the French milk and fat supplements (Ireland, 2003; Ireland et al, 2002) and some British 
tables (Deharveng et al, 1999). 
Therefore, to overcome differences in definitions, analytical methods, units and modes of expression 
and to promote comparability, in the present thesis the same food composition table was applied for 
all survey centres. However, considering the above mentioned limitations, one has to bear in mind 
that the intake of the different FA of a single individual is only an approximation of reality and. 
IV.2.1.5 RECOMMENDATIONS & GUIDELINES 
a. Nutrient recommendations 
Considerable differences exist between the recommendations from different expert organizations or 
nutrition advisory boards of several countries (Table 3, p34). On one hand, these differences are the 
result of the limited scientific information on which the recommendations are based (Huybrechts, 
2008). The scientific data essentially comes from observational and experimental studies in humans 
and sometimes selected animal studies in the absence of human data (Institute of Medicine.Food and 
Nutrition Board, 2005). However, these studies are all subject to limitations and generally do not 
account for all factors influencing the dietary requirements. As been explained in the introduction, 
nutrient requirements differ largely between individuals and vary in function of several factors such 
as age, sex, genetic background, disease, physical activity, etc. On the other hand, differences in 
recommendations result from differences in criteria of adequate intake. In the past, nutrient 
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recommendations were set up to prevent deficiency syndromes, however, nowadays 
recommendations are often aimed at prevention of chronic diseases. 
These differences in recommendations as well as the different definitions of inadequate intake, as 
described in the introduction, complicate the interpretation of dietary intake data of a population. As 
the current study was conducted in a European population, the recommendations of the FAO were 
applied.  
b. Food based dietary guidelines 
Although a large variation in dietary habits exists in the studied population, the DQI-A was based on 
the Flemish FBDG, to assess compliance with these guidelines. These guidelines were selected 
because of the great similarities with the CINDI pyramid developed by the WHO. The Flemish 
guidelines however are more specific concerning quality of different food items and recommended 
quantities.  Compared to dietary guidelines of the other European countries rather minor differences 
were found (http://www.eufic.org/article/en/page/RARCHIVE/expid/food-based-dietary-guidelines-
in-europe/). The French and Austrian guidelines put greater emphasis on vegetables versus cereal 
intake compared to the Flemish. Furthermore, daily olive oil consumption is a specific 
recommendation in the Greek and Spanish guidelines. Given the large similarities on the most 
important aspects of the dietary guidelines the authors considered it appropriate to apply the Flemish 
guidelines to a European population. Still, as a consequence of the use of the Flemish guidelines for 
all the European adolescents, this could have led to potential differences in the DQI-A across survey 
centres due to different dietary habits. However, these differences were, at least partially, captured by 
applying the multilevel analyses, which take into account the clustering of cases within cities. 
Nonetheless, investigation of the differential functioning of the DQI-A across European countries 
would be interesting.  
c. Diet Quality Index for Adolescents 
Diet quality indices can provide an overall assessment of the dietary quality of a person or 
population. In contrast to many other diet quality indices, the DQI-A in the present study was not 
based on nutrient intakes, avoiding the limitations that coincide with the use of food composition 
data, as discussed above. Furthermore, the DQI-A is a continuous score that can easily be applied in 
statistical analyses to express compliance to different dietary guidelines at the same time.  
In general, the DQI-A showed a good validity as indicator for overall dietary quality by confirming 
the expected associations with food and nutrient intakes and status (Chapter III.3). Overall, it could 
be concluded that the DQI-A is a good surrogate marker for assessing the compliance with the 
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dietary guidelines even though there seems a discrepancy with the nutrient recommendations for FA 
intake, while the dietary guidelines are supposed to be based upon the nutrient recommendations. 
However, the same study demonstrated that the DQI-A was significantly associated with the n-3 FA 
serum status. As such, the lack of association with the FA nutrient intake might also be attributed to 
errors in the food composition table.  
IV.2.1.6 STATISITICAL MODELLING  
Statistical modeling techniques can be used to minimize the day-to-day variance in an individual‟s 
diet, which may result in misleading estimates. Several statistical procedures for estimating the usual 
intake distribution from repeated 24h dietary recalls are available, such as the Iowa State University 
(ISU) method (Nusser et al, 1996), the multiple source method (MSM) (Haubrock et al, 2011), the 
National Cancer Institute (NCI) method (Tooze et al, 2006), Statistical Program for Age-adjusted 
Dietary Assessment, AGE-MODE (Waijers et al, 2006), the method described by Buck et al. (1995), 
etc. Nevertheless, there are differences between the methods in the used statistical models, the 
assumptions and the backtransformations (Souverein et al, 2011). In a recent study of Souverein et 
al. a comparison was made between the NCI Method, MSM, SPADE and the ISU Method. This 
comparison showed no important differences. For nutrients, all estimates of the percentiles and mean 
were within 5% of each other (Souverein et al, 2011). The standard deviation of the bias was 
somewhat higher for the ISU Method and MSM, indicating that the uncertainty of these methods is 
somewhat larger than that of the NCI and SPADE Methods (Souverein et al, 2011). Furthermore, 
results showed that in all four methods the estimated usual intake distributions became more variable 
when study size decreased, when the intake data were less normally distributed and when the 
variance ratio increased (Souverein et al, 2011). However, in the present thesis the population size 
was sufficiently large to minimize this problem. Souverein and colleagues concluded that all 
compared methods seemed to provide good estimates of the usual intake distribution of nutrients 
(Souverein et al, 2011). As such, it was chosen to use the European MSM, developed in the frame of 
the EFCOVAL project. This method has the advantage that the software is freely available and that 
covariates can be included.  
Naturally, a correct estimation of the usual intake is inherent to valid input-data of the 24h recalls. As 
such, this method is also subject to the problems of misreporting, discussed above. Furthermore, 
there was no data included on consumption frequency of foods and all adolescents were considered 
as habitual consumers for both foods and nutrients. Therefore, for certain foods this could have 
introduced a bias on the individual level.   
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IV.2.2 PHYSICAL ACTIVITY & FITNESS ASSESMENT 
The level of moderate and vigorous physical activity was calculated from data derived from self-
reported questionnaires. As with self-assessment for dietary intake, this physical activity data is 
subject to under- or over-reporting and identification of misreporters is difficult. As described in 
more detail in Part II Methods, physical activity scores were truncated in the different domains to 
avoid-over-estimations (Ottevaere et al, 2011). Still, over-reporting cannot be ruled out completely 
for those adolescents reporting values underneath these cut-offs. Underreporting in contrast was not 
corrected for as it is possible that certain adolescents did not perform any moderate or vigorous 
activity during the surveyed period. As described previously, a more objective measure of physical 
activity by accelerometry was available in the HELENA study. However, as non-wearing diaries 
were unavailable for a large proportion of the study population, this data could not be corrected for 
non-wearing time accordingly and might also be biased towards underestimation (Ottevaere et al, 
2011). Therefore, in the present thesis the self-reported questionnaire data was selected as indicator 
for physical activity as this was available for the largest number of adolescents and as such enhanced 
statistical power.  
The maximal rate of oxygen uptake (VO2max) is considered as a gold standard for measurement of 
cardiorespiratory fitness. However, measurement of the VO2max is difficult and costly in large-scale 
studies. As such, several equations have been developed to estimate this marker (Ruiz et al, 2008). In 
the frame of the HELENA study a new equation was developed and tested. This equation resulted in 
only a slight non-significant underestimation of the measured VO2max by 0.5ml/kg/min (Ruiz et al, 
2008).  
 
IV.2.3 CONFOUNDING FACTORS 
Several factors were included in the analyses as confounding factors. A short overview of their 
strengths and limitations is given below.  
As measure of body composition BMI and body fat percentage were used. Given adolescents are still 
growing and experience important changes in body composition during their transition from 
childhood to adulthood, BMI was adjusted for age and sex and standard deviation scores were 
calculated. In studies, BMI is widely applied as it is easy to obtain and measurements are not subject 
to interobserver variance. However, a limitation of this indicator is that it does not distinguish 
between fat mass and lean mass and as such, is a poor indicator for adiposity (Wells and Fewtrell, 
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2006). In this respect, body fat percentage, calculated with the formulae of Slaughter is a better 
marker. However, in the HELENA study this indicator was only calculated based on de tricipital and 
subscapular skinfold and as such does not account for central adiposity (Wells and Fewtrell, 2006). 
Moreover, measurement of skinfolds is more subject to inter- and intra-observer variability.  
Because sexual maturation is linked with several physiological changes during adolescence, it is 
important to take this measure into account in an adolescent population. Although, assessment of 
Tanner stage is subjective with a considerable inter-observer variation, it was chosen to evaluate the 
Tanner staging by a medical doctor as self-reporting has been shown to be much less accurate 
(Azevedo et al, 2009; Desmangles et al, 2006).  
Choosing the best variable for measuring socioeconomic status depends on the consideration of the 
likely pathway and the relevance of the indicator for the population under study (Shavers, 2007). In 
the present thesis, it was assumed that maternal educational level had the highest impact on dietary 
related factors. This parameter, however, does not capture the financial aspects which might allow 
access to more healthy foods (Shavers, 2007). To capture this dimension the Family Affluent Scale 
(Currie et al, 2008) was evaluated in one study. However, both these indicators showed to be of little 
importance in the research questions under consideration.   
 
IV.2.4 SERUM FATTY ACID STATUS AND LIPID POOLS 
In the literature, the serum fatty acid status is described in several units such as conc%, mol% area%, 
g/100g, µmol/L, mg/L, making comparison complicated. In literature the most common method to 
express FA status is the use of percentaged FA profiles (Spinneker, 2009). Nevertheless, the 
percentaged FA profiles are influenced by the number of FA included in the profile and the height of 
each FA peak. A previous study by Spinneker et al. comparing FA expressed as conc%, area% or 
absolute amounts in the HELENA study concluded that FA levels based on conc% may be more 
reliable than FA expressed as area%, because conc% calculations take into account the molecular 
mass of each FA detected and thus do not refer simply to a peak area. On the other hand the use of 
area% gave the opportunity to enlarge the FA profile with FA not present in the FAME standard. In 
the present thesis, sensitivity analysis comparing the FA expressed as conc% or as area% 
demonstrated that the conclusions were similar. As such, area% was used for all studies.   
Furthermore, as described in the introduction, FA status of an individual can be assessed in several 
biological lipid pools (e.g. adipose tissue, NEFA, TG, cholesteryl-esters, serum PL, red blood cell 
PL,..), each having different properties and sometimes a different specificity for certain fatty acids. 
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Also, sometimes the FA composition of a specific PL fraction such as phosphatidylcholine, 
phosphatidylinositol, phosphatidylethanolamine,… is described (Hodson et al, 2008). As such, 
comparison between these different lipid pools and FA fractions is difficult or even impossible.  
 To overcome these problems, recommendations for a uniform mode of expression and lipid pool 
would be valuable for future studies.   
 
IV.2.5 GENE SELECTION 
A limitation in this thesis is that the analyses were restricted to only the FADS rs174546 and LIPC 
rs1800588 polymorphisms whilst numerous other SNP‟s might play a role in the determination of the 
FA status, as described in the introduction. However, as the fieldwork took place in 2006-2007, the 
genotyping was limited to genes and SNP‟s that were considered to be of interest at that time. 
Meanwhile in the years that passed, literature on this topic has largely expanded and new SNP‟s of 
interest have been identified. With these new insights, it would be interesting to use remaining 
biosamples to genotype these newly selected SNP‟s in the HELENA study population if financing 
would be available.   
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IV.3 RELEVANCE TO PUBLIC HEALTH 
 
FA intake has been associated with several chronic diseases in humans, such as coronary heart 
disease, cancer, asthma, rheumatoid arthritis and other auto-immune diseases. Pathways are currently 
not completely understood, however, there is evidence that the FA in serum PL modulate immune 
functions and inflammatory processes via their function as lipid mediator and modulator of gene 
transcription. However, as addressed in this thesis, the FA serum status depends on both dietary 
intake as well as metabolic factors, which is controlled by enzymes encoded by polymorphic genes 
(Simopoulos, 2010).  
Previous research showed that variants in the genes of delta-5 and delta-6 desaturase (FADS1 and 
FADS2 gene) were associated with lower AA and higher LA levels (Schaeffer et al, 2006; 
Simopoulos, 2010). Furthermore, in our adolescent population, we demonstrated that a common 
variant in the promoter region of the LIPC gene, encoding hepatic lipase, influenced the stearic acid 
and AA serum levels (Chapter III.6). These findings suggest that certain individuals may require 
different amounts of individual FA for both normal development as for the prevention and 
management of chronic diseases (Simopoulos, 2010). These genetic variants both had a minor allele 
frequency above 20%, indicating that it concerns a considerable part of the population.   
Defining nutrient requirements from DNA sequences in daily practice may seem progressive, 
however, it would allow to tailor more specifically nutrient requirements of groups of individuals 
(Harland, 2005). This will become certainly of importance in an era where nutrition gradually turns 
towards a more tailored approach with functional foods and nutripharmaceutics. However, before 
this will be reality several remaining questions need to be answered. For example, it needs to be 
further examined whether high or even pharmaceutical doses of FA may have adverse effects and 
thus how much, in what form and combination we need to supply these nutrients to obtain maximal 
health benefit with minimal risk (Harland, 2005).  
However, as long as the scientific knowledge and technical possibilities are insufficient to 
recommend individualized nutrient intakes, the current global recommendations should be followed. 
The present PhD thesis indicated that in our study population more than half of the adolescents had 
an inadequate intake of the n-3 PUFA and an intake of SFA exceeding the recommendations. In the 
light of tracking of chronic diseases such as CVD and obesity (Camhi and Katzmarzyk, 2010), as 
well as the long term effects by metabolic programming in early life (Gluckman et al, 2010), it is 
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important to tackle lifestyle related problems in young age such as childhood and adolescence. As 
such, it is important to further stimulate sufficient intake of n-3 PUFA. This can be obtained by the 
consumption of fish, particularly fatty fish, twice per week or by alternatives such as single cell oils 
or genetically modified organisms, which might be more sustainable in an ecological point of view. 
Also, a more frequent consumption of fish or meat alternatives instead of meat could help to 
diminish the excessive intakes of SFA. As can be concluded from the study described in Chapter 
III.1, these interventions should mainly be directed towards younger-aged boys as this group seemed 
to have the least beneficial FA intake pattern.  
Furthermore it is important to encourage global lifestyle advice on dietary habits and physical 
activity in all age groups and both sexes, as these also have been shown to contribute to a more 
beneficial FA serum profile or interact with the genetic variants. For example, it has been shown that 
fiber intake influences to a large extent the lipid metabolism. In this regard the food based dietary 
guidelines remain of high importance on public health level. However, towards the population it 
would be helpful to better tune the lifestyle and nutrient recommendations between different health 
authorities, as differences in current recommendations can be confusing and distrusting.  
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IV.4 FUTURE RESEARCH 
 
Studies assessing the health effects of FA generally focus on FA intake and not on FA status. 
However, the findings in this thesis confirmed that the serum FA status of an individual is not only 
determined by the fatty acid intake but also in a substantial part determined by other factors such as 
genetic background. This variance in genetic background and its interaction with diet could partly 
explain the inconsistencies that are sometimes found in these studies. As such, further research on 
dietary interventions, influencing the daily dietary habits (e.g. the Mediterranean Diet), should 
consider other factors such as genetic variability or should simultaneously assess the effect of the 
intervention on the FA status. Furthermore, supplementation studies are often difficult to compare as 
a wide array in dosage of FA supplements are used, varying from nutritional dosage to 
pharmacological amounts. Also, the background diet is often not considered (Calder, 2008a). 
However, due to the endogenous metabolism of FA this could greatly influence the outcome of the 
FA serum status.  Well established dose-response studies, considering the above mentioned factors, 
would aid to fill these gaps. Moreover, before considering supplementation in the broad population it 
is necessary to investigate whether pharmaceutical doses of FA may have adverse effects and in what 
form and combination we should supply these nutrients to obtain maximal health benefit with 
minimal risk (Harland, 2005).  
Furthermore, as discussed previously, the findings on the interaction of genetic variation in the LIPC 
gene with diet and physical fitness need to be confirmed in other studies in different age groups. 
Moreover, the effect of this interaction should be explored with hard end points, such as diseases 
status, before substantiated recommendations can be made. Also, the combined influence of physical 
activity and diet on the FA serum level should be investigated and the influence of other dietary 
factors apart from FA should be investigated. Indeed, dietary-derived regulators of gene expression 
may be nutritive (e.g. FA, iron or selenium) and non-nutritive (e.g. phytochemicals) components of 
food, metabolites of food components (e.g. eicosanoids, retinoic acid), results from the cooking 
process (e.g. heterocyclic amines in cooked meat) or end products of intestinal bacterial metabolism 
(e.g. SCFA) (Harland, 2005). Moreover, research should be elaborated to other SNPs in the LIPC 
and FADS genes as well as other genes such as ELOVL2, GCKR, genes encoding the 
apolipoproteins, … (see Introduction, Table 4, p 39). The identification of genes of interest should 
be guided by results obtained in GWAS studies (Demirkan et al, 2012; Gieger et al, 2008). In future 
studies, it would also be interesting to further explore the possible pathways by which the observed 
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effects are caused. A helpful aid would be the measurement of enzyme-activity and not only the 
concentration levels of end products, however, such analyses can be costly in large scale studies, 
which are nevertheless necessary to detect differences with sufficient power.  
Another possible pathway by which the effect of FA on health and disease could be influenced is the 
human gut microbiome. The gut bacteria are responsible for the production of short chain fatty acids. 
As described in the introduction, these SCFA are an important energy source for the colonocytes but 
also have anti-inflammatory, anti-oxidant and anti-carcinogenic effects (Leonel and Alvarez-Leite, 
2012; Meijer et al, 2010). As such, it can be assumed that phylogenic differences in the gut 
microbiota can have its effect on the production of SCFA and thus health outcome, however, this 
domain is still largely unexplored.  
It is impossible to give a complete list of future research prospects, however, a final important issue 
that should be raised in the field of FA research is the conformity in the mode of expression of the 
FA profile and the lipid pools that are investigated, as, this would allow better comparison between 
studies and thus a faster gain of knowledge.  
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IV.5 GENERAL CONCLUSION 
 
Based on the findings of this thesis, it can be concluded that the serum PL FA status of an individual 
is in a large extent determined by both dietary intake and genetic predisposition, with both factors 
having probably a more or less equal contribution. It has been demonstrated that the dietary FA 
intake is not only important by its direct effect as source or precursor of certain fatty acids, but that it 
also exerts an important role by the interaction with certain genes. This interplay between diet and 
genes suggests that individuals with a certain genetic background would require different amounts of 
individual FA for having the same biological effect.  
Moreover, it has been shown that other factors such as the global dietary pattern and the physical 
activity of an individual are of importance. As such, in attendance of further insight which would 
allow personalized nutrition in the daily practice, it remains important to focus on the general 
guidelines for a healthy lifestyle, including both dietary habits and physical activity. Furthermore, in 
view of the low intakes of n-3 LCPUFA and the excessive intakes of SFA, which have been detected 
in our adolescent study population, attention should be drawn towards the daily food patterns of this 
specific age group. Consequently, it is important to focus health strategies on the quality of fats and 
not only on the quantity.  
 
 
185 
PART V. SUMMARY 
 
Both quantity and quality of dietary fatty acid (FA) intake have been associated with several non-
communicable diseases in humans, such as cardiovascular disease, cancer, neurologic disorders, 
inflammatory and auto-immune diseases. Pathophysiologic mechanisms underlying these 
associations are currently not completely understood. However, through their function as lipid 
mediator and modulator of gene transcription, FA might interfere in and modulate the disease 
processes. FA intake is one of the determinants of the FA serum status, which ultimately determines 
these effects. Other factors, such as the genetic variants of certain genes, sex, body composition, etc, 
which influence the metabolism of the FA, have been shown to play a role as well.  
 
The general aim of this thesis was to further elaborate the current knowledge on the influence of 
dietary FA intakes and its interaction with polymorphisms in the FADS1 and LIPC gene, on the FA 
serum status in the healthy population. This insight could help us to identify possible mechanisms to 
modulate the FA serum status and as such help to prevent or treat the non-communicable diseases, 
mentioned above. Although most of these diseases usually manifest in adulthood, cardiometabolic 
risk factors may already appear at younger age and may track into adulthood. As such, this thesis 
focused on adolescents and was imbedded in the „Healthy Lifestyle in Europe by Nutrition in 
Adolescence Cross-Sectional Study‟ (HELENA-CSS), which had as main objective to obtain reliable 
and comparable data on nutrition- and health-related parameters in a sample of 3528 European 
adolescents (aged 12.5-17.5 years).  
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In a first study, the usual FA intake and its main food sources were described in this adolescent 
population and the variation in intake as a function of non-dietary factors, such as sex, age, body 
composition, sexual maturation, socio-economic status and physical activity was explored. 
Compared to the recommendations of the Food and Agriculture Organization, almost all adolescents 
had an excessive intake of saturated fatty acids (SFA) (99.8%) and an inadequate intake of n-3 FA 
(>50%). In general, girls had a more beneficial FA intake pattern; however, the differences between 
sexes disappeared in the older aged adolescents (15-17.5 years) except for the poly-unsaturated fatty 
acid (PUFA) intake, which continued to be higher in the older adolescent female population. 
Furthermore, chronological age was a stronger determinant of FA intake than sexual maturation and 
no differences in fat intake were observed as a function of maternal education level or body 
composition, measured as BMI z-score or body fat percentage. In the male population, fat and fatty 
acid intake was inversely related to their level of physical activity. The main contributors to total fat, 
SFA, mono-unsaturated fatty acids (MUFA) and PUFA intake were meat, dairy products and 
cakes/pies/biscuits. Generally, meat was a slightly higher contributor in boys whilst cakes, pies and 
biscuits as well as nuts and seeds seemed to be of higher importance in girls. Another study indicated 
that, although adolescents with a better overall dietary quality had higher levels of total fat intake and 
SFA than their counterparts with a less beneficial dietary pattern, they derived their fat intake from 
more recommended food sources. In particular a higher consumption of dairy products and lower 
consumption of snacks and sauces was observed in adolescents with a Diet Quality Index for 
Adolescents (DQI-A) score in the upper quartile.  
 
In a second study, the influence of specific food intake on the serum phospholipid (PL) FA 
concentration was investigated by exploring the correlations and the amount of variance that was 
explained by these nutritional factors. It was demonstrated that the percentage of variation in PL FA 
serum levels due to dietary intake varied from 14.2% for n-3 FA to 7.0% for total MUFA. For 
arachidonic acid (AA) and linoleic acid (LA) this was respectively 10.8% and 10.7%. This indicated 
that dietary intake is indeed a factor of considerable importance on the FA serum status but that other 
determinants also interfere such as the homeostatic control mechanisms and a wide array of genetic, 
environmental and life-style factors.  
 
In a final study the influence of genetic predisposition on the PL FA serum status was explored. In 
the HELENA study population it was demonstrated that genetic variability in the rs174546 single 
nucleotide polymorphism (SNP) of the FADS1 gene, encoding for the Δ5-desaturase, was associated 
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with higher serum PL concentrations of LA and α-linolenic acid (ALA) and lower levels of AA and 
eicosapentaenoic acid (EPA). In the LIPC gene, the minor allele of the rs1800588, resulting in a 
lower activity of hepatic lipase, was associated with higher levels of stearic acid. Furthermore, an 
interaction effect between the rs1800588 SNP and dietary LA intake as well as between this SNP and 
estimated VO2max on the serum PL AA levels was demonstrated.  
 
Overall, these findings indicated that the dietary FA intake influences the FA serum status by its 
direct effect as source or precursor of certain FA, but that it also exerts an important role by the 
interaction with certain genes. This interplay between diet and genes demonstrated that individuals 
with a certain genetic background would require different amounts of individual FA to achieve the 
same biological effect and thus might benefit from so called “personalized nutrition”. Moreover, it 
can be concluded that other factors such as the global dietary pattern and the physical activity of an 
individual are of importance and that it remains essential to further encourage compliance to these 
general public health guidelines. More specifically, attention should be drawn to higher intakes of n-
3 LCPUFA and lower intakes of SFA in adolescent age.  
 
Nevertheless, these findings were subject to some limitations, such as the lack of accuracy of the 
estimated FA intake, the variation in international recommendations, not being able to correct for 
alcohol intake and smoking habits, the limited comparability to other studies assessing lipid pools 
other than phospholipids and the limited number of genetic variants that have been analysed. As 
such, future studies should be extended to the investigation of other polymorphisms in the LIPC and 
FADS genes as well as to other genes; and the gene-environment effect on hard endpoints, such as 
the development of the above mentioned diseases, should be assessed. Moreover, in dietary 
intervention and supplementation studies, genetic variability should be considered. Also, in 
supplementation studies it should be examined whether pharmaceutical doses of FA may have 
adverse effects. Ultimately, based on such results we might be able to deduce in what form and 
combination, as supplement or via the diet, we need to supply these nutrients to obtain maximal 
health benefit with minimal risk.  
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PART VI. SAMENVATTING 
 
Zowel de kwantiteit als de kwaliteit van de inname van vetzuren (VZ) werd geassocieerd met het 
vóórkomen en/of voorkómen van verschillende niet-overdraagbare aandoeningen zoals hart- en 
vaataandoeningen, kanker, neurologische aandoeningen, inflammatoire en auto-immuun ziekten. De 
mechanismen waarlangs de VZ de ziekteprocessen beïnvloeden zijn op heden nog onvolledig 
gekend, doch, mogelijks verloopt dit via hun functie als signaalmolecule of modulator van de 
gentranscriptie. Echter, de VZ serumconcentratie, die uiteindelijk bepalend is voor deze effecten, 
hangt niet enkel af van de VZ inname. Er werd aangetoond dat ook andere factoren, die het endogene 
metabolisme van de VZ beïnvloeden, een rol spelen zoals ondermeer de genetische variatie, het 
geslacht en de lichaamssamenstelling.  
 
De algemene doelstelling van dit proefschrift was het verruimen van de huidige kennis betreffende 
de invloed van de vetzuurinname op de VZ serumconcentratie van een individu en zijn interactie-
effect met polymorfismen in het FADS1 en LIPC gen. Dergelijk inzicht kan leiden tot de identificatie 
van mogelijke aangrijpingspunten waardoor de VZ serumstatus kan worden gemoduleerd en aldus 
bepaalde aandoeningen kunnen worden voorkomen of behandeld. Hoewel de meeste van deze 
aandoeningen pas tot uiting komen op volwassen leeftijd werd er vastgesteld dat metabole 
risicofactoren reeds op jonge leeftijd kunnen aanwezig zijn en dat deze verder blijven bestaan tot op 
volwassen leeftijd. Bijgevolg werd in dit proefschrift de focus gelegd op adolescenten. Het 
proefschrift was ingebed in de “Healthy Lifestyle in Europe by Nutrition in Adolescence Cross-
Sectional Study” (HELENA-CSS), waarvan de hoofddoelstelling was om betrouwbare en 
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vergelijkbare gegevens over voedings- en gezondheidsgerelateerde parameters te verzamelen in een 
steekproef van 3528 Europese adolescenten van 12,5-17,5 jaar oud.  
 
In een eerste studie werden de gebruikelijke VZ inname en hun voornaamste voedingsbronnen 
beschreven bij deze groep van adolescenten. Tevens werd onderzocht in hoeverre de vetzuurinname 
functie is van niet-voedingsgerelateerde factoren zoals geslacht, leeftijd, lichaamssamenstelling, 
seksuele maturatie, socio-economische status en fysieke activiteit. In vergelijking met de 
aanbevelingen van de “Voedsel- en landbouworganisatie” hadden vrijwel alle adolescenten een 
excessieve inname van verzadigde vetzuren of “saturated fatty acids” (SFA) (99,8%) en een 
inadequate inname van n-3 VZ (>50%). Algemeen beschouwd hadden meisjes een VZ inname 
patroon dat beter met de aanbevelingen strookte, echter, de verschillen tussen jongens en meisjes 
verdwenen grotendeels bij de oudste groep onderzochte adolescenten. Uitzondering was  de inname 
van meervoudig onverzadigde vetzuren of “poly-unsaturated fatty  acids” (PUFA), waarvan de 
inname hoger bleef bij de meisjes. Verder bleek de chronologische leeftijd een sterkere bepalende 
factor te zijn van de VZ inname dan de seksuele maturiteit. De inname van vetten was niet 
verschillend in functie van het opleidingsniveau van de moeder of van de lichaamssamenstelling, 
gemeten als BMI z-score en lichaamsvetpercentage. Wel was bij de jongens de inname van vetten en 
VZ omgekeerd gerelateerd met de hoeveelheid fysieke activiteit die zij uitoefenden.  
 
De voornaamste bronnen van totale vetinname, de SFA, de enkelvoudig onverzadigde VZ of “mono-
unsaturated fatty acids” (MUFA) en de PUFA waren vlees, zuivelproducten, en zoete 
voedingswaren. Doorgaans was de bijdrage van vlees iets hoger bij jongens terwijl bij meisjes zoete 
voedingswaren en noten/zaden belangrijker bleken. Daarnaast toonde een andere studie aan dat 
adolescenten met een kwalitatief beter voedingspatroon een hogere totale inname van vetten en SFA 
hadden dan adolescenten met een ongezonder voedingspatroon, doch dat deze eersten hun vetten 
haalden uit meer aanbevolen voedselbronnen, met name, een hoger aandeel uit zuivelproducten en 
een lager aandeel uit snacks en sauzen.  
 
In een tweede studie werd de invloed nagegaan van de inname van specifieke voedingsmiddelen op 
de VZ in de serum fosfolipide fractie. Er werd onderzocht hoe sterk de correlatie was tussen inname 
en aandeel in de fosfolipide fractie, en hoeveel van de variatie in vetzuurstatus verklaard kon worden 
door de verschillen in inname. Uit de resultaten van deze studie bleek dat de variatie in de VZ 
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samenstelling in de serum fosfolipide fractie, te verklaren door inname met de voeding, tussen de 
14,2% (voor de n-3 VZ) en 7,0% (voor de MUFA) bedroeg. Voor arachidonzuur en linolzuur was dit 
respectievelijk 10,8% en 10,7%. Dit wijst erop dat de voedingsinname inderdaad een van de 
bepalende factoren is voor de VZ serumstatus, doch dat ook andere determinanten interfereren zoals 
de homeostatische controle mechanismen en een brede waaier aan genetische, levensstijlgerelateerde 
en omgevingsfactoren.  
 
In een laatste studie werd tenslotte de invloed onderzocht van de genetische voorgeschiktheid op de 
VZ serum status. In de HELENA studiepopulatie werd aangetoond dat de genetische variatie in het 
rs174546 polymorfisme van het FADS1 gen, dat codeert voor het Δ5-desaturase enzym, geassocieerd 
was met hogere serum fosfolipiden concentraties van linolzuur en α-linoleenzuur alsook met lagere 
concentraties van arachidonzuur en eicosapentaoeenzuur. Tevens werd gevonden dat in het LIPC 
gen, het minor allel van rs1800588, dat resulteert in een lagere activiteit van hepatisch lipase, 
geassocieerd was met een hogere concentratie van stearinezuur. Tot slot werd een interactie-effect 
geobserveerd tussen het rs1800588 polymorfisme en de inname van linolzuur alsook tussen het 
polymorfisme en de geschatte VO2max op de concentratie van arachidonzuur in de serum fosfolipide 
fractie.  
 
Algemeen geven deze resultaten aan dat de inname van VZ via de voeding de VZ serum status 
beïnvloedt, zowel via een direct effect als bron of voorloper van bepaalde VZ, als via een indirect 
effect via de interactie met bepaalde genen. Dit samenspel tussen voeding en genetische achtergrond 
wijst er op dat individuen met een bepaalde genetische achtergrond mogelijks een verschillende 
inname van bepaalde VZ behoeven om een zelfde biologische effect te verkrijgen en dat deze 
personen dus baat zouden kunnen hebben bij zogenaamde “gepersonaliseerde voeding”. 
Daarenboven kan er besloten worden dat ook andere factoren zoals het globale voedingspatroon (niet 
alleen de vetzuurinname) en de mate van fysieke activiteit van belang zijn en dat het dus essentieel 
blijft om verder de huidige algemene gezondheidsadviezen aan te bevelen bij het brede publiek. In 
het bijzonder dient bij de adolescenten de aandacht gevestigd te worden op een hogere inname van 
de n-3 VZ en een lagere inname van VVZ.  
 
Ten slotte blijft het van belang om te wijzen op de beperkingen van het onderzoek dat tot 
bovenstaande conclusies heeft geleid, zoals de beperkte accuraatheid van de geschatte VZ inname, de 
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variatie in internationale nutriënten aanbevelingen, de onmogelijkheid om te corrigeren voor alcohol 
inname en rookgewoonten, de beperkte vergelijkbaarheid met andere studies die andere vetfracties 
dan de phospholipiden bestudeerden alsook het beperkt aantal genetische polymorfismen die 
geanalyseerd werden. Bijgevolg kan voorgesteld worden om in volgende studies bijkomende 
polymorfismen te bestuderen in het FADS en LIPC gen, alsook polymorfismen in andere genen. 
Tevens dienen de interactie-effecten tussen omgeving en genetische achtergrond te worden 
bestudeerd op harde eindpunten, zoals de ontwikkeling van hoger genoemde, niet-overdraagbare, 
aandoeningen. Daarnaast is het van belang om in voedingsinterventie en supplementatie studies, de 
genetische variabiliteit mee in rekening te brengen. Ook is het belangrijk om in supplementatie 
studies te evalueren of farmaceutische dosissen van VZ nadelige effecten kunnen hebben. Op basis 
van dergelijke resultaten zal men tot slot kunnen bepalen in welke toedieningsvorm en combinatie, 
als supplement of via de dagelijkse voeding, deze nutriënten moeten aangeboden worden om een 
maximaal gezondheidseffect te bekomen met een minimum aan risico.  
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Appendix 1: Overview of the fatty acid serum concentration in the complete HELENA study population, expressed in different units.  
 
N Mean SD Median P5 P95 
 
      
SFA(µmol/L) 1019 2253.68 322.38 2226.43 1799.84 2788.29 
Lauric Acid C12:0 (µmol/L) 1019 1.71 1.62 1.29 0.61 4.34 
Myristic Acid C14:0 (µmol/L) 1019 17.90 7.64 16.51 9.48 30.20 
Palmitic Acid C16:0 (µmol/L) 1019 1180.51 208.61 1158.74 888.91 1534.52 
Stearic Acid C18:0 (µmol/L) 1019 509.08 98.77 500.49 367.26 670.96 
MUFA (µmol/L) 1019 369.35 93.13 357.90 249.24 515.61 
Oleic Acid C18:1n9 (µmol/L) 1019 259.00 74.14 249.18 169.63 371.95 
PUFA (µmol/L) 1019 1469.17 275.46 1443.64 1087.95 1906.78 
Ʃn-6 (µmol/L) 1019 1342.90 255.47 1317.19 986.57 1770.42 
LA C18:2n6 (µmol/L) 1019 849.78 177.08 829.93 595.36 1148.94 
AA C20:4n6 (µmol/L) 1019 353.38 93.14 348.75 229.01 515.39 
Ʃn-3 (µmol/L) 1019 126.27 50.50 117.41 65.87 216.95 
ALA C18:3n3 (µmol/L) 1019 5.48 3.43 4.67 1.93 11.83 
EPA C20:5n3 (µmol/L) 1019 18.32 13.30 15.42 5.00 43.18 
DHA C22:6n3 (µmol/L) 1019 102.47 40.13 95.57 53.47 176.47 
       SFA (%area) 1021 45.36 1.48 45.29 43.22 47.56 
Lauric Acid C12:0 (%area) 1021 0.03 0.03 0.02 0.01 0.07 
Myristic Acid C14:0 (%area) 1021 0.35 0.12 0.34 0.21 0.55 
Palmitic Acid C16:0 (%area) 1021 27.45 1.49 27.46 25.23 29.82 
Stearic Acid C18:0 (%area) 1021 13.11 1.05 13.12 11.45 14.78 
MUFA (%area) 1021 14.79 2.08 14.69 11.82 17.91 
Oleic Acid C18:1n9 (%E) 1021 9.96 1.82 9.90 7.52 12.59 
PUFA (%area) 1021 39.85 1.96 39.82 36.81 43.00 
Ʃn-6 (%area) 1021 35.46 2.38 35.45 31.59 39.35 
LA C18:2n6 (%area) 1021 22.08 2.58 22.01 17.94 26.42 
AA C20:4n6 (%area) 1021 9.60 1.88 9.58 7.10 12.48 
Ʃn-3 (%area) 1021 4.28 1.31 4.05 2.69 6.71 
ALA C18:3n3 (%area) 1021 0.14 0.07 0.12 0.06 0.29 
EPA C20:5n3 (%area) 1021 0.49 0.33 0.42 0.14 1.05 
DPA C22:5n3 (%area) 1021 0.67 0.19 0.64 0.42 1.05 
DHA C22:6n3 (%area) 1021 2.93 0.96 2.81 1.78 4.63 
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Appendix 1 - continued 
      
 
N Mean SD Median P5 P95 
 
      
SFA (%conc) 1019 50.26 1.50 50.27 47.95 52.58 
Lauric Acid C12:0 (%conc) 1019 0.05 0.04 0.04 0.02 0.12 
Myristic Acid C14:0 (%conc) 1019 32.01 1.61 32.00 29.53 34.54 
Palmitic Acid C16:0 (%conc) 1019 0.48 0.16 0.46 0.28 0.75 
Stearic Acid C18:0 (%conc) 1019 13.78 1.08 13.79 12.12 15.48 
MUFA (%conc) 1019 9.98 1.52 9.88 7.80 12.22 
Oleic Acid C18:1n9 (%conc) 1019 6.99 1.31 6.94 5.24 8.94 
PUFA (%conc) 1019 39.75 1.94 39.74 36.65 42.99 
Ʃn-6 (%conc) 1019 36.30 2.33 36.26 32.62 40.14 
LA C18:2n6 (%conc) 1019 23.03 2.62 22.97 18.79 27.50 
AA C20:4n6 (%conc) 1019 9.56 1.88 9.54 7.02 12.42 
Ʃn-3 (%conc) 1019 3.40 1.15 3.19 2.00 5.50 
ALA C18:3n3 (%conc) 1019 0.15 0.08 0.13 0.06 0.31 
EPA C20:5n3 (%conc) 1019 0.49 0.33 0.42 0.14 1.07 
DHA C22:6n3 (%conc) 1019 2.76 0.92 2.61 1.64 4.31 
SD Standard Deviation; P5 5th percentile; P95 95th precentile; SFA Saturated fatty acid; MUFA mono-
unsaturated fatty acid; PUFA Poly-unsaturated fatty acid; LA linoleic acid; AA Arachidonic acid; ALA alfa-
linolenic acid; EPA eicosapentaenoic acid; DHA docosahexaenoic acid 
  
  
  
 
  
DANKWOORD 
 
223 
DANKWOORD 
The world is round and the place which may seem like the end may also be only the beginning. 
(Ivy Barker Priest) 
 
Het dankwoord, een aantal welgemeende en oprechte beschouwingen die op geen enkel referentie en 
op geen enkel hard bewijs gebaseerd zijn en precies daarom met zekerheid authentiek zijn. Het is 
echter onmogelijk om alle mensen op te sommen die ik dankbaar ben omdat ze op de een of andere 
manier bijgedragen hebben tot de mogelijkheid om dit proefschrift neer te leggen. Gaande van mijn 
familie en vrienden over mijn leerkrachten en professoren tot de participerende adolescenten, wil ik 
jullie dan ook allen hiervoor bedanken zonder een rangorde toe te kennen.  
In het bijzonder toch enkele woorden van dank voor mijn promotoren en begeleidster die mij door dit 
hele proces geleid hebben, Prof. dr. Stefaan De Henauw, Prof. dr. Myriam Van Winckel en dr. Inge 
Huybrechts. Stefaan, bedankt voor alle kansen die je me geboden hebt door te kunnen participeren 
aan grootschalig Europees onderzoek, gebruik te maken van bestaande databanken en om me de 
ruimte en mogelijkheden te bieden om mezelf verder te ontplooien op diverse vlakken. Myriam, 
bedankt om erop toe te zien dat het evenwicht tussen doctoraat en kliniek toch steeds bewaard bleef. 
Bedankt ook voor het vertrouwen dat je me steeds schonk en voor de bemoedigende woorden als de 
twijfel al eens toesloeg. Inge, jij hebt me bijgestaan tijdens de eerste stappen van het 
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collega‟s van de vakgroep Maatschappelijke Gezondheidkunde willen bedanken die in deze 
afgelopen tijd mijn pad hebben gekruist. In het bijzonder een dank u aan Kristien Debrock om het 
reilen en zeilen van de dienst op de juiste koers te houden en voor de bijstand bij de talrijke 
administratieve zaken. Ook een hartelijke dank aan Christine Ghysbrecht voor de hulp bij de 
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en Charlene bedankt om ons in te leiden en bij te staan in het veldwerk. Inge, Isabelle en Mandy 
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bureaugenoten en nieuwe collega‟s Karen, Annelies, Yasmina, Stephie – allen nog veel succes in 
jullie verdere traject op de dienst! Tine, ook jij nog veel succes in het afwerken van je doctoraat, ik 
kijk al uit naar jouw verdediging! Of course also a very big “thank you” to all the members of the 
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ik natuurlijk ook de financierende organisaties bedanken, met name het Fonds voor 
Wetenschappelijk Onderzoek (FWO) voor het toekennen van een aspirantenmandaat, en de Europese 
Commissie voor de financiering van de HELENA Studie binnen het zesde kaderprogramma.  
Naast mijn onderzoekswerk heb ik ook het geluk gehad om mijn klinische vaardigheden en kennis te 
kunnen uitbreiden. Bedankt aan de kindergastro-enterologen Myriam, Stephanie, Saskia en Ruth om 
mij in te wijden in de kindergastro-enterologie, bedankt voor de tijd die jullie tijdens consultaties en 
stafvergaderingen in opleidingen staken en om mij op te nemen in jullie groep gedurende deze 4 jaar. 
Tevens mijn dank aan Stephanie Boterdaele en Marleen Janssens voor de fantastische 
administratieve ondersteuning!  
Naast de collega‟s wil ik uiteraard ook mijn vrienden bedanken. In het bijzonder, Sofie, Sophie, 
Veerle, Veerle, Hannah en uiteraard alle wederhelften, bedankt voor de ontspannen momenten en de 
hechte vriendschap, of we elkaar nu regelmatig zien of niet, het maakt niet uit, we weten dat we 
steeds bij elkaar terecht kunnen in goede of slechte tijden maar laat die goede tijden maar primeren! 
Ook nog mijn oprechte dank aan mijn mentor tijdens mijn studietraject aan de universiteit, Dr. Jo 
Ossieur. Onze paden zijn de laatste tijd wat uiteen gelopen maar zonder jou zou er bij mij van de 
studies geneeskunde wellicht nooit sprake geweest zijn. Bedankt voor de vele leuke en leerzame 
momenten.  
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Net als bij onderzoek, graaf je in een dankwoord langzaam maar zeker dieper en kom je zo dichter 
bij de essentie van de zaak. Pépé, het verlies van vele dierbaren is niet gemakkelijk maar jouw 
verhalen houden onze herinneringen aan de mémés en pépé levendig. Mama en papa, bedankt voor 
alle geboden kansen, voor de vrijheid om de wereld te ontdekken, voor de vele lessen en wijsheden 
die jullie mij meegegeven hebben en om mij te ondersteunen tijdens al mijn bezigheden. Het geeft 
een enorme geborgenheid te weten dat jullie steeds voor ons allemaal klaar staan, zowel voor broer 
en mij als voor Dieter en Joke, die jullie evenzeer tot jullie eigen kinderen rekenen. Dan spreek ik 
nog niet over de kleinkinderen. Mama (oma), dankzij jou moeten wij ons nooit zorgen maken over 
opvang of wat dan ook. De thuis en de liefde die jij aan Joachim schenkt verzachten de 
schuldgevoelens die bij mij al eens zouden durven opkomen als ik wat doorwerk en minder tijd heb 
voor hem. Alle voorgaande uitingen van dank in dit hoofdstuk volstaan niet om mijn dankbaarheid 
hiervoor weer te geven, ik weet niet wat ik zonder jullie zou aanvangen! 
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uitgebreide en gedetailleerde raad en tevens daad. We hebben al vele mooie momenten samen mogen 
beleven en bij jou, Joke en Noah is het altijd gezelligheid troef! En natuurlijk mogen ook tante 
Carole en nonkel Hendrik, op wie we steeds kunnen rekenen, niet aan mijn lijstje ontbreken. Ook aan 
mijn schoonouders dank voor de warmte en de gastvrijheid om ons gezinnetje steeds de mogelijkheid 
te bieden er een weekendje tussenuit te knijpen.  
Mijn laatste dankwoorden zijn voor mijn gezinnetje. Vooreerst mijn rots in de branding, Dieter, mijn 
schat, bij jou kan ik steeds tot rust komen, jij schenkt me het vertrouwen dat ik nodig heb om verder 
te gaan en bent mijn leider op onbekende wegen. We hebben samen een fantastische zoon en zijn in 
blijde verwachting van een tweede kapoentje. Joachim, bedankt voor je mooie lach, je enthousiasme 
en je opgewektheid reeds ‟s morgens vroeg (soms té vroeg), wij zijn zeker dat je een supergoede 
grote broer zal zijn! Lieverds, jullie zijn het meest dierbare in mijn leven! 
Nogmaals hartelijk dank aan iedereen! 
Krishna
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